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Abstract 
 
Phenotypic and transcriptomic consequences of ribosomal DNA copy 
number variation in Caenorhabditis elegans and Saccharomyces 
cerevisiae 
André Zylstra 
 
Ribosomal DNA (rDNA) forms the template for mature ribosomal RNA (rRNA) and shows 
considerable sequence conservation through evolution.  In eukaryotic genomes rDNA is 
present in one or more tandem repeat arrays, with copy number variation (CNV) 
commonly observed in inter- and intra-species comparisons. rDNA CNV has been 
primarily studied in the budding yeast Saccharomyces cerevisiae, where an 
environmentally sensitive copy number amplification mechanism corrects for repeat loss 
from this inherently unstable locus. Furthermore, there is much evidence implicating rDNA 
instability and production of extrachromosomal rDNA circles (ERCs) as causative processes 
in yeast replicative ageing. By contrast, the functional consequences of rDNA CNV have 
been largely understudied in metazoans and as such rDNA CNV represents a source of 
poorly understood genomic variation. I undertook this project to investigate possible 
functional and transcriptomic consequences of rDNA CNV in an animal model, the 
nematode Caenorhabditis elegans. Additionally, I produced and analysed RNA-seq 
datasets studying the transcriptomic effects of rDNA CNV, either due to genomic CNV or 
ERC accumulation, in S. cerevisiae. 
After developing methods for assaying rDNA copy number in C. elegans by pulsed field 
gel electrophoresis (PFGE) and quantitative PCR, I determined that there was notable 
variation between and within laboratory strains. Using a genetic crossing strategy, I 
derived strains believed to be essentially isogenic with either wild type (WT) or 
approximately 2.5-fold amplified rDNA. A variety of phenotypic assays found generally 
small effect sizes for differences unambiguously attributed to rDNA CNV. Some 
experiments were, however, confounded by unexpected developmental differences and 
3 
 
strain pathology, likely the consequence of unidentified background genetic variation. 
Transcriptomic analyses were consistent with these observations and revealed some genes 
differentially expressed between samples with different rDNA CN at either young or aged 
timepoints. 
Comparison of log-phase yeast samples with divergent rDNA CN similarly revealed few 
differentially expressed genes, although gene ontology enrichment analysis suggested 
effects on specific processes such as ribosome biogenesis. I also generated and analysed 
an ageing RNA-seq dataset which demonstrated that rDNA CNV in the form of ERC 
accumulation has significant effects on the ageing transcriptome. ERC accumulation 
influences the expression of hundreds of genes with strong enrichment for several 
previously identified age-related processes. Finally, using Northern blotting, I identified a 
common set of changes in rRNA processing intermediates, reminiscent of stress-related 
effects, which occur with ageing in variety of genetic backgrounds. 
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1 Introduction 
1.1 The rDNA locus has widespread effects on organismal 
physiology 
Ribosomal DNA (rDNA) loci are those serving as the vital templates for ribosomal RNA 
(rRNA) transcription. In addition to the deep evolutionary conservation of rRNA gene 
sequences across phylogenetic domains, a conserved feature of eukaryotic rDNA is its 
organisation into tandem repeat arrays (Melnikov et al. 2012). Repetitive regions are 
inherently prone to copy number (CN) instability due to the tendency towards intra-
chromosome homologous recombination (HR) or unequal sister chromatid exchange 
(USCE); as a result, rDNA CN is widely variable between and within eukaryotic species – 
likely even between different human tissues within individuals (Prokopowich et al. 2003; 
Hallgren et al. 2014). Therefore rDNA copy number variation (CNV) represents an often 
overlooked class of genomic variation which, much like the invisible cosmic dark matter to 
which it has been compared, may exert noticeable effects on its more familiar 
surroundings (McStay 2016). rDNA CNV is implicated in influencing the expression of 
potentially thousands of protein coding genes, affecting susceptibility to physical and 
mental pathology, is a common feature in the early stages of cancer progression, and may 
play a role in determining human lifespan (Gibbons et al. 2014; Wang and Lemos 2017; Xu 
et al. 2017; Chestkov et al. 2018; Malinovskaya et al. 2018; Valori et al. 2019). Furthermore 
rDNA CN is dynamic and under endogenous control in model systems (Ritossa 1968b; 
Kobayashi and Ganley 2005; Lu et al. 2018; Iida and Kobayashi 2019). Indeed, it appears 
central nutrient sensing pathways can drive intergenerational change in rDNA CN, which 
has the potential to act as a mechanism for rapid environmentally-sensitive genomic 
adaptation (Aldrich and Maggert 2015; Jack et al. 2015). 
Nonetheless, understanding of how rDNA CNV might affect other aspects of cellular and 
organismal physiology is currently limited. Eukaryotic rDNA CNV mechanisms are best 
studied in the budding yeast Saccharomyces cerevisiae (herein generally referred to as 
yeast). However, a detailed outline of how rDNA CNV influences gene expression has only 
very recently been mapped out for a single gene, that encoding the histone deacetylase 
(HDAC) Sir2 (Michel et al. 2005; Iida and Kobayashi 2019). Critically low numbers of rDNA 
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repeats are pathological, even lethal, if they cannot support the exacting demands for 
ribosomal RNA (rRNA) (Ritossa et al. 1966; Delany et al. 1994, 1995), but how CNV above 
that threshold exerts effects on processes beyond ribosome synthesis is much less clear. 
Plausible candidates include contacts between rDNA and other loci in 3D nuclear 
architecture or effects on global heterochromatin levels (Paredes and Maggert 2009; Yu 
and Lemos 2016). Despite the apparent relevance to key human health concerns, basic 
principles of rDNA CNV-dependent biology are very poorly characterised in animals. In 
this regard Drosophila is probably the best studied model, with the rRNA deficits (and 
accompanying phenotypic effects) at very low rDNA CNs and the global heterochromatin 
and nuclear architecture changes with milder CN contractions identified in that system 
(Ritossa et al. 1966; Paredes and Maggert 2009; Yu and Lemos 2016). However, we still 
lack a wide-ranging survey of potential phenotypic effects of rDNA CNV as well as clear 
mechanistic detail on how these might be mediated. This represents a significant gap in 
our understanding of the phenomenon of rDNA CNV in animals. Thus, I undertook this 
PhD to study the phenotypic and transcriptomic consequences of rDNA CNV using yeast 
and Caenorhabditis elegans as a new animal model for rDNA biology. 
1.2 rDNA loci in eukaryotes 
Genes for the 18S, 5.8S and 25S rRNA homologs are universally present within rDNA 
repeats in a head-to-tail pattern, separated by short spacers, and are transcribed by RNA 
polymerase I (Pol I) into a single pre-rRNA. This is the 35S transcript in budding yeast and 
the 45S transcript in mammals. Repeats containing this 35S rDNA unit, also often 
organised head-to-tail, are typically physically separated in genomes from repeat arrays 
containing the 5S rRNA gene, which is transcribed by RNA polymerase III (Pol III) 
(Sochorová et al. 2018). However this is not always the case; S. cerevisiae and other diverse 
species have 5S genes integrated with 35S genes into a single repeating unit, although 
transcription by separate polymerases is maintained (Bergeron and Drouin 2008). 35S/45S 
rDNA (generally referred to herein simply as rDNA) repeat units vary considerably in size 
between eukaryotes, primarily due to different intergenic spacer (IGS) lengths: yeast rDNA 
repeats are ~9.1 kb while repeat units in humans and mice are 43 kb and 45 kb 
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respectively (Gonzalez and Sylvester 1995; Grozdanov et al. 2003). A schematic illustration 
of rDNA repeat structure in yeast is shown in Figure 1.1. 
Yeast has a single rDNA array, comprising the majority of chromosome XII, with total copy 
number ~150 – 200. Humans have five loci on the short arms of the five acrocentric 
chromosomes 13, 14, 15, 21, and 22 with total copy number varying between about 200 – 
700 (Henderson et al. 1973; Chestkov et al. 2018; Malinovskaya et al. 2018). Human 5S 
rDNA is present separately in tandem arrays on chromosome 1 with variable, ~1.6 – 2.3 
kb, repeat sizes (Sørensen and Frederiksen 1991). In addition to rRNA genes, rDNA repeats 
house a number of non-rRNA functional elements, such as replication origins, replication 
fork barriers (RFB) and in some cases mRNAs – for example, the yeast TAR1 transcript, 
anti-sense to a portion of the 25S gene, codes for a mitochondrial protein (Coelho et al. 
2002). The IGS regions also have several sequences transcribed by RNA Polymerase II (Pol 
II), some of which appear to function in controlling rDNA repeat CN (Kobayashi and 
Ganley 2005). With the atypical co-localisation of the 35S and 5S repeats in S. cerevisiae, 
this Pol II transcription, or possibly Pol II stalling, also appears to help enforce separate 
Figure 1.1 Schematic illustration of one S. cerevisiae rDNA repeat 
RNA Polymerase I (Pol I) transcribes the 35S pre-rRNA (dotted arrow) from the promoter in 
External Transcribed Spacer 1 (ETS1) to the terminator site in ETS2. The mature 18S, 5.8S, and 
25S rRNAs are processed from this single transcript by removal of ETS and Internal 
Transcribed Spacer (ITS) regions. RNA Polymerase III (Pol III) transcribes the 5S locus from the 
opposite strand. TAR1 is an RNA Polymerase II (Pol II) gene transcribed anti-sense to part of 
the 25S rRNA gene. The ARS (Autonomously Replicating Sequence) in Intergenic Spacer 2 
(IGS2) of each repeat is a weak replication origin, a subset of which fire during S-phase. E-pro 
is a bi-directional Pol II promoter. The Replication Fork Barrier (RFB) when bound by Fob1 
acts to permit replication fork progression only in the same direction as Pol I transcription. 
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transcriptional domains for Pol I and Pol III thereby avoiding interference during the 
production of the two primary rRNA transcripts for ribosome biogenesis (Mayan and 
Aragón 2010; Freire-Picos et al. 2013). 
1.3 rDNA transcription and ribosome biogenesis 
Ribosome biogenesis (RiBi), the production of ribosome translation units involving ~200 
protein and RNA assembly factors, is the central function of the rDNA and the nucleolus, 
the nuclear compartment where it is located. I focus description here mainly on the yeast 
literature as RiBi is best understood in that system and the specific details are more 
relevant to the work described in later chapters. rRNA synthesis, the initial step in RiBi, is 
an intensely energetically demanding process and production of rRNA represents ~60% 
active transcription in exponentially growing cells (Warner 1999; Woolford  Jr and Baserga 
2013). Owing to this transcriptional frenzy, 80% of total cellular RNA may be rRNA – 
resulting in the requirement for routine rRNA depletion procedures in the current age of 
high throughput RNA sequencing (RNA-seq). At wild-type (WT) rDNA CNs, not all repeats 
are simultaneously transcriptionally active (Conconi et al. 1989; Dammann et al. 1993); 
indeed, in WT cells only around 50% of repeats are active at any one time, though this 
proportion can be pushed towards 100% if rDNA CN is sufficiently limiting (Haaf et al. 
1991; French et al. 2003). Inactive repeats exhibit a silenced chromatin state while active 
repeats show a unique open chromatin structure. Whether this is completely nucleosome 
depleted, or instead features dynamic nucleosome positioning, is controversial. However it 
is clear that the active chromatin structure is facilitated by the high-mobility group DNA 
binding protein Hmo1 (Dammann et al. 1993; Jones et al. 2007; Merz et al. 2008; 
Murugesapillai et al. 2014). Interestingly, individual repeats are not constitutively active 
under WT CN conditions, but rather cycle back and forth, spending ~5 min ON, allowing a 
burst of around 190 35S primary transcripts to be produced, before cycling OFF 
temporarily (Tan and Van Oudenaarden 2010). This rotation of active duty may be 
important in the maintenance of rDNA repeat integrity; strains with critically low rDNA CN, 
and hence enforced constant high levels of transcription, are impaired for rDNA double 
strand break (DSB) repair and hypersensitive to genotoxic stress (Ide et al. 2010). 
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Mammals have a more complex system of epigenetic regulation of active repeat number 
as they are able to adjust their effective rDNA CN by silencing repeats via DNA 
methylation (reviewed in McStay and Grummt 2008; Bierhoff et al. 2014). This epigenetic 
mark can be applied directly to cytosine residues immediately 5` of a guanine residue 
(CpG sites). The chromatin environment of inactive copies is instituted by NoRC (nucleolar 
remodelling complex), which recruits a variety of histone modifiers and DNA 
methyltransferases (Zhou et al. 2002; Mayer et al. 2006; Bierhoff et al. 2014). NoRC is 
targeted to the rDNA by promoter-associated RNAs (pRNAs) derived from short 
transcripts from an intergenic promoter upstream of the canonical Pol I transcription start 
site (TSS) (Mayer et al. 2006). Inactive repeats generally show hypermethylation at the Pol I 
promoter, methylation of H3K9 / H3K27 and H4K20, and low levels of H4 acetylation 
(Santoro et al. 2002; Ghoshal et al. 2004; Bierhoff et al. 2014). Conversely active repeats 
show hypomethylated promoters, H3K4 dimethylation, H4 acetylation (Santoro et al. 2002; 
Ghoshal et al. 2004; Bierhoff et al. 2014). Active repeats also display a conserved nucleolar-
specific chromatin mark, histone H2A glutamine 104 methylation (H2AQ104) (Tessarz et al. 
2013). Interestingly, mammals also show an inactive but transcriptionally ‘poised’ repeat 
state with hypomethylated promoters and both activating H3K4 trimethyl and silencing 
H3K27 trimethyl histone marks (Xie et al. 2012). 
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Figure 1.2 Initiation of rDNA transcription by RNA Polymerase I 
A) Illustration of the key protein components required for initiation of rDNA transcription by Pol 
I.  
B) Rrn3 is a significant control point for rRNA synthesis. The protein has a short half-life due to 
rapid ubiquitylation and degradation by the proteasome. Rrn3 binding to the A43 subunit of the 
Pol I complex allows localisation to the rDNA ETS1 promoter. Without Rrn3, Pol I show low DNA 
binding affinity. Initiation of rRNA transcription can be rapidly modulated by changing Rrn3 
synthesis rates; under stress mTOR is inhibited which reduces RRN3 transcription. Protein 
abundance falls quickly due to rapid turnover, thereby rapidly repressing rRNA synthesis. 
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1.3.1 Control of Pol I transcription at the rDNA 
For repeats in the ON state in yeast, rDNA transcription by Pol I initiates at the 5` end of 
the ETS1 region and terminates 3` of ETS2 (Figure 1.1). Transcriptional activation relies on 
four accessory complexes in addition to the Pol I holoenzyme: core factor (CF, consisting 
of Rrn6, Rrn7, and Rrn11) which binds the core promoter element; upstream activating 
factor (UAF, consisting of Rrn5, Rrn9, Rrn10, Uaf30, and histones 3 and 4) further 5` at the 
upstream element; TATA-binding protein (TBP); and Rrn3 which physically interacts with 
subunit A43 of Pol I and Rrn6 of CF (Figure 1.2) (reviewed in Jackobel et al. 2018). 
Association of Rrn3 with Pol I is a critical limiting step in transcriptional initiation, without 
which Pol I shows minimal DNA binding. RiBi is finely controlled by the metabolic master 
regulator kinase complex mTOR to link growth rate to nutrient status. Modulation of Rrn3 
abundance is a major route by which repression of the mTOR reduces rRNA synthesis 
(Claypool et al. 2004; Philippi et al. 2010). Rrn3 is constitutively ubiquitylated and thus has 
a short half-life due to rapid degradation by the proteasome; upon mTOR inhibition by 
rapamycin, RRN3 transcription is downregulated, leading to depletion of the protein 
product and inhibition of Pol I initiation (Figure 1.2) (Philippi et al. 2010). A similar effect 
mediated by Rrn3 depletion is seen in the down shift in rRNA synthesis associated with 
the log-phase to stationary phase transition, where transcription rates may drop to 10-
30% log-phase levels (Claypool et al. 2004). However, initiation can also be regulated at 
the level of the number of active repeats which is reported not to be regulated by mTOR 
(Claypool et al. 2004). The rate of activation of repeats is mediated by the HDAC Rpd3 as 
repeats cycle into the ON state more often in rpd3Δ cells (Tan and Van Oudenaarden 
2010). Rpd3 is required for the successful inactivation of repeats during the shift to 
stationary phase – acting as part of the Rpd3L complex, it facilitates the deposition of 
histones H4 and H2B at rDNA repeats in partnership with Spt16 of the FACT complex 
(Sandmeier et al. 2002; Johnson et al. 2013). Interestingly, Hmo1 also appears to be a 
regulatory target of mTOR since rapamycin treatment causes dissociation of Hmo1 from 
active rDNA repeats (Berger et al. 2007). Thus activation of rRNA synthesis is modulated 
both at the level of Pol I recruitment and the specific chromatin environment in which it 
operates, though fundamentally it is the total number of transcribing Pol I molecules, 
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rather than number of active repeats, which determines overall rRNA production (French 
et al. 2003). 
Transcriptional elongation by Pol I may also a target for regulation of RiBi, however less is 
known compared to initiation processes (recently reviewed in Scull and Schneider 2019). 
Mutations in the Paf1 complex (Cdc73, Ctr9, Leo1, Paf1, Rtf1), which has several roles in 
ensuring normal Pol II transcription, can interfere with rRNA synthesis; there is some 
evidence that the complex facilitates Pol I elongation and is required for response to 
mTOR inhibition (Zhang et al. 2009, 2010). Spt4 and Spt5 also form a complex which acts 
as a key Pol II elongation factor but also interacts with Pol I and localises at the rDNA 
(Viktorovskaya et al. 2011). Mutations in these genes can disrupt Pol I transcription as well 
as downstream pre-rRNA processing (Schneider et al. 2006a; Anderson et al. 2011). It is 
unsurprising that factors affecting elongation rate should impact on post-transcriptional 
processing of the pre-rRNA as binding of some of the many RNA and protein factors 
(~200) involved in RiBi occurs co-transcriptionally (Kressler et al. 2017). Pol I transcribes at 
an average rate of ~40 nucleotides s-1 and takes around 170 s to complete a 35S 
transcript at the standard yeast growth temperature of 30 °C (Koš and Tollervey 2010). 
Correct folding of the emerging transcript assists in deposition of processing factors and 
hence slowed elongation can disrupt the finely tuned assembly line (Schneider et al. 2007). 
Interestingly, Pol I does not appear to progress at a uniform rate – there is a major stalling 
site in the 18S rRNA gene and polymerase density is lower over the internal transcribed 
spacer (ITS) regions suggesting comparatively faster motion – it is therefore likely that 
rDNA primary sequence has been optimised through evolution to enable correct folding 
and processing kinetics of the emerging 35S transcript (El Hage et al. 2010; Clarke et al. 
2018). 
1.3.2 Post transcriptional processing of pre-rRNA 
Processing of the 35S involves several sequential endo- and exo-ribonucleolytic cleavages, 
considerable 2`-O-ribose methylation, and uridine to pseudouridine isomerisation 
(reviewed by Watkins and Bohnsack 2012; Fernández-Pevida et al. 2015; Kressler et al. 
2017). These events happen early, often co-transcriptionally, and are catalysed by small 
nucleolar ribonucleoprotein particles (snoRNPs) whose sequence specific binding is 
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enabled by temporary base paring of constituent small nucleolar RNAs (snRNAs) with the 
nascent transcript. The temporal sequence of transcript cleavages is illustrated in Figure 
1.3. ETS1 at the 5` end of the 35S is trimmed away by cuts at site A0 and/or A1; the 
enzyme(s) responsible are currently undetermined, though cleavages are known to occur 
with the U3 snoRNP bound to the transcript ETS1 (Fernández-Pevida et al. 2015). In 
normal productive rRNA-processing the next cleavage occurs at A2, probably catalysed by 
either Rcl1 or Utp24 (which may also cut at A1) (Horn et al. 2011; Wells et al. 2016; Kressler 
et al. 2017). This produces the 20S pre-18S rRNA which is eventually cleaved at site D, 
after export to the cytoplasm, by Nob1 (Udem and Warner 1973; Fernández-Pevida et al. 
2015). The other product of A2 cleavage is the 27S-A2 pre-rRNA which can be processed 
Figure 1.3: Summary of major pre-rRNA processing steps in S. cerevisiae under optimal 
growth conditions 
The 35S is the largest detectable Pol I product transcribed from the rDNA and contains sequences 
for the mature 18S, 5.8S, and 25S rRNAs. The first processing steps are removal of ETS1 by 
endonucleolytic cleavages at A0 and/or A1 as well as endonucleolytic removal of part of ETS2. 
Then cleavage at A2 produces the 20S, later processed to the mature 18S by cleavage at site D 
after export to the cytoplasm. The 27S-A2 is also produced by the A2 cut which can be further 
processed by two pathways: the major pathway, representing used for about 85% of transcripts, 
or the minor pathway, used for about 15% of transcripts. Processing in this manner produces 
functional mature rRNAs. 
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via either a major pathway, starting with endonucleolytic cleavage at A3 and 
exonucleolytic processing to B1S, or a minor pathway, involving a cut at B1L (Fernández-
Pevida et al. 2015). 5.8S and 25S precursors are separated by cutting at site C2 and are 
trimmed to their mature rRNA boundaries by the exosome and several other 
exonucleases. 
An alternative 35S processing pathway is activated under diverse stresses and results in 
early cleavage at A3 rather than A2, controlled partly by mTOR and casein kinase 2 (CK2) 
(Kos-Braun et al. 2017) (Figure 1.4). On the pre-18S side of the process, this generates the 
non-productive 23S intermediate, rather than 20S, which is polyadenylated by the TRAMP 
complex, dependent on Trf4, and subsequently degraded by the exosome, depending on 
Rrp6 (LaCava et al. 2005). Conversely the 27S-A3 product is substrate for normal 
processing and hence one might expect this to result in an imbalance of large ribosomal 
Figure 1.4: Summary of major pre-rRNA processing steps in S. cerevisiae under stress 
A rapid switch from productive rRNA processing (as depicted in Figure 1.3) to a non-
productive mode occurs early in the response of S. cerevisiae to a diverse array of stresses 
(Kos-Braun et al. 2017). This involves a switch from use of the A2 ITS1 site to cleavage at A3 
instead. The non-productive 23S pre-18S intermediate and the 27S-B intermediate are 
degraded rather than processed further. This switch is under control by mTOR and CK2 
activity. 
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subunits (containing 25S, 5.8S, and 5S rRNAs) and small ribosomal subunits (containing 
the 18S). However, Kos-Braun et al. 2017 reported arrested synthesis of ribosomal large 
subunits as well as small subunits, with processing of 27S species arresting before the C2 
cleavage. This switch in processing is the first major event in the downregulation of 
ribosome biogenesis in response mTOR inhibition, as control of Pol I initiation via Rrn3 
and repression of ribosome protein synthesis have slower kinetics (Claypool et al. 2004; 
Kos-Braun et al. 2017). 
1.3.3 Coordinated regulation of ribosome synthesis and assembly 
By the time final processing of rRNAs is completed, they are already associated with many 
of the ~80 protein components of the mature ribosome (Kressler et al. 2017). To produce 
a functional translation unit, cells need to coordinate synthesis of stoichiometric amounts 
of products from all three RNA polymerases as well as existing ribosomes. Much of this 
regulation appears to ultimately derive from nutrient sensing regulators like mTOR 
(Lempiäinen and Shore 2009). RiBi and ribosomal protein (RP) genes are activated by 
general transcription factors like Reb1 and Abf1 but there are also several more specific 
regulatory mechanisms which generally ensure adequate production of these key proteins 
(Bosio et al. 2017). mTOR directly phosphorylates and activates the transcription factor 
Sfp1 which positively regulates both RP genes and RiBi factors and appears to function in 
the control of cell size – sfp1Δ results in strong downregulation of both gene classes 
(Albert et al. 2019b). The yeast ribosomal protein S6 kinase homolog, Sch9, also acts 
downstream of mTOR by inhibiting Tod6, Dot6, and Stb3 which otherwise together 
repress RiBi and RP genes by recruiting the repressive Rpd3L HDAC complex at RP gene 
promoters (Lippman and Broach 2009; Huber et al. 2011). Both RP and RiBi genes are co-
ordinately downregulated under a variety of stressors in tandem with induction of the 
environmental stress response (ESR) (Gasch et al. 2000, 2017). This transcriptional pattern 
is a robust age-related feature reported in studies of replicatively ageing yeast 
transcriptomes, further underscoring the physiological importance of yoking together 
expression of these ribosome-associated genes (Yiu et al. 2008; Hu et al. 2014; Janssens et 
al. 2015; Cruz et al. 2018; Hendrickson et al. 2018). 
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Several mechanisms exist to coordinate production of rRNA with RPs, the base 
constituents of ribosomes. Much of this has been found to depend on the transcriptional 
activator Ifh1 which regulates RP genes and only a very small set of others. Ifh1 is 
recruited to RP gene promoters by a physical interaction with Fhl1 which is constitutively 
localised at RP promoters. These proteins are vital for normal RP gene transcription, Ifh1 is 
essential and loss of Fhl1 attenuates ribosome synthesis by ~90% (Schawalder et al. 2004; 
Wade et al. 2004; Rudra et al. 2005). Ifh1 can associate with CK2, Utp22, and Rrn7 (the 
latter two are involved in pre-rRNA processing) as the CURI complex (Rudra et al. 2007). 
Utp22 directly interacts with Ifh1, titrating it into the CURI complex and away from RP 
gene promoters when demand for rRNA-processing factors is low (Albert et al. 2016). This 
accounts for the prolonged Ifh1 sequestration after rapamycin treatment, while a different 
short-lived process mediates release of Ifh1 from RP genes with faster kinetics dependent 
on Sch9 (Albert et al. 2016). Ifh1 is post-translationally modified by CK2 phosphorylation 
as well as acetylated by the Gcn5 acetyl-transferase of the SAGA complex (Rudra et al. 
2007; Downey et al. 2013). Acetylation appears to somewhat reduce the transcriptional 
activator capacity of Ifh1 and can be reversed by sirtuin HDACs under mTOR control, 
though exactly how this modification contributes to Ifh1 regulation under normal growth 
is unclear (Downey et al. 2013).  
Should these co-regulation mechanisms fail and rRNA and RP production becomes 
unbalanced, there are failsafe mechanisms to prevent serious proteotoxic crisis. Orphan 
RPs in the nucleus not incorporated into ribosomes are rapidly tagged via ubitquitylation 
and removed by the proteasome in a process termed ERISQ (excess ribosomal protein 
quality control) (Sung et al. 2016a, b). Should this be insufficient, RPs tend to aggregate in 
the nucleus. This aggregation results in a highly specific transcriptional response in two 
sets of genes which helps redress the issue. Firstly, RP aggregation lead to activation of 
the ancient highly-conserved proteostasis regulator Hsf1 which induces folding chaperone 
expression and, especially important in RP clearance, Rpn4 which in turn upregulates 
expression of proteasome genes (Solís et al. 2016; Pincus et al. 2018; Albert et al. 2019a; 
Tye et al. 2019). Secondly, RP genes, but not RiBi genes, are simultaneously 
downregulated; this appears to result from rapid release of Ifh1 from RP gene promoters 
due to Ifh1 sequestration in RP aggregates (Albert et al. 2019a). This is a very compact 
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negative feedback process relying simply on Ifh1 and Hsf1 – no change in mTOR activity 
or activation of the Msn2/4 mediated ESR was seen under conditions leading to RP gene 
aggregation (Tye et al. 2019). 
Interestingly it seems that the Pol I transcription rate may be the master pace-setter for 
RiBi as a whole; blocking the Rrn3-dependent control of rRNA transcription downstream 
of mTOR, with concomitant rapamycin treatment, results in maintenance of high levels of 
35S rRNA, 5S rRNA, and RP gene mRNA transcription (Laferté et al. 2006). This depends 
on Hmo1, also responsible for maintaining active rDNA repeat chromatin – deletion of 
Hmo1 abrogates much of the effect of constitutive Pol I activity on Pol II under mTOR 
inhibition and also compromises RP gene repression under rapamycin treatment (Berger 
et al. 2007). It is less clear how production of 5S rRNA by Pol III is matched to other 
ribosome components. However, Maf1, the only known yeast negative regulator of Pol III, 
is phosphorylated by mTOR which results in its cytoplasmic localisation away from Pol III 
under plentiful nutrient conditions (Cieśla and Boguta 2008). Overall, the rDNA and 
associated protein factors are dominant players in the production of cellular translation 
machinery, demand for which can exceed 200,000 ribosome units per yeast cell cycle - 
~2000 fully assembled ribosomes per minute. 
1.4 rDNA copy number variation 
The high copy number of rDNA repeats reflects the intense requirements for both 35S and 
5S rRNA transcription. RP production can be supported by single gene loci due to the 
potential for translation of each mRNA multiple times, representing a significant 
amplification of signal. By contrast, rRNA needs must be met by raw transcriptional activity 
– requirements for which can only be met by the redundancy of template copies in 
eukaryotic cells (French et al. 2003). However, the repetitive structure of rDNA makes it 
inherently unstable and prone to CNV. Large numbers of identical repeats make rDNA a 
hotspot for intra-chromosomal HR; during such events one or more copies can be lost as 
an extra-chromosomal rDNA circle (ERC) (Figure 1.5 A) (Ozenberger and Roeder 1991; 
Kobayashi 2011). Another DNA damage response pathway, single strand annealing (SSA), 
can occur due to the large regions of homology in rDNA repeats; repair of double strand 
breaks via this mechanism also leads to loss of copies (Figure 1.5 B). rDNA is also a 
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frequent site of HR between sister chromatids during the cell cycle (Szostak and Wu 1980). 
In the event of USCE, copies can be gained or lost which leads to CNV (Takeuchi et al. 
2003). Consequently, rDNA arrays show considerable variation in copy number between 
and within species which correlates with genome size (Prokopowich et al. 2003; Stults et 
al. 2008; Bik et al. 2013; Saka et al. 2016; Kwan et al. 2016; Chestkov et al. 2018; 
Malinovskaya et al. 2018). Furthermore co-variation in 35S and 5S rDNA CN is reported in 
mammals - potentially a mechanism for maintaining stoichiometric production of different 
rRNAs (Gibbons et al. 2015). Remarkably rDNA CNV even occurs within an individual, 
resulting in mosaicism – CN differences have been reported between brain regions in a 
pathological context and are frequently observed in cancers (Hallgren et al. 2014; Wang 
and Lemos 2017; Xu et al. 2017; Valori et al. 2019). Owing to this widespread CNV, rDNA 
potentially provides an understudied source of cryptic genomic variation. 
1.4.1 Mechanisms of directed rDNA CNV in S. cerevisiae 
Repetitive arrays like the rDNA have a tendency to lose repeats via USCE or SSA 
(Kobayashi 2011). Hence organisms must counteract this via amplification-biased CNV 
mechanisms. The best understood model for such directed rDNA CNV is in budding yeast 
(Figure 1.6). Each yeast rDNA repeat contains a highly recombinogenic region, termed 
HOT1, in the IGS1/2 intergenic region between 35S sequences which can even induce 
recombination if placed in a different genomic context (Keil and Shirleen Roeder 1984; 
Ward et al. 2000). Binding of the nucleolar zinc-finger protein Fob1 at the RFB sequence in 
IGS1 acts as a polar blockage to the progression of DNA replication forks, allowing 
replication only in the direction of Pol I transcription (Brewer and Fangman 1988; Brewer 
et al. 1992; Kobayashi et al. 1992). Replication forks moving in the opposite direction stall 
at the RFB due to Fob1-mediated blockage. This can result in DSBs which are generally 
resolved by HR-dependent replication coupled repair processes (Kobayashi et al. 1998). 
The close association of rDNA repeats between chromosomes, which facilitates repair by 
recombination between sister chromatids, is encouraged by the ability of Fob1 to 
oligomerise while bound to RFB sequences in a process termed ‘chromosome kissing’ 
(Choudhury et al. 2015; Zaman et al. 2016). It is interesting to note that RFB sequences 
occur in rDNA intergenic regions in diverse species such as fission yeast 
(Schizosaccharomyces pombe), pea (Pisum sativum), mice, and humans (Hernández et al. 
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1993; Little et al. 1993; López-Estraño et al. 1998; Sanchez et al. 1998). While evolutionarily 
unrelated to Fob1, which appears to be a recently co-opted retrotransposon integrase, Pol 
I transcription termination factors are involved in replication fork blocking at RFBs in 
fission yeast (Rep1) and mammals (TTF-1) which may hint at more general mechanisms for 
directed rDNA CNV (Gerber et al. 1997; Dlakić 2002; Sánchez-Gorostiaga et al. 2004). 
Interestingly, in addition to this Fob1 mediated chromosomal rDNA CNV, it appears yeast 
are able to dynamically modulate Fob1-dependent production of ERCs in response to 
chromosomal rDNA CN and rRNA synthesis demands (Mansisidor et al. 2018). 
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Figure 1.5 Multicopy arrays like the rDNA are prone to loss of repeats by multiple 
mechanisms 
Adapted from Kobayashi 2011. 
A) Replication-independent repair of damaged repeats can occur via homologous recombination 
between repeats on the same chromosome. This can result in one or more copies lost as an extra-
chromosomal rDNA circle (ERC). 
B) Single strand annealing, another replication independent process, can also result in loss of a 
repeat copy during repair of double strand breaks. 
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Figure 1.6: The current major model of regulated rDNA CN amplification in S. cerevisiae 
A) Under WT rDNA CN conditions, cohesion complexes bind in IGS2 and ensure close alignment 
of sister chromatids during DNA replication. Double strand breaks can be induced in one 
chromatid after Fob1-dependent unidirectional replication fork stalling at the RFB. Equal sister 
chromatid recombination allows repair between aligned repeats without copy number (CN) 
changes.  
B) CN loss results in downregulation of SIR2 at transcript and protein levels (see Figure 1.7). This 
relieves inhibition of Pol II transcription from the bidirectional promoter E-pro in IGS1. E-pro 
transcription disrupts cohesin-dependent alignment of sister chromatids. This can potentially 
result in unequal sister chromatid recombination and CN can change during subsequent repair. 
35 
 
 
There is a second major player in current models of yeast rDNA CNV which enables cells 
to adjust rDNA CN should it deviate from the WT set point (Figure 1.6, Figure 1.7). The 
HDAC Sir2 has key silencing roles at the yeast rDNA, HML/HMR silent mating type loci, 
and telomeric regions (Rine and Herskowitz 1987; Smith and Boeke 1997; Bryk et al. 1997; 
Gartenberg and Smith 2016). At the rDNA, Sir2 is the catalytic component of the RENT 
(regulator of nucleolar silencing and telophase) complex consisting of Sir2, Net1 and 
Cdc14 (Straight et al. 1999). Sir2 activity appears to moderate transcription by Pol II from 
intergenic regions, primarily IGS2/1, where its deacetylase activity compacts chromatin 
and prevents accumulation of H3K4 methylation (Li et al. 2006). This silencing effect is 
Figure 1.7: The Kobayashi lab model for negative feedback regulation of rDNA CN 
A variety of mechanisms make rDNA arrays unstable and prone to repeat loss (see Figure 1.5). 
Upon repeat loss a portion of the cellular pool of UAF, a key protein complex for Pol I 
transcriptional initiation, re-localises specifically to the SIR2 promoter. This represses SIR2 
expression and leads to decreased cellular Sir2 protein. Under WT rDNA CN conditions, Sir2 
silences transcription from the IGS1 E-pro site; however, E-pro becomes transcriptionally active 
under low CN conditions with Sir2 depletion. This weakens cohesion between sister chromatids 
and allows for CN variation (CNV) by unequal sister chromatid exchange (USCE) (see Figure 1.6).  
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especially important around a non-coding bidirectional Pol II promoter element, E-pro, in 
IGS1 near the RFB site. Disruption of transcription from E-pro disrupts the orderly 
association of sister chromatids by cohesin, thereby promoting unequal sister chromatid 
exchange and CNV (Kobayashi and Ganley 2005). Loss of rDNA silencing by Sir2 deletion 
or inhibition leads to greatly increased Pol II transcription at the rDNA IGS1/2 and 
profoundly unstable rDNA CN. Conversely, rDNA deletions lead to release of a pool of Sir2 
which re-locates and enhances silencing at telomeric and mating type loci (Michel et al. 
2005). Sir2 is also downregulated at transcript and protein levels upon rDNA CN loss 
resulting in increased CNV-inducing E-pro activity – thus a mechanism was proposed 
where this forms a negative feedback loop to re-adjust rDNA CN dependent on the 
balance of Sir2 (Figure 1.7). Such a mechanism was demonstrated this year by the 
Kobayashi group; yeast possess a fixed pool of UAF (a major Pol I transcriptional activating 
complex) some of which relocates to the Sir2 promoter in the event of rDNA deletions 
(Iida and Kobayashi 2019). There it represses SIR2 expression, thus relieving E-pro 
silencing and encouraging rDNA CNV (Iida and Kobayashi 2019).  
While HR is a key feature of the Kobayashi lab model, it is not absolutely required for 
rDNA amplification. rDNA CN recovery from deletions is evident in the absence of the 
critical HR protein Rad52 or members of the Rad52 epistasis group Rad51 and Rad59 
(Houseley and Tollervey 2011). Both processes are operative in WT cells and choice of the 
HR-independent mechanism is promoted by functional H3K56 acetylation cycling; when 
this is disrupted, for example by deletion of the H3K56 acetylase RTT109 or the chromatin 
assembly protein ASF1, constitutive CN hyperamplification by HR-independent 
mechanisms occurs (Houseley and Tollervey 2011; Ide et al. 2013; Jack et al. 2015). 
Similarly deletion of the Hst3 and Hst4 HDACs, which target acetylated H3K56, severely 
compromises recombination with sister chromatids and results in HR-independent rDNA 
amplification (Muñoz-Galván et al. 2013; Jack et al. 2015). That disruption of either 
deposition or removal of H3K56 acetylation has similar effects, demonstrates that H3K56 
cycling is the important quantity rather than simply high / low H3K56. A rolling-circle 
amplification method has been demonstrated to contribute to the hyperamplification in 
rtt109Δ backgrounds; it has not yet been shown whether this is generally responsible for 
the HR-independent pathway, thought it would seem consistent with the requirement for 
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highly processive DNA polymerase activity found by Houseley and Tollervey (Ide et al. 
2013). 
1.4.2 Mechanisms of directed rDNA CNV in Drosophila melanogaster 
Directed rDNA CNV is essentially unstudied in other species except Drosophila, an 
organism for which there does not appear to be published information about an rDNA 
RFB. rDNA clusters in Drosophila are present in heterochromatic locations on the X and Y 
chromosomes. Ritossa and colleagues discovered that the bobbed phenotype, presenting 
with delayed development and shortened bristles, resulted from compromised rRNA 
synthesis due to rDNA deletions (Ritossa et al. 1966; Ritossa 1968a). It was found that 
heritable rDNA CN increases on X chromosomes, termed rDNA magnification, could 
rescue the bobbed phenotype caused by an rDNA deficient Y chromosome (Ritossa 
1968a). A different process was found to cause non-heritable compensatory rDNA 
amplification which was also capable of phenotypic rescue (Tartof 1971). The precise 
mechanism of rDNA magnification has not yet been determined, however current 
evidence is considered consistent with USCE during HR (Tartof 1974; Bianciardi et al. 
2012). It appears a similar, if not identical, process underlies the stochastic recovery of 
rDNA CN in male germline stem cells in the event of inheritance of a reduced Y-linked 
rDNA array (Lu et al. 2018). Another Drosophila mutant phenotype abo, abnormal oocyte, 
can be rescued by rDNA amplification (Krider and Levine 1975; Krider et al. 1979). 
Evidence is consistent with the abo gene product being a negative regulator of histone 
production (Berloco et al. 2001). The hypothesised mechanism by which rDNA 
amplification rescues the phenotype, titration of excess histones, is reminiscent of the 
titration of interacting protein factors in the yeast CNV model and may point at a more 
general principle of action (Iida and Kobayashi 2019). 
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1.4.3 rDNA CNV as an environmentally-sensitive adaptive mechanism 
Evidence from both yeast and Drosophila work has demonstrated that rDNA CNV can be 
controlled by major nutrient sensing pathways. A previous PhD student in the Houseley 
lab elucidated a mechanism wherein activity of the master metabolic regulator mTOR was 
required for CNV to occur (Jack et al. 2015). Inhibition of mTOR by rapamycin treatment or 
calorie restriction repressed rDNA amplification in a very low CN mutant. This effect was 
mediated via de-repression of HDACs Sir2, Hst3, and Hst4 in the context of reduced 
mTOR activity. The Maggert group similarly reported diet-dependent transgenerational 
effects on rDNA CNV; male flies fed a high yeast diet had male progeny with ~10% 
reduced rDNA CN, with the effect also dependent on mTOR (Aldrich and Maggert 2015). 
Interestingly, constitutive activation of the insulin/insulin-like signalling pathway, another 
major nutrient sensor, was sufficient to induce the appearance of supernumerary nucleoli. 
The authors interpreted that as a signal of rDNA instability consistent with potential loss 
of repeats as DNA circles. Between organisms, mTOR activity was seen to be required for 
amplification or contraction – this suggests it may act more as a gating mechanism while 
other factors determine CNV direction. These two publications imply the potential for 
rDNA CNV to be a rapid method of genome evolution by adapting CN to prevailing 
environmental conditions – indeed, conceptually similar adaptive CNV has been published 
by the Houseley lab in the context of yeast responding to toxic Cu2+ concentrations (Hull 
et al. 2017). 
1.5 Phenotypic consequences of rDNA CNV  
A prerequisite of the adaptive rDNA CNV hypothesis is that there are phenotypic 
consequences of such CNV. There are many hints rDNA CNV has functional consequences 
from various model systems, however we are still very far from a comprehensive 
understanding of such effects or the mechanisms responsible.  
1.5.1 rDNA CN-sensitive phenotypes in prokaryotes 
Insights into the relationships between rDNA CN, growth and metabolism come from 
studies looking at CNV of bacterial rrn operons, loci encoding all three bacterial rRNAs. 
Experiments with Escherichia coli strains engineered to possess between 5 and 10 rrn 
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copies - wild type (WT) cells have 7 – showed that 5 or 6-copy strains were smaller and 
had significantly lower RNA : DNA and protein : DNA ratios than WT (Gyorfy et al. 2015). 
Meanwhile 8 to 10-copy strains were larger but did not differ significantly from WT in 
terms of RNA : DNA or protein : DNA ratios. There also seem to be direct outcomes for 
cell growth as non-WT strains generally divided slower and cells with more extreme 
changes (5,6, or 10 copies) spent longer in lag phase when grown in rich medium. In 
competition experiments WT strains outcompeted 5-, 6-, 9-, or 10-copy strains under 
fluctuating nutrient conditions. However 5 or 6 copy strains had an advantage when 
grown with stable, but limiting, nutrient supply. 
These results are largely concordant with other work which considered a range of bacterial 
species and reported a log-log correlation between maximal growth rate and rrn CN 
(Roller et al. 2016). The authors also found a general trend towards greater translational 
capacity, but also metabolic inefficiency, with increasing rrn count. Similarly, higher CN 
species respond faster to influxes of nutrients into the growth medium (Klappenbach et al. 
2000). Interestingly, growth rate variation with rrn CN occurs primarily under conditions of 
plentiful nutrients, such as during laboratory culture, but correlations disappear in more 
nutrient-poor environments (Wu et al. 2017; Li et al. 2019). These suggest that rrn CN is 
under selection in the bacterial domain and that it reflects and influences metabolic and 
growth strategies; higher CN seems to be adaptive for faster (but less efficient) growth 
under high or intermittently high nutrient availability, while lower copy numbers seem to 
limit growth rates but may facilitate more efficient metabolism adaptive in nutrient poor 
conditions. Consistently, faster growing early coloniser species tend to have higher rrn CN 
while those succeeding them after nutrient availability drops have lower average rrn 
numbers (Nemergut et al. 2015). 
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1.5.2 rDNA CN-sensitive phenotypes in eukaryotes  
 
The effects of rDNA CNV in eukaryotes generally appear more complicated than the 
picture emerging from the bacterial literature – Figure 1.8 provides an abstracted 
summary. Work with two single-celled ciliates found growth rate to anti-correlate with 
rDNA CN (Fu and Gong 2017). While this seems diametrically opposed to the bacterial 
work, the authors also found rDNA CN to correlate with cell volume, as has been found in 
other protist studies, which itself is inversely related to growth rate (Zhu et al. 2005; Godhe 
et al. 2008). Further underscoring the difference from bacteria, in yeast, rRNA production 
and growth rates are virtually identical between strains with WT CN (~150 copies) and 
dramatically lowered CN (~40 copies) (Kobayashi et al. 1998; French et al. 2003). 
Importantly, not all rDNA repeats are active in eukaryotes with WT CN – usually only 
~50% or fewer under even rapid growth conditions (Conconi et al. 1989; Haaf et al. 1991; 
French et al. 2003). Therefore, it may be that in larger-celled eukaryotes the direct 
Figure 1.8 Summary of known effects of rDNA CN on rRNA levels and organism 
phenotypes 
Eukaryotes typically have more rDNA copies than required for optimal rRNA synthesis during 
rapid cell growth (often 2x or more) and can buffer steady state rRNA amounts across a range 
of rDNA CNs. Critically low numbers of rDNA repeats cannot support sufficient rRNA synthesis 
and are lethal during development. There is a range of CNs which can be viable but result in 
gross phenotypes or pathology (e.g. bobbed in Drosophila). It is currently poorly characterised 
whether there are major phenotypic effects from rDNA CNV within the range capable of 
supporting optimal rRNA synthesis, or at very high CNs. 
41 
 
relationship between rDNA CN and growth rate has been broken due to the higher CNs 
(10 to >1000x greater than in bacteria) which allow effective buffering of rRNA synthesis 
in the face of variable template abundance (Prokopowich et al. 2003). Indeed, there were 
minimal differences in rRNA abundance observed between diploid, trisomic, or tetrasomic 
chicken embryos despite 1.5-2x rDNA CN increases (Muscarella 1985).  
Why eukaryotes consistently have an apparent CN surplus relative to that required to 
sustain maximal rRNA production is mysterious. Insufficient repeats to support rRNA 
synthesis can certainly have pathological or lethal consequences which indicates lower 
bounds on viable rRNA buffering capacities. rDNA deletions in Drosophila cause the 
bobbed phenotype, possibly the earliest known rDNA CN-dependent effect, presenting 
with delayed development and shortened bristles (Ritossa et al. 1966; Ritossa 1968a). 
Similarly, major rDNA deletions, leaving < 50% WT CN, result in embryonic lethality in 
chickens (Delany et al. 1994, 1995). Moving beyond direct effects on rRNA abundance, 
yeast with progressive rDNA deletions below ~110 copies show dose dependent 
sensitisation to genotoxic insults (Ide et al. 2010). This phenotype appears a consequence 
of the heavy transcription of the reduced template pool required to sustain rRNA levels; 
the authors found repair of double strand breaks in the rDNA was defective at low CNs 
and argued for a model where inactive repeats facilitate sister chromatid cohesion and 
replication-coupled repair by homologous recombination. This does not fully explain WT 
rDNA CNs however, as even a moderately rDNA-contracted ~110 copy strain was as 
resilient as those with ~150 repeats, furthermore lab strains stably maintain WT CNs even 
in the absence of exogenous mutagens (Ide et al. 2010). Overall, direct phenotypic 
consequences of rDNA CNV at CNs supporting normal rRNA synthesis remain somewhat 
elusive – indeed, comparisons of various commercial chicken lines has not revealed any 
concrete phenotypic connections despite variation in nucleolar size and rDNA CN (Su and 
Delany 1998; Delany and Krupkin 1999; Delany 2000). 
Despite the dearth of gross phenotypic markers of rDNA CNV, it is reported to have 
considerable influence on coding gene expression. Work which assayed gene expression 
by microarray in Drosophila lines with varying degrees of rDNA deletion found hundreds 
of genes differentially expressed (Paredes et al. 2011). The claim that these are bona fide 
rDNA-sensitive transcripts was bolstered by the fact that many were differentially 
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regulated in the same direction to greater degrees with more profound CN loss. rDNA 
CN-sensitive gene expression is also reported in human blood cells where thousands of 
such loci have been found using RNA-seq (Gibbons et al. 2014). Interestingly, while both 
studies reported functional enrichment for specific pathways, these were not shared 
between the two organisms. Another RNA-seq experiment, looking at maize (Zea mays) 
found far fewer, less than 100, rDNA CN-sensitive genes (Li et al. 2018). Furthermore rDNA 
CN and rRNA abundance were not correlated, though the authors therein showed 
widespread and functionally coherent co-regulation of gene expression with rRNA 
expression. That there is wide variation in estimates of genes affected by rDNA CNV is 
difficult to reconcile with the hypothesis of basic conserved principles for mediating such 
an effect. It is worth noting however that there have been some questions raised over the 
accuracy of CNs derived from whole genome resequencing data in the human work which 
gave the largest total (Symonová 2019). Given the variety of organisms and approaches so 
far employed, I saw an opportunity to collect high quality gene expression datasets from 
model organisms, with rDNA quantified by robust and accurate techniques, to improve 
our understanding of this phenomenon. 
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1.5.3 rDNA CNV in human pathology 
rDNA CNV very likely has important consequences for human health, with CNV present 
among human populations and emergence of new array length polymorphisms 
documented among first degree relatives (Stults et al. 2008). rDNA CN was raised relative 
to healthy controls in the cerebral cortex of elderly patients suffering from a class of 
dementia – interestingly it was also lowered in the cerebellum of the same group 
(Hallgren et al. 2014). Increased rRNA transcription has also been suggested to play a role 
in Down’s syndrome which results from human trisomy 21, notably chromosome 21 
containing an rDNA cluster (reviewed in Demirtas 2009). Average rDNA CN is higher 
among schizophrenia patients relative to healthy controls (blood samples assayed) with 
possibly raised rRNA transcription in certain subgroups (Veiko et al. 2003; Krzyżanowska et 
al. 2015; Chestkov et al. 2018). This has further been suggested to underlie some of the 
negative association between schizophrenia and rheumatoid arthritis, where arthritis 
sufferers have fewer active rDNA repeats than average (Oken and Schulzer 1999; 
Lyapunova et al. 2013; Chestkov et al. 2018). There is a possibility that rDNA CNV in 
schizophrenia sufferers may be at least partially a function of the treatment; exposure of 
the model nematode worm Caenorhabditis elegans (C. elegans) to several antipsychotic 
drugs appeared to increase signalling through the insulin/insulin-like pathway which is 
linked to rDNA instability in Drosophila (Weeks et al. 2010). Finally, there are poorly 
understood complex interactions between numbers of active rDNA copies and the viability 
of patients with chromosome abnormalities as well as in ageing cohorts (Lyapunova et al. 
2017; Malinovskaya et al. 2018). These results imply that rDNA CN interacts with various 
genetic or environmental stressors with potentially critical, though underappreciated, 
consequences for human survival in vulnerable states. 
There has been significant recent interest in rDNA CNV in the context of carcinogenesis 
and tumour biology. Consistent with high levels of recombination at the rDNA in cancers, 
three publications have found rDNA CNV among a variety of tumour types (Stults et al. 
2009; Wang and Lemos 2017; Xu et al. 2017; Valori et al. 2019). Different methods of rDNA 
CN estimation were employed between the studies with Wang and Lemos 2017 and Xu et 
al. 2017 relying primarily on computational calculation from genome resequencing data, 
as in Gibbons et al. 2014, 2015, while Valori et al. 2019 employed a well validated qPCR 
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method. Overall it appears that the occurrence of rDNA CNV depends on mutation profile 
but it is unclear exactly whether specific mutations bias copy number gain, loss, or 
generally increased variability. One specific example with CN validation from two 
independent methods was the finding of reduced rDNA CN in mouse leukaemia model; 
the potent tumour suppressor PTEN was conditionally deleted in haematopoietic stem 
cells which resulted in both malignant transformation and consistent rDNA CN decrease 
(Xu et al. 2017). Wang and Lemos 2017 reported increases in the 5S : 45S rDNA ratio in 
some cancer types, particularly evident in instances of another critical tumour suppressor 
TP53, which correlated with tumour proliferation rate. However, Valori et al. 2019 did not 
find evidence for strong 5S : 45S CN correlations in either breast cancer or healthy 
samples, contrary to a previous study who reported concerted rDNA CNV between the 
two loci in humans and mice (Gibbons et al. 2015). It will be vital for verified methods for 
rDNA CNV to become standard so that swift and reliable progress can be made in this 
area – new evidence that high rDNA CN may be a risk factor for lung cancer implies such 
techniques may be valuable to screening or preventative efforts as well (Hosgood  III et al. 
2019). 
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Table 1.1 Summary of reports detailing rDNA CNV and human pathology 
Species Condition 
45S rDNA 
differences Location Study type Study 
Human 
Age-related 
dementia Increased CN 
Cerebral 
cortex 
Observational 
Hallgren et 
al. 2014 
Human 
Age-related 
dementia Decreased CN Cerebellum 
Observational 
Hallgren et 
al. 2014 
Human 
Down's 
syndrome 
(Trisomy 21) Increased CN Organism wide Review 
Demirtas 
2009 
Human Schizophrenia Increased CN 
Blood 
(Leukocytes) Observational 
Veiko et al. 
2003 
Human Schizophrenia Increased CN Raphe Nucleus Observational 
Krzyżanowsk
a et al. 2015 
Human Schizophrenia Increased CN 
Blood 
(Leukocytes) Observational 
Chestkov et 
al. 2018 
Human 
Rheumatoid 
Arthritis 
Decreased 
active CN 
Blood 
(Leukocytes) Observational 
Lyapunova et 
al. 2013 
Human Ageing 
Decreased CN 
variance 
Blood 
(Leukocytes) Observational 
Malinovskaya 
et al. 2018 
Human Cancer 
Increased CN 
instability Lung, Colon Observational 
Stults et al. 
2009 
Human Cancer 
Generally 
decreased CN Various Observational 
Wang & 
Lemos 2017 
Human Cancer 
Decreased CN 
in some 
subtypes Various Observational 
Xu et al. 2017 
Mouse 
PTEN-/- 
induced 
cancer Decreased CN Leukaemia Experimental 
Xu et al. 2017 
Human Cancer 
Increased CN 
instability Breast Observational 
Valori et al 
2019 
 
1.6 rDNA instability and CNV in the ageing process 
Ageing, considered as the progressive age-related functional decline of organisms which 
results in or accompanies a decreasing probability of survival per unit time, represents a 
complex and interlinked shift in many phenotypes within an individual organism – 
collectively termed the “Hallmarks of Ageing” (López-Otín et al. 2013). Remarkably, 
advances in uncovering the molecular mechanisms of ageing over the last three decades 
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has found impressive commonalities in ageing processes even between organisms as 
divergent as yeast and humans (Janssens and Veenhoff 2016).  
1.6.1 rDNA CNV during mammalian ageing remains controversial 
Given the evidence that rDNA likely plays a role in carcinogenesis, one of the primary age-
related pathologies in multicellular organisms, it is perhaps unsurprising that contributions 
of rDNA CNV to the ageing process, or vice versa, have been proposed (Wang and Lemos 
2017; Xu et al. 2017; Valori et al. 2019). However evidence from different studies and 
techniques has not always consistent. In the 1970’s Strehler and colleagues performed 
several experiments comparing rDNA CN in slower dividing tissues (brain, myocardium, 
and skeletal muscle) with others (e.g. liver and spleen) using hybridisation-based assays. 
Their general finding across different mammals, including humans, was an age related 
decline in rDNA CN in slower dividing tissues relative to others (Johnson et al. 1972, 1975; 
Johnson and Strehler 1972; Strehler and Chang 1979; Strehler et al. 1979). This would be 
consistent with the loss of Y-linked rDNA copies seen in ageing male Drosophila (Lu et al. 
2018). Others using similar assays found more complicated trends, including age related 
increase in rDNA CN in the liver, and questioned whether excessive protein crosslinking 
might result in lower hybridisation in aged samples, thereby producing the lower CN 
estimates (Gaubatz et al. 1976; Gaubatz and Cutler 1978). Additionally, Gaubatz and 
colleagues saw no changes in rDNA CN in ageing mouse myocardium or late passage 
cells from an epithelial cell line (Peterson et al. 1984).  
Since these studies were published, the alternative technique of qPCR has been developed 
which has been employed to test similar questions. A report which looked at cerebral and 
cerebellar cortex reported no correlation of rDNA CN with age (Hallgren et al. 2014). 
Another which studied adipose tissue saw a loss of 25S and 5.8S repeats, but bizarrely not 
18S sequences, with age (Zafiropoulos et al. 2005). Two more recent studies employing 
either hybridisation-based methods or qPCR did not find significant correlation in mean 
rDNA CN of human blood cells with age (Malinovskaya et al. 2018; Valori et al. 2019). The 
Malinovskaya et al. 2018 work did, however, find reduced variation in rDNA CN in their 
elderly cohort relative to younger ages though this was not supported by Valori et al. 
2019. The Malinovskaya et al. 2018 authors speculated that this might indicate earlier 
death of individuals with more extreme rDNA CNs – possibly resulting from rDNA CN 
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variants acting as an endogenous stressor. Finally a novel technique, employing the 
sequence specific binding of fluorophore-functionalised transcription activator-like 
effector proteins, suggests significant loss of rDNA repeats in senescent cultured cells as 
well as cells derived from patients with ‘accelerated ageing’ pathologies (Werner’s 
syndrome and Hutchinson-Gilford progeria syndrome). It is interesting to note that this 
seems consistent with the finding that rDNA CNV in budding yeast and Drosophila is 
promoted by broadly pro-ageing pathways like mTOR and insulin/insulin-like signalling 
(Aldrich and Maggert 2015; Jack et al. 2015). Overall, the question of whether rDNA CN 
changes during animal, particularly mammalian, ageing does not currently have 
straightforward answer. It seems likely that CN in circulating blood cells is stable with age 
given the most recent evidence, though to assume that this is representative of all tissues 
is probably too simplistic and further work with updated methodologies will be required 
(Malinovskaya et al. 2018; Valori et al. 2019).  
1.6.2 Mammalian rDNA hosts a conserved epigenetic ageing clock 
A recent major advance in the mammalian ageing field has been the discovery of ageing 
methylation ‘clocks’ (Horvath 2013; Wagner 2017). Training machine learning models on 
organism-specific age-annotated whole genome DNA methylation data enabled the 
development of different predictors which could estimate age in mice, humans, or dogs 
(Horvath 2013; Stubbs et al. 2017; Thompson et al. 2017). Models rely on a few hundred 
‘most-informative’ CpG sites and can predict chronological age (age since birth in weeks, 
months, years etc.) with impressive accuracy; age estimates from the model for mice 
recently published by the Reik lab showed >0.8 correlation with chronological age with a 
median absolute error of 3.3 weeks (Stubbs et al. 2017). More remarkably, the age 
predictions seem to track some measure of ‘biological’ age since interventions known to 
increase lifespan, such as calorie restriction or rapamycin treatment, cause animals to 
show younger age predictions from their methylome than same-aged controls (Petkovich 
et al. 2017; Wang et al. 2017). A similar model has now been published which considers 
only the CpG sites in rDNA repeats and showed within-species accuracy comparable to 
models considering sites genome wide (Wang and Lemos 2019). The major advance in the 
rDNA model is that it can give reasonable estimations for chronological age using 
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homologous rDNA CpGs across mammalian species, potentially implying deep functional 
conservation of the mechanisms responsible.  
1.6.3 rDNA instability and CNV via ERC production is a causative 
factor in yeast replicative ageing pathology 
In contrast to the animal literature, rDNA CNV is an integral part of current theories of 
budding yeast replicative ageing. Replicative lifespan is the measure of the number of 
successful divisions a yeast cell can undergo before senescing. Initially it seemed that 
rDNA amplification, in the form of ERC accumulation discovered by the Guarente lab, was 
an excellent candidate for a putative ageing signal which might eventually cause cessation 
of cell division (Sinclair and Guarente 1997). ERCs seemed an ideal explanation as 
abundance increases dramatically with advanced replicative age and they are 
preferentially retained in mother cells at mitosis (Sinclair and Guarente 1997; Denoth-
Lippuner et al. 2014).  
ERC production seems to rely on similar processes to chromosomal rDNA CNV and 
depends critically on HR – deletion of the key HR gene RAD52 results in almost complete 
attenuation of ERC formation (Park et al. 1999). Once formed, ERCs are capable of 
replication during normal cell cycling due to the presence of the ARS replication origin 
within each yeast rDNA repeat (Figure 1.1). It appears replication of ERCs along with 
asymmetric retention in mother cells is the primary cause of age-related accumulation. 
ERC build-up follows exponential kinetics which are more consistent with a replication 
model rather than increased age-related formation (Morlot et al. 2019). Furthermore 
deletion of SAGA-complex components, which anchor DNA molecules without 
centromeres at nuclear pores during cytokinesis, leads to greatly reduced accumulation 
with age without disrupting ERC formation (Denoth-Lippuner et al. 2014). The RFB protein 
Fob1 which enables rDNA CNV also facilitates, though is not necessary for, ERC 
production since deletion reduces ERC abundance in young and aged cells (Defossez et al. 
1999; Lindstrom et al. 2011; Morlot et al. 2019). Conversely deletion of Sir2, which 
normally silences rDNA IGS transcription at E-pro and inhibits rDNA CNV (Figure 
1.6,Figure 1.7), raises ERC levels early in the yeast lifespan (Kaeberlein et al. 1999). Key 
findings for the ERC-induced ageing model were that sir2Δ strains show reduced 
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replicative lifespan, but that fob1Δ and SIR2 overexpression (OE) strains had increased 
lifespan (Defossez et al. 1999; Kaeberlein et al. 1999). 
 
Subsequently the Kobayashi lab integrated additional evidence, including findings that 
replicative lifespan could be dissociated from ERC accumulation, into a broader ‘rDNA 
theory of yeast ageing’ (Ganley et al. 2009; Ganley and Kobayashi 2014). Under their 
model, the rDNA represents the most unstable region of the genome and hence is the 
proverbial canary in the coalmine with regard to genotoxic stress and DNA damage. This 
is consistent with the Guarente lab’s fob1Δ and sir2Δ / SIR2 OE data as those results can 
be interpreted through the lens of ERC formation reporting on rDNA instability, rather 
Figure 1.9 ERC-dependent model of S. cerevisiae replicative ageing 
Extrachromosomal rDNA circles (ERCs) accumulate during WT yeast ageing with exponential 
kinetics prior to passage through the senescence entry point (SEP). The SEP demarcates an abrupt 
change in cell phenotype with characteristic dilation of cell cycle duration and other pathologies. 
Yeast initially have very few, or zero, ERCs due to the asymmetric retention of ERCs within mother 
cells during division. Formation of an ERC, likely through DNA repair at the chromosomal rDNA 
locus, occurs in a stochastic manner resulting in the Pre-ERC Phase of life having different 
duration in different cells. Due to the asymmetric retention of ERCs within mother cells, and the 
presence of the ARS (replication origin) within rDNA sequences, ERCs undergo an exponential 
increase in numbers. Data in Morlot et al. 2019 suggests that a threshold ERC amount is reached 
after ~13 generations which may result in the SEP. 
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than being pathological per se (Defossez et al. 1999; Kaeberlein et al. 1999; Ganley and 
Kobayashi 2014). Furthermore some of the most highly conserved anti-ageing 
interventions across species, calorie restriction and mTOR inhibition by rapamycin, reduce 
rDNA instability and recombination, with Sir2 being a major downstream effector (Ha and 
Huh 2011; Salvi et al. 2013; Jack et al. 2015).  
Despite the focus on rDNA instability by Kobayashi and Ganley, evidence provides strong 
indications that ERC accumulation, in and of itself, is sufficient to cause pathology. Cell 
cycle induction and subsequent progression though cell cycle phases is severely 
compromised and delayed in yeast nearing senescence (Neurohr et al. 2018). Furthermore, 
occasionally division of aged mothers results in almost complete segregation of ERCs to 
the daughter cells, which consequently show massively reduced replicative potential. 
Conversely mother cells, freed of their ERC burden, are temporarily rejuvenated and show 
improved cell cycle parameters with apparently extended replicative lifespan. Prior to 
complete age-related cell cycle arrest, budding yeast undergo a rapid expansion in cell 
cycle duration, approximately tripling division time, for the final ~5 divisions – termed the 
senescence entry point (SEP) (Fehrmann et al. 2013). Using single-cell microfluidic 
techniques combined with fluorescence microscopy, the Charvin lab has found rDNA CN 
begins to increase notably in the few cell divisions before the SEP is reached and even 
more dramatically thereafter (Morlot et al. 2019). This appears to be consistent with the 
Neurohr et al. 2018 findings. Importantly sir2Δ cells, with shortened lifespan and more 
rapid ERC accumulation, underwent the SEP at much younger replicative ages. Conversely, 
fob1Δ mutants lived longer, as expected, but appeared to show two distinct ageing 
trajectories; approximately 30% cells underwent a similar rDNA CN increase and SEP to 
WT cells, while the other 60% showed no signs of the SEP or much rDNA CNV (Morlot et 
al. 2019). The authors proposed a model wherein stochastic initial ERC formation sets in 
motion a subsequent exponential ERC accumulation process which is ultimately severely 
pathological and leads to the SEP (Figure 1.9). This is distinct from the rDNA theory of 
ageing which focuses closely on the role of rDNA instability and seems to better fit the 
most recent data, although some other older findings are more problematic (Ganley et al. 
2009; Neurohr et al. 2018; Morlot et al. 2019). Notably, while rDNA CN-sensitive gene 
expression is reported in a few systems there is, as yet, no published analysis of whether 
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CNV via ERCs has an influence on the ageing transcriptome – this represents a significant 
gap in our current understanding of their effects on the phenotype of replicatively aged 
cells (Paredes et al. 2011; Gibbons et al. 2014; Li et al. 2018). 
A key point in the Charvin lab’s data is the finding that nucleolar Pol I levels increase 
concomitant with the rDNA CN increase attributed to ERCs (Morlot et al. 2019). Similarly 
pre-18S rRNA appeared to accumulate pre- and post-SEP, meanwhile cellular ribosome 
levels remained constant, measured by fluorescent tagging of the large ribosomal subunit 
protein Rpl13a. This implies age-related dysregulation of ribosome biogenesis in ageing 
yeast. This seems consistent with a previous analysis of the ageing mRNA transcriptome 
and proteome, which unveiled a progressive uncoupling of protein and transcript levels as 
well as causally implicating the ribosome biogenesis machinery in age-related change 
(Janssens et al. 2015). It is also interesting that generally ribosome biogenesis and 
ribosomal protein gene transcripts are downregulated with age in yeast, if not in absolute 
terms at least relative to the transcriptome as a whole (Yiu et al. 2008; Hu et al. 2014; 
Janssens et al. 2015; Janssens and Veenhoff 2016; Hendrickson et al. 2018). Ribosomal 
protein gene deletions, or those more broadly reducing translation, often extend life span 
in yeast, worms, and flies (Kapahi et al. 2004; Kaeberlein et al. 2005; Hansen et al. 2007; 
Steffen et al. 2008; Steffen and Dillin 2016). Overall, ribosome biogenesis and translation 
appear to be central nodes in the cellular ageing network; furthermore, rDNA instability 
and CNV, as ERC accumulation, now appears to be relevant in age-related ribosomal 
biogenesis complications and thus highlights the need for a detailed look at ribosome 
biogenesis through the lifespan. 
Replicative lifespan is the primary context in which rDNA CNV / instability has been linked 
to ageing in yeast. The chronological ageing paradigm, measuring the duration non-
dividing cells survive after reaching stationary phase, has not been employed much with 
regard to studying rDNA phenomena. However, the literature available suggests that 
chronologically ageing cells do not accumulate ERCs, although they show moderate 
tendencies towards rDNA instability and nucleolar morphological changes (Ashrafi et al. 
1999; Lewinska et al. 2014). Thus it seems rDNA instability may be a common phenotype 
between yeast ageing models. Nonetheless, increasing ERC abundance appears to 
critically depend on cell division; this is in line with the model of  ERC accumulation as 
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primarily supported by amplification and retention during replicative ageing, rather than 
de novo formation (Sinclair and Guarente 1997; Denoth-Lippuner et al. 2014). Intriguingly 
it has been recently found that mammalian SIRT7, a homolog of yeast Sir2, is involved in 
maintaining rDNA stability and that instability promotes cell senescence – thus 
establishing rDNA instability as a potential cause of cellular ageing in mammals and 
reinforcing the potential generalisability of findings from the replicative ageing yeast 
paradigm (Paredes et al. 2018). Finally it is worth noting that, while rDNA instability and 
CNV are strongly implicated in ageing, a study which was published after I began this 
project found no correlation between inherited rDNA CN and replicative lifespan in yeast 
(Kwan et al. 2016). 
1.7 Caenorhabditis elegans as a new animal model of rDNA CNV 
There is a sound evidential basis supporting a significant role of rDNA CNV in influencing 
animal phenotypes. Furthermore, a strong case can be made for involvement of rDNA 
CNV in organismal ageing processes. rDNA CNV is evident among human populations 
and has already been linked to various pathologies (Stults et al. 2008; Hallgren et al. 2014; 
Chestkov et al. 2018; Malinovskaya et al. 2018). Therefore there is currently a gap in our 
understanding of what further implications this known source of genomic variation might 
have for human health and phenotypic diversity – particularly of the fundamentals for 
what might mediate such downstream phenotypic effects.  
As such, a simple model organism was desirable which would permit rapid analysis of 
potential rDNA CN-sensitive phenotypes. Understanding of rDNA CNV-related processes 
is currently best in the budding yeast S. cerevisiae (Nelson et al. 2019). However yeast, 
though an invaluable model for elucidating basic conserved principles of molecular 
biology, is a single-celled fungus and thus lacks many important features one might look 
for in a broader model of animal biology. There is already some literature on rDNA CNV in 
Drosophila and flies are an established system for investigating ageing (Piper and 
Partridge 2018). However median WT lifespan in Drosophila is approximately 70 days, 
meaning lifespan assays would require a few months before full results would be available. 
The most widely used mammalian model, mice, would likely provide the greatest 
generalisability to humans of any findings, but the timing issues vis-à-vis ageing and other 
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assays would be considerably worse than Drosophila. Therefore I considered 
Caenorhabditis elegans, a free living nematode worm, as a candidate for work on rDNA 
CNV given the interest in ageing biology. C. elegans have a 3-4 day life cycle with average 
WT lifespan of 2-3 weeks under standard conditions. Hence assaying lifespan, or other life 
history traits such as fecundity or developmental rate, is much accelerated in worms 
compared even with Drosophila. Furthermore, worms are very well established as an 
ageing model, where the relevant processes are understood in considerable molecular 
detail (reviewed in Tissenbaum 2015; Denzel et al. 2019).  
C. elegans are eminently suitable as a model for rDNA studies. Worms have a single 
autosomal 35S rDNA tandem array adjacent to the 3` telomere on chromosome I with 
literature estimates of ~55 – 100 copies in the N2 strain typically used as WT (Sulston and 
Brenner 1974; Ellis et al. 1986; The C. elegans Sequencing Consortium 1998). They also 
possess a separate 5S rDNA array on chromosome V, previously estimated to be ~110 
copies in size (Nelson and Honda 1985, 1986). In both regards this is arguably more 
similar to the human genomic organisation of rDNA repeats, autosomal 45S arrays with a 
single 5S locus, than either yeast or Drosophila; yeast 35S and 5S genes are incorporated 
into a single repeat unit and Drosophila 35S array homologs are present on X and Y sex 
chromosomes. The worm rDNA repeat is 7.2 kb, of which most is transcribed by Pol I 
leaving only short IGS regions (Saijou et al. 2004). Additionally, while RiBi has been 
minimally studied in worms, it appears processing of pre-rRNA intermediates follows a 
broadly similar pattern to that of yeast (Saijou et al. 2004). Herein I adopt the yeast 
nomenclature to refer to homologous molecules between species for consistency (e.g. 35S 
refers to the primary Pol I transcript, 25S refers to the largest mature rRNA etc.). Genetic 
heterogeneity between worms within a strain is such that are generally considered 
isogenic. The C. elegans predominant reproductive strategy is hermaphroditic self-
fertilisation (though male animals are generated with low (<1%) frequency and can 
fertilise hermaphrodites) which is considered to have driven genomic loci to homozygosity 
over many years of culturing in labs. Therefore we expected C. elegans would present a 
system where potentially subtle rDNA CN-dependent phenotypes should be detectable 
over a background of minimal genotypic noise. 
54 
 
Prior to starting this project, two recently published articles had reported on significant 
rDNA CNV among C. elegans isolates and nematode species more generally (Bik et al. 
2013; Thompson et al. 2013). Thus it seemed likely that germline rDNA CNV was active in 
C. elegans and, as suggested by Bik et al. 2013, under selection. Thus we were relatively 
confident that rDNA CN makes phenotypic contributions in worms as it appears to in 
other species. Interestingly, there is between-worm heterogeneity in some phenotypes 
such as stress resistance despite individuals being considered isogenic (Burga et al. 2011; 
Casanueva et al. 2012). We hypothesised that this might result from inter-individual rDNA 
CNV which was not assayed in previously published work. After beginning this project, it 
was found by the Antebi lab and co-workers that smaller nucleolar sizes appear to be 
associated with or, in the case of C. elegans, predictive of longevity in multiple systems 
(Tiku et al. 2017; Tiku and Antebi 2018). This was of great interest, given the nucleolus 
organises around the rDNA and is the site of early ribosome biogenesis, and led to my 
assaying nucleolar size as a function of rDNA CN.  
Overall, my investigation into basic phenotypic and transcriptomic contributions of rDNA 
CNV in both worms and yeast represents a timely contribution which addresses several 
important outstanding gaps in our understanding of rDNA biology. 
1.8 PhD project aims, direction and thesis plan 
The initial aims of this project were two-fold: 
1. To screen for and investigate rDNA CN-sensitive phenotypes in C. elegans. 
2. To examine inter-individual rDNA CNV as a possible cause for previously 
discovered phenotypic variance between worms considered isogenic. 
After an initial assay development and optimisation phase, necessary to remedy the lack 
of standard C. elegans rDNA CN assays, I made considerable successful progress on point 
1. Results from this phase of work are presented in Section 3. Point 2 would have required 
a more sophisticated rDNA CN assay capable of accurately estimating CN in single worms, 
however considerable technical difficulties with this meant points 2 could not be 
addressed. I therefore pursued a comparative biology approach using transcriptomic data 
to look for conserved effects of rDNA CNV in worms and yeast. I found evidence of rDNA 
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CN-sensitive transcription in both systems, though functional categories appeared to be 
more species-specific, as described in Section 4. I decided to further characterise the role 
of rDNA CNV, in the form of ERC accumulation, in the yeast model during ageing. Section 
5 describes this work as well as an exploratory investigation into RiBi changes during yeast 
ageing. 
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2 Materials and Methods 
2.1 Solutions and Media 
2.1.1 General 
1x TBE solution 
10.8 g/l Tris base, 5.5 g/l boric acid, 4 ml/l 0.5 M EDTA pH 8 
Glyoxal mix 
5% glycerol, 8% glyoxal, 1.2X BPTE, 20 μg/ml ethidium bromide in DMSO 
1x BPTE solution 
3 g/l PIPES, 6 g/l Bis-Tris, 2 ml/l 0.5 M EDTA pH 8.0 
Gel depurinating solution 
250 mM HCl 
Gel denaturing solution 
500 mM NaOH 
Gel neutralising solution 
1.5 M NaCl, 0.5 M Tris HCl pH 7.5 
1x SSC 
150 mM NaCl, 15 mM sodium citrate pH 7-8 
PFGE wash buffer 
10 mM Tris pH 7.6, 50 mM EDTA 
PFGE fixing buffer 
70% EtOH, 30 mM EDTA pH 8.0, 200 mM Tris HCl pH 8.0 
PK buffer 
100 mM EDTA, 0.2 % sodium deoxycholate, 1% sodium lauryl sarcosine (prepared fresh) 
Proteinase K (stock solution) 
10 mM Tris pH 7.5, 1 mM CaCl2, 5% glycerol (w/v), 20 mg/ml Proteinase K (Roche) 
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1x TE 
10 mM Tris HCl pH 8.0, 1 mM EDTA pH 8.0 
Church Hyb 
0.17 M Na2HPO4, 79 mM NaH2PO4, 120mM SDS, 1mM EDTA pH 8.0, 10 g/L BSA  
2.1.2 C. elegans-specific 
NGM agar 
3 g/l NaCl, 20 g/l agar, 2.5 g/l peptone, 1ml/l 5mg/ml cholesterol in EtOH, 25 ml/l 1M 
KPO4 buffer pH 6.0, 1 ml/l 1M MgSO4, 1 ml/l 1M CaCl2 
1M KPO4 buffer pH 6.0 
108.3 g/l KH2PO4, 35.g g/l K2HPO4 
M9 buffer 
3 g/l KH2PO4, 7.56 g/l Na2HPO4, 5 g/l NaCl, 1 ml/l MgSO4 
Hypochlorite bleach solution 
10% (v/v) sodium hypochlorite, 500 mM KOH 
DNA lysis buffer 
200 mM NaCl, 100 mM Tris-HCl pH 8.5, 50 mM EDTA pH 8.0, 0.5 % (v/v) SDS, 0.1 mg/ml 
Proteinase K 
2.1.3 S. cerevisiae-specific 
Solid growth medium 
YPD agar – 2% peptone, 1% hydrolysed yeast extract, 2% glucose, 2% agar 
Liquid growth medium 
YPD – 2% peptone, 1% hydrolysed yeast extract, 2% glucose 
YPGal – 2% peptone, 1% hydrolysed yeast extract, 2% galactose 
1x PBSE 
137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 2 mM KH2PO4, 2 mM EDTA pH 8.0 
17 U/µl Lyticase stock 
17 U/μl lyticase (Sigma > 2000 U/mg L2524), 10 mM KPi pH 7, 50% glycerol 
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Buffer A 
1.2 M sorbitol, 50 mM EDTA pH 8.0, 10 mM DTT, 340 U/ml lyticase 
Buffer B 
0.3% (v/v) SDS, 50 mM EDTA, 100 μg/ml RNase A 
2.2 General materials and methods 
2.2.1 PCR 
OneTaq PCR 
Per 50 μl: 25 μl 2x OneTaq Hotstart, 1 μl 100 nM forward primer, 1 μl 100 nM reverse 
primer, 1 μl template DNA, 22 μl distilled H2O. 
Conditions: 94 °C 1 min, [94 °C 15s, 53 °C 15s, 68 °C 1 min/kb] x35, 68 °C 5 min. 
Phusion PCR 
Per 50 μl: 10 μl 5x Phusion buffer, 1 μl 10 mM dNTPs, 1 μl 100 nM forward primer, 1 μl 100 
nM reverse primer, 1 μl template DNA, 0.5 μl Phusion Hot Start (NEB), 35.5 μl distilled H2O. 
Conditions: 98 °C 30 s, [98 °C 10s, 53 °C 15s, 72 °C 30 s/kb] x35, 72 °C 5 min, 4 °C hold. 
Takara LA PCR 
Per 40 μl: 4 μl 10x LA PCR Buffer II, 6.4 μl Takara 2.5 mM dNTPs, 0.8 μl 100 nM forward 
primer, 0.8 μl 100 nM reverse primer, 0.8 μl template DNA, 0.4 μl Takara LA Taq, 26.8 μl 
distilled H2O. 
Conditions: 94 °C 1 min s, [98 °C 10s, 48 °C 20s, 68 °C 30 s/kb] x35, 72 °C 10 min, 4 °C 
hold. 
2.2.2 DNA separation by gel electrophoresis 
DNA was separated on 1-2% agarose gels depending on the expected size of relevant 
bands of interest. Running buffer was 1x TBE. DNA bands were visualised by adding 2.5 μl 
SYBR Safe (ThermoFisher) per 100 ml gel before pouring the gel, gels were then imaged 
using a Gel Doc™ XR+ system (Bio-Rad). Bands requiring gel extraction were extracted 
using the QIAquick Gel Extraction Kit (Qiagen). 
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2.2.3 RNA separation by gel electrophoresis 
RNA samples were glyoxylated by incubating a 5:1 ratio of glyoxal mix : sample at 55 °C 
for 1 h. RNA was hen separated on a 1.2% agarose (Melford) gel in 1x BPTE running 
buffer. Gels were imaged using either a Gel Doc™ XR+ system (Bio-Rad) under UV-
transillumination or a Typhoon FLA 7000 (GE Life Sciences) with fluorescence stage. Gels 
were blotted according to the Northern blotting protocol. 
2.2.4 Southern blotting 
PFGE gels were washed with freshly made gel depurinating solution for 15 min. Then gels 
were rinsed with water and washed with gel denaturing solution for 40 min. Finally, gels 
were washed twice for ≥20 min with gel neutralising solution. 
DNA was blotted to an Amersham Hybond-N+ (GE Life Sciences) nylon membrane by 
upward transfer using 6x SSC as transfer buffer. Blotting was allowed ≥16 h to complete 
before DNA was UV cross linked to the membrane in a UV Stratalinker 1800 (GE Life 
Sciences). Membranes were stored at -20 °C until use. 
Random primed radiolabelled probes were generated using [α-32P] dCTP. Membranes 
were pre-hybridised at the hybridisation temperature in hybridisation buffer for ≥1 h 
before addition of radiolabelled probe. All C. elegans PFGE blots were hybridised in 
ULTRAHyb™ (ThermoFisher) at 42 °C. Probe hybridisation occurred overnight. Specific 
probes used are noted in the results chapter and figure legends, probes were amplified 
from gDNA using PCR primers in . 
Membranes probed with ULTRAHyb™ at 42 °C were rinsed twice with 6x SSC at RT and 
washed with a further 6x SSC at 42 °C for ≥15 min. Membranes were then washed with 
pre-warmed 0.1x SSC, 0.1% SDS twice for ≥20 min each at 42 °C. Membranes were 
imaged using a Typhoon FLA 7000 (GE Life Sciences). When required, probes were 
stripped from membranes by washing three times with boiling 0.1x SSC, 0.1% SDS. 
Blots showing yeast ERCs and rDNA were probed with random primed probes. 
Membranes were hybridised in Church Hyb at 55 °C. Probe hybridisation occurred 
overnight. Probes were generated from PCR from genomic DNA, primers . Membranes 
were rinsed twice with 6x SSC at RT and washed with a further 6x SSC at 55 °C for ≥15 
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min. Membranes were then washed with pre-warmed 0.5x SSC, 0.1% SDS twice for 20 min 
each at 55 °C. Membranes were imaged using a Typhoon FLA 7000 (GE Life Sciences). 
2.2.5 Northern Blotting 
Gels were first washed for 20 min with 75 mM NaOH, and then for ≥20 min with gel 
neutralising solution.  
RNA was blotted to an Amersham Hybond-N+ (GE Life Sciences) nylon membrane by 
upward transfer using 6x SSC as transfer buffer. Blotting was allowed ≥16 h to complete 
before RNA was UV cross linked to the membrane in a UV Stratalinker 1800 (GE Life 
Sciences). Membranes were stored at -20 °C until use. 
When random primed radiolabelled probes were used the protocol was as for Southern 
blotting with Church Hyb.  
When oligo probes were used these were labelled with [γ-32P] dATP. probes in . 
Membranes were pre-hybridised at the hybridisation temperature in hybridisation buffer 
for ≥1 h before addition of radiolabelled probe. Blots were hybridised in ULTRAHyb-
Oligo™ (ThermoFisher) at 42 °C. Probe hybridisation occurred overnight. Membranes were 
rinsed twice with 6x SSC at RT and washed with a further 6x SSC at 42 °C for ≥15 min. 
Membranes were then washed with pre-warmed 2x SSC, 0.5% SDS twice for 20 min each 
at 42 °C. Membranes were imaged using a Typhoon FLA 7000 (GE Life Sciences). 
2.2.6 RNA-seq library preparation and sequencing 
Polyadenylated RNA was isolated from extracted RNA using the NEBNext® Poly(A) mRNA 
Magnetic Isolation Module kit (NEB) according to manufacturer’s instructions.  
Libraries were prepared from poly(A)+ RNA using either the NEBNext® Ultra™ Directional 
RNA Library Prep Kit for Illumina® (NEB) or the NEBNext® Ultra™ II Directional RNA 
Library Prep Kit for Illumina® (NEB). Reagent volumes used were halved relative to 
manufacturer’s recommendations except for the PCR amplification step which was 
performed as directed. AMPure XP beads (Beckman Coulter) were used as set out in the 
NEB kit instructions, with an additional second (0.9x AMPure beads) clean-up following 
PCR amplification. 
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The NEBNext® Ultra™ kit was used to prepare all worm RNA-seq libraries and those from 
yeast samples comparing different genomic rDNA copy numbers (Described in Section 
4.2.3). 
The NEBNext® Ultra ™ II kit was used to prepare libraries for yeast stains with spt3Δ or 
rad52Δ gentoypes and associated WT samples (Described in Section 5). 
Before sequencing, libraries were quantified with the KAPA Library Quantification Kit for 
Illumina (Roche) and run on a 2100 Bioanalyser (Agilent) using a High Sensitivity DNA chip 
(Agilent) as per manufacturer’s instructions. 
Libraries were sequenced on a NextSeq500 (Illumina) in HighOutput mode according to 
manufacturer’s instructions, producing 75bp single-ended reads. 
2.3 C. elegans-specific materials and methods 
2.3.1 C. elegans strains 
Table 2.1 C. elegans strains used in this work 
Strain Genotype Source Reference 
CGC N2 
(Hermaphrodite 
stock) Wild Type CGC 
Sulston and 
Brenner 1974 
CGC N2 (Male 
stock) Wild Type CGC 
Sulston and 
Brenner 1974 
DR1564 daf2-(m41) III CGC 
Gems et al. 
1998 
DR1565 daf2-(m596) III CGC 
Gems et al. 
1998 
DR1568 daf-2(e1371) III CGC 
Gems et al. 
1998 
DR1572 daf-2(e1368) III CGC 
Gems et al. 
1998 
DR1574 daf-2(e1391) III CGC 
Gems et al. 
1998 
CB1370 daf-2(e1370) III CGC 
Gems et al. 
1998 
DA1113 eat-2(ad1113) II CGC 
McKay et al. 
2004 
EG8922 
oxTi981 [eft-3p::GFP::2xNLS::tbb-2 3'UTR + 
HygR] I CGC 
Frøkjær-
Jensen et al. 
2014 
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EG7890 
oxTi706 [eft-3p::tdTomato::H2B::unc-54 3'UTR 
+ Cbr-unc-119(+)] II; unc-119(ed3) III CGC 
Frøkjær-
Jensen et al. 
2014 
EG7892 
oxTi612 [eft-3p::tdTomato::H2B::unc-54 3'UTR 
+ Cbr-unc-119(+)] unc-119(ed3) III CGC 
Frøkjær-
Jensen et al. 
2014 
MOC90 
oxTi981 [eft-3p::GFP::2xNLS::tbb-2 3'UTR + 
HygR] I; oxTi706 [eft-3p::tdTomato::H2B::unc-
54 3'UTR + Cbr-unc-119(+)] II; unc-119(ed3)(?) 
III This work N/A 
MOC95 Wild Type (heterozygous High / WT rDNA CN) This work N/A 
MOC96 daf2-(m596) III (High rDNA CN) This work N/A 
MOC97 
oxTi706 [eft-3p::tdTomato::H2B::unc-54 3'UTR 
+ Cbr-unc-119(+)] II; unc-119(ed3)(?) III (High 
rDNA CN) This work N/A 
MOC98 As MOC97 This work N/A 
MOC99 
oxTi981 [eft-3p::GFP::2xNLS::tbb-2 3'UTR + 
HygR] I (WT rDNA CN) This work N/A 
MOC100 As MOC99 This work N/A 
MOC101 
oxTi981 [eft-3p::GFP::2xNLS::tbb-2 3'UTR + 
HygR] I; oxTi706 [eft-3p::tdTomato::H2B::unc-
54 3'UTR + Cbr-unc-119(+)] II; unc-119(ed3)(?) 
III (WT rDNA CN) This work N/A 
MOC102 
oxTi981 [eft-3p::GFP::2xNLS::tbb-2 3'UTR + 
HygR] I; oxTi706 [eft-3p::tdTomato::H2B::unc-
54 3'UTR + Cbr-unc-119(+)] II; unc-119(ed3)(?) 
daf-2(m596) III (WT rDNA CN) This work N/A 
MOC132 
oxTi981 [eft-3p::GFP::2xNLS::tbb-2 3'UTR + 
HygR] I; oxTi612 [eft-3p::tdTomato::H2B::unc-
54 3'UTR + Cbr-unc-119(+)] unc-119(ed3)(?) III This work N/A 
MOC159 
oxTi612 [eft-3p::tdTomato::H2B::unc-54 3'UTR 
+ Cbr-unc-119(+)] unc-119(ed3)(?) III (High 
rDNA CN) This work N/A 
MOC161 As MOC159 This work N/A 
MOC160 As MOC159 This work N/A 
MOC165 
oxTi981 [eft-3p::GFP::2xNLS::tbb-2 3'UTR + 
HygR] I; oxTi612 [eft-3p::tdTomato::H2B::unc-
54 3'UTR + Cbr-unc-119(+)] unc-119(ed3)(?) III 
(WT rDNA CN) This work N/A 
MOC166 As MOC165 This work N/A 
MOC167 As MOC165 This work N/A 
SJL1 cguIs1[fib-1p::fib-1::GFP::3' UTR fib-1] 
Szecheng 
John Lo, 
CECF 
Taiwan Yi et al. 2015 
MOC121 
oxTi706 [eft-3p::tdTomato::H2B::unc-54 3'UTR 
+ Cbr-unc-119(+)] II; unc-119(ed3)(?) III; 
cguIs1[fib-1p::fib-1::GFP::3' UTR fib-1] (High 
rDNA CN) This work N/A 
MOC122 As MOC121 This work N/A 
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MOC124 
oxTi706 [eft-3p::tdTomato::H2B::unc-54 3'UTR 
+ Cbr-unc-119(+)] II; unc-119(ed3)(?) III; 
cguIs1[fib-1p::fib-1::GFP::3' UTR fib-1] (WT 
rDNA CN) This work N/A 
MOC125 As MOC124 This work N/A 
RB831 tbx-8(ok656) CGC 
The C. elegans 
Deletion 
Mutant 
Consortium 
MOC219 tbx-8(ok656) (High rDNA CN) This work N/A 
MOC220 As MOC219 This work N/A 
MOC221 As MOC219 This work N/A 
MOC222 tbx-8(ok656) (WT rDNA CN) This work N/A 
MOC223 As MOC222 This work N/A 
MOC224 As MOC222 This work N/A 
 
Some strains were provided by the CGC, which is funded by NIH Office of Research 
Infrastructure Programs (P40 OD010440). 
2.3.2 C. elegans culture 
C. elegans were maintained under standard conditions on solid NGM agar medium 
seeded with a lawn of E. coli OP50. Animals were kept at 20 °C for experimental work and 
most maintenance. During maintenance some plates were kept temporarily at 16 °C. 
Plates used were typically either 6 cm or 9 cm diameter. 
Media was autoclaved before pouring to plates. Plates were dried for at least 2 days 
before seeding with E. coli. Bacteria were grown overnight in LB broth at 37 °C in a 
shaking incubator; cultures could be kept at 4 °C for up to 2 months and used for plate 
seeding. After seeding, plates were kept at RT for at least 2 days to plates to dry and the 
lawn to thicken. Plates were stored at 4 °C if not used within a few days of seeding. 
2.3.3 Strain crossing 
Males were obtained for strain crossing either by heat shock of parental animals or 
feeding with klp-16 RNAi expressing E. coli strains. Males were allowed to mate with 
young adult hermaphrodites overnight and hermaphrodites singled to fresh plates. F1 
offspring from successful crosses were pooled and F2 progeny singled for phenotypic 
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assay. Homozygosity of fluorescence phenotypes was confirmed in the F3 generation. 
Lines derived from single F2 progeny were thereafter maintained as separate strains. 
2.3.4 DNA extraction 
2.3.4.1 Extract-N-Amp kit 
The Extract-N-Amp Tissue PCR kit (Sigma Aldrich) was used to extract DNA for PCR 
genotyping. A sample of 100-1000 worms in PFGE fixing buffer was pelleted and buffer 
removed. 50 μl kit Extraction solution was added along with 12.5 μl kit Tissue prep 
solution. Samples were incubated at 55 °C for 10 min followed by 95 °C for 3 min. 50 μl of 
kit Neutralisation solution was then added to complete the extraction. 
2.3.4.2 Phenol-chloroform 
~2000 worms stored in PFGE fixing buffer were pelleted and the supernatant removed. 
Pellets were re-suspended in 500 μl DNA lysis buffer with 0.1 mg/ml Proteinase K and 
incubated at 65 °C for 2 h. Samples then incubated at 95 °C for 30 min. RNase A was 
added to a final concentration of 0.1 mg/ml and samples incubated at 37 °C for 1 h. DNA 
was extracted by phenol-chloroform extraction with 1 volume phenol-chloroform buffered 
at pH 8 with Tris. The aqueous phase was removed and subjected to a further round of 
phenol-chloroform extraction and a final chloroform extraction. The aqueous phase was 
kept. DNA was then ethanol precipitated with 0.1 volumes 3M sodium acetate and 0.5 μl 
GlycoBlue co-precipitant (ThermoFisher). Pelleted DNA was allowed to air dried and then 
re-suspended in 1x TE. Extracted DNA concentration was quantified with a Nanodrop 
2000 (ThermoFisher). 
2.3.5 RNA extraction 
Frozen samples of worms in TRIzol™ Reagent (ThermoFisher) were thawed at 37 °C, 
vortexed for 30 s, and frozen on liquid nitrogen. This was performed for 6 freeze-thaw 
cycles. Samples were then alternately vortexed for 30 s and placed on ice for 30 s. 6 cycles 
were performed and tubes allowed to stand 5 min at RT. RNA was separated from other 
cell contents by chloroform extraction. The aqueous phase was removed and RNA 
precipitated with isopropanol. RNA was pelleted and washed with ice cold 75% EtOH. 
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After air drying for 5 min the pellet was re-suspended in nuclease free water and stored at 
-20 °C. RNA concentration was quantified using a Qubit RNA HS Assay kit (ThermoFisher). 
2.3.6 Strain genotyping 
Genotyping of daf-2 or tbx-8 alleles was performed by PCR from genomic DNA extracted 
with the Extract-N-Amp Tissue PCR kit (Sigma Aldrich). Specific loci were amplified with 
the Phusion® High-Fidelity DNA Polymerase (NEB) using primers in  with 1 μl genomic 
DNA extract. PCR products were separated by agarose gel electrophoresis. tbx-8(ok656) 
genotype was assayed using 2 primer sets by PCR. Genotype could be detected by 
presence / absence of bands under SYBR safe stain. daf-2(m596) is a single nucleotide 
substitution and so PCR product sequences were verified by Sanger sequencing 
(outsourced to the commercial provider GENEWIZ).  
2.3.7 rDNA copy number assay by Pulsed Field Gel Electrophoresis 
Worms were washed from plates with 5-10 ml 1x M9 solution, typically recently starved 
mixed-age cultures were used. Tubes were centrifuged at 1500 RPM for 1 min (MSE 
Mistral 1000) and the supernatant removed. Worms were washed with a further 10 ml 1x 
M9, centrifuged at 1500 RPM for 1 min and the supernatant removed. Worms were then 
either re-suspended in PFGE wash buffer for immediate use or stored at -20 °C in 1 ml 
PFGE Fixing Buffer. Worm samples could be stored like this for at least 2 months. 
Worm density per sample was estimated using a microscope and density was adjusted 
such that there were approximately 1000 worms in 60 µl PFGE wash buffer for each 
sample. Worm suspensions were mixed with 40 µl molten CleanCut Agarose (Bio-Rad) by 
vortex mixer. Suspensions were pipetted into plug moulds using wide-bore tips. Plugs 
were allowed to set at 4 °C. During this process, plugs were kept horizontal where possible 
to limit worms settling and affecting homogeneous distribution of DNA inside the plugs. 
Once set, plugs were incubated at 50 °C in freshly made PK buffer with 1 mg/ml 
proteinase K in for 2 h - overnight. 
PK buffer was removed, plugs were washed four times for at least 1 h with 1x TE with 
gentle agitation. On the second and third washes 1x TE with 1 mM PMSF was used. 
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Following washing, plugs were stored at 4 °C, where DNA was stable for at least 1 month, 
or immediately used for restriction enzyme digestion. 
Before restriction digest, plugs were cut in half with a clean razor blade and one half-plug 
per sample was equilibrated 1x CutSmart® Buffer (NEB) twice for 15 min. Half-plugs were 
then incubated at 37 °C in 100 µl 1x CutSmart® Buffer containing 10 U restriction enzyme 
(PmeI (NEB) for 35S blots; KpnI-HF (NEB) for 3S blots) for 2 h. Digestion buffer was then 
removed, and half-plugs equilibrated in freshly made 0.5x TBE for 30 min. 
For visualisation of WT rDNA CN bands, half-plugs were placed into the wells of a 1.0% 
gel made with Pulsed Field Certified Agarose (Bio-Rad). A plug containing S. cerevisiae 
chromosomal DNA (NEB) was used as a size marker. Gels were run using a CHEF-DR® III 
system (Bio-Rad) in freshly made 0.5x TBE running buffer cooled to 14 °C at 6 V/cm with 
included angle set to 120° and current switch times linearly ramped between 60 – 120 s. 
Total run time was set to between 21 – 24. For visualisation of larger rDNA CN bands the 
process was as above except: gel percentage 0.8%, running buffer 1x TBE, potential 
difference 3 V/cm, 300 – 900 s linearly ramped switch times, total run time 68 h, markers 
were Hansenula wingei chromosomes. 
Following electrophoresis, gels were stained for 15 min in 125 pg/ml ethidium bromide 
(Bio-Rad). Gels were then imaged using either a Gel Doc™ XR+ system (Bio-Ra) under UV-
transillumination or a Typhoon FLA 7000 (GE Life Science) with fluorescence stage. 
Gels were then blotted according to the Southern blotting protocol. 
rDNA CN was estimated by first finding marker band migration distances from the EtBr 
stained gel image, using ImageJ, and fitting a cubic spline in R to act as a band size-
distance calibration curve. rDNA band migration distances were similarly obtained from 
the radioprobed blot image. rDNA band sizes were calculated from the marker band 
calibration curve; rDNA CN was then estimated by dividing calculated band sizes by 
known repeat sizes after correction for restriction enzyme cut site location. 
2.3.8 rDNA copy number assay by qPCR 
Genomic DNA extracted by the phenol-chloroform method was amplified in 4 μl reactions 
on 384 well plates (BioRad). Each reaction contained 1x Maxima Probe qPCR mix (no ROX) 
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(ThermoFisher), 300 nM 35S and 5S rDNA primer pairs (), 100 nM 35S and 5S qPCR probes 
(), 1 ng input C. elegans genomic DNA, and 1 ng salmon sperm DNA. Samples were run on 
a C1000 Touch Thermal Cycler (BioRad) with conditions: 95 °C 10 min, [95 °C 15 s, 60 °C 
30 s, plate read] x40, Melt curve program. 
Data was analysed with BioRad CFX Manager™ and R software packages. 
2.3.9 Population synchronisation by hypochlorite bleach treatment 
Animals from a colony with gravid adults were washed from plates in 5 – 10 ml 1x M9 
buffer. Samples were centrifuged and bacterial supernatant removed by washing with 
more 1x M9. Samples were again pelleted and the supernatant removed. Worms were 
then incubated for approximately 6 min in 5 ml hypochlorite bleach solution. Samples 
were then centrifuged and washed with 1x M9 three times. Egg suspensions were allowed 
to hatch overnight in 1x M9 which provided a well synchronised set of L1 arrested larvae. 
2.3.10 Fecundity assay 
Ten L4 animals per strain were isolated in individual wells of a 12 well plate (with NGM 
agar and E. coli OP50 lawn) and passed to a fresh plate every 24 h. Progeny produced 
between this initial plating and subsequent passage were defined as having been laid on 
day 0. Parental animals were picked to a flame after day 8. Live progeny were counted 
manually on each plate 2-4 days after the parent was removed. 
2.3.11 UV-tolerance assay 
Two protocols were used. For the first experiment, approximately 100 non-synchronised 
eggs per strain were moved to a fresh 6 cm plate and placed outside of the bacterial lawn. 
Plates were irradiated with 0, 100, or 250 Jm-2 UV radiation in a Stratalinker 1800 (GE Life 
Sciences). Plates were immediately covered with aluminium foil to prevent photo-recovery 
and kept overnight under standard conditions. Hatched larvae and unhatched eggs were 
counted manually after 24 h. The embryonic survival percentage was calculated from the 
ratio of hatched larvae to unhatched eggs. 
For the second experiment, a synchronised set of eggs were obtained from a 1.5 h egg lay 
and approximately 50 moved to fresh plates in duplicate per strain per UV dosage. Eggs 
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were counted before irradiation with 0, 50, or 150 Jm-2 UV. Plates were immediately 
covered with foil and kept under standard conditions. Plates were blinded and surviving 
animals counted manually 3 days later. Percentage survival to adulthood was calculated 
from the ratio of total live animals to eggs on the plate at the start of the experiment. 
2.3.12 Developmental rate assay 
Three experiments were performed. For the first, eggs were isolated from gravid adults by 
hypochlorite bleach treatment and overnight L1 arrest. Approximately 200 animals per 
strain were then grown under standard conditions for two days on 9 cm plates. Worms 
were checked regularly for entry into L4 lethargus on the second day after plating 
beginning at 45 h after plating. Cessation (or dramatic reduction) of pharyngeal pumping 
was the primary phenotypic marker used to determine entry into L4 lethargus. Once 
counted as having entered lethargus worms were removed to avoid duplicate counting. 
Plates were checked approximately once an hour until ~53 hours after worm plating. 
For the second experiment eggs were again isolated by hypochlorite bleaching and L1 
arrest. Approximately 30 animals per strain were plated to each of 4x 6 cm plates. Plates 
were blinded and kept at standard conditions for two days. Plates were checked regularly 
for entry into L4 lethargus starting at 45 h after plating as before. Plates were checked 
approximately once an hour until ~57 hours after worm plating. Plates were un-blinded 
for analysis. 
The third experiment was conducted as the second experiment, however counting began 
46 h after plating and continued until ~57 hours after plating. 
2.3.13 Lifespan assay 
Animals were synchronised at L1 stage by hypochlorite bleaching and overnight arrest. 
Approximately 300 larvae per strain were plated on 6 cm NGM plates at staggered times 
to account for developmental timing differences. MOC160, MOC166, MOC167 were 
plated 2 h after MOC159, MOC161, and MOC165. At late L4 stage, worms were re-plated 
to NGM with 25 μM FUDR (Sigma Aldrich) and 10 μg/ml nystatin (Sigma Aldrich) which 
induce sterility and inhibit growth of fungal contaminants respectively. This was defined as 
day 0, plates were blinded and subsequently scored every 1-2 days, starting on day 5, until 
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all worms had died. Worm death was confirmed by gentle prodding of the head or tail 
with a worm pick. Worms which died with visible pathology were censored.  
2.3.14 Mutation penetrance assay 
Synchronised eggs were collected during a 3 h egg lay. Approximately 100 eggs per strain 
were then re-plated to 6 cm plates in duplicate. Plates were blinded and maintained under 
standard conditions. Unhatched eggs were counted ~24 h later. After another ~48 h 
plates were scored for numbers of phenotypically WT adults, delayed or morphologically 
deranged live animals, and corpses. The number of ‘missing’ worms was then calculated as 
the difference between number of eggs plated and the sum of observations for all scored 
groups. 
2.3.15 Nucleolar size assay 
Synchronised populations of worms were collected by a 2 h egg lay. Plates were blinded 
and young adult animals used for microscopy. Before imaging ~20 animals were 
transferred to an agar pad on a glass slide. Animals were immobilised with levamisole 
solution. Animals were imaged at 63x magnification using a Nikon A1R confocal 
fluorescence microscope. Images of GFP and tdTomato fluorescence in hypodermal cells 
hyp9 and hyp10 were captured at 512 px resolution with 0.1 μm/pixel. Nucleolar size was 
manually determined using ImageJ software from GFP fluorescence signal before un-
blinding of samples.  
2.4 S. cerevisiae-specific methods 
2.4.1 S. cerevisiae yeast strains 
Table 2.2 S. cerevisiae yeast strains used in this work 
Strain ID Genotype 
Strain 
background Reference 
JH1156 
MATa ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-
100 fob1Δ::HIS3 (~190 rDNA repeats) W303 
Cioci et al. 
2003 
JH1157 
MATa ade2-1 ura3-1 trp1-1 leu2-3,112 his3-11 can1-
100 fob1Δ::HIS3 (~25 rDNA repeats) W303 
Cioci et al. 
2003 
CJ29 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fob1::hygMX6 
(~180 rDNA repeats) BY4741 Jack 2014 
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JH81 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 fob1::hygMX6 
(~180 rDNA repeats) BY4741 Jack 2014 
CJ187 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mms22::HIS3 
(>500 rDNA repeats) BY4741 This work 
CJ188 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mms22::HIS3 
fob1::LEU2 (~190 rDNA repeats) BY4741 This work 
CJ189 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mms22::HIS3 
fob1::LEU2 (~160 rDNA repeats) BY4741 This work 
AZ1 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mms22::HIS3 
fob1Δ::LEU2 (~70 rDNA repeats) BY4741 This work 
AZ3 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mms22::HIS3 
fob1Δ::LEU2 (>500 rDNA repeats) BY4741 This work 
AZ5 
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mms22::HIS3 
fob1Δ::LEU2 (>500 rDNA repeats) BY4741 This work 
JH935 
ade2::hisG/ade2::hisG his3/his3 leu2/leu2 lys2/+ 
met15D::ADE2/+ ura3D0/ura3Δo trp1D63/trp1D63 
hoD::SCW11pr-Cre-EBD78-NatMX/hoD::SCW11pr-
Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2/lOXp-UBC9-
loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX/loxP-
CDC20-Intron-loxP-HPHMX s288c - MEP 
Lindstrom 
and 
Gottschling 
2009 
JH1069 
ade2::hisG/ade2::hisG his3/his3 leu2/leu2 lys2/+ 
met15D::ADE2/+ ura3D0/ura3Δo trp1D63/trp1D63 
hoD::SCW11pr-Cre-EBD78-NatMX/hoD::SCW11pr-
Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2/lOXp-UBC9-
loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX/loxP-
CDC20-Intron-loxP-HPHMX spt3::TRP1/spt3::TRP1 s288c - MEP This work 
JH1052 
ade2::hisG/ade2::hisG his3/his3 leu2/leu2 
met15D::ADE2/lys2 ura3D0/ura3D0 trp1D63/trp1D63 
hoD::SCW11pr-Cre-EBD78-NatMX/hoD::SCW11pr-
Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2/loxP-UBC9-
loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX/loxP-
CDC20-Intron-loxP-HPHMX rad52::TRP1/rad52::TRP1 s288c - MEP This work 
CJ257 
ade2::hisG/ade2::hisG his3/his3 leu2/leu2 lys2/+ 
met15D::ADE2/+ ura3D0/ura3Δo trp1D63/trp1D63 
hoD::SCW11pr-Cre-EBD78-NatMX/hoD::SCW11pr-
Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2/lOXp-UBC9-
loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX/loxP-
CDC20-Intron-loxP-HPHMX sir2::KANMX/sir2::KANMX s288c - MEP 
Lindstrom 
and 
Gottschling 
2011 
CJ261 
ade2::hisG/ade2::hisG his3/his3 leu2/leu2 lys2/+ 
met15D::ADE2/+ ura3D0/ura3Δo trp1D63/trp1D63 
hoD::SCW11pr-Cre-EBD78-NatMX/hoD::SCW11pr-
Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2/lOXp-UBC9-
loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX/loxP-
CDC20-Intron-loxP-HPHMX 
fob1Δ::kanMX/fob1Δ::kanMX s288c - MEP 
Lindstrom 
and 
Gottschling 
2009 
JH1005 
ade2::hisG/ade2::hisG his3/his3 leu2/leu2 lys2/+ 
met15D::ADE2/+ ura3D0/ura3Δo trp1D63/trp1D63 
hoD::SCW11pr-Cre-EBD78-NatMX/hoD::SCW11pr-
Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2/lOXp-UBC9-
loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX/loxP-
CDC20-Intron-loxP-HPHMX rtt109::TRP1/rtt109::TRP1 s288c - MEP This work 
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CC570 
ade2::hisG/ade2::hisG his3/his3 leu2/leu2 lys2/+ 
met15D::ADE2/+ ura3D0/ura3Δo trp1D63/trp1D63 
hoD::SCW11pr-Cre-EBD78-NatMX/hoD::SCW11pr-
Cre-EBD78-NatMX loxP-UBC9-loxP-LEU2/lOXp-UBC9-
loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX/loxP-
CDC20-Intron-loxP-HPHMX fob1::TRP1/fob1::TRP1 s288c - MEP This work 
 
2.4.2 Yeast culture 
2.4.2.1 Culture on solid medium 
Cells were typically grown on autoclaved YPD agar medium (Formedium) at 30 °C. When 
selecting for auxotrophic markers autoclaved YNB agar was used, supplemented with the 
appropriate amino acid dropout media. 
2.4.2.2 Culture in liquid medium 
As standard conditions, liquid cultures were grown in filter sterilised YPD (Formedium) in a 
shaking incubator, 30 °C at 200 rpm.  
Cells in the YPD vs. YPGal experiment described in Section 5.2.10 were grown either in YEP 
broth (Formedium) supplemented with either 2% Glucose or Galactose (all filter sterilised). 
2.4.3 Yeast genetic modification 
Inserts were amplified by PCR from pFA6a plasmids, described in Longtine et al. 1998, with 
the Takara LA polymerase. 8 x 107 cells were washed twice with distilled water before 
mixing with 240 μl PEG 3350 50% w/v, 34 μl PCR product, 50 μl Salmon sperm DNA, 36 μl 
1M lithium acetate solution. Samples were incubated at 42 °C in a water bath for 40 min. 
Cells were then pelleted, re-suspended in water and spread onto an auxotrophic marker 
selection plate. 
2.4.4 Isolation of aged cells using the Mother Enrichment Programme 
Adapted from the method previously published in Lindstrom and Gottschling 2009. 
Cells from single colonies on solid medium were grown under standard conditions for ~6 
h. A sample was then diluted in 25 ml fresh YPD and grown overnight to mid-log phase 
(OD600 0.2 – 1.0). 1.25x10
6
 cells were biotin-labelled and inoculated into 125 ml YPD and 
grown at standard conditions for 2 h before addition of β-estradiol to a final 
72 
 
concentration of 1 μM. Aged samples were harvested by pelleting of cells, resuspension in 
70% EtOH, and freezing at -80 °C. 
Thawed samples were pelleted and re-suspended in 1x ice cold PBSE. Samples were 
centrifuged on a Percoll® gradient to enable removal of cell debris. Cells were re-
suspended in ice cold PBSE and bound to strepdavidin-iron beads. Cells were then 
washed three times with ice cold PBSE on an LS column in a strong magnetic field 
(Miltenyi Biotec). Cells were then eluted in ice cold PBSE and pelleted. The supernatant 
was removed and the cell pellet immediately frozen on liquid nitrogen. Pellets were stored 
at -80 °C until use. 
2.4.5 rDNA copy number assay by Pulsed Field Gel Electrophoresis 
5x107 stationary phase cells were harvested and washed with 1 ml PFGE wash buffer. Cells 
were pelleted and the supernatant was removed. Cells were re-suspended in 50 µl PFGE 
wash buffer containing 17 U/µl lyticase. Cells were mixed with 50 µl molten CleanCut 
Agarose (Bio-Rad). Suspensions were pipetted into a 100 µl plug mould using wide-bore 
tips. Plugs were allowed to set for 30 min at 4 °C. 
Once set, plugs were incubated at 37 °C in 500 ml PFGE wash buffer with 0.34 U/µl 
Lyticase for 1 h. Plugs were then incubated at 50 °C in 500 µl PK buffer with 1 mg/ml 
proteinase K overnight. 
PK buffer was removed, plugs were washed four times for at least 1 h with 1x TE with 
gentle agitation. After washing plugs were stored at 4 °C in 1x TE. 
Before use plugs were cut in half with a clean razor blade. Half-plugs were placed into the 
wells of a 0.8% gel made with Certified Megabase Agarose (Bio-Rad). A plug containing 
Hansenula wingei chromosomal DNA (Bio-Rad) was used as a size marker. Gels were run 
using a CHEF-DR® III system (Bio-Rad) in freshly made 1x TBE running buffer cooled to 14 
°C at 3 V/cm with included angle set to 120° and current switch times linearly ramped 
between 300 – 900 s. Total run time was set at 68 h.  
Following electrophoresis gels were stained for 15 min in 400 ml of 125 pg/ml ethidium 
bromide (Bio-Rad). Gels were rinsed with water for 5 min and then imaged using either a 
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Gel Doc™ XR+ system (Bio-Rad) under UV-transillumination or a Typhoon FLA 7000 (GE 
Life Sciences). 
rDNA CN was estimated by first finding marker band migration distances from the EtBr 
stained gel image, using ImageJ, and fitting a cubic spline in R to act as a band size-
distance calibration curve. Chromosome XII band migration distances were similarly 
obtained from the gel image and chromosome sizes estimated from the calibration curve. 
WT rDNA was considered as 180 copies and CN of other samples estimated by 
chromosome XII size comparison assuming any size difference resulted from rDNA CNV. 
2.4.6 RNA extraction 
RNA was extracted using reagents from the mirVana™ miRNA Isolation Kit (ThermoFisher). 
Frozen cell pellets were re-suspended in 50 μl kit Lysis/Binding buffer with 50 μl Zirconium 
beads (0.5 mm) on ice. Cells were lysed with a bead beater at 4 °C. 250 μl Lysis/Binding 
buffer was added along with 15 μl kit miRNA Homogenate Additive. Samples were mixed 
and left for 10 min on ice. RNA was extracted with acid phenol-chloroform (kit) and 
precipitated in EtOH. RNA was pelleted and washed with 70% EtOH. Pellets were air dried 
for 5 min before resuspension in nuclease free water. 
RNA was quantified either with the Quant-iT™ RiboGreen™ RNA Assay Kit (ThermoFisher) 
or the Qubit RNA HS Assay kit. 
2.4.7 DNA extraction 
2.4.7.1 Colony lysis for genotyping 
One freshly grown colony from solid media per test was re-suspended in 30 μl 0.2% SDS. 
Samples were incubated at 98 °C for 20 minutes and extract used as template for PCR with 
One Taq® polymerase. 
2.4.7.2 Phenol-chloroform method 
2 ml of a stationary culture was pelleted at and re-suspended in 1 ml 50 mM EDTA. This 
was again pelleted, re-suspended in 250 μl Buffer A, and incubated at 37 °C for 45 min. 
This was pelleted and the pellet re-suspended in 400 μl Buffer B and incubated at 37 °C 
for 30 min. 4 μl 20 mg/ml proteinase K was added and the sample mixed by gentle 
pipetting with a wide bore tip. Sample incubated at 65 °C for 30 min. 160 μl 5M potassium 
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acetate was added and the sample mixed then incubated on ice for 30 min. Samples were 
centrifuged at 10000 g for 10 min and the supernatant kept in a fresh tube. 500 μl phenol-
chloroform was added and the sample mixed on a rotary wheel for 30 min. Sample was 
again centrifuged at 10000 g for 10 min and the aqueous phase pipetted to a fresh tube 
with a wide bore tip. 0.4 μl isopropanol was added and the sample mixed. DNA was 
pelleted by centrifuging at 10000 g for 10 min. Pellet was washed with 70% EtOH and air 
dried for 10 min. Finally samples were re-suspended in TE and incubated overnight at 4 
°C. DNA was stored at 4 °C until use. Digestion with restriction enzymes was performed 
before separation by gel electrophoresis. 
2.5 Bioinformatics 
2.5.1 S. cerevisiae RNA-seq analysis 
Fastq file quality control was performed using FastQC 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/), FastQ Screen 
(https://www.bioinformatics.babraham.ac.uk/projects/fastq_screen/), and MultiQC (Ewels 
et al. 2016). Summary plots from MultiQC for all RNA-seq datasets generated for this 
thesis are shown in Figure 8.1, Figure 8.2, Figure 8.3, and Figure 8.4 in the Appendix. Read 
trimming was performed using Trim Galore! 
(https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) with Cutadapt (Martin 
2011). Reads were aligned to the S. cerevisiae R64-1-1 reference genome using the 
HISAT2 splice-aware read mapper (Kim et al. 2019).  
Further quality control, normalisation, and exploratory analysis of yeast RNA-seq data was 
performed using Seqmonk 
(https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/) and R (R Core Team 
2019). For analysis of gene expression, opposite-strand mapped reads were counted in a 
Seqmonk over protein coding genes and both raw counts, as well as log2 transformed 
read counts normalised for total library size, were exported. Importantly, reads over the 
mitochondrial DNA and rDNA (XII: 448562 – 491295) were excluded as these can skew 
normalisation in ageing cells (Cruz et al. 2018). For the analysis where IGS1/2 expression 
was quantified, pseudo protein coding gene loci were added to the reference genome at 
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coordinates XII: 458433 – 459675 (IGS2) and XII: 459797 – 460711 (IGS1) in both strand 
directions.  
In R, raw counts were normalised using the DESeq2 package (Love et al. 2014). Differential 
expression testing was also performed with DESeq2 with statistical significance thresholds 
stated in the main text. Log2 read counts normalised for library size were used to produce 
scatter plots. All work in R made use of the ‘Tidyverse’ packages (Wickham 2017). Plotting 
of figures was performed with the ‘ggplot2’ (Wickham 2016) and ‘ggpubr’ (Kassambara 
2019) packages. Colour schemes were from the ‘viridis’ (Garnier 2018) and ‘RColorBrewer’ 
packages (Neuwirth 2014). GO term enrichment analysis was performed using the GOrilla 
web tool (Eden et al. 2007, 2009). 
Analysis of Pol II transcription from rDNA was performed by counting reads in 50 bp 
running windows between coordinates XII: 450000 – 470000. These totals were then 
normalised for library size using read totals mapped over protein coding genes (excepting 
rDNA and mitochondrial DNA as above). Normalised read counts were exported to R for 
plotting. 
RNA-seq data published in Hendrickson et al. 2018 was downloaded in fastq format from 
the European Nucleotide Archive (ENA) and processed as above. 
2.5.2 C. elegans RNA-seq analysis 
Reads in fastq files were quality controlled, trimmed, and mapped using software as for S. 
cerevisiae RNA-seq analysis. Reads were aligned to an edited reference genome; 
sequences I: 15069280 – 15071033 and I: 15060299 – 15061150 were removed from the C. 
elegans genome assembly WBcel235 in order to leave a single intact rDNA repeat locus; 
sequences for pCFJ453 (Frøkjær-Jensen et al. 2016) (including tdTomato and Cbr-unc-119 
marker genes) and pCFJ1660 (Frøkjær-Jensen et al. 2014) (including GFP and HygR) were 
added as additional chromosomes. Annotation files, as provided by Ensembl release 95, 
were updated accordingly. 
Further quality control, normalisation, and exploratory analysis of worm RNA-seq data was 
performed using Seqmonk. Opposite-strand mapped reads were quantified over protein 
coding genes using the RNA-seq pipeline quantitation option with merging of transcript 
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isoforms. This was performed to produce both raw counts, as well as log2 transformed 
read counts normalised for total library size. Raw counts were normalised in R using the 
DESeq2 package. DESeq2 was used to perform differential expression testing with chosen 
significance threshold stated in the main text. Log2 read counts normalised for library size 
were used to produce scatter plots. Analysis of Pol II transcription from rDNA was 
performed by counting reads in 50 bp running windows between coordinates I: 15059000 
– 15069800. These totals were then normalised for library size using read totals mapped 
over protein coding genes. 
2.5.3 ChIP-seq analysis 
Hsf1 ChIP-seq data (S. cerevisiae) published in Pincus et al. 2018 was downloaded in fastq 
format from the ENA. Quality control was performed using FastQC. Read trimming was 
performed using Trim Galore! with Cutadapt. Reads were aligned to the S. cerevisiae R64-
1-1 genome with Bowtie2 in paired-end mode (Langmead and Salzberg 2012). Using 
Seqmonk, reads were counted in 50 bp windows genome wide and normalised to total 
library size. Windows falling within the rDNA (XII: 451401 – 468901) were normalised for 
rDNA CN by dividing by 90 (2 copies of the rDNA in the reference genome, WT CN is 
~180 copies). 
HSF-1 ChIP-seq data (C. elegans) published in Li et al. 2016 was downloaded in fastq 
format from the ENA. QC and read trimming as for S. cerevisiae ChIP-seq data. Reads were 
aligned to the C. elegans WBcel235 genome, edited as in Section 2.5.2, with Bowtie2. 
Reads were counted in 200 bp windows genome wide. Windows falling within the rDNA (I: 
15060201 – 15068800) were normalised for rDNA CN by dividing by 90. 
2.6 Oligonucleotides, PCR primers, and qPCR probes 
Table 2.3 Oligonucleotide sequences used in this work 
Name Sequence Comment 
F2 rDNA CCCGTGATATCCACAAACCT 
Forward primer to amplify IGS1 probe 
from C. elegans gDNA with R2 rDNA 
R2 rDNA ACCGAACCACGATCATCAAG 
Reverse primer to amplify IGS1 probe 
from C. elegans gDNA with F2 rDNA 
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F14 rDNA GGAGGGCAACATCATATTTAGATC 
Forward primer to amplify 5S rDNA 
probe from C. elegans gDNA with R14 
rDNA 
R14 rDNA CCAAGTACTAACTGGACTCAACGT 
Reverse primer to amplify 5S rDNA 
probe from C. elegans gDNA with F14 
rDNA 
F5 rDNA TCACGAGTCGTCTCAACACA 
Forward qPCR primer to detect 35S 
rDNA from C. elegansgDNA with R5 
rDNA 
R5 rDNA CGAACCACGATCATCAAGAC 
Reverse qPCR primer to detect 35S 
rDNA from C. elegansgDNA with F5 
rDNA 
F11 rDNA TCATCACCTTCCCACATCTC 
Forward qPCR primer to detect 5S rDNA 
from C. elegansgDNA with R11 rDNA 
R11 rDNA TTCATCCATGTTGGAGAACG 
Reverse qPCR primer to detect 5S rDNA 
from C. elegansgDNA with F11 rDNA 
F1 daf-2 seq AGCTGCTTGATATACTTGAAGCA 
Forward primer to amplify region 
containing daf-2(m596) allele site from 
C. elegans gDNA. Used for genotyping 
with R2 daf-2 seq 
R2 daf-2 seq GTCGAAAGAGTTCAGAGTTGTTG 
Reverse primer to amplify region 
containing daf-2(m596) allele site from 
C. elegans gDNA. Used for genotyping 
with F1 daf-2 seq 
F1 tbx-8 
ACAAATACACACCAGTAATGTCAAT 
CTA 
Forward primer to produce amplicon in 
tbx-8(+) genotype from C. elegans 
gDNA. Used for genotyping with R1 tbx-
8 
R1 tbx-8 AAGTGTTAATGCGGGCTCAAT 
Reverse primer to produce amplicon in 
tbx-8(+) genotype from C. elegans 
gDNA. Used for genotyping with F1 tbx-
8 
F2 tbx-8 GTATGTGGTCAGAGGTCTCACG 
Forward primer to produce amplicon in 
tbx-8(ok656) genotype from C. elegans 
gDNA. Used for genotyping with R2 tbx-
8 
R2 tbx-8 CTTGCTCTTCTTTCTTGACATTTTT 
Reverse primer to produce amplicon in 
tbx-8(ok656) genotype from C. elegans 
gDNA. Used for genotyping with F2 tbx-
8 
Ce rRNA 4 
GTCAACTAACTTCCTCTCCGCAAAG 
AAGAAGAAG 
Used for radiolabel probing Northern 
blots of C. elegans RNA. Detects the 
same pre-18S rRNAs as probe 4 in 
Saijou et al. 2004 
FOB1 UP45 
ACAATTTAACGATTGTGTGAGTGTG 
AATTTGTGCTGAGGATAACACGGA 
TCCCCGGGTTAATTAAG 
Forward primer to produce FOB1 
deletion amplicon from pFA6a plasmids 
with FOB1 DN45 
FOB1 DN45 
TTTTCACCTATGGTGACTCCTCCTTT 
CATTCTATCCTACATATTAGAATTCG 
AGCTCGTTTAAAC 
Reverse primer to produce FOB1 
deletion amplicon from pFA6a plasmids 
with FOB1 UP45 
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FOB1 C GCCTCCTCATAATGTCGATGAG 
Used with FOB1 C for 3-primer 
genotyping PCR to verify FOB1 deletion 
FOB1 D GCCTCTTGTAATATTGTTCAAGGAA 
Used with FOB1 D for 3-primer 
genotyping PCR to verify FOB1 deletion 
KL LEU2 F2 TGGTGATACAAGTTTCAACAATG 
Used in 3-primer genotyping PCR to 
verify deletion by LEU2 
18S F2 CGCGGTAATTCCAGCTCCAA 
Forward primer to amplify 18S probe 
from S. cerevisiae gDNA with 18S R2 
18S R2 GGGCCCAAAGTTCAACTACGA 
Reverse primer to amplify IGS1 probe 
from S. cerevisiae gDNA with 18S F2 
JH1371 
GAAACTTACAAGCCTAGCAAGACC 
GCGCACTTAAGCGCAGGCCCG 
Used for radiolabel probing Northern 
blots of S. cerevisiae RNA. Detects the 
same 35S, 20S and 23S pre-rRNAs 
NTS1 F1 
long 
CGAGTAGTGTAGTGGGTGACCATA 
CGCGAAACTCA 
Forward primer to amplify IGS1 probe 
from S. cerevisiae gDNA with NTS1 R1 
long 
NTS1 R1 
long 
GAGCCGGGGCCTAGTTTAGAGAGA 
AGTAGACTGA 
Reverse primer to amplify IGS1 probe 
from S. cerevisiae gDNA with NTS1 F1 
long 
 
Table 2.4 qPCR probes used in this work 
Probe Sequence 
35S rDNA [6FAM]CCGCTATGTGTCTCCTGGTGGC[BHQ1] 
5S rDNA [Cy5]CGGACAGCCATGCTCCCTCA[BHQ3] 
 
3 Phenotypic consequences of rDNA copy number 
amplification in C. elegans 
3.1 Introduction 
rDNA CNV is an understudied source of inter- and intra-species variation, including within 
the human population. Furthermore rDNA CNV is reported to affect various phenotypes, 
including the ageing process, in several different model organisms as well as driving 
differential coding gene expression; it is also implicated in some human pathologies. 
Unfortunately our understanding of which traits might be rDNA CN-sensitive across 
animal species, or how such effects might be mediated, is rather lacking. Indeed most 
previous work in animals which examined the effects of rDNA CNV looked at contexts 
where rDNA was partially deleted. Hence CNV around WT CNs, as well as possible effects 
of CN amplification, are very poorly characterised in model systems. My aim was to 
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determine whether there are phenotypic consequences of rDNA CN in C. elegans, using 
the worms as a highly experimentally tractable metazoan model. 
3.2 Results 
3.2.1 Development of methods to assay rDNA CNV in C. elegans 
rDNA CNV has been minimally studied in worms and so there are no standard protocols 
to measure rDNA CN.  Some work has reported on nematode rDNA by estimating CN 
from whole genome resequencing, however this is too expensive and time consuming to 
be used as a routine assay (Bik et al. 2013; Thompson et al. 2013). The “gold standard” 
technique for rDNA CN estimation in yeast, where it has received much more attention, is 
pulsed field gel electrophoresis (PFGE). This technique allows physical separation of very 
large pieces of DNA (up to a few Mb in length) on an agarose gel. After electrophoresis, 
rDNA arrays can be visualised either with a DNA stain (e.g. EtBr) or Southern blotting 
followed by hybridization with radiolabeled probes. I spent the first 6 – 9 months of my 
project adapting and optimising a standard yeast PFGE method and succeeded in 
developing a robust protocol for visualising worm 35S and 5S rDNA arrays. Restriction 
digest using enzymes without cut sites inside the rDNA repeats allowed detection of intact 
rDNA arrays by subsequent PFGE, blotting and probing with 32P-labelled random primed 
probes (35S rDNA was visualised with a probe amplified from C. elegans gDNA with 
primers F2 rDNA / R2 rDNA; 5S rDNA could be similarly visualised with a probe amplified 
with primers F14 rDNA / R14 rDNA, primer sequences in Table 2.3) (Figure 3.1 A). While 
one of the chromosome I telomeres is present on the same restriction fragment as the 
35S array, I was not concerned about telomere length variation confounding results as C. 
elegans telomeres are similar in size to a single 35S rDNA repeat and thus would 
contribute negligibly to band size variability (Raices et al. 2005). My final protocol is quite 
similar to the only published PFGE method for C. elegans of which I am aware (Browning 
et al. 1996). However I optimised timings of several steps during preparation of the DNA 
which reduced the total protocol time by >24 h. Full details of the final version of the 
method are in Section 2.3.7. 
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qPCR has also been used in various organisms to assay rDNA CN (e.g. Paredes et al. 2009, 
Jack et al. 2015; Gibbons et al. 2014, 2015), hence I developed a method for use in C. 
elegans samples. This technique uses qPCR probes to enable multiplexing of the 35S and 
copy number reference reactions within a single plate well. To measure copy number of a 
multicopy locus one might typically load different wells with the same amount of sample 
but different primers for either the multicopy locus or a single copy control. Normalisation 
of the values derived for the multicopy locus by the single copy reference then allows an 
estimate of copy number. This general method is vulnerable to errors arising from 
differential loading of multicopy and reference wells, e.g. due to pipetting errors. By 
contrast, the advantage of performing multiplex amplification reactions is that it obviates 
concerns about differential loading between sample and reference, thus producing more 
accurate data. A secondary benefit is that it allows twice as many samples to be measured 
simultaneously as wells are not split between multicopy and reference. However, I 
struggled to get a single copy locus to amplify successfully in multiplex with the 35S 
multicopy amplification reaction. I therefore chose to use the 5S rDNA locus as a multi-
copy reference instead, since both that and the 35S locus amplified well in multiplex. My 
PFGE assays had shown that the 5S is relatively stable between strains, more than the 35S, 
and so it seemed reasonable to normalise 35S data by 5S. 5S normalisation factors were 
scaled by 5S CN estimated from PFGE. Primers for the 35S amplification reaction were F5 
rDNA / R5 rDNA, primers for the 5S reaction were F11 rDNA / R11 rDNA, primer 
sequences in Table 2.3, qPCR probe sequences in Table 2.4. 
Initially my intention was to derive a qPCR protocol to enable 35S rDNA CN estimation in 
single worms, however that proved too technically challenging. Specifically, the between 
worm rDNA CNV implied by my single worm qPCR data was higher than could reasonably 
be believed given population-level PFGE data. Hence so I chose not to pursue developing 
the method. Regardless, the two techniques I had developed enabled investigation of 
several interesting questions about population-level phenotypic trends resulting from 
different average rDNA CN. 
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3.2.2 daf-2 mutants show elevated rDNA CN 
rDNA instability, and copy number amplification by ERC accumulation, are implicated as 
pro-ageing factors by several yeast studies (Sinclair and Guarente 1997; Ganley et al. 2009; 
Ganley and Kobayashi 2014). Furthermore at the start of my project two reports had been 
recently published showing rDNA CNV was responsive to nutrient abundance in yeast and 
flies (Aldrich and Maggert 2015; Jack et al. 2015). Both papers found active TOR signaling 
was necessary for CNV and work in Drosophila also showed increases in CNV by 
constitutive activation of insulin/insulin-like signaling (Aldrich and Maggert 2015). In C. 
elegans the insulin/insulin-like signaling pathway is one of the best characterised ageing-
related pathways. Indeed, the early finding that mutations in the worm insulin/insulin-like 
receptor daf-2 can double WT lifespan had a profound impact by bringing the study of 
ageing into the realm of experimental tractability (Kenyon et al. 1993; Kenyon 2011). 
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Figure 3.1 daf-2 mutant C. elegans strains show rDNA CNV by both PFGE and qPCR assays 
A) Schematic of the PFGE / Southern blot assay for C. elegans rDNA CN. Restriction fragment 
described is that of the 35S array which is immediately adjacent to one chromosome I telomere.  
83 
 
I was interested to assay rDNA CN in long-lived daf-2 strains. Given the role of nutrient 
sensing pathways in rDNA CN determination, I expected that daf-2 mutants might show 
different 35S rDNA CN compared with WT worms. A selection of daf-2 strains were 
obtained from the Caenorhabditis Genetics Center (CGC) all of which are reported to 
display extended lifespan (Gems et al. 1998). All daf-2 strains showed elevated rDNA CN 
by both PFGE and qPCR assay – there was a strong Pearson correlation of 0.84 between 
CN estimates from the two techniques (Figure 3.1 B-D). One strain, DR1565 (daf-2(m596) 
III), had a very large rDNA band which ran close to the resolution limit of the gel. 
Accurately assessing the size of this band was therefore difficult as bands differing in size 
by hundreds of kb can be indistinguishable in this gel region. I therefore ran a second gel 
with adjusted run parameters to verify the band size copy number estimation (Figure 3.1 
E). Interestingly the 5S rDNA array, present separately from the 35S in the worm genome, 
B) Southern blot probed with a 32P-radiolabelled random primed probe against the 35S rDNA 
(amplified from C. elegans gDNA with primers F2 rDNA / R2 rDNA, Table 2.3), samples 
prepared as shown in A with restriction digest by PmeI. Lanes labelled N2 were from CGC 
N2H cultures considered WT. All others are long-lived daf-2 hypomorphic mutants. Each lane 
loaded with DNA from approx. 500 worms of mixed ages. rDNA CN estimates by comparison 
to known-size yeast chromosome markers run on the same gel.  
C) Results from multiplex qPCR where regions of the 35S and 5S rDNA repeats were 
amplified from extracted genomic DNA and quantified by changing fluorescence of 
sequence-specific fluorophore-labelled probes. 35S rDNA CN (primers F5 rDNA / R5 rDNA, 
Table 2.3, probe 35S, Table 2.4) was calculated by normalisation of the 35S Ct values by 5S Ct 
values, adjusted for known 5S rDNA CN  (primers F11 rDNA / R11 rDNA, Table 2.3, probe 5S, 
Table 2.4) estimated from F. Values shown are the mean of 8 technical replicates. 
D) Comparison of values from C and band sizes from B. ρ is Pearson’s product moment 
correlation coefficient.  
E) Samples as in B run with PFGE settings to allow better resolution of longer DNA fragments. 
The additional sample AD1113 is from a strain with the eat-2(da1113) allele. rDNA CN 
estimates by comparison to Hansenula wingei chromosome markers run on the same gel. 
F) Samples as in B with restriction digest by KpnI-HF and run with settings for resolving 
shorter DNA fragments. Blot probed with 32P-radiolabelled random primed probe against the 
5S rDNA (amplified from C. elegans gDNA with primers F14 rDNA / R14 rDNA, Table 2.3). 
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was considerably less variable in CN (Figure 3.1 F). I was confident that the different rDNA 
band sizes under PFGE primarily reflected changes in the number of rDNA repeat units, 
rather than expansion of intergenic regions or insertion of foreign sequences, due to the 
high correlation with qPCR data which would be insensitive to such effects. This also 
further allayed any concerns about telomere length polymorphism confounding 35S rDNA 
size estimation as qPCR would similarly not be affected by that. Since PFGE results were 
well validated by qPCR I generally relied on PFGE alone for assessing CN; this is historically 
an accepted practice in the yeast rDNA CNV community. 
That rDNA CN was expanded in daf-2 hypomorph mutants seemed to be particularly 
consistent with the work in Aldrich and Maggert 2015 which demonstrated decreased 
rDNA CN in progeny of male Drosophila fed a rich diet. I considered the hypothesis that, 
conversely, reduced signaling through the nutrient sensitive insulin/insulin-like pathway in 
daf-2 in worms might have induced rDNA CN amplification. One plausible alternative 
hypothesis was that the amplified rDNA CN might have phenotypic effects which 
conferred a selective advantage particularly in the daf-2 background. Another possibility 
was that the high rDNA CN array segregating in daf-2 lines might derive from a common 
ancestor and was, in fact, unrelated to daf-2 mutations. 
3.2.3 Raised rDNA CN in daf-2 mutants may be inherited rather than 
induced by daf-2 mutations 
C. elegans larvae can be frozen and thawed with sufficient viability to allow long-term 
preservation of archived stocks. Nonetheless one has little information about how strains 
were maintained prior to freezing at the CGC when ordering. As such, I was unable to 
draw strong conclusions about a possible causal role of the daf-2 mutations in the 
observed rDNA CNV, as there were many other potentially important factors which I had 
no assurance had been controlled. At least some of the daf-2 alleles I tested originated 
from chemical mutagenesis, after which mutant isolates are typically backcrossed to a WT 
strain, usually the N2 C. elegans line (Swanson and Riddle 1981). Many of the daf-2 mutant 
strains I assayed appear to have been submitted to the CGC from the Riddle lab after their 
work characterising daf-2 phenotypes (Gems et al. 1998). In Gems et al. 1998 it is noted 
that strains were backcrossed three times to the CGC N2 male stock. The CGC distributes 
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two N2 stocks: a hermaphrodite line (N2H) maintained as self-fertilising hermaphrodites, 
and a stock maintained with a high proportion of males (N2M) resulting from male-
hermaphrodite mating. These stocks are genetically divergent and show phenotypic 
differences, e.g. N2M show ~10% increased lifespan relative to N2H (Gems and Riddle 
2000). 
I had used N2H-derived cultures as the N2 WT control (Figure 3.1 B-C, E-F) and thus 
considered the possibility that the daf-2 strains assayed may have inherited a larger rDNA 
array from an N2M common ancestor, which then underwent further CNV in different 
lineages. Running N2M and N2H samples on the same gel revealed a much expanded 35S 
rDNA array in the N2H relative to N2M stocks (Figure 3.2). This left inheritance from the 
N2M stock as the most parsimonious explanation for elevated rDNA CN in the set of daf-2 
strains I had assayed. Since the N2M rDNA CN is within the range of the daf-2 strains it is 
difficult to argue for any directional effect of daf-2 mutations, or selection in that 
background, on rDNA CN. 
  
Figure 3.2: Different N2 strain (WT) stocks from the CGC possess different 35S rDNA CN 
alleles 
Two N2 (WT) stocks are distributed by the CGC. N2H is considered WT herein and by most 
publications. daf-2 strains shown in Figure 3.1 were likely backcrossed to N2M stock shown 
here to have higher rDNA CN than N2H. Therefore elevated rDNA CN in daf-2 strains may 
have been initially inherited from N2M. 
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3.2.4 Derivation of copy number variant strains 
While possible effects of daf-2 mutation on rDNA CN seemed dubious, the discovery of 
strains with raised rDNA CNs presented opportunity to derive reagents which would allow 
me to investigate potentially rDNA CN-sensitive phenotypic traits. By crossing daf-
2(mutant) high rDNA CN worms with daf-2(+) WT rDNA CN worms I planned to isolate 
almost isogenic strains with highly divergent rDNA CN (Figure 3.3 A).  
To facilitate rapid screening of cross progeny genotypes, I generated a strain with 
fluorophores integrated close to a WT CN rDNA array and daf-2(+) by crossing strains 
EG8922 x EG7890, previously published by Christian Frøkjær-Jensen (Frøkjær-Jensen et al. 
2014). The resultant strain was then backcrossed 3x to N2H. This strain expressed nuclear-
targeted GFP from an integration site close to the rDNA and red nuclear-targeted 
tdTomato from a site expected to be close to daf-2, full genotype: oxTi981 [eft-
3p::GFP::2xNLS::tbb-2 3'UTR + HygroR] I; oxTi706 [eft-3p::tdTomato::H2B::unc-54 3'UTR + 
Cbr-unc-119(+)] II; unc-119(ed3) III(?). This double-fluorescent strain (MOC90) was crossed 
to the daf-2 mutant strain with the largest rDNA array (DR1565, daf-2(m596)) (Figure 3.1 B, 
E). See Figure 3.3 A for an illustration. 
Two independent lines were derived from different F2 mothers for each of the four 
possible homozygous fluorophore combinations (red, green, red & green, no 
fluorescence). rDNA copy number was inherited as expected based on GFP expression 
except for MOC95 (Figure 3.3 B, right panel). This strain expressed GFP but appears to 
have inherited one high CN and one WT CN rDNA array. Surprisingly, PCR genotyping of 
the daf-2 locus revealed inheritance unlinked from tdTomato expression. Partial 
genotypes with strain codes are shown in Figure 3.3 B, left panel. I traced this to an 
incorrect annotation of the parental tdTomato inserted strain; the marker is likely present 
on chromosome II rather than near the daf-2 locus on chromosome III. Among the eight 
isolates was at least one of each double homozygous genotype, which enabled me to 
start performing some experiments. These strains are referred to as having come from my 
first set of crosses. 
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Figure 3.3: Crossing high rDNA CN daf-2 mutant strain DR1565 with a double fluorescent 
strain allowed derivation of comparable high and WT rDNA CN strains 
A) Schematic showing the crossing plan for strain derivation. Right hand parental strain had a GFP 
marker integrated close to a WT CN rDNA array on chromosome I and was intended to have a 
tdTomato fluorescent marker near a daf-2(+) allele on chromosome III. High CN daf-2 mutant 
parental strain was DR1565 which showed approximately 2.5-fold increased rDNA CN over WT. 
Selection for / against fluorophores was intended to facilitate collection of progeny strains with 
desired genotypes. 
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However, I was concerned that my experimental results would be vulnerable to 
confounding by potentially non-silent background mutations. These would be 
undetectable if working with only single isolates representing some genotypes. Hence I 
bred another double fluorescent strain (EG8922 x EG7892), which Sharlene Murdoch 
kindly backcrossed 3x to the N2H WT strain for me, full genotype: oxTi981 [eft-
3p::GFP::2xNLS::tbb-2 3'UTR + HygroR] I; oxTi612 [eft-3p::tdTomato::H2B::unc-54 3'UTR + 
Cbr-unc-119(+)] unc-119(ed3)(?) III. Crossing was repeated as in Figure 3.3 A (MOC132 x 
DR1565), five lines were isolated from different F2 progeny for each of the four possible 
homozygous fluorophore combinations. rDNA CN and GFP expression were again 
inherited as expected with the exception of a few strains heterozygous for different-sized 
rDNA arrays (Figure 3.3 C, left panel). Genotyping of the daf-2 locus did not show 
complete linkage with tdTomato expression, however three lines of each double 
homozygous genotype were recovered. Genotypes and strain codes are present in (Figure 
3.3 C, right panel), lines kept are indicated with strain codes on Figure 3.3 C, left panel. 
These strains are referred to as having come from my second set of crosses. Strains with 
homozygous rDNA CN comparable to that of N2M, ~80-100 copies, are referred to as 
having WT rDNA CN. Strains inheriting a ~2.5-fold amplified rDNA array from DR1565 are 
referred to as having high rDNA CN. 
  
B) Right hand panel: rDNA genotyping of strains isolated from individual F2 animals from my 
first set of crosses. Samples analysed by PFGE / Southern blot as described in Figure 3.1 A-B. 
Left hand panel: rDNA CN was generally as expected given GFP fluorescence apart from 
MOC95 which was heterozygous for rDNA CN alleles. daf-2 alleles did not segregate as 
expected from tdTomato fluorescence – fluorophore was likely on chromosome II rather than 
III.  
C) Right hand panel: rDNA genotyping of strains isolated from individual F2 animals from my 
second set of crosses. Samples analysed by PFGE / Southern blot as described in Figure 3.1 
A-B. Left hand panel: rDNA CN and daf-2 allele segregation as expected from fluorescence 
phenotypes. Lanes labelled were from isolates given strain designations shown.  
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3.2.5 rDNA copy number shows minor variation over time 
Following strain isolation, it was important to first ascertain whether all rDNA copy 
numbers remained stable in their new genetic background. I had evidence to suggest that 
the high CN in daf-2 mutants was inherited from the N2M stock (Figure 3.2). However, if 
daf-2 did, in fact, have an effect on rDNA CN, I hypothesised that the high CN rDNA array 
might contract in a daf-2(+) background and the WT CN array might expand in daf-2 
mutants. It was unclear how rapidly these possible changes might occur, rDNA CN 
amplification takes many generations in yeast (e.g. Jack et al. 2015), however a generation 
comprises more germline cell divisions in multicellular species and 10% changes in rDNA 
CN have been reported over a single generation in Drosophila (Aldrich and Maggert 
2015).  
In order to follow potential changes occurring over very small numbers of generations, 
samples of mixed F3/F4, F4/F5, and F5/F6 colonies were collected following the first strain 
crossing attempt. For each sample the younger generation would have been significantly 
more populous. Running these samples via PFGE revealed no evidence of rapid copy 
number change in any genotype (Figure 3.4 A). The one caveat is that moderate rDNA 
array contractions or expansions in the high CN strains may not have been detectable, as 
the high CN band runs near the resolution limit of the gel. This intergenerational stability 
of rDNA CN argues against worms possessing mechanisms for rapid directional rDNA CN 
change, certainly not ones sensitive to effects of daf-2 mutations. This result was also 
valuable as it meant strain rDNA CN identity could be considered stable, at least for a few 
generations. Hence experiments would not need to be performed upon freshly bred F3 or 
F4 animals. 
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Figure 3.4: rDNA CN is generally stable although amplification-biased CNV is observed 
over 10-20 generations of standard culture 
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As noted in Section 3.2.4, a second cross was performed to derive rDNA CN variant 
isolates. I had decided to focus on the six strains WT for daf-2 (daf-2(+)) strains, with half 
WT rDNA CN and half high rDNA CN. I decided that since I had found no strong evidence 
for an interaction between daf-2 mutations and rDNA CN. rDNA CN seemed static over 
short timescales, hence I decided to look for variation over a longer time period. A sample 
collected shortly after strain isolation was compared to a descendant population sample 
collected 12 weeks later, maintained over that period with standard techniques (Figure 3.4 
B). I estimate this time difference represents about 20 generations given C. elegans are 
reproductively active after 3-4 days development at 20 °C. A sample from frozen 
populations was also compared, I estimate these are about 10-15 generations divergent 
from the first samples taken.  
Over this longer timescale WT rDNA CN strains displayed maintenance of a clear band of 
the parental size, along with some additional rDNA bands up to about 20 copies larger 
than the parental band. High CN rDNA arrays were again poorly resolved under PFGE 
conditions best for visualising WT arrays, hence samples from high CN strains were also 
run under conditions allowing greater separation of larger fragments (Figure 3.4 C). This 
revealed a similar tendency for robust maintenance of the parental rDNA CN with some 
amplifications evident. In the case of the MOC160 frozen-thawed population, a substantial 
amplification of about 50 copies was evident.  
  
A) PFGE / southern blot as in Figure 3.1 A-B. Samples from isolates from my first set of 
crosses. Left hand lane per strain is from F3/F4 mixed population. Middle lane is from F4/F5 
mixed population. Right hand lane is from F5/F6 mixed population. Partial strain genotypes 
shown in Figure 3.3 B. No CNV is visible over the course of 2-3 generations. 
B)  PFGE / southern blot as in Figure 3.1 A-B. Samples from isolates from my second set of 
crosses. Samples in each lane as shown in key. Amplification-biased rDNA CNV is evident over 
10-20 generations in 2/3 WT rDNA CN strains. 
C) As B with high rDNA CN samples run under PFGE settings for resolution of larger rDNA 
bands (as in Figure 3.1E). 1/3 high rDNA CN strains showed amplification-biased rDNA CNV 
under standard conditions. 
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It is worth noting that worm propagation necessarily involves re-plating a small fraction of 
the total population every generation. As such, rare alleles could suddenly become 
comparatively overrepresented in successive populations if sampling were not 
representative. I tried to mitigate this by passing ~30 animals at re-plating (many C. 
elegans workers will pass ~5 animals for strain maintenance). Given the number of 
generations animals were propagated for, I would expect that under these conditions CNV 
frequency would not be grossly over- or under-estimated. Of course, my methodology 
does not preclude unintentional selection for phenotypes which may be linked to rDNA 
CN. 
As a major consequence of these experiments I was satisfied that strains remained 
representative of either approximately WT or ≥2.5-fold amplified rDNA CN for several 
generations, representing months of standard propagation. I considered populations as 
acceptable for use in experiments if they had been thawed less than 3 months prior. 
Frequent CNV would be expected to result in greater heterogeneity among descendent 
populations, identified by smears rather than defined bands on Southern blots. Therefore, 
the fact that after ~20 generations a small number of clear bands can be detected per 
strain argues against a general tendency towards CNV. Although occasional CNV can be 
detected in populations which have undergone freeze-thaw cycles, there is no consistent 
indication that the stress of freeze-thaw leaves permanent imprints on population rDNA 
CN. 
Taken together these results suggest that generally rDNA CN is preserved during C. 
elegans reproduction with occasional CNV events which may be amplification-biased. 
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3.2.6 Developmental rate differences cannot be attributed to rDNA CN 
rDNA CNV is quite evident between nematode species and wild isolates of C. elegans (Bik 
et al. 2013; Thompson et al. 2013). One potential explanation for these differences is that 
rDNA CN differences in these populations have been selected for because they provide an 
advantage to traits that influence fitness. I decided to examine developmental rate as one 
of many such traits. Faster growth may be correlated with earlier reproduction, which 
could be advantageous if resources were limiting. Furthermore, some of my planned 
experiments (especially RNA-seq) would require tight synchronisation of populations and 
hence it was important to determine whether there were significant developmental rate 
differences between my strains. This is a common concern as developmental time 
differences of several hours are routinely observed between different C. elegans 
genotypes.  
C. elegans pass through 4 larval stages before reaching adulthood. At each transition 
worms moult, undergo a period of reduced motility, and cease pharyngeal pumping for 1-
2 hours. This period of quiescence is termed ‘lethargus’ and the L4 lethargus, marking the 
transition between the final larval stage and young adulthood, can be relatively easily 
observed under a dissecting microscope. I chose to use the time from release from early 
developmental arrest until entry into L4 lethargus as a measure of developmental time. 
There are various standard methods for obtaining developmentally synchronised C. 
elegans cultures. For these experiments I isolated eggs from gravid adults by hypochlorite 
bleach treatment and allowed eggs to hatch suspended in nutrient-free buffer overnight. 
This is a standard technique which leads to developmental arrest at the L1 stage and is 
considered to give tight synchronisation. Animals were then grown on solid medium 
under standard conditions. Worms were plated at approximately equivalent population 
densities within an experiment as this can influence speed of development (Ludewig et al. 
2017). Worms were checked regularly for entry into L4 lethargus on the second day after 
plating, taking cessation (or dramatic reduction) of pharyngeal pumping as the primary 
phenotypic marker. I performed three experiments using this general design with some 
minor variations, full details are in Section 2.3.12. These experiments were performed 
using the six daf-2(+) strains, from the second set of crosses as described in Section 3.2.4. 
Significant differences in developmental rate between some of the six strains tested were 
94 
 
evident (Figure 3.5 A). Across all three experiments the two high rDNA CN strains MOC159 
and MOC161 took approximately 1.5 – 2 h longer to reach L4 lethargus than the fastest 
strains. Meanwhile the other high rDNA CN strain, MOC160, was one of the fastest to 
develop. Notably the time to L4 lethargus recorded during experiment 1 was generally 
shorter by several hours across all strains. This is probably due to the higher population 
density used in this experiment which accelerates development (Ludewig et al. 2017). 
Figure 3.5 A shows that not all animals in each experiment were scored as having reached 
L4 lethargus during the observation period, since the maximum proportion which reached 
L4 lethargus was ~0.8. Based on my assessment of the appearance of the worms 
remaining at the end of the experiment, this population primarily consisted of slow 
developers rather than ones which developed at a normal rate but whose lethargus 
phenotype had not been noticed at an earlier time point. 
Data from all three experiments was fit using a Cox proportional hazards model with 
‘Experiment’ and ‘Strain’ as categorical predictor variables (Cox 1972). Development time 
did not differ significantly between strains MOC160 (high CN), MOC166 (WT CN), and 
MOC167 (WT CN) (p > 0.05). However, these strains developed significantly faster than 
strains MOC159 (high CN), MOC161 (high CN), and MOC165 (WT CN) (p < 0.05). Among 
the slower strains, MOC159 and MOC161 did not differ significantly (p > 0.05) but 
MOC165 developed faster than the other two (p < 0.05). 
Developmental rate differences were not due to rDNA CN since high CN strains were 
present in both fast and slower developing groups. Instead this observation suggested 
that there were differences in genetic background which had significant effects on 
developmental rate independent of rDNA CN. Median time to L4 lethargus for fast 
developing strains is shown in Figure 3.5 B. I used this information to adjust strain plating 
times for my later RNA-seq and lifespan experiments. This experiment was one of a few 
which highlighted the value in deriving three strains per rDNA as it allowed detection of 
background mutation effects and avoided potentially entirely false conclusions about 
rDNA CN phenotypes. 
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Figure 3.5: Developmental rate difference between strains could not be attributed to rDNA 
CN 
A) Strains from my second set of crosses were synchronised by hypochlorite bleach and 
overnight arrest at L1. On the second day after plating under standard growth conditions, plates 
were scored regularly for animals entering L4 lethargus. Data from all three experiments were 
analysed using a Cox proportional hazards model with ‘Strain’ and ‘Experiment’ as categorical 
independent predictors. Development time did not differ significantly between strains MOC160 
(high CN), MOC166 (WT CN), and MOC167 (WT CN) (p > 0.05). However, these strains developed 
significantly faster than strains MOC159 (high CN), MOC161 (high CN), and MOC165 (WT CN) (p 
< 0.05). Among the slower strains, MOC159 and MOC161 did not differ significantly (p > 0.05) 
but MOC165 developed faster than the other two (p < 0.05). High rDNA CN strains shown in 
magenta, WT rDNA CN shown in purple. 
B) Boxplots with median time to L4 lethargus shown as calculated from data shown in A. 
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3.2.7 Increased rDNA copy number may increase fecundity 
Fecundity (i.e. the total number of live progeny produced per self-fertilised 
hermaphrodite) is another life-history trait upon which one might expect natural selection 
to operate. As for developmental rate, assuming the variety of rDNA copy numbers in C. 
elegans populations is a result of selection, fecundity seemed a reasonable trait to study 
as potentially rDNA CN-sensitive. 
Two experiments were performed to assay fecundity across strains produced from my first 
crossing attempt (see Section 3.2.4). I intended to test one strain per double homozygous 
genotype (WT or high rDNA CN, daf-2(+) or mutant daf-2 (m596)). However, the first of 
these experiments was performed prior to PCR genotyping the daf-2 locus and hence one 
strain (MOC100) was included based on a false assumption of its genotype; this strain was 
expected to be WT rDNA CN daf-2(m596) however it was actually WT rDNA CN daf-2(+). 
Data recorded for this strain were plotted for the correct genotype in Figure 3.6, top 
panel, which is why there are more observations for the WT rDNA daf-2(+) genotype for 
experiment 1. 
Ten L4 animals per strain were isolated on individual plates and passed to a fresh plate 
every ~24 h. Progeny produced between this initial plating and subsequent passage were 
defined as having been laid on Day 0. Parental animals were picked to a flame after Day 8. 
Live progeny were counted 2-4 days after the parent was removed. Not all parental worms 
survived until the end of the experiment and so only eggs laid before the end of Day 5 
were considered for analysis. Progeny counts from animals dying before this point were 
excluded. After removal of these very short-lived animals, 97.5% progeny recorded over 
the whole time period were laid before the end of Day 5 and were included in the final 
analysis. 
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Data displayed in Figure 3.6 suggest an increase in fecundity in a daf-2(+) background in 
the presence of a high rDNA CN. While progeny totals were generally higher in the 
second experiment, the differences in mean progeny laid between WT rDNA CN and high 
rDNA CN were 29.0 and 29.1 for first and second experiments respectively. In both 
experiments this represents about a 10-12% increase in high rDNA CN relative to WT. 
Totals in the daf-2(m596) background can only be compared in the second experiment 
due to the aforementioned genotyping issues. The high rDNA CN strain laid a mean of 6.2 
eggs more than the WT CN, approximately 3% more. Consistent with published work, 
animals with the daf-2(m596) mutant allele produced fewer progeny than the WT (Gems 
Figure 3.6: High rDNA CN may moderately increase fecundity in a daf-2(+) background 
Ten L4 animals per strain were isolated on individual plates and passed to a fresh plate every ~24 
h. Progeny laid were counted 2-4 days after removal of parental animals. Surviving parental 
animals were picked to a flame after re-plating 8 times. Egg totals shown are those laid before 
day 6 of adulthood comprising 97.5% all progeny observed during the experiment. Results from 
animals which did not survive that long were not shown. Parental animals from strains from my 
first set of crosses, one strain per genotype expect high rDNA CN daf2-(+) in experiment 1 where 
there are two (due to unexpected daf-2 allele segregation). Error bars show mean ± 95% 
confidence interval. Samples within a genotype per experiment considered technical replicates. 
Mean differences in total eggs laid between High rDNA CN and WT rDNA CN in the daf2(+) 
background were 29.0 and 29.1 in experiments 1 and 2 respectively. Mean differences in total 
eggs laid between High rDNA CN and WT rDNA CN in the daf2(m596) background was 6.2 in 
experiment 2. Further statistical analysis not performed due to insufficient independent biological 
replicates. 
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et al. 1998; Luo et al. 2010). I did not perform statistical comparisons with this data as 
progeny totals from individual worms of the same strain within an experiment are 
considered as technical replicate measures. Hence the data represent results from only 
two biological replicate tests. 
I consider this data to provide weak evidence for a positive influence on fecundity of 
increased rDNA CN in an otherwise WT genetic background. The effect size (~10-12% 
increase) in High CN vs. WT CN strains is plausibly biologically meaningful. However, it is 
worth noting that the difference examined in these experiments represents ~2.5-fold CNV; 
CN is relatively stably inherited and I found little evidence for spontaneous CNV of 
comparable magnitude (Figure 3.4). Thus, it is unclear whether possible fecundity 
differences downstream of rDNA CN would be large enough for significant natural 
selection towards higher rDNA CNs. Aside from limited replicate numbers for these 
experiments, only a single strain exemplar was assayed for most genotypes. This means 
that potentially confounding background genetic effects were undetectable and, based on 
the developmental timing differences from my second set of cross strains, a serious 
concern. As such, I would want data from a wider selection of strains before being 
confident that an rDNA CN-dependent effect on fecundity is a general feature within C. 
elegans.  
3.2.8 Increased rDNA copy number does not affect resistance to UV-
irradiation 
Yeast with reduced rDNA CN are hypersensitive to growth inhibition by mutagenic agents 
(Ide et al. 2010). Ide et al. demonstrated a dose-dependent increase in sensitivity to 
methyl methanesulfonate or UV-irradiation when rDNA CN was reduced below 110 copies 
(WT rDNA CN is ~150-200 copies in lab yeast strains). Growth inhibition in low CN strains 
was attributed to compromised replication-coupled recombination repair of the rDNA 
caused by constant transcription of all repeats by RNA Pol I. The rDNA CNV between the 
worm strains I had derived only allowed testing of the hypothesis that there would be 
differential resistance to mutagens between high CN and WT CN strains. Notably, this is a 
different comparison to the one performed in yeast; I did not have a strong expectation 
that there would be a difference due to raised rDNA CN here as there were no differences 
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in mutagen sensitivity even at copy numbers slightly below WT. However, there are few 
reported rDNA CN-sensitive phenotypes and this one was facile to test. I used UV-
irradiation for mutagenic challenge in these experiments for its simple application in 
specified doses.  
Approximately 100 non-synchronised eggs were irradiated with 0 (control group), 100, or 
250 Jm-2 UV radiation. Hatched larvae and unhatched eggs were counted after 24 h. The 
embryonic survival percentage was calculated from the ratio of hatched larvae to 
Figure 3.7: Experiments testing whether rDNA CN affects resistance to UV-radiation 
A) Approximately 100 non-synchronised eggs were irradiated with 0 (control group), 100, or 250 
Jm-2 UV radiation. Hatched larvae and unhatched eggs were counted after 24 h. The embryonic 
survival percentage was calculated from the ratio of hatched larvae to unhatched eggs. 
Percentage embryonic survival was modelled by ANOVA with predictor categorical variables 
‘rDNA CN’, ‘UV dose’, and the interaction of ‘rDNA CN : UV Dose’. There were significant effects 
of UV Dose, rDNA CN (p = 0.0021) and the interaction term (p = 0.0049). Post-hoc testing 
showed only a significant difference between WT and high rDNA CN samples at 250 Jm-2 
(Tukey’s honest significance test, p = 0.0007). 
B) Synchronised eggs from a 1.5 h egg lay were counted before irradiation with 0, 50, or 150 Jm-
2 UV radiation. Plates were blinded and surviving animals 3 days later. Percentage survival to 
adulthood was calculated from the ratio of total live animals to eggs. Data were analysed by 
ANOVA as in A though here using the percentage survival to adulthood as the dependent 
variable. Again there was a significant main effect of UV Dose as expected. However there was 
no significant effect of rDNA CN (p = 0.25) or rDNA CN : UV Dose interaction (p = 0.71). 
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unhatched eggs. Scores calculated from different strains with the same rDNA CN within an 
experiment were considered as biological replicate measures. Percentage embryonic 
survival was modelled by ANOVA with predictor categorical variables ‘rDNA CN’, ‘UV 
dose’, and the interaction of ‘rDNA CN : UV dose’ (Figure 3.7A). There was obviously a 
significant effect of UV dose, though also significant effects of rDNA CN (p = 0.0021) and 
the interaction term (p = 0.0049). Post-hoc testing showed only a significant difference 
between WT and high rDNA CN samples at 250 Jm-2 (Tukey’s honest significance test, p = 
0.0007).  
These results suggest that, surprisingly, WT rDNA CN strains better resist genotoxic stress 
at embryonic stages to a proportionally greater degree at higher UV doses.  
There were, however, significant issues relating to the design of that UV exposure 
experiment. Firstly, eggs did not come from a synchronised cohort. Given that two of the 
three high rDNA CN strains were slower developing, it was possible that there would be 
average differences in time from egg lay to UV irradiation. I felt this could plausibly affect 
resistance to mutagens. Secondly, I had some difficulty confidently calling hatched and 
unhatched eggs and decided counting live worms would be more reliable. Finally I had 
not blinded plates before scoring which naturally introduces the potential for conscious 
and unconscious experimenter biases. 
Therefore I conducted a second experiment. A synchronised set of eggs were obtained 
from a 1.5 h egg lay. Eggs were counted before irradiation with 0, 50, or 150 Jm-2 UV. 
Plates were blinded and surviving animals counted 3 days later. Percentage survival to 
adulthood was calculated from the ratio of total live animals to eggs (Figure 3.7B). Data 
were analysed similarly to the first experiment, here using the percentage survival to 
adulthood as the dependent variable. Again there was a significant main effect of dose as 
expected. However there was no significant effect of rDNA CN (p = 0.25) or rDNA CN : UV 
Dose interaction (p = 0.71). 
While the data were not consistent between my two experiments I weigh the evidence 
from the second more strongly given the improved experimental design. Thus, I conclude 
that it is unlikely that rDNA CN raised above WT levels affects mutagenic stress in 
embryonic / larval worms. It is notable that overall survival percentages were lower in the 
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second experiment despite the milder radiation doses. Survival to adulthood is a more 
stringent criterion than merely hatching, so population attrition during larval development 
in the second experiment may explain this discrepancy. 
3.2.9 rDNA copy number does not affect mutation penetrance of the tbx-
8(ok656) allele 
Genetic mutations can have heterogeneous phenotypic effects on individuals even in the 
absence of known genetic variation elsewhere in the genome, such as within populations 
of C. elegans considered isogenic (Burga et al. 2011; Casanueva et al. 2012). Allele 
penetrance is quantified as the fraction of animals whose phenotype diverges from WT. 
Penetrance can be modulated by intrinsic and extrinsic factors including induction of 
stress-response genes such as chaperone proteins; as such, incompletely penetrant 
mutations may be considered a sensor for the stress buffering capacity of an organism 
which is highly sensitive to additional genetic or environmental stressors (Casanueva et al. 
2012). rDNA CN in a human population is reported to show unchanged mean but reduced 
variance at advanced age compared to a younger group (Malinovskaya et al. 2018). 
Malinovskaya et al. proposed that individuals with more extreme rDNA CN may have 
reduced lifespans, potentially explaining the narrowing of CN range in the population. 
Under this hypothesis one could view extreme variations in rDNA CN as genetic stressors 
which might become synthetically pathogenic when additional stresses compromise 
buffering mechanisms. I therefore hypothesised that high rDNA CN might compound the 
deleterious effects of an incompletely penetrant allele, potentially resulting in increased 
mutation penetrance.  
I chose to use the tbx-8(ok656) allele as a model incompletely penetrant mutation due to 
its easily scored phenotypes. Populations homozygous for this allele show incompletely 
penetrant embryonic and larval lethality, as well as morphological disorders during 
development (Andachi 2004; Baugh et al. 2005; Burga et al. 2011). A strain possessing the 
tbx-8(ok656) allele was crossed with the faster growing of the high rDNA CN daf-2(+) 
strains derived from my second cross (see Section 3.2.4) (RB831 x MOC160). Six 
homozygous tbx-8 mutant lines were isolated descended from different F2 animals, three 
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lines with WT rDNA CN and three with high CN. rDNA CN was assayed by PFGE, tbx-8 
allele status was verified by PCR. 
Synchronised eggs for the mutation penetrance assay were collected during a 3 h egg lay, 
equal numbers of eggs per strain were then re-plated. Plates were blinded and unhatched 
eggs counted ~24 h later. After another ~48 h plates were scored for numbers of 
phenotypically WT adults, delayed or morphologically deranged live animals, and corpses. 
The number of ‘missing’ worms was then calculated as the difference between number of 
eggs plated and the sum of observations for all scored groups. Relative proportions of 
counts in each group for strains with high or WT rDNA CN are shown in Figure 3.8, along 
Figure 3.8: rDNA CN does not affect mutation penetrance of the tbx-8(ok656) allele 
3 tbx-8 mutant isolates with high rDNA CN and 3 with WT rDNA CN were propagated from 
individual F2 animals derived by crossing strains RB831 (+ve control shown) and MOC160 (-ve 
control shown). Equal numbers of synchronised eggs per strain were plated after a 3 h egg lay. 
Plates were blinded and unhatched eggs counted ~24 h later. After another ~48 h plates were 
scored for numbers of phenotypically WT adults, delayed or morphologically deranged live 
animals, and corpses. The number of ‘missing’ worms was then calculated as the difference 
between number of eggs plated and the sum of observations for all scored groups. There was 
no significant difference in mean percentage of phenotypically WT adults between high and WT 
rDNA CNs (two-sided Student’s t-test, p > 0.05). There was also was no statistically significant 
difference in the average proportions of animals in each scored category between the two 
groups (chi-squared test, p > 0.05). 
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with parental strains RB831 and MOC160 included as positive and negative controls 
respectively. 
I treated values recorded for different strains of the same rDNA CN as biological 
replicates. There was no significant difference in mean percentage of phenotypically WT 
adults between high and WT rDNA CNs (two-sided Student’s t-test, p > 0.05). Similarly, 
there was no statistically significant difference in the average proportions of animals in 
each scored category between the two groups (chi-squared test, p > 0.05). I concluded 
that there was no support for a model where elevated rDNA CN acts as a stressor in 
developing worms. Ideally we would have liked to test the hypothesis that rDNA CNV 
might underlie some of the inter-individual differences in stress resistance / buffering 
capacity reported by Casanueva, Burga, and Lehner; I was unable to examine this directly 
as I did not have a reliable technique for measuring single worm rDNA CN. Nonetheless, 
that there were no significant differences in mean mutation penetrance between strains 
with a large CN difference argues strongly that very little inter-individual variance could 
plausibly be driven by rDNA CNV. 
3.2.10 Raised rDNA CN may increase nucleolar size 
The Antebi lab has reported that nucleolar size in young adult C. elegans shows a strong 
anti-correlation with eventual lifespan (Tiku et al. 2017). Interestingly, mutations in the C. 
elegans gene ncl-1 can reduce the lifespan extending effects of a wide variety of 
mutations and interventions which typically confer long lifespan; ncl-1 loss-of-function 
mutations cause expanded nucleoli and higher steady state rRNA levels. This suggest 
many lifespan extension mechanisms may depend on the ability to reduce RiBi. The 
nucleolus forms at the rDNA and is the site of rDNA transcription by Pol I as well as the 
early stages of RiBi. As such, I was very interested to determine whether rDNA CN 
influences nucleolar size; my hypothesis was that nucleoli might be larger in a high rDNA 
CN strain. 
I crossed a high rDNA CN, daf-2(+) strain from my first set of crosses (see Section 3.2.4) 
with a strain carrying an integrated Fib-1::GFP fusion (MOC98 x SJL1). FIB-1 is a nucleolar 
protein, ortholog of human FBL (fibrillarin), and hence the construct enabled clear 
visualisation of nucleoli when used in concert with the nuclear-targeted tdTomato 
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inherited from MOC98 (a high rDNA CN daf-2(+) strain from my first set of crosses). 
Independent lines were isolated from individual F2 progeny and rDNA CN assayed by 
PFGE (full genotype: oxTi706 [eft-3p::tdTomato::H2B::unc-54 3'UTR + Cbr-unc-119(+)] II; 
unc-119(ed3) (?) III; cguIs1[fibp-1::fib-1::GFP:: fib-1 3' UTR]). For the imaging experiment, a 
synchronised population was obtained with a 2 h egg lay. Later, plates were blinded and 
images captured of young adult animals by confocal fluorescence microscopy (Figure 3.9 
A-B). Nucleolar size was determined in the most distal tail hypodermal cells, hyp9 and 
hyp10 (binucleate), as these were easiest to consistently and rapidly acquire. Ten animals 
were imaged for each of the two isolates representing high or WT rDNA CN. 
The data support the predicted trend towards larger nucleoli with high rDNA CN (Figure 
3.9 C). Individual worms from a strain within a single experiment replicate are usually 
considered as technical replicates. Hence my data only represents biological duplication of 
the experiment, two isolates used per rDNA CN. These samples are, however, non-
independent since they were grown at the same time using the same batch of plates etc. 
Nonetheless, I attempted to estimate the size of the apparent effect on nucleolar size of 
rDNA CN using a linear mixed model. Nucleolar area was modelled as dependent on 
rDNA CN (fixed categorical variable, WT / High), nucleolus (fixed categorical variable, 
Hyp9 / Hyp10-A / Hyp10-B), and strain isolate (random variable). This model estimated 
that, on average, High rDNA CN worms had nucleoli 0.31 µm larger than those in WT 
rDNA CN worms with a p-value of 0.23. 
This experiment provides some reasonable, though not rigorously statistically significant, 
evidence that raising rDNA CN increases average nucleolar size. Based on the Antebi lab’s 
observation that larger nucleolar size is a predictor of shorter lifespan, I therefore 
hypothesised that strains with higher rDNA CN would show reduced lifespan relative to 
isogenic strains with WT rDNA CN (Tiku et al. 2017). 
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Figure 3.9: High rDNA CN may increase nucleolar size in young adult C. elegans 
A) Illustration of the most distal hypodermal cells in the tail of hermaphrodite C. elegans. Adapted 
from https://www.wormatlas.org. Note hyp10 is a binucleate syncytium. 
B) Example picture captured by confocal fluorescence microscopy showing hyp9 and hyp10 nuclei 
/ nucleoli. Nuclei were visualised by a nuclear-targeted tdTomato fluorophore (magenta) and 
nucleoli via a fib-1::GFP fusion protein (cyan). Worms immobilised with levamisole and imaged at 
63x magnification. White dotted lines indicate the outline of the worm tail, added manually. 
C) Synchronised populations of two isolates each with high or WT rDNA (and fluorophores as for 
B) were obtained with a 2 h egg lay. Sample were blinded and images captured of young adult 
animals as described in B. Nucleolar outlines were defined manually and size calculated with 
ImageJ software. Ten animals were imaged for each of the two isolates representing high or WT 
rDNA CN. Black bars indicate mean of all samples from both isolates per rDNA CN. Modelling 
nucleolar size with a linear mixed model (dependent on rDNA CN, nucleolus measured, and strain 
isolate) suggests nuclei were 0.31 μm larger in High rDNA CN worms (p = 0.23). 
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3.2.11 Potential effects of rDNA copy number on lifespan could not be 
determined due to strain pathology 
rDNA CNV and instability are implicated as causes of age-related pathology in 
replicatively aged yeast (Ganley and Kobayashi 2014). Aged cells amplify their rDNA CN 
through the production and accumulation of ERCs, decreasing or increasing ERC 
formation has reported positive and negative consequences for lifespan respectively 
(Sinclair and Guarente 1997; Defossez et al. 1999; Kaeberlein et al. 1999). Recent work 
suggests that ERC accumulation occurs concomitant with aberrant increases in rRNA 
transcription and compromises induction of key cell cycle regulators (Neurohr et al. 2018; 
Morlot et al. 2019). Age-related rDNA CNV has also been seen in mammalian systems with 
one study raising the possibility that humans with more extreme rDNA CNs may not 
survive to advanced age (Ren et al. 2017; Malinovskaya et al. 2018). In C. elegans, nucleolar 
size in young adults is reported to correlate with reduced lifespan and my measurements 
suggested higher rDNA CN might enlarge nucleoli (Figure 3.9 C) (Tiku et al. 2017). Given 
these lines of evidence, it is interesting that chromosomal rDNA CN did not correlate with 
lifespan in a survey of yeast deletion mutants (Kwan et al. 2016). Overall findings from 
various sources led me to predict that strains with high rDNA CN would show reduced 
lifespan relative to WT CN controls. 
A standard lifespan assay was performed using daf-2(+) strains from my second set of 
crosses (see Section 3.2.4) including three strains each with WT or high rDNA CN. Animals 
were synchronised at L1 stage by hypochlorite bleaching and overnight starvation. Larvae 
were plated on NGM at staggered times to account for developmental timing differences 
(see Section 3.2.6). At late L4 stage worms were re-plated to NGM containing FUDR and 
nystatin which induce sterility and inhibit growth of fungal contaminants respectively. This 
was defined as day 0 and plates were subsequently scored every 1-2 days, starting on day 
5, until all worms had died. 
Unfortunately the possible impact of rDNA CN on lifespan could not be assessed as strain 
pathology compromised the experiment. Only worms dying without visible pathology, 
beyond normal age-related changes, are included in lifespan analyses – the remainder are 
censored. Moderate numbers of censored individuals are well tolerated and can be 
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incorporated into standard statistical analysis. However, for each strain > 60% worms had 
to be censored. Most animals died with vulval protrusion or extrusion of internal tissues 
through the vulva - likely differing degrees of the same underlying pathology. I had not 
previously noticed this phenotype as being a problem as typically strains were re-plated 
once worms reached Day 2-3 or adulthood. The issue is not a consequence of rDNA CN as 
all strains were seriously affected, though to possibly differing degrees. All strains share an 
insert, including the tdTomato fluorophore, on chromosome III which may be the 
common causative factor. Drugs added to the plates are unlikely to be responsible - 
worms were aged in the absence of FUDR for my RNA-seq experiment (Section 4.2.2) and 
I noted the same phenotype. Furthermore, FUDR and nystatin are commonly used for C. 
elegans work, particularly lifespan assays. Unrelated strains exhibiting similar pathologies 
has been noted in C. elegans labs as well (personal communication, Nick Stroustrup). It is 
possible that the pathology might have been cured by backcrossing strains several times 
with N2H, however that would have represented a significant time investment. I therefore 
decided to wait on the results of my RNA-seq experiments (described in Section 4.2.2) – if 
any known ageing related pathways / genes were differentially regulated by rDNA CN I 
would then return to lifespan assays. 
3.2.12 High rDNA CN has effects on ribosome biogenesis in young adult 
worms 
Adequate rates of ribosome biogenesis depend critically on rDNA CN – insufficient rRNA 
resulting from excessive rDNA deletions causes the bobbed phenotype in flies and 
embryonic lethality in chickens (Ritossa et al. 1966; Delany et al. 1994, 1995). In contrast, 
chick embryos with ~1.5-2x rDNA CN did not show proportional increases in rRNA levels, 
suggesting capacity to buffer steady state rRNA abundance from copy number 
amplification. After transcription of the rDNA by Pol I, the 35S primary transcript goes 
through a number of downstream processing steps resulting in several pre-rRNA 
intermediate species. Northern blots can be probed for specific targets, allowing 
visualisation of the steady state abundances of these intermediates to examine steps in 
ribosome biogenesis upstream of mature rRNAs. This might reveal effects that are not 
apparent at the level of mature rRNA, indicating differences in the rate of production or 
degradation. A set of such probes for C. elegans was published in Saijou et al. 2004 and I 
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aimed to use modified versions of these to investigate whether early pre-rRNA 
abundances were affected by rDNA CNV, as a proxy for effects on ribosome biogenesis as 
a whole. 
I performed two experiments aimed at assaying rRNA intermediates in young adult 
worms. In the first experiment, I synchronised populations with a 2 h egg-lay and 
harvested adults on the third day after the egg-lay. In the second experiment, I 
synchronised strains by hypochlorite bleaching and L1 arrest by overnight starvation. I 
then plated ~200 larvae per strain and harvested adults on the second day after plating. 
The second experiment was performed to a different protocol as I expected that it would 
allow better control of population density. RNA was extracted from worms and separated 
by electrophoresis under denaturing conditions. I blotted gels and probed membranes 
with a 32P-radiolabelled DNA oligo probe (Ce rRNA 4, Table 2.3) targeted to the ITS1 
region based on the sequences in Saijou et al. 2004. Pre-rRNA band intensities were 
normalised to the 18S band for each respective lane as measured from EtBr stain images 
taken before blotting. I further normalised band intensities to the mean value for WT 
rDNA CN samples within each experiment to allow comparison between experiments. I 
had not controlled for different developmental timings and I had some concerns about 
differential control for population density between experiments; however, I did not see 
obvious effects of these in the data and so decided to pool data from both experiments 
after normalisation to improve statistical power. 
I observed a similar band pattern to that reported in Saijou et al. 2004 (Figure 3.10 B). 
Using their band labelling convention, I found a clearly defined band ‘a’, which seems to 
correspond to the primary rRNA transcript – 35S in yeast. I also detected bands ‘b’ and ‘d’ 
which seem to roughly correspond to yeast 20S and 23S pre-18S species, although in 
yeast the 23S species is non-productive for mature rRNA and this remains undetermined 
in worms. Bands ‘b’ and ‘d’ were quantified together as they were not always clearly 
separated on the blot images. Normalised band intensities were analysed by ANOVA with 
‘rDNA CN’ and ‘band’ as categorical predictor variables. This identified a significant main 
effect of rDNA CN (p = 0.0031) as high CN samples showed lower mean normalised 
intensity of only 83.5% WT band ‘a’ and 77.4% combined bands ‘b’ and ‘d’ (Figure 3.10 B).  
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It seems somewhat surprising that high rDNA CN should have reduced levels of pre-rRNA 
intermediates. The natural expectation would be that higher CN might lead to higher 
overall levels of transcript production, potentially resulting in greater abundance of 
processing intermediates. However one cannot take this result to imply that high rDNA 
CN necessarily results in lower levels of rDNA transcription. The steady state intermediate 
levels, as measured in this assay, are the result of both synthesis and degradation rates. 
Hence it is equally possible that downstream processing steps are more rapid in high CN 
backgrounds resulting in diminished steady state pre-rRNA abundances. Either way, this 
experiment demonstrates that rDNA CNV affects early steps in RiBi in young adult C. 
elegans. 
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Figure 3.10: High rDNA CN is associated with reduced levels of pre-18S rRNA 
intermediates in young adult worms 
A) C. elegans pre 18-S rRNA molecules visualised by 32P-radiolabelled oligo probe (Ce rRNA 4, 
Table 2.3). Band ‘a’ is homologous to the yeast 35S transcript. Bands ‘b’ and ‘d’ appear to be 
homologous to yeast 20S and 23S pre-rRNA species, although whether productive/non-
productive status is maintained between species is unknown. Band identities as in Saijou et al. 
2004. 
B) Northern blot from RNA extracted from young adult animals from strains from my second set 
of crosses. High CN strains MOC159, MOC160, and MOC161. WT CN strains MOC165, MOC166, 
and MOC167. RNA separated by agarose gel electrophoresis under denaturing conditions. Blot 
probed with a 32P-labelled oligo probe against C. elegans rDNA ITS1. Unlabelled lanes were from 
daf-2 mutant samples and are not included in the analysis in C.  
C) Band intensities from B and a second similar experiment were normalised by per-lane 18S 
intensity determined from EtBr stained gel pictures taken before blotting. Values per-band 
further normalised by mean WT values per-blot to allow comparison. Normalised band 
intensities were analysed by ANOVA with ‘rDNA CN’ and ‘band’ as categorical predictor 
variables. This identified a significant main effect of rDNA CN (p = 0.0031). Error bars show mean 
± 95% confidence interval (calculated using a bootstrap method with 1000 bootstrap samples). 
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3.3 Discussion 
The primary purpose of the work presented here was to assess whether rDNA CNV 
represents an underappreciated source of phenotypic variation among animals. These 
experiments are also significant specifically for the C. elegans field as, although strains are 
normally considered isogenic, it is not known to what extent this is true. Were rDNA CNV 
found to have been extensive, and strongly linked to phenotypes, it might have called into 
question some existing data, as well as suggesting a possible explanation for phenotypic 
variance among a supposedly isogenic genetic background. I found evidence that rDNA 
can influence some worm phenotypes and physiology, however the effect size for these 
did not appear particularly large. Fecundity and nucleolar size trended toward higher 
values with more rDNA copies, while early RiBi was affected too. Most published work has 
focused on rDNA CN reductions, whereas I compared high and WT rDNA CNs, so it is 
perhaps unsurprising that I did not see some phenotypes such as mutagen sensitivity or 
embryonic lethality which have been found in other model systems (Delany et al. 1994, 
1995; Ide et al. 2010). The rather subtle nature of rDNA CN influence is further highlighted 
by the greater effects resulting from apparent background genetic variation. 
Developmental differences can be a significant confounder in some time-sensitive 
experiments and I was only able to detect these due to the second round of crosses I 
performed, where I isolated more exemplar strains of each rDNA CN. It is still possible that 
rDNA CN impacts on development, for example if suppressor mutations were differentially 
inherited among my strains, however I could not establish that with the data available. It 
was disappointing that I could not conduct a viable lifespan assay; given the nucleolar 
differences I saw, that experiment would have been a neat test of the Antebi lab’s 
hypothesis that nucleolar size is a reliable predictor of worm lifespan (Tiku et al. 2017).  
One could question whether the ~2.5-fold rDNA CN difference I examined represents 
biologically meaningful CNV. Different sources of evidence suggest that it is, not least the 
fact that I found some apparently rDNA CN-sensitive phenotypes. A factor of 2.5 
represents a significant fraction of the rDNA CNV (~6- to 8-fold) reported between 
divergent nematode species and C. elegans wild isolates (Bik et al. 2013; Thompson et al. 
2013). The Bik et al. 2013 authors argued that, since C. elegans mutation accumulation 
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lines – where selective pressure is abrogated – accumulated ~2x rDNA copies in 400 
generations, natural selection is likely responsible for maintenance of WT copy numbers. 
This line of reasoning reinforces the evidence that the ~2.5-fold difference in my data is 
not something the worm genome can buffer entirely consequence-free. Finally, the most 
reliable estimates for CNV among human populations, where evidence for some rDNA 
CN-sensitive phenotypes is emerging, have a range of 2-4x (Chestkov et al. 2018; 
Malinovskaya et al. 2018). This compares favourably with my worm CNV. 
Directional rDNA CNV, along with proposed mechanisms, has been reported in both flies 
and yeast (Ritossa 1968b; Kobayashi et al. 1998; Kobayashi and Ganley 2005; Bianciardi et 
al. 2012). It is unclear whether a similar process is present in worms. rDNA CN gain in 
mutation accumulation lines would seem to suggest a tendency to gain rDNA repeats in 
the absence of potentially opposing selective forces. The numbers reported for mutation 
accumulation lines in Bik et al. 2013 are not particularly consistent with a model of gradual 
changes. My data also suggest an amplification-biased CNV mechanism in worms as 
larger rDNA arrays appeared in the population over around 20 generations of 
propagation (Figure 3.4 B-C). This observation fits best with a model of intergenerational 
CNV being a rare, with discrete CN changes of perhaps ≥5 copies occurring in a small 
fraction of reproductive events. The trend towards higher CN arrays appearing and 
persisting in populations as minor alleles may alternatively be taken as evidence that 
larger rDNA arrays generally offer fitness advantages. I favour the former hypothesis, that 
there are amplification-biased CNV mechanisms, given that I detected fairly minor 
phenotypic differences resulting from rDNA CN differences much greater than these 
apparent spontaneous variants – these do not seem likely to have supported a 
competitive advantage. 
My initial finding of elevated rDNA CN in daf-2 mutants appeared to be consistent with 
nutrient sensing pathways influencing CNV, as reported in other organisms (Figure 3.1 B, 
E) (Aldrich and Maggert 2015; Jack et al. 2015). However the subsequent discovery of a 
significantly enlarged rDNA array in the N2M stock - with which most, if not all, of the daf-
2 mutant strains had been backcrossed – makes it very difficult to argue for a causal role 
of daf-2 mutation (Figure 3.2). Hence it remains unclear whether environmentally directed 
rDNA CNV operates in C. elegans. The CNV between N2M and N2H, and common use of 
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the former for strain backcrossing, implies many experiments in the worm literature may 
have been conducted in the presence of passenger rDNA CN differences. Though, due to 
the subtle nature of the rDNA CN-sensitive phenotypes reported herein, I doubt the effect 
has been particularly pernicious. Nonetheless, I echo the suggestion of the Gems lab to 
stop using the CGC N2M stock on rDNA CNV grounds in addition to the genetic variants 
they demonstrated (personal communication, “N2 male” is a long-lived fln-2 mutant – 
Worm Breeder’s Gazette; Zhao Y, Wang H, Poole R, Gems D). It is furthermore interesting 
to note the presence of the unidentified variant which caused slow development in some 
of my strains; these had a daf-2 mutant as a parent which raises the possibility that such 
background mutations may have confounded published measurements of daf-2 
phenotypes. Specifically, some daf-2 mutants are reported to be slow to develop. 
Overall, I developed a pair of assays for accurate rDNA CN estimation in C. elegans and 
used these in tandem with a variety of techniques to uncover potential variant phenotypes 
dependent on 35S rDNA CNV. I was interested to take this work further by conducting 
genome wide transcriptomic studies using RNA-seq to determine whether rDNA CNV also 
had an impact on gene expression, as reported in other organisms (Paredes et al. 2011; 
Gibbons et al. 2014; Li et al. 2018). I hoped that this would prove a hypothesis-generating 
analysis to guide further experimental work. 
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4 rDNA CNV has significant, but limited, impacts on 
the transcriptome in C. elegans and S. cerevisiae 
4.1 Introduction 
My phenotypic assays of C. elegans, described in Section 3, generally found that there 
were only very subtle effects of a 2.5-fold increase in rDNA CN. The main positive findings 
were a possibly raised average brood size (Figure 3.6), a trend towards larger nucleoli at 
high CNs (Figure 3.9), and effects on pre-rRNA processing (Figure 3.10). I was interested to 
carry out RNA-seq to investigate potential effects on gene transcription from rDNA CNV. 
This had twin objectives: first, to assess how widespread effects of rDNA CNV might be, 
and second, to be a hypothesis generating exercise to inform potential further wet lab 
work. Varying estimates exist in the literature for numbers of genes whose transcription is 
influenced by rDNA CN in different models, from tens in maize to thousands in human 
samples (Paredes et al. 2011; Gibbons et al. 2014; Li et al. 2018). These reports further 
suggest various biological processes which might be affected, including ribosome 
biogenesis and mitochondrial electron transport. I hoped to shed more light on which 
previous estimates for the number of rDNA CN-sensitive genes were likely to be in the 
right orders of magnitude and to search for potentially common transcriptomic signatures 
of rDNA CNV between model organisms. 
4.2 Results 
This chapter includes results from several RNA-seq differential expression analyses where 
varying numbers of genes were called as statistically significantly different after correcting 
for multiple testing. I chose to use different cutoff thresholds for calling genes as 
significantly differentially expressed at different points. My default significance threshold 
was FDR < 0.05, however sometimes the resulting lists of genes included many hundreds, 
or even a few thousand, genes. In these cases, I often chose to use the more stringent FDR 
< 0.001 cutoff with the aim of reducing low-quality ‘hits’ and maintaining gene sets at 
reasonable sizes. 
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4.2.1 Developmental rate differences were a serious confounder in young 
samples 
I did not have strong hypotheses about where in the worm lifespan rDNA CNV might be 
most consequential, hence two time points were chosen: young adult, before adult tissue 
becomes contaminated by developing embryos, and 10 days old, given my continued 
interest in possible roles of rDNA CNV in ageing. 10 day old samples would be post-
reproductive and so it was hoped that germline tissue would not dominate the signal – in 
any case this would be controlled for by comparing only age-matched samples. Strains 
were synchronised by hypochlorite bleach and overnight L1 arrest. Animals were plated at 
the same density, to avoid de-synchronisation from density-dependent growth effects, 
and harvested as young adults a few hours after the median time to L4 lethargus (Ludewig 
et al. 2017). Two independent replicates of each strain were collected, there were general 
differences in development rate between the two replicates and so exact time of harvest 
differed – I estimated developmental equivalence from morphology.  
Worms for the aged time point were grown at higher density and washed to new plates 
every two days to prevent overgrowth by progeny. This was only partially successful, so 
surviving aged adults were picked to a separate plate before harvesting at day 10 of 
adulthood. As noted in my lifespan assay (Section 3.2.11), many worms died prematurely 
with vulval rupture. Hence those sequenced represent the population most resistant to 
this pathology. mRNA was enriched via poly(A)+ selection before library preparation and 
all libraries sequenced on the same lane which obviated any concerns about batch effect. 
One library was prepared and sequenced per strain per independent replicate for young 
adult samples resulting in 12 total. One library was sequenced per strain for aged samples 
– 6 in total. 
To determine whether rDNA CNV was a major factor in determining gene expression, I 
plotted samples after PCA of per gene normalised log-transformed read counts (Figure 
4.1 A). Aged and young samples clearly separated on PC1 which explained a very large 
fraction (75.1%) of the total variance. This is consistent with the major gene expression 
changes reported for ageing worms (reviewed in Son et al. 2019). While samples did not 
appear to differentiate based on rDNA CN, two sets of young samples clustered away 
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from the others on both PC1 and PC2. The divergent samples, MOC159 / 161, were from 
the two high rDNA CN strains previously seen to be significantly developmentally delayed 
(Figure 3.5). Median time to L4 lethargus was approximately 2 h longer in the slower 
developing strains and so I had attempted to correct for this difference by plating these 2 
h earlier than the faster strains. Unfortunately this does not appear to have been 
successful, as there are large gene expression differences between the fast and slow 
developing high CN strains (Figure 4.1 B); there is a set of >2000 genes expressed >2-fold 
higher in the slower developing MOC159 / 161. Many of these genes form a visually 
distinct cluster (Figure 4.1 B, green points) and I considered that this might result from 
aneuploidy, something which could plausibly affect expression of thousands of genes on a 
single chromosome simultaneously. However the genes in this cluster are globally 
distributed which strongly argues against that possibility. Attempted synchronisation 
seems to have been more successful in WT CN strains; MOC165, previously found to be 
somewhat slower developing, shows overall gene expression is mostly comparable to the 
other WT CN strains (Figure 4.1 C). 
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Figure 4.1: RNA-seq in young adult C. elegans revealed some large differences dependent 
on growth rate, but very few rDNA CN-sensitive genes 
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To further investigate these differences, I considered the RNA-seq QC measures applied to 
this dataset (see Sections 2.5.2, 2.5.1, and Figure 8.1). However, there were no obvious 
technical causes for the divergence of MOC159 / MOC161 libraries; read quality scores 
were high, PCR duplication was acceptable and similar to other samples, reads mapped 
well, and there was no contamination from other species detected by FastQ Screen. 
Therefore I concluded that sample differences arose from genuine biological divergence. I 
compared genes differentially expressed between young slow strains, MOC159 / 161 (high 
Worm strains with different rDNA CNs, WT or high (~2.5-fold greater than WT), were 
synchronised by hypochlorite bleach and overnight L1 arrest. 2 independent replicates of each 
strain, 3 strains per rDNA CN, were collected at a young adult time point. Worms for the day 10 
aged time point, one replicate per strain, were grown at higher density and washed to new 
plates every two days to prevent overgrowth by progeny. A subset of ~150 surviving aged 
adults were picked to a separate plate before harvesting at day 10 of adulthood. Total RNA was 
extracted and mRNA was enriched via poly(A)+ selection before library preparation. All libraries 
sequenced on the same lane. Reads were aligned to an edited C. elegans genome with GFP, 
HygR, and tdTomato marker genes added. Reads were counted over protein coding genes 
(CDS) with counts for different isoforms merged. Differential expression testing was performed 
with DESeq2. Moderated FDRs were obtained the Benjamini-Hochberg method to correct for 
multiple testing. Hits were considered statistically significant for FDR < 0.05. Plots B-E show 
mean log2 counts per CDS normalised for total library size. 
A) Log2 counts over CDS, normalised for total library size, for all samples were analysed by PCA. 
PC1 correlates with age of samples. Young adult slow developing high rDNA CN samples 
(MOC159, MOC160) cluster away from others. 
B) Over 2000 genes were differentially expressed at the young adult time point between high 
rDNA CN slow developing strains (MOC159, MOC161) and the faster developing strain 
(MOC160). A large, visually distinct, cluster of genes was expressed > 2-fold higher in slower 
strains. This was not due to aneuploidy as genes were globally distributed. 
C) Expression between young adult WT rDNA CN slow developing strain (MOC165) and WT 
rDNA CN fast strains (MOC166, MOC167) was similar. A cluster of genes with expression linked 
to age (as in A) was expressed lower in ‘fast’ strains than the ‘slow’ strain. This suggests some 
developmental de-synchronisation between strains. 
D) There were 52 differentially expressed genes at the young adult time point between fast 
developing high rDNA CN strain MOC 160 and comparable WT rDNA CN strains (MOC166, 
MOC167). This included marker genes linked to WT rDNA CN GFP and HygR. 
E) There were 21 differentially expressed genes at the aged time point between high and WT 
rDNA CN samples. A cluster of Hsf-1 inducible heat shock proteins showed a trend for higher 
expression at WT rDNA CNs. Marker genes as in D. 
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rDNA CN), and the faster MOC160 (high rDNA CN) (DESeq2, Benjamini-Hochberg 
corrected FDR < 0.001) (Figure 4.1 B). There were many broad Gene Ontology (GO) terms 
enriched among genes significantly upregulated in the faster developing strain. Notable 
among these were various developmental and reproductive processes, oogenesis, and 
spermatogenesis (Table 4.1). Genes expressed significantly lower in the faster strains were 
enriched for terms related to protein phosphorylation and dephosphorylation, as well as 
sperm development (Table 4.2). Sperm development occurs during larval development in 
C. elegans, whereas oogenesis begins late in development and is most active in adults 
(Hubbard and Greenstein 2005). Hence the transcriptomic differences likely arise from the 
slower developing high CN strains being delayed relative to the faster ones, despite the 
attempted plating time correction. Interestingly, many of the genes upregulated in slow 
developing high CN strains were also expressed higher in the faster developing WT CN 
strains (MOC166 / 167) relative to the slower WT CN strain MOC165 (Figure 4.1 C). Under 
the assumption that this expression pattern is a signature of developmentally younger 
animals, this suggests that MOC165 (WT rDNA CN) animals were developmentally ahead – 
plating these earlier than the others was probably an overcorrection. This is further 
supported by the fact that MOC165 (WT rDNA CN) libraries showed the lowest PC1 values 
of all young adult libraries, i.e. closest to the aged samples and furthest from slow 
developing young samples (Figure 4.1 A). 
Table 4.1 Selected GO terms enriched among genes upregulated in the fast developing high 
rDNA CN strain vs. slow developing high rDNA CN strains 
GO term FDR q-value Enrichment 
reproductive process 1.06E-81 2.67 
developmental process 1.40E-70 1.99 
multicellular organism development 9.70E-68 2.32 
anatomical structure development 2.17E-58 2.03 
embryo development ending in birth or egg hatching 1.32E-57 3.16 
germ cell development 3.11E-15 2.88 
reproduction 7.36E-15 2.67 
vulval development 2.79E-11 2.94 
post-embryonic animal organ development 5.11E-11 2.89 
eggshell formation 1.56E-09 4.72 
oogenesis 2.85E-12 3.52 
spermatogenesis 3.39E-05 2.46 
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Table 4.2 Selected GO terms enriched among genes downregulated in the fast developing 
high rDNA CN strain vs. slow developing high rDNA CN strains 
GO term FDR q-value Enrichment 
protein dephosphorylation 3.00E-51 5.69 
protein phosphorylation 2.71E-28 2.98 
regulation of cell proliferation 4.08E-09 3.64 
spermatid development 8.88E-05 7.18 
flagellated sperm motility 1.73E-02 10.37 
sperm motility 1.67E-02 10.37 
alpha-amino acid biosynthetic process 3.43E-02 2.9 
 
This analysis suggested that possible transcriptomic effects of rDNA CNV were likely 
dwarfed by those stemming from age and developmental differences. This was not 
particularly surprising given known gene expression shifts over the worm lifetime and the 
generally subtle rDNA CN-sensitive phenotypes reported in Section 3 (Son et al. 2019). 
These results further illustrate the value in deriving multiple independent lines with 
genetic traits of interest as a protective measure against spurious conclusions. My strains 
would typically have been considered essentially isogenic given parental strains were 
backcrossed 3x to N2 (double fluorescent parent backcrossed to N2H by Sharlene 
Murdoch, high rDNA CN daf-2 parent reported 3x outcrossed, probably to N2M, on CGC 
website), however this is very clearly incorrect. As expected, precise developmental 
synchronisation, while sometimes difficult in practice, is also of fundamental importance in 
making valid comparisons between worms at young time points.  
4.2.2 rDNA CN-sensitive gene expression in worms 
I was interested to test whether there were genes whose expression was modulated by 
rDNA CNV. I had prepared two libraries from independent young adult samples of each 
strain, intended to give six replicates representing each rDNA CN size. However, 
potentially confounding effects of differing developmental rates were present among 
some of my young sample libraries meaning not all samples could be included in the 
comparison. In order to minimise the effect of these differences, only young samples of 
fast-developing MOC160 (high rDNA CN) and MOC166 / 167 (WT rDNA CN) were used 
for differential expression testing, as these showed very similar overall profiles (Figure 4.1 
D). 52 genes were differentially expressed between high rDNA CN and WT rDNA CN 
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young adult samples (DESeq2, BH corrected FDR < 0.05). As expected, among these were 
GFP and HygR which are marker genes only present in the WT CN strains; these were 
detectable as I added them to an edited reference genome before read mapping. 
Differential expression of HygR is less pronounced than GFP due to reads aligning to the 
unc-54 5` UTR fused to HygR in all samples. GO term enrichment analysis revealed a few 
enriched terms, related to bacterial defence responses, with FDR values between ~0.04 – 
0.08 driven by the same 5 genes (Table 4.3). I did not follow up those hits as effect size for 
most was relatively low, log2 fold changes (high rDNA CN vs. WT rDNA CN): lys-4 = 0.402, 
T19D12.4 = 0.522, F55G11.4 = 0.704, lys-7 = 1.05, clec-70 = 1.8. 
Table 4.3 GO terms enriched among genes differentially expressed between young adult 
high rDNA CN vs. WT rDNA CN strains 
GO term P-value FDR q-value Enrichment 
defense response to bacterium 2.66E-05 1.55E-01 13.88 
response to bacterium 2.66E-05 7.75E-02 13.88 
peptidoglycan metabolic process 3.58E-05 6.95E-02 201.23 
peptidoglycan catabolic process 3.58E-05 5.21E-02 201.23 
glycosaminoglycan catabolic process 5.95E-05 6.94E-02 160.99 
defense response to other organism 6.91E-05 6.71E-02 11.37 
response to other organism 7.09E-05 5.91E-02 11.31 
response to external biotic stimulus 7.28E-05 5.31E-02 11.24 
response to biotic stimulus 7.28E-05 4.72E-02 11.24 
cell wall macromolecule catabolic process 1.25E-04 7.26E-02 114.99 
multi-organism process 1.38E-04 7.32E-02 9.82 
defense response 1.54E-04 7.48E-02 7.19 
aminoglycan catabolic process 2.13E-04 9.55E-02 89.44 
cell wall macromolecule metabolic process 2.66E-04 1.11E-01 80.49 
defense response to Gram-positive bacterium 5.00E-04 1.94E-01 19.17 
response to external stimulus 5.55E-04 2.02E-01 7.26 
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Table 4.4 GO terms enriched among genes differentially expressed between aged high rDNA 
CN vs. WT rDNA CN strains 
GO Term P-value FDR q-value Enrichment 
long-chain fatty acid biosynthetic process 1.99E-06 1.16E-02 780.55 
long-chain fatty acid metabolic process 9.93E-06 2.89E-02 390.27 
unsaturated fatty acid biosynthetic process 1.85E-05 3.60E-02 292.7 
unsaturated fatty acid metabolic process 1.85E-05 2.70E-02 292.7 
cellular response to heat 6.00E-05 7.00E-02 167.26 
chaperone cofactor-dependent protein refolding 8.96E-05 8.70E-02 137.74 
'de novo' posttranslational protein folding 8.96E-05 7.46E-02 137.74 
'de novo' protein folding 1.01E-04 7.34E-02 130.09 
protein refolding 1.38E-04 8.94E-02 111.51 
cellular response to unfolded protein 1.81E-04 1.06E-01 97.57 
chaperone-mediated protein folding 1.81E-04 9.60E-02 97.57 
lipid biosynthetic process 2.25E-04 1.09E-01 23.89 
response to unfolded protein 2.85E-04 1.28E-01 78.05 
cellular response to topologically incorrect 
protein 2.85E-04 1.19E-01 78.05 
fatty acid biosynthetic process 4.11E-04 1.60E-01 65.05 
small molecule biosynthetic process 5.39E-04 1.96E-01 17.74 
response to topologically incorrect protein 5.60E-04 1.92E-01 55.75 
catechol-containing compound catabolic 
process 8.54E-04 2.77E-01 1,170.82 
norepinephrine metabolic process 8.54E-04 2.62E-01 1,170.82 
norepinephrine biosynthetic process 8.54E-04 2.49E-01 1,170.82 
dopamine catabolic process 8.54E-04 2.37E-01 1,170.82 
catecholamine catabolic process 8.54E-04 2.26E-01 1,170.82 
ammonium ion metabolic process 8.59E-04 2.18E-01 45.03 
 
In marked contrast to the young samples, transcriptomes of all aged samples showed very 
similar overall profiles and clustered together under PCA (Figure 4.1 A). This bolsters the 
hypothesis that expression differences between fast- and slow-developing strains resulted 
from divergent developmental staging, rather than a polymorphic locus with wider 
ranging effects. Consequently, all aged samples (one per strain, i.e. three per rDNA CN 
size) were included for differential expression testing which again revealed a small number 
of genes (21) differentially expressed between high and WT copy number strains (DESeq2, 
BH corrected FDR < 0.05) (Figure 4.1 E). There were few functional commonalities between 
these, generally poorly annotated, genes. Among this set were the two marker genes GFP 
and HygR as expected. Two fatty acid desaturases fat-5 and fat-6 were expressed lower in 
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high CN strains which accounted for the only significantly enriched GO categories (FDR < 
0.05) though there were others near that threshold (Table 4.4). 
Interestingly, there appears to be a small cluster of transcripts (hsp-16.1, hsp-16.11, hsp-
16.41, hsp-16.48, hsp-16.49, and hsp-16.2) which were not statistically significantly 
differentially expressed but nonetheless showed a trend of raised expression in WT CN 
aged samples. These are expressed similarly to hsp-70 which was found as differentially 
expressed (Figure 4.1 E) and, along with hsp-70, have folding chaperone activity and are all 
among the genes most highly induced by the conserved heat shock response factor Hsf-1 
under heat shock (Brunquell et al. 2016). Expression of this small group of HSPs may 
indicate WT CN strains were experiencing greater proteotoxic stress than high CN strains. 
It is possible that this is an unintended consequence of expression of GFP and/or HygR in 
the aged WT CN animals, although expression of GFP under a constitutive promoter does 
not seem to activate HSF1 targets (personal communication, Olivia Casanueva). 
Interestingly, overexpression of HSPs extends lifespan in C. elegans, hence higher HSP 
expression with age would be consistent with the predicted longer lifespan of WT rDNA 
CN strains based on smaller nucleoli figure in results chapter 1 (Yokoyama et al. 2002; 
Walker and Lithgow 2003; Tiku et al. 2017). 
Two genes were significantly differentially expressed at both young and aged timepoints: 
lev-10 and B0511.11 (Figure 4.2). Differential expression of lev-10 was not directionally 
consistent between time points. In contrast, B0511.11 was more highly expressed in the 
high rDNA CN background at both time points. Both genes are poorly annotated which 
makes interpretation difficult. Taken together, the results presented suggest that raising 
rDNA CN by approximately 2.5-fold has minimal impact on the C. elegans whole animal 
transcriptome in both young and aged adults. This is consistent with the results reported 
in Section 3, where phenotypic effects of rDNA CNV were found to be generally minor, 
but is somewhat surprising given reports of much larger sets of genes responsive to rDNA 
CNV in Drosophila and humans (Paredes and Maggert 2009; Gibbons et al. 2014). 
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Figure 4.2 Expression plots for two genes differentially expressed in both young and aged 
worm samples 
lev-10 and B0511.11 were differentially expressed (DESeq2, BH corrected FDR < 0.05) in WT vs. 
high rDNA CN comparisons at both time points. 
A) rDNA CN-dependent expression of lev-10 was not directionally consistent between samples 
of different ages. 
B) rDNA CN-dependent expression of B0511.11 was directionally consistent between samples of 
different ages. Interpretation is difficult as the gene is poorly annotated. 
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4.2.3 rDNA CN-sensitive gene expression in yeast 
The mechanisms and effects of rDNA CNV are best understood in S. cerevisiae. WT yeast 
dynamically adjust their rDNA CN by producing variable numbers of ERCs in young cells, 
while in aged cells the overproduction of ERCs, and associated rDNA instability, have been 
considered causal elements in ageing (Sinclair and Guarente 1997; Ganley and Kobayashi 
2014; Mansisidor et al. 2018). Furthermore a well characterised mechanism for amplifying 
chromosomal rDNA repeats is influenced by nutrient status in an mTOR-dependent 
manner (Takeuchi et al. 2003; Kobayashi and Ganley 2005; Jack et al. 2015). This regulation 
depends on control of Sir2 and there is strong evidence supporting SIR2 as an rDNA CN-
sensitive gene (Michel et al. 2005; Iida and Kobayashi 2019). It seems that maintaining an 
appropriate rDNA CN is integral to yeast cellular function, however whether there are 
widespread impacts on gene expression has not, to my knowledge, been tested. I had 
found the C. elegans transcriptome to be very stable under rDNA CNV, but it was possible 
that effects in specific tissues or cell types might be lost when measuring RNA from whole 
animals – there was also unfortunately some confounding genetic variability which likely 
limited detection power. As such I was interested to investigate whether transcriptomic 
stability in the presence of rDNA CNV was also evident in single-celled yeast model, where 
genetic and growth phase homogeneity would also be more reliable. 
Jon Houseley had previously sequenced log phase RNA-seq libraries from yeast strains, 
fob1Δ to maintain rDNA CN, with either WT rDNA CN (strain YJH1156, around rDNA 180 
copies) or around 35 copies (Strain YJH1157, referred to as very low CN), however analysis 
of this data had not been done. I processed the fastq files to mapped BAM files as 
described in Section 2.5.1, I refer to this data as the Houseley dataset. Two libraries 
prepared from biological replicate samples were available for WT and very log CNs. In 
contrast to my worm dataset, rDNA CN was the major contributor to between-sample 
variation – replicates separated well by rDNA CN on PC1 which explained 51.4% of the 
total variance (Figure 4.3 A). There were 165 genes differentially expressed between WT 
and very low rDNA CN samples (DESeq2, BH corrected FDR < 0.05) (Figure 4.3 B). Genes 
with higher expression in the very low CN background were enriched for GO terms related 
to ribosome biogenesis and nucleotide synthesis (FDR < 0.05) (selected terms in Table 4.5, 
full GOrilla output in Appendix Table 8.1) This probably reflects a requirement for more 
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intensive rRNA production to avoid ribosome depletion in rDNA challenged cells, indeed 
strains with comparable rDNA CNs are forced to activate essentially all repeats and display 
greatly elevated Pol I density per repeat (French et al. 2003). Conversely, terms relating to 
retrotransposition and response to external stimuli were enriched among genes down 
regulated in the very low CN background (FDR < 0.05) (selected terms in Table 4.6, full 
Gorilla output in Appendix Table 8.2). 
  
Figure 4.3 rDNA CN-sensitive gene expression in S. cerevisiae samples between WT and 
very low CN strains 
2 replicates of either WT (strain JH1156) or very low rDNA CN (strain JH1157) yeast strains 
were grown to mid-log. Total RNA was extracted, poly-A enriched and prepared as RNA-seq 
libraries. All wet lab work performed by Jon Houseley. Reads were aligned to the S. cerevisiae 
genome and counted over protein coding genes. Differential expression testing was 
performed with DESeq2. Moderated FDRs were obtained the Benjamini-Hochberg (BH) 
method to correct for multiple testing. Hits were considered statistically significant for FDR < 
0.05. 
A) Log2 counts over CDS, normalised for total library size, for all samples were analysed by 
PCA. PC1 captures the majority of the total variance. Samples with different rDNA CN separate 
on PC1 indicating rDNA CNV contributed highly to differences between samples. 
B) Plot shows mean log2 counts per CDS normalised for total library size. 165 genes were 
called differentially expressed between very low and WT rDNA CN. 
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Table 4.5 Selected enriched GO terms among genes significantly upregulated at very low 
rDNA CN vs. WT rDNA CN 
GO Term P-value FDR q-value Enrichment 
ribosome biogenesis 4.82E-14 1.27E-10 7.03 
rRNA processing 3.89E-12 5.11E-09 5.43 
rRNA metabolic process 1.56E-11 1.64E-08 4.86 
ribonucleoside monophosphate biosynthetic 
process 5.65E-11 4.95E-08 10.04 
nucleoside monophosphate biosynthetic process 9.25E-11 6.95E-08 9.69 
ribonucleotide biosynthetic process 3.63E-10 2.12E-07 8.78 
IMP metabolic process 4.42E-10 2.32E-07 32.43 
ribose phosphate biosynthetic process 8.31E-10 3.97E-07 8.27 
nucleoside monophosphate metabolic process 1.23E-09 5.40E-07 8.03 
ncRNA processing 1.50E-09 6.06E-07 3.93 
ribosomal large subunit biogenesis 1.34E-07 2.61E-05 10.42 
 
Table 4.6 Selected enriched GO terms among genes significantly downregulated at very low 
rDNA CN vs. WT rDNA CN 
 
I had found evidence of functionally significant gene expression changes resulting from 
large rDNA deletions in yeast. However, my worm data compared WT and high rDNA CNs 
and so I aimed to produce an analogous dataset in yeast. Yeast with a deletion at the 
MMS22 locus show greatly expanded rDNA CN, however this is abrogated if rDNA CN is 
stabilised by prior deletion of the replication fork barrier protein FOB1 (Ide et al. 2013; 
Jack 2014). A previous PhD student in the Houseley lab, Carmen Jack, had produced 
strains with mms22::HIS3 (strain CJ187, high rDNA CN), referred to as mms22Δ, and 
fob1::LEU2 mms22::HIS3 (strains CJ188, CJ190, both WT rDNA CN), referred to as fob1Δ 
mms22Δ, genotypes. In order to generate an isogenic strain with stable high rDNA CN I 
GO Term P-value FDR q-value Enrichment 
transposition, RNA-mediated 8.85E-19 4.66E-15 18.19 
DNA integration 4.69E-11 8.22E-08 19.33 
cellular response to external stimulus 6.83E-06 5.13E-03 6.61 
cell communication 6.83E-06 4.49E-03 6.61 
response to extracellular stimulus 1.15E-05 6.08E-03 6.2 
response to external stimulus 1.88E-05 9.00E-03 5.84 
energy reserve metabolic process 2.86E-05 1.16E-02 13.47 
RNA phosphodiester bond hydrolysis 3.27E-05 1.23E-02 4.83 
response to abiotic stimulus 3.76E-05 1.32E-02 4.76 
regulation of DNA amplification 1.25E-04 4.09E-02 88.92 
negative regulation of DNA amplification 1.25E-04 3.85E-02 88.92 
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further deleted FOB1 in the mms22:HIS3 (CJ187, high rDNA CN) background which 
generated two mms22::HIS3 fob1::LEU2 (strains AZ3, AZ5, both high rDNA CN) strains, 
referred to as mms22Δ fob1Δ. Fortuitously one isolate had undergone a substantial rDNA 
deletion during the transformation process providing a further mms22Δ fob1Δ (strain 
YAZ1, low CN strain); this was not surprising as rDNA contractions were recently reported 
to occur frequently during standard LiCl-heat shock yeast transformation (Kwan et al. 
2016). rDNA CN for these strains was verified before sequencing by PFGE (Figure 4.4). 
  
Figure 4.4 Chromosome XII PFGE shows rDNA CNV among sequenced yeast strains 
Approx. 60% S. cerevisiae chromosome XII is the rDNA repeat cluster. DNA was extracted from 
stationary phase cells and separated on an agarose gel by PFGE. rDNA CNV was estimated from 
mobility of chromosome XII bands as visualised by EtBr stain (white asterisks). WT rDNA CN 
defined as 180 repeats. Relative band sizes estimated by comparison to known-size Hansenula 
wingei chromosomes run as markers in a separate lane. 
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Figure 4.5 rDNA CN-sensitive gene expression in S. cerevisiae samples between WT, high, 
and low rDNA CN samples 
Samples from strains shown in Figure 4 were grown, processed, and analysed as in Figure 4.3. 
A) As Figure 4.3 A. rDNA CN does not align fully with either PC1 or PC2 though high rDNA CN 
samples cluster away from WT and low CN on PC2. Thus rDNA CN was not the primary 
contributor to variance in this dataset. 
B) As Figure 4.3 B. 39 genes differentially expressed. 
C) As Figure 4.3 B.  52 genes differentially expressed. 
D) As Figure 4.3 B.  62 genes differentially expressed. 
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To prepare samples for sequencing, I grew 2 biological replicates each of: 2 strains of 
fob1Δ (CJ29, JH81, both WT rDNA CN), 1 strain of mms22Δ (CJ187, high rDNA CN), 1 
strain of mms22Δ fob1Δ (AZ1, low rDNA CN), 2 strains of fob1Δ mms22Δ (AZ3, AZ5, both 
WT rDNA CN), and 2 strains of mms22Δ fob1Δ (CJ188, CJ190, both high rDNA CN). Cells 
were cultured in YPD and harvested in mid-log phase at OD600 between 0.35 – 0.75. Total 
RNA was isolated and libraries prepared from Poly-A selected transcripts. 1 library per 
strain per biological replicate was prepared, a total of 16 RNA-seq libraries. Sequenced 
reads were processed to aligned BAM files by the Babraham Institute Bioinformatics Core 
as described in Section 2.5.1, this data is referred to as the Zylstra dataset. 
There were no confounding global shifts with transcriptomes broadly appearing similar 
(Figure 4.5 A-D). Plotting samples after PCA showed high CN samples somewhat 
separated from low and WT samples on PC2 (Figure 4.5 A). Among these samples 39 
genes were differentially expressed between low and WT rDNA CNs (Figure 4.5 B) 
(DESeq2, BH corrected FDR < 0.05), showing enrichment for genes involved in carboxylic 
acid biosynthesis, alpha-amino acid biosynthesis – arginine in particular –, and 
glycolysis/gluconeogenesis (FDR < 0.05) (selected terms in Table 4.7, full GOrilla output in 
Appendix Table 8.3). Between high and WT CN, 52 genes were differentially expressed 
(Figure 4.5 C) (DESeq2, BH corrected FDR < 0.05), however no GO terms were enriched 
among this set. Finally, comparing high and low CN samples revealed 62 differentially 
expressed genes (Figure 4.5 D) (DESeq2, BH corrected FDR < 0.05). Genes with amino acid 
synthesis-related GO terms were enriched this set (FDR < 0.05) (selected terms in Table 
4.8, full GOrilla output in Appendix Table 8.4). 
Table 4.7 Selected GO terms enriched among genes differentially expressed between low 
rDNA CN vs. WT rDNA CN samples 
GO Term P-value FDR q-value Enrichment 
carboxylic acid biosynthetic process 1.51E-11 3.97E-08 10.26 
arginine biosynthetic process 1.56E-07 1.17E-04 71.36 
alpha-amino acid biosynthetic process 6.15E-07 4.04E-04 10.44 
gluconeogenesis 2.19E-06 1.05E-03 40.14 
hexose biosynthetic process 2.19E-06 9.59E-04 40.14 
glycolytic process 1.72E-05 4.76E-03 24.7 
pyruvate biosynthetic process 2.01E-05 5.03E-03 23.79 
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Table 4.8 Selected GO terms enriched among genes differentially expressed between low 
rDNA CN vs. high rDNA CN samples 
GO Term P-value FDR q-value Enrichment 
alpha-amino acid biosynthetic process 8.30E-20 4.36E-16 16.08 
arginine biosynthetic process 1.59E-10 7.62E-08 59.8 
aspartate family amino acid biosynthetic process 5.27E-08 1.98E-05 14.5 
glutamine family amino acid metabolic process 7.04E-08 2.47E-05 13.99 
organonitrogen compound biosynthetic process 7.77E-08 2.56E-05 3.15 
glutamine family amino acid biosynthetic 
process 1.97E-07 6.09E-05 22.15 
aspartate family amino acid metabolic process 2.28E-07 6.67E-05 12.08 
ornithine metabolic process 1.11E-06 3.07E-04 44.3 
tryptophan biosynthetic process 1.88E-05 3.95E-03 49.84 
methionine biosynthetic process 3.32E-05 6.73E-03 13.11 
 
I was interested to see whether there were genes found to be rDNA CN-sensitive between 
the Zylstra dataset and the Houseley data. Comparing lists of genes differentially 
expressed between very low vs. WT CN (Houseley data) or low vs. high CN (Zylstra data), 
i.e. the greatest CN differences in each dataset, revealed a significant overlap of 6 genes 
(Fisher’s exact test, odds ratio = 4.32, p = 4.2 x 10-3). Of these, 3 are annotated as 
transposable element genes in the Saccharomyces Genome Database 
(https://www.yeastgenome.org) and retrotransposon expression was not directionally 
consistent between the two datasets (Figure 4.6 D). The other genes were SIR2, HMO1, 
and PHO3 (Figure 4.6 A-B). Expression of SIR2 was reduced in samples with lower rDNA 
CN and increased in samples with higher CN, consistent with literature reports of SIR2 
repression in the event of rDNA deletions (Michel et al. 2005; Iida and Kobayashi 2019). 
HMO1 behaved similarly, however expression changed little from WT CN to high CN. 
Conversely, expression of PHO3 was increased at lower CN and decreased at high CN. 
HMO1 is a particularly interesting gene in this context as it is a key player in promoting 
Pol I transcription and facilitates the unique open chromatin structure of actively 
transcribed rDNA repeats (Dammann et al. 1993; Gadal et al. 2002; Hall et al. 2006; Merz et 
al. 2008; Murugesapillai et al. 2014). Potentially rDNA CN-sensitive regulation may 
maintain an appropriate balance of Hmo1p between the rDNA and other genomic sites 
where it is also active, such as many RP gene promoters. Action at rDNA and RP genes 
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may help maintain stoichiometric production of the many ribosome components (Berger 
et al. 2007; Kasahara et al. 2008; Reja et al. 2015). 
Between the two yeast datasets several gene sets had shown significant enrichment, 
though enriched GO categories were not shared between the two experiments. I aimed to 
test whether there were nonetheless consistent trends which may not have reached the 
threshold of significance in both datasets. Indeed, ribosome biogenesis (GO:0042254) 
annotated genes were on average more highly expressed in lower copy number 
backgrounds in both experiments (Figure 4.6 C). Retrotransposons (GO:0032197) (Figure 
4.6 D) and genes annotated as part of alpha-amino acid biosynthesis (GO:1901607) 
(Figure 4.6 E) behaved inconsistently between the two datasets, however expression 
differences for retrotransposons relative to WT were most pronounced at lower copy 
numbers. There were no differences in ribosome biogenesis genes between high and WT 
CN samples at either time point in my worm analysis, consistent with the yeast data high 
vs. WT CN comparison (Figure 4.6 F). Together, these results suggest a moderate 
upregulation of ribosome biosynthesis genes in the event of rDNA deletions. There is 
plausible functional logic for such an effect as low rDNA CN cells must transcribe their 
diminished repeat pool more intensively to stave off potentially serious phenotypic 
consequences of rRNA insufficiency, examples of which include the bobbed phenotype in 
Drosophila and embryonic lethality in chickens (Ritossa et al. 1966; Delany et al. 1994; 
French et al. 2003). 
4.2.4 Increased rDNA copy number results in increased ncRNA 
expression from rDNA in yeast but not in worms 
ncRNA transcription by Pol II can be observed from rDNA in yeast in addition to canonical 
Pol I transcription of the rRNA genes (Santangelo et al. 1988; Kobayashi and Ganley 2005; 
Houseley et al. 2007). Indeed, transcription from a bidirectional E-pro site in NTS1 (Figure 
1.1) is reported to drive rDNA amplification in event of deletions (Kobayashi and Ganley 
2005). Expression from the rDNA was quantified in 50bp windows to enable assessment of 
levels of ncRNA transcripts from sites not annotated as genes. I refer to transcription in 
the same direction as Pol I elongation as “sense” and in the opposite direction as 
“antisense”.  
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Figure 4.6 Consistent rDNA CN-dependent expression changes were found for 3 yeast 
genes, few clear trends among genes annotated to selected GO terms 
A-B) 3 yeast genes, SIR2, HMO1, and PHO3 were significantly differentially expressed in a 
directionally consistent manner between my data (Figure 5) and data collected by Jon Houseley 
(Figure 3). SIR2 was expected from previous literature (Michel et al. 2005; Iida and Kobayashi 
2019). 
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In both yeast datasets, transcription from several non-rRNA regions appears to increase 
considerably as rDNA CN increases (Figure 4.7 A-B). ncRNA transcription from the rDNA is 
more visible the Zylstra data samples (Figure 4.7 B), however in both datasets there is 
evidence of large rDNA CN-dependent differences in transcription in sense and antisense 
directions from IGS1/2. Interestingly, this is contrary to what would be expected under a 
published model for rDNA repeat amplification, where CNV is thought to be driven by 
increased bidirectional transcription from the E-pro site in IGS1 (Kobayashi and Ganley 
2005). Furthermore the location of IGS1/2 transcription peaks, with a pronounced trough 
around the 5S locus, suggests the majority of Pol II transcripts from the region may be 
shorter and with different TSS than has been previously suggested (Houseley et al. 2007). 
In the Zylstra dataset there is further clear evidence of increasing antisense ETS1/2 (fitting 
well with Mayán 2013) and ITS1/2 transcription with increasing rDNA CN. In the sense 
direction, ETS1 transcription is similar between low and WT CN samples but raised at high 
CN. Antisense ITS transcripts are present at a very low level in the low CN background but 
are greatly increased at WT CN and further at high CN. This is probably a consequence of 
inhibition of Pol II activity in a context of elevated Pol I occupancy (Cioci et al. 2003; 
French et al. 2003; Cesarini et al. 2010). More unexpected is that these ITS transcript peaks 
C) DESeq2 normalised expression values relative to WT rDNA CN samples for all yeast genes 
annotated with GO:0042254 (ribosome biogenesis) were plotted for data from the two yeast 
datasets. RiBi genes showed a consistent trend towards upregulation at low rDNA CN. GO term 
considered due to enrichment among genes differentially expressed in the very low vs. WT 
rDNA CN comparison. 
D) As C for all yeast genes annotated with GO:0032197 (transposition, RNA-mediated). GO term 
considered due to enrichment among genes differentially expressed in the very low vs. WT 
rDNA CN comparison. Trends not consistent between datasets. 
E) As C for all yeast genes annotated with GO:1901607 (alpha-amino acid biosynthetic process). 
GO term considered due to enrichment among genes differentially expressed in the low vs. WT 
rDNA CN comparison. Trends not consistent between datasets. 
F) DESeq2 normalised expression values relative to WT rDNA CN samples for all worm genes 
annotated with GO:0042254 (ribosome biogenesis) were plotted for data from the time points. 
Consistent with yeast data, C, there was no difference in RiBi gene expression in high rDNA CN 
samples relative to WT samples. 
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do not extend into rRNA genes, indicating that Pol II accessibility is remarkably different 
over the length of the 35S transcribed region.  
Figure 4.7 Pol II transcript expression from non-rRNA regions of the rDNA repeat broadly 
correlate with rDNA CN 
Reads were quantified over the S. cerevisiae rDNA region in 50 bp windows (XII: 450000-470000). 
The S. cerevisiae reference genome contains 2 identical rDNA repeats so only 1 is shown. ‘Sense’ 
reads were defined as those originating from transcripts transcribed in the same direction as Pol I 
transcribes the 35S (i.e. ETS1, 18S-> ETS2). Lines show mean of isogenic replicates within the same 
rDNA CN range. 
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A) Data from the Houseley dataset. There is evidence of decreased expression in sense and 
antisense directions at IGS1/2 in the very low CN sample relative to WT. 
B) Data from the Zylstra dataset. As in A, there is evidence for broadly rDNA CN proportional 
expression from IGS1/2. Additionally ETS1 in sense direction. ETS1/2 and ITS1/2 in both 
directions. 
Figure 4.8 rDNA CN-dependent differences in Pol II transcription from the rDNA were not 
dependent on FOB1 or MMS22 deletion 
Data processed as in Figure 4.7. High and WT rDNA CN samples were clearly separated regardless 
of single or double mutant genotypes which indicates that expression depends primarily on rDNA 
CN in these samples. The main exception is in the mms22Δ High CN samples where expression is 
perhaps lower than the mms22Δ fob1Δ High CN samples in IGS1 – this is consistent with the 
importance of Fob1 for targeting the silencing HDAC Sir2 to IGS1 (Straight et al. 1999; Buck et al. 
2016). 
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In addition to increasing rDNA instability, Fob1 is important for targeting the Sir2-
containing RENT complex to facilitate silencing of Pol II transcription within the rDNA 
(Straight et al. 1999; Buck et al. 2016). All sequenced yeast samples had fob1Δ as part of 
their genotype to stabilise copy number variants. I therefore considered it important to 
check that whether levels of ncRNA transcription in my samples might be affected by 
inefficient Sir2 recruitment to the rDNA in the absence of Fob1. To do this, I compared 
data from mms22Δ (high rDNA CN) and fob1Δ (WT rDNA CN) single mutants with that 
from matched-rDNA CN double mutants (Figure 4.8). The mms22Δ (high rDNA CN) single 
mutant behaved much like the high rDNA CN mms22Δ fob1Δ double mutant, indicating 
that ncRNA expression rises with increased rDNA CN independent of FOB1 deletion. 
However, there is somewhat reduced signal in the sense direction from the mms22Δ (high 
rDNA CN) single mutant in IGS1 relative to the mms22Δ fob1Δ (high rDNA CN) double 
mutant; this is consistent with the published evidence that Fob1 is more important for 
Sir2-dependent silencing that region, as one would therefore expect higher Pol II 
transcription from IGS1 in fob1Δ genotypes (Buck et al. 2016). The fob1Δ (WT rDNA CN) 
single mutants also showed similar levels of transcripts across the rDNA locus to the fob1Δ 
mms22Δ (WT rDNA CN) double mutant – suggesting that differences in transcript levels 
are not an artefact of MMS22 deletion. Sense transcripts mapped to rRNA genes 
themselves seemed to be generally higher in samples with higher CN my dataset, 
although I am wary of interpreting this as showing higher levels of rRNA in higher CN 
backgrounds as the pattern was not replicated in the older data. Also, libraries were made 
from RNA subject to poly(A)+ selection and small differences in purification efficiency 
could lead to spurious results given the initial abundance of rRNA. 
Quantifying transcripts from the rDNA in the worm dataset shows no evidence of major 
ncRNA transcription beyond that of Pol I at either young or aged timepoints (Figure 4.9 A-
B); this diverges from reported rDNA Pol II activity in vertebrates with larger intergenic 
regions within their repeats (Mayer et al. 2006; Agrawal and Ganley 2018). As in yeast, 
higher rDNA CN samples tended to have more reads from sense rRNA transcripts at both 
timepoints. Unexpectedly, worm samples showed elevated expression over mature rRNA 
sequences in both sense and antisense directions – what biological mechanism could 
cause this is unclear, though incomplete preservation of strandedness during library 
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preparation is a possible artefactual cause. A small loss of strandedness could give rise to 
impressive numbers of artefactual antisense reads from the highly transcribed rDNA. 
Furthermore, loss of library strand specificity was experienced by a couple of other 
workers in the lab using the same reagents as I used to prepare those worm libraries. That 
high rDNA CN in worms is also associated with more sense reads over rRNA genes lends 
more support to the possibility that higher rDNA CN leads to higher rRNA levels, though 
the caveat about poly(A)+ selection applies here too.  
In summary, there were no trends in non-rRNA transcript expression from the rDNA 
shared between both models – indeed, given the apparent complete lack of Pol II activity 
at the C. elegans rDNA, anomalous among animals studied to date, this organism may 
prove not be the best model for all aspects vertebrate rDNA biology. On the other hand, 
yeast demonstrated considerable variability in Pol II transcription at a variety of rDNA sites 
dependent on CNV. The locations of transcript peaks suggest the full complement of 
transcripts from this locus have not yet been reported in the literature. Interestingly, lower 
expression of IGS1 expression at lower rDNA CNs challenges the prominent Kobayashi lab 
model for induced rDNA CNV at low CNs. 
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Figure 4.9 There is little detectable Pol II-derived transcription at the C. elegans rDNA locus 
C. elegans RNA-seq data processed as in Figure 1. Reads were quantified in 50 bp windows over 
the rDNA repeat of a custom edited C. elegans reference genome (I: 15059000 – 15069800) (see 
Section 2.5.2). Dashed vertical line indicates where a second copy of 18S was removed from the 
reference – expression peaks either side correspond to regions immediately 5` and 3` to the 18S 
gene. 
A-B) show little evidence for Pol II-derived intergenic transcription at the C. elegans rDNA repeat. 
Reads mapping between 18S and 5.8S or 5.8S and 25S likely correspond to Pol I transcript or 
derivatives. Antisense reads mapping within mature rRNA gene boundaries may be due to partial 
loss of strandedness during library preparation. 
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4.2.5 rDNA CNV influences expression of subtelomeric genes 
independent of SIR2 in yeast 
In yeast strains with partial rDNA deletions, a portion of the cellular pool of Sir2 is 
redistributed leading to increased silencing of HML/HMR and telomeric loci (Michel et al. 
2005). This increased silencing occurs despite SIR2 downregulation at the transcript and 
protein levels. My analysis had revealed only three individual genes which could be 
confidently classed as rDNA CN-sensitive, however I was interested whether there might 
be general trends in expression for subtelomeric genes. I defined subtelomeric genes as 
ones present within 30 kbp of chromosome ends, a heuristic based on previous literature 
(Brown et al. 2010; Ellahi et al. 2015). This produced a list of 476 genes (7.2% of the whole 
genome list) which showed a moderate trend towards reduced expression at lower rDNA 
CNs (Figure 4.10 A). 
In order to test whether this could be explained by Sir2 relocation, I generated lists of 
genes whose expression changed upon SIR2 deletion. I downloaded and processed (as 
described in Section 2.5.1) RNA-Seq data from Ellahi et al 2015 and Hendrickson et al 
2018, two studies where log-phase sir2Δ and WT samples were sequenced. Taking 
differentially expressed genes (DESeq2, BH corrected FDR < 0.01) either up- or down-
regulated in both sets of samples resulted in a list of 37 whose expression increased upon 
SIR2 deletion (SIR2-repressed) and 173 where expression decreased (SIR2-induced). As 
expected, there was a strong enrichment for subtelomeric genes in the SIR2-repressed list 
(Fisher’s Exact Test, odds ratio = 12.7, p = 9 x 10-12) while there was not in the SIR2-
induced list (Fisher’s Exact Test, odds ratio = 0.88, p = 0.71). There were no GO terms 
enriched among SIR2-repressed genes (FDR > 0.05), though HML/HMR genes were SIR2-
repressed as reported in previous literature (Rusche et al. 2003). Among SIR2-induced 
genes was a large enrichment for retrotransposon-related terms (90.9% genes annotated 
with transposition, RNA-mediated, GO:0032197); there was also weaker enrichment for 
genes terms related to pheromone response and cellular conjugation (FDR < 0.05) 
(selected terms in Table 4.9, full GOrilla output in Appendix Table 8.5). Gene sets driving 
enrichment of pheromone response and conjugation terms overlap considerably and have 
mostly haploid, mating type a, or mating type α specific gene expression (Johnson 1995). 
These are variously regulated by factors expressed from mating type loci which are all 
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abnormally de-silenced in sir2Δ cells (Rine and Herskowitz 1987; Rusche et al. 2003). 
Hence genes annotated to these terms are probably not SIR2-induced per se but rather 
repressed by SIR2-repressed factors. I consider it probable that retrotransposons being 
apparently SIR2-induced is due to a similar indirect mechanism. Nonetheless, 
consistencies between the two RNA-seq experiments, and with other literature, give high 
confidence that the genes identified are genuinely SIR2 regulated, whether directly or 
indirectly. 
Table 4.9 Selected GO terms enriched among SIR2-induced genes 
GO Term P-value FDR q-value Enrichment 
transposition, RNA-mediated 1.49E-122 7.84E-119 31.28 
DNA integration 5.10E-55 8.94E-52 29.17 
response to pheromone 9.33E-10 3.27E-07 10.07 
positive regulation of conjugation 1.00E-08 3.11E-06 9.46 
positive regulation of conjugation with cellular 
fusion 1.00E-08 2.94E-06 9.46 
positive regulation of multi-organism process 2.32E-08 6.42E-06 8.8 
positive regulation of reproductive process 2.33E-08 6.12E-06 7.79 
 
Surprisingly there was no consistent pattern of expression of SIR2-repressed genes across 
different rDNA CNs (Figure 4.10 B); this was true even for the subset in subtelomeric 
locations (Figure 4.10 C-D). Plotting gene expression relative to WT against distance from 
the chromosome end shows that the moderate rDNA CN-dependent trend in 
subtelomeric expression is driven by genes in the most telomere-proximal 10 – 15 kb 
(Figure 4.10 E). These results do not fit with a model where rDNA deletions result in 
subtelomeric gene repression by redistribution of Sir2. They further indicate that 
transcriptomic effects of rDNA CNV are not primarily Sir2 mediated. Hence the trend 
towards lower subtelomeric expression at lower rDNA CN remains currently unexplained. 
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Figure 4.10 There is a Sir2-independent trend towards lower subtelomeric gene 
expression at lower rDNA CNs 
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Subtelomeric yeast genes were defined as those within 30 kbp of chromosome ends, 
comprising 476 genes (7.2% of the whole genome list). SIR2-regulated genes were defined as 
those differentially expressed (DESeq2, BH corrected FDR < 0.01) in log-phase sir2Δ yeast 
samples relative to matched WT controls in data from Ellahi et al. 2015 and Hendrickson et al. 
2018; SIR2-repressed genes were those significantly upregulated (Log2 fold change relative to 
WT > 0) in sir2Δ samples in both datasets (37 genes).  
A) DESeq2 normalised expression values relative to WT rDNA CN samples for all subtelomeric 
yeast genes. There may be a moderate tendency towards lower expression in low rDNA CN 
contexts. 
B) rDNA CN did not consistently affect expression of SIR2-repressed genes. 
C) As B for the subset of subtelomeric genes which are also SIR2-repressed. 
D) Expression of non-SIR2-repressed subtelomeric genes is representative of all subtelomeric 
genes (compare with A). 
E) The trend towards lower expression of subtelomeric genes at lower rDNA CNs is driven by 
genes in the most telomere-proximal 10 – 15 kbp of chromosomes. 
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4.3 Discussion 
4.3.1 rDNA CN-sensitive gene expression shows little conservation 
between species 
Sequencing of mRNA revealed some evidence for rDNA CN-sensitive gene expression in 
tens to hundreds of genes in yeast and worms. This is somewhat consistent with previous 
reports from Drosophila and human studies, though these studies reported hundreds to 
thousands of such genes (Paredes et al. 2011; Gibbons et al. 2014). That there should be 
fewer in yeast is expected given relative genome sizes and gene complements, however 
the genomes of D. melanogaster and C. elegans are of comparable sizes, so such a 
discrepancy in the number of rDNA CN-sensitive genes is surprising. Concordant with my 
data, a recent report on maize found only 32 genes whose expression correlated 
significantly with rDNA CN (Li et al. 2018). One possibility is that gene expression is more 
responsive to rDNA CN losses; the work in Drosophila looked exclusively at rDNA 
deletions of varying severity and functionally coherent differences appeared stronger at 
lower yeast CNs in my data (Paredes et al. 2011). Additionally, my worm dataset compared 
a 2.5-fold increase in CN with WT samples and suggests that effects of CN amplification 
are remarkably well buffered.  
Before further discussion, there are important caveats which should be mentioned that 
may influence interpretation of some published work and my yeast data. Firstly, in both 
the human and maize studies reporting rDNA CN-sensitive expression, rDNA CN was 
calculated from whole genome resequencing data (Gibbons et al. 2014; Li et al. 2018). I 
found similar methods used to estimate rDNA CN in Million Mutation Project worm strains 
to be unreliable when compared against PFGE (data not shown), hence I treat the 
published reports with some caution (Thompson et al. 2013). Furthermore, as noted in 
Symonová 2019, some of the rDNA CN estimates for human samples in Gibbons et al. 
2014 were surprisingly low and other authors have reported significantly different ranges 
for human populations assayed by different methods (Chestkov et al. 2018; Malinovskaya 
et al. 2018). Secondly, my yeast data came from strains deleted for FOB1 – a necessary 
step to stabilise rDNA CN. It was recently found that log phase populations adjust their 
total rDNA dosage by the Fob1-dependent production of ERCs, reaching steady state 
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about 11 divisions after a CNV event (Mansisidor et al. 2018). Since ERCs are typically 
retained by mothers at cell division, the rDNA CN-dependent expression changes, as seen 
in my analysis, may therefore be limited in WT populations to cells having recently 
undergone CNV or young progeny (Sinclair and Guarente 1997; Denoth-Lippuner et al. 
2014).  
There were very few overlaps between putative rDNA CN-sensitive genes between my 
datasets in either organism. Hence there are few genes where one can be confident of 
consistent rDNA CN effects on expression. It appears effects of rDNA CN are generally 
subtle, so the low replicate number for some samples/comparisons potentially limited 
detection power. Furthermore yeast strains used for the older RNA-seq dataset were from 
a different (W303) genetic background than ones used in my sequenced samples 
(BY4741). Detection difficulties notwithstanding, even had more replicates been 
performed it is unclear how biologically meaningful further statistically significant hits 
would be, given that expression fold changes would likely be small. Among the worm 
strains, there were clear effects of background genetic variation in the young samples, 
most clearly shown though effects on developmental rate; it is quite possible that some 
low amplitude rDNA CN-dependent signals were swamped by noise from other 
undetected heterogeneity. Conversely, I expect variation between yeast mutants (within a 
strain background) was negligible due to the use of haploid asexually propagating 
populations and a targeted homologous recombination-based transformation method. 
Three non-retrotransposon genes were differentially expressed in both yeast datasets 
(Houseley, WT vs. very low rDNA CN, and Zylstra, high vs. low rDNA CN). Of these, SIR2 
was expected based on previous publications and is discussed below (Section 4.3.2). 
HMO1 was similarly generally downregulated at lower copy numbers and rDNA CN-
sensitivity is probably functionally significant (Figure 4.6 A-B) – Hmo1 is involved in rRNA 
transcription by Pol I, maintains the dynamic and nucleosome poor chromatin structure of 
active rDNA repeats, and is required for mTOR-mediated RP gene repression via 
interactions with RP gene promoters (Dammann et al. 1993; Gadal et al. 2002; Hall et al. 
2006; Berger et al. 2007; Kasahara et al. 2008; Merz et al. 2008; Murugesapillai et al. 2014; 
Reja et al. 2015). Low copy number strains may have fewer active rDNA repeats, due to 
fewer being available, leading to reduced requirement for nucleolar Hmo1 (French et al. 
146 
 
2003). Possibly expression must be matched to active rDNA levels to avoid negative 
consequences of excessive redistribution to other loci. Expression of PHO3, an acid-
phosphatase for thiamin phosphate substrates, broadly anti-correlated with rDNA CN 
(Figure 4.6 A-B) (Schweingruber et al. 1986; Nosaka 1990). However, the functional logic 
behind this expression pattern is unclear, as it is for the two differentially expressed genes 
in both young and aged worms. 
Analysis of the two yeast datasets suggests a functional link between expression of 
ribosome biogenesis genes and rDNA CN (Figure 4.6 C); genes annotated as involved in 
ribosome biogenesis were enriched among differentially expressed genes in the very low 
CN samples and showed a trend towards lower expression in the low CN samples. A study 
in human blood cells similarly found enrichment for ribosome biogenesis-related terms, 
although they reported a positive correlation between expression and CN for the genes 
involved (Gibbons et al. 2014). The Drosophila analysis reported functional enrichment for 
the mitochondrial electron transport chain and lipid metabolism, though this was not seen 
in my datasets (barring reduced fat-5 and fat-6 expression in high CN aged worms) or 
other studies (Paredes et al. 2011; Gibbons et al. 2014; Li et al. 2018).  
Overall, evidence from mRNA-transcriptome wide studies in multicellular eukaryotes is 
conflicted as to the extent which rDNA CNV affects gene expression: the largest estimate 
for rDNA-sensitive genes comes from a human study with potentially serious caveats 
noted above, while other studies in Drosophila and maize gave totals much closer to those 
from my yeast data (Paredes et al. 2011; Gibbons et al. 2014; Li et al. 2018). My worm data 
meanwhile is a low-end outlier, though the detection power in that experiment was 
compromised by background genetic heterogeneity and low replicate numbers in some 
contexts. The yeast system probably allows the greatest control over genetic and 
environmental confounders; thus I conclude from my data that rDNA CNV genuinely can 
influence gene expression, functional biological effect sizes are probably not large, and 
that probably only a few hundred genes at most are significantly affected under lab 
conditions. Given the experimental advantages of the S. cerevisiae system where more is 
known about rDNA biology, alongside the fact that transcriptome profiling did not 
suggest any further phenotypic assays for C. elegans, I decided to work with yeast for my 
later experiments. 
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4.3.2 SIR2 expression is influenced by rDNA copy number but does not 
mediate rDNA copy number effects on expression at subtelomeric 
loci 
The regulation of one bona fide rDNA-CN sensitive gene, yeast SIR2, offers insight into a 
potential mechanism for this effect. SIR2 was significantly differentially expressed in a 
coherent manner (expression broadly correlates with rDNA CN) in both my datasets 
(Figure 4.6 A-B). This is expected as decreased SIR2 transcript and Sir2 protein expression 
have been previously reported in strains with reduced rDNA CN (Michel et al. 2005; Iida 
and Kobayashi 2019). Iida and Kobayashi recently showed that, when rDNA copies are 
lost, elements of the Pol I transcription-activating UAF complex relocate to – and repress – 
the SIR2 locus. Previous work by the Kobayashi lab suggested that Sir2 silences 
transcription from a bidirectional E-pro site in the NTS1 rDNA region and that this 
transcription facilitates Fob1-dependent rDNA CNV; their recent work argues that this 
operates a negative feedback circuit for maintaining rDNA CN around WT levels, giving an 
explanation for such a regulatory pattern (Figure 1.6, Figure 1.7) (Kobayashi and Ganley 
2005; Iida and Kobayashi 2019).  
ChIP-seq data presented by Iida and Kobayashi suggest regulation by UAF is SIR2 specific. 
However SIR2 itself offers a similar example of titration of a regulatory factor by rDNA 
copies. Silencing at HML/HMR and telomeric loci increases due to redistribution of Sir2 in 
the event of rDNA CN loss (Michel et al. 2005). Conversely such silencing is relieved in 
ageing yeast, which gain rDNA copies as ERCs, due to sequestration of Sir2 in the 
nucleolus (Sinclair and Guarente 1997; Kennedy et al. 1997; Salvi et al. 2013). I found a 
trend towards lower expression of subtelomeric genes with lower rDNA CN (Figure 4.10 A, 
D-E) which was most pronounced closest to the telomere. This would be as expected 
under a model where Sir2 (with Sir3 and Sir4) concentrate at telomeres, with a gradient of 
diminished occupancy and silencing further away. However, I found that SIR2-repressed 
genes did not show a clear pattern of silencing at lower rDNA CNs, which would be 
expected if Sir2 binding is increased for the non-rDNA genome, even when considering 
only the subset at subtelomeric positions (Figure 4.10 B-C). This is consistent with the 
findings in Ellahi et al. 2015; Sir2/3/4 ChIP peaks occur at discrete subtelomeric locations 
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and expression of only a small fraction of subtelomeric genes changes upon deletion of 
SIR2/3/4. It therefore appears there may be other unknown mechanisms linking broad 
trends in subtelomeric gene expression with rDNA CN beyond SIR2 redistribution.  
4.3.3 Yeast and worms show divergent effects of rDNA copy number on 
Pol II-mediated transcription from the rDNA 
Both of my yeast datasets demonstrate expression of ncRNA from non-rRNA gene regions 
of the rDNA which varies with rDNA CN (Figure 4.7 A-B). This is a well-established 
phenomenon in yeast with reported key roles in rDNA CNV (Santangelo et al. 1988; 
Kobayashi and Ganley 2005). Additionally stalled Pol II in the rDNA is implicated in 
maintenance of nucleolar structure, targeting of replication factors to the rDNA ARS, and 
spatial separation of Pol I and Pol III activity (Mayan and Aragón 2010; Mayan 2013; 
Freire-Picos et al. 2013). Pol II transcription at intergenic rDNA regions is silenced by Sir2 
as part of the rDNA-targeted RENT complex and transcripts are rapidly degraded by the 
nuclear exosome (Smith and Boeke 1997; Bryk et al. 1997; Straight et al. 1999; Li et al. 
2006; Houseley et al. 2007; Vasiljeva et al. 2008). Transcription from most non-rRNA gene 
rDNA regions seems to broadly correlate with rDNA CN, in agreement with previous 
reports which found low CN strains to produce fewer Pol II transcripts (Figure 4.7 A-B) 
(Cioci et al. 2003; Cesarini et al. 2010). It is intuitive that more template should beget more 
transcript, however the model for regulated CNV put forward by Kobayashi and 
colleagues relies on increased bidirectional transcription from E-Pro in IGS1 at lower copy 
numbers – this seems inconsistent with my data (Kobayashi and Ganley 2005; Iida and 
Kobayashi 2019). Interestingly, while I see rDNA CN-correlated SIR2 expression changes as 
previously reported, these appear insufficient to maintain Pol II transcription at WT levels 
over the whole rDNA (Michel et al. 2005; Iida and Kobayashi 2019). However, this may be 
a useful feature if Pol II occupancy is required for maintenance of normal nucleolar 
function, e.g. by normalizing replication factor allocation by array size (Mayan 2013).  
The location of peaks in my data is also surprising given some previously reported TSS 
and lengths of rDNA-derived ncRNA. For example, an RNA has been described extending 
in the sense direction from the E-pro site in IGS1 through the 5S locus and into IGS2 – 
sense counts drop precipitously around the 5S and peak in IGS2, suggesting a smaller 
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species with an IGS2 TSS may be more abundant (Houseley et al. 2007). Conversely, my 
data is relatively consistent with the findings in Mayan and Aragón 2010 where 
transcription from the IGS region was assayed with several RT-qPCR primer pairs. Short 
transcripts from the ETS regions, as seen particularly in my mms22Δ fob1Δ samples (Figure 
4.7 B, Figure 4.8), have also been reported by the same author (Mayán 2013). In my data 
there are striking transcription peaks in the two ITS segments in the antisense direction 
which essentially disappear at low copy numbers. That these transcripts do not extend 
into any of the rRNA genes is remarkable; this may be due to reduced Pol I occupancy in 
ITS and the presence of putative Pol I stalling sites at 3` and 5` ends of the rRNA genes (El 
Hage et al. 2010; Clarke et al. 2018). Proportion of active repeats, and Pol I density at 
those repeats, is greater at lower rDNA CNs, therefore Pol II ITS transcription is likely 
prevented by the high level of Pol I activity at low CNs (Cioci et al. 2003; French et al. 2003; 
Cesarini et al. 2010). Were Pol II ITS transcription occurring from Pol I-inactive repeats, 
transcripts would presumably not be subject to this bounding effect. Hence my data imply 
that ITS transcription must come from active repeats which are not Pol I saturated, under 
the assumption that Pol I stalling is key to excluding Pol II from rRNA genes. Since higher 
CNs feature more Pol II transcription, and assuming similar levels of total Pol I output, this 
suggests that ‘extra’ rDNA copies are not all completely silenced. As a result higher CN 
strains might posess more active repeats and could potentially have an advantage under 
conditions requiring a rapid acceleration of rRNA production. There is some support for 
this latter concept from bacterial studies, though the inverse was noted in other single-
celled eukaryotes (Gyorfy et al. 2015; Roller et al. 2016; Fu and Gong 2017). 
In contrast to the yeast datasets, C. elegans samples showed no clear trends in possible 
Pol II transcription from the rDNA (Figure 4.9). Indeed they showed very little indication 
that Pol II is active at the rDNA in worms at all, setting C. elegans apart from other animal 
systems where such transcripts have been reported (Mayer et al. 2006; Agrawal and 
Ganley 2018). The C. elegans rDNA repeat (7.2 kb) is much shorter than that of mice or 
humans (45 kb and 43 kb) (Ellis et al. 1986; Gonzalez and Sylvester 1995; Grozdanov et al. 
2003). Compared with the similarly-sized S. cerevisiae rDNA repeat, C. elegans have very 
little intergenic sequence – Saijou et al. 2004 reports virtually the entire repeat as being 
Pol I transcribed and my own Northern blots suggest there may be ~500 bp which are not 
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typically transcribed. As in mammlian systems, and unlike S. cerevisiae, the 5S is present in 
a different repeat array which reduces intergenic size and relieves the need to isolate 
different RNA polymerases by Pol II activity (Mayan and Aragón 2010). Worm samples 
consistently displayed antisense-mapping transcripts with clear boundaries at the rRNA 
gene loci (Figure 4.9). It is unclear what process could give rise to this, though artefact 
from partial loss of strandedness during library preparation is a possibility. Unfortunately 
the C. elegans rDNA is relatively understudied which limits further comparisons. 
Overall, the data presented this chapter provides strong evidence for the phenomenon of 
rDNA-CN sensitive gene expression. However the degree to which this is biologically 
relevant, beyond some clear examples like SIR2 and likely HMO1 in yeast, remains to be 
determined. Furthermore the functional categories of genes whose expression may be 
rDNA CN-linked appear divergent between organisms. This may be taken to imply that 
basic mechanisms for mediating such an effect are not well conserved and the forces 
driving linkage of gene expression to rDNA CN are rather heterogeneous between 
eukaryotic lineages. 
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5 ERC-dependent and ERC-independent effects on 
gene expression and ribosome biogenesis in S. 
cerevisiae ageing 
5.1 Introduction 
The transcriptomic analyses presented in Section 4.2.3 demonstrated a small but 
consistent effect of rDNA CN reduction on ribosome biogenesis gene expression in yeast, 
thus establishing the phenomenon of rDNA CN-sensitivity in S. cerevisiae. In addition to 
undergoing CNV at the chromosome XII rDNA locus, yeast have a capacity for rDNA 
amplification by the production of ERCs (Sinclair and Guarente 1997; Takeuchi et al. 2003; 
Ganley et al. 2009; Mansisidor et al. 2018). ERC formation has been proposed as a causal 
factor in yeast ageing (Kennedy et al. 1997; Defossez et al. 1999; Kaeberlein et al. 1999; 
Morlot et al. 2019); there now is strong evidence that ERC accumulation can cause age-
related pathology (Figure 1.9), though whether ERC formation initiates the ageing process 
has not been conclusively determined (Neurohr et al. 2018). Much of the literature treats 
ERCs as aberrant, however ERC formation in young cells may be advantageous as it was 
recently shown to dynamically adjust based on chromosomal rDNA CN in a manner 
modulated by demand for rRNA (Mansisidor et al. 2018). The effects of ERC formation are 
best understood in yeast, though DNA circles containing 35S/47S or 5S rDNA have also 
been detected in other model systems (Cohen et al. 2003, 2010; Cohen and Segal 2009). 
Interestingly ERCs can re-integrate into the chromosomal genome and hence represent a 
potential pathway for rDNA CNV, though it is conceivable that this induces increased 
rDNA instability (Ganley et al. 2009; Mansisidor et al. 2018).  
ERC formation is influenced by some of the same factors which affect chromosomal rDNA 
CNV though there are also significant differences. Deletion of FOB1 reduces both rDNA 
CNV and ERC formation in young cells while deletion of SIR2 does the opposite (Sinclair 
and Guarente 1997; Defossez et al. 1999; Kaeberlein et al. 1999). ERC formation likely 
occurs via intra-chromatid HR and depends on the presence of functional RAD52 (Park et 
al. 1999). rDNA CNV is similarly compromised by RAD52 deletion, although there is a non-
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HR-dependent rDNA amplification mechanism (Houseley and Tollervey 2011; Jack et al. 
2015). Interestingly, disrupting H3K56 acetylation, cycling of which is involved in HR-
independent CNV, is generally associated with chromosomal rDNA hyperamplification as 
well as increased ERC levels in young cells (Han et al. 2007; Houseley and Tollervey 2011; 
Ide et al. 2013; Jack et al. 2015). Not all publications support the rDNA amplification 
phenotype in rtt109Δ however (Kwan et al. 2016). The age-related accumulation of ERCs 
relies primarily on their ability to replicate during passage through the cell cycle along 
with asymmetric segregation and retention within the mother cell during mitosis; this is 
achieved by anchoring ERCs to nuclear pores during mitosis with the interaction mediated 
by the SAGA-complex (Denoth-Lippuner et al. 2014). 
To date, no studies have reported whether the presence of ERCs makes a defined 
contribution to the ageing yeast transcriptome, though there is some discussion of the 
topic in Hendrickson et al. 2018. My previous work had not revealed an obvious functional 
transcriptomic consequence of raised yeast rDNA CN; However, I was interested to ask 
whether rDNA amplification by ERCs, representing a greater CN increase in a potentially 
different chromatin context, might have a more profound effect in the cell (Hendrickson et 
al. 2018; Morlot et al. 2019). 
5.2 Results 
This chapter includes results from several RNA-seq differential expression analyses where 
varying numbers of genes were called as statistically significantly different after correcting 
for multiple testing. I chose to use different cutoff thresholds for calling genes as 
significantly differentially expressed at different points. My default significance threshold 
was FDR < 0.05, however sometimes the resulting lists of genes included many hundreds, 
or even a few thousand, genes. In these cases, I often chose to use the more stringent FDR 
< 0.001 cutoff with the aim of reducing low-quality ‘hits’ and maintaining gene sets at 
reasonable sizes.  
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5.2.1 WT ageing samples recapitulate published yeast age-related gene 
expression changes 
A variety of mutant strains are reported to affect age-related ERC accumulation and most, 
if not all, have effects on other key cellular processes. As such, relying on data from any 
single mutant introduces the potential to confuse differences arising from the absence of 
ERCs or disruption of other functions. I chose to work with mutants deleted for RAD52, 
vital for homologous recombination, or SPT3, a SAGA complex constituent. Importantly 
these strains differ in how they attenuate accumulation of ERCs, rad52Δ blocks formation 
while spt3Δ reduces maternal retention, and in their replicative lifespans, rad52Δ are 
short-lived (Park et al. 1999) while spt3Δ have approximately WT lifespan (personal 
communication, Matthew Crane, Kaberlein lab). Hence any genes found to be differentially 
expressed in the same direction with age in both mutants could very likely be traced to 
ERC abundance rather than pathway-specific or lifespan effects. Complete abrogation of 
ERC formation in rad52Δ mutants was first reported by Park et al. 1999. Figure 5.1 shows 
the greatly reduced ERC accumulation in ageing spt3Δ cells (strain JH1069, probed with 
probe amplified from S. cerevisiae gDNA with primers NTS1 F1 long / NTS1 R1 long. Table 
2.3); I grew and harvested cells while Michelle King performed all other wet lab work for 
this figure. 
Isolation of aged cells presents a challenge as, due to the geometric growth of yeast 
populations, old cells represent a vanishingly small proportion of an exponentially dividing 
culture. I used the Mother Enrichment Programme (MEP) method, first developed by the 
Gottschling lab, to collect samples which are highly enriched (typically >80%) for aged 
cells present since initial inoculation of the culture (Lindstrom and Gottschling 2009). 
Briefly, a sample from a log phase culture is first biotin-labelled and then grown in the 
presence of β-estradiol. This drug activates a synthetic genetic circuit which prevents 
division of new-born daughters, thereby linearising population growth and allowing 
cultures to reach advanced ages without nutrient depletion. After ethanol fixation at 
harvest, aged cells are isolated on a column in a magnetic field by adhesion to 
streptavidin-bound iron beads while daughters and other debris are washed away. The 
aged mother-enriched sample can then be used as input for most molecular biology 
techniques. 
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Samples were grown overnight in YPD to mid-log phase (OD600 0.2 - 1.0) for biotin 
labelling. An unlabelled log phase sample was kept for RNA extraction to serve as a young 
reference. Aged cultures were inoculated with 1.25 x 106 labelled cells, starting density 1 x 
104 cells ml
-1, and were harvested at 24 h and 48 h. rad52::TRP1 (JH1052, rad52Δ) and 
spt3::TRP1 (JH1069, spt3Δ) mutant strains were previously generated by Jon Houseley in 
the s288c MEP background (JH935, WT), all strains were diploid. WT and spt3Δ samples 
were grown in parallel, rad52Δ samples grown on a different occasion. RNA was extracted 
and 500 ng total RNA was used as input for poly(A)+ mRNA selection and subsequent 
library preparation. In total, 3 libraries from different biological replicates were sequenced 
for WT and spt3 per time point, as well as 2 libraries per time point for rad52. 
Figure 5.1 spt3Δ cells accumulate ~10-fold fewer ERCs that WT cells during replicative 
ageing 
A) WT (JH935) or spt3Δ (JH1069) cells were grown to mid-log phase in YPD and either fixed in 
EtOH or used to start ageing cultures using the MEP protocol. Ageing cultures were first biotin-
labelled and then aged for 24 h or 48 h in YPD with 1 µM β-estradiol. Aged cultures were 
inoculated with 1.25 x 106 labelled cells, starting density 1 x 104 cells ml
-1. Fixed cell samples 
were enriched for aged cells by binding biotin-labelled cells to streptavidin-iron beads and 
washing through a column in a magnetic field. High molecular weight DNA was then extracted, 
restriction enzyme digested, and separated by agarose gel electrophoresis. Gels were blotted 
by upward transfer to nylon membranes. This was probed with a 32P-radiolabelled random 
primed probe against rDNA sequence (amplified from S. cerevisiae gDNA with primers NTS1 F1 
long / NTS1 R1 long, Table 2.3). Cells grown and harvested by AZ, all other wet lab work by 
Michelle King. 
B) Quantitation of A, summed ERC signal was normalised by that of the single chromosomal 
rDNA repeat band 
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I first aimed to validate my WT ageing time course by comparing age-related gene 
expression changes with previous literature. As expected, a large fraction of the 
transcriptome changed expression with age as 2552 genes were differentially expressed 
between log and 48 h (DESeq2, BH corrected FDR < 0.001). Functional changes were 
largely consistent with previous reports: GO term enrichments among genes upregulated 
with age suggest increased retrotransposition, expression of cell wall-associated genes 
and increased mitochondrial respiration (FDR < 0.05) (selected terms in Table 5.1, full 
GOrilla output in Appendix Table 8.6); genes downregulated with age were enriched for a 
variety of terms, many involved in translation (cytoplasmic and mitochondrial), tRNA 
aminoacylation, glycolysis, and protein folding (FDR < 0.05) (Selected terms in Table 5.2, 
full GOrilla output in Appendix Table 8.7) (Yiu et al. 2008; Hu et al. 2014; Janssens et al. 
2015; Janssens and Veenhoff 2016; Hendrickson et al. 2018). A major anomaly in my data 
relative to published literature was an enrichment for ribosome biogenesis related genes 
(RiBi genes) among those upregulated during ageing – these are typically reported to 
show lowered age-related expression. This was particularly surprising because expression 
of RiBi genes and ribosomal protein (RP) genes is usually tightly coordinated to maintain 
stoichiometry of rRNA and RPs (reviewed in de la Cruz et al. 2018). 
Table 5.1 Selected GO terms enriched among genes upregulated during WT yeast ageing 
GO Term P-value FDR q-value Enrichment 
rRNA processing 4.27E-15 1.12E-11 2 
ribosome biogenesis 1.76E-13 2.31E-10 2.11 
transposition, RNA-mediated 6.02E-12 3.52E-09 2.61 
fungal-type cell wall organization 2.03E-11 1.07E-08 2.03 
cell wall assembly 2.36E-11 1.13E-08 3.13 
energy coupled proton transport, down 
electrochemical gradient 1.08E-06 1.83E-04 3.74 
ATP synthesis coupled proton transport 1.08E-06 1.78E-04 3.74 
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Table 5.2 Selected GO terms enriched among genes downregulated during WT yeast ageing 
GO Term P-value FDR q-value Enrichment 
translation 4.03E-99 7.07E-96 3.34 
cytoplasmic translation 5.22E-76 4.58E-73 4.12 
mitochondrial translation 1.30E-17 3.41E-15 2.75 
tRNA aminoacylation for protein translation 4.99E-11 8.75E-09 3.31 
ATP generation from ADP 3.73E-09 4.17E-07 3.49 
glycolytic process 3.73E-09 4.09E-07 3.49 
protein folding 1.35E-07 1.12E-05 2 
nicotinamide nucleotide biosynthetic process 1.39E-06 8.24E-05 2.53 
 
To diagnose whether my dataset differed from those previously generated by the 
Houseley lab under similar conditions, I compared my data with the dataset published in 
Cruz et al. 2018. My log and aged libraries clustered near similarly aged samples under 
PCA (Figure 5.2 A).  As was previously reported in Cruz et al. 2018, ageing clearly explained 
most of the variance on PC1 (58.2%) in the composite dataset. Furthermore, there were 
extremely high correlations between normalised log2 gene expression values in my data 
and the prior dataset at all ages (Pearson’s r = 0.984, 0.989, 0.991 at log, 24 h and 48 h 
respectively) (Figure 5.2 B-C). Comparison of RiBi genes between my samples of all 
genotypes suggested that it was, in fact, the WT log samples which were outliers relative 
to expectations (Figure 5.3). Expression of RiBi genes decreased from 24h to 48h in all 
genotypes and from log to 24 h in spt3Δ and rad52Δ. However, median log2 expression of 
these genes was 0.7 – 0.8 log2 units greater in mutant log-phase samples relative to WT 
(Figure 5.3 B); indeed, median log2 expression of RiBi genes was greater than, or equal to, 
WT log samples in all other time points in all genotypes. These differences are unexpected 
and together strongly suggest that abnormally low RiBi gene expression in the WT 
background at log-phase accounts for the apparent surprising upregulation of RiBi genes 
with age in my WT samples. As such, I am confident that my aged WT data represents a 
reliable baseline against which to compare data from spt3Δ and rad52Δ mutants. 
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Figure 5.2 WT ageing RNA-seq libraries showed high similarity to comparable data previously 
published by Houseley lab 
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Figure 5.3 Comparison of all samples with WT-log phase suggests anomalous expression of 
RiBi genes in WT log-phase samples 
spt3Δ (JH1069, 3 biological replicates per time point) and rad52Δ (JH1052, 2 biological replicates 
per time point) RNA-seq data was prepared as New WT data in Figure 5.2. Raw read counts were 
collected over protein coding genes and normalised by DESeq2. Average expression at all time 
points and genotypes was found relative to the WT log samples. RP and RiBi gene lists were as 
used in Gasch et al. 2017. 
A WT ageing time course was prepared using the MEP technique as in Figure 5.1 with all 
work performed by AZ. Aged cells were purified and total RNA extracted. This was used to 
produce RNA-seq libraries after poly(A)+ selection with 3 biological replicate libraries per 
time point. Sequenced reads were aligned to the S. cerevisiae genome and counted over 
protein coding genes (New dataset). Log2 normalised read counts were compared with 
similar data published in Cruz et al. 2018 generated by the authors of that work (Old 
dataset). 
A)  Comparison of log2 normalised read counts by PCA found the New and Old datasets to 
be in good agreement. The majority of the variance in this composite dataset is explained by 
PC1 and age-matched samples cluster close together on PC1.  
B-D) Plotting mean gene expression at all three time points between New and Old datasets 
showed high correlation between the datasets. 
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5.2.2 ERCs are a major site of RNA Polymerase II transcription in aged 
yeast 
The rDNA in yeast is a site of transcription by all three cellular DNA-dependent RNA 
polymerases at different, and somewhat overlapping, loci (Santangelo et al. 1988; 
Kobayashi and Ganley 2005; Houseley et al. 2007; Mayan and Aragón 2010). I 
demonstrated in Section 4.2.4 that changing chromosomal rDNA CN has a profound 
influence on the abundance of transcripts arising from RNA Pol II activity at the rDNA 
(Figure 4.7). In that analysis, transcription in both sense (defined as the direction of 
canonical Pol I transcription) and antisense (opposite to canonical Pol I transcription) 
orientations was broadly proportional to rDNA CN in most IGS, ETS, and ITS regions. In 
the strains tested in that experiment, transcription differences can confidently be assigned 
to the chromosomal rDNA CNV as all strains were fob1Δ which drastically reduces ERC 
formation in young cells (Defossez et al. 1999; Lindstrom et al. 2011). Accumulation of 
ERCs during ageing represents an alternative context for rDNA amplification. It is not fully 
understood whether ERC-bound rDNA repeats generally behave like their chromosomal 
twins; they are indistinguishable by primary sequence although it is conceivable that the 
local chromatin and regulatory environments might differ. Greatly increased histone H3 
ChIP-seq signal over rDNA sequences in aged cells does, however, suggest that ERCs are 
at least partly chromatinised (Cruz et al. 2018). 
I expected increased RNA Pol II transcript levels from the rDNA in ageing cells, relative to 
young samples, for three reasons. First, the raw increase in CN provided by ERCS in WTs 
would suggest a similar outcome to that seen in my chromosomal rDNA CNV strains. 
Secondly, abundance of the main rDNA silencing factor, the HDAC Sir2 within the RENT 
complex, decreases with age and hence rDNA would be expected to become more 
accessible (Kaeberlein et al. 1999). Finally the Tyler lab has reported major increases in IGS 
transcripts with age measured by qPCR, which they attributed to ERC accumulation (Pal et 
A) As expected, RP gene expression was generally lower at aged time points in all samples. 
B) Average RiBi gene expression was higher than or equal to WT log at all time points in all 
genotypes. This suggests the WT log sample showed anomalously low RiBi gene expression as 
RiBi genes are typically downregulated with age in a coordinate manner with RP genes. 
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al. 2018). I calculated expression over the rDNA for all WT, rad52Δ, and spt3Δ samples in 
50 bp windows (see Sections 4.2.4 and 2.5.1). My expectations were borne out, all three 
genotypes demonstrated marked age-related increases in Pol II transcripts with a very 
similar overall profile (WT shown in Figure 5.4 A). Consistent with the hypothesis that ERCs 
contribute to this transcriptional increase, expression was highest in the WT samples, with 
the greatest number of ERCs, and lowest in the rad52Δ, expected to have the fewest 
(Figure 5.4 B-C) (Park et al. 1999). Most transcript peaks were located close to similar 
peaks seen in my previous dataset analysed in Section 4.2.4 – consequently I conclude 
that the chromatin environment of ERCs and chromosomal rDNA repeats is very similar, at 
least as far as it impacts on RNA polymerase transcription. 
In summary, I have found strong evidence that ERCs are transcriptionally active, consistent 
with Pal et al. 2018, and that they contribute considerably to the large increase in Pol II 
transcript abundance seen in aged yeast. Nonetheless, ERC abundance is not the only 
explanatory factor for this, as a rise in transcripts, qualitatively similar but in reduced 
quantity, is seen even in aged rad52Δ and spt3Δ backgrounds. Generally transcript 
boundaries appear the same from ERCs and chromosomal repeats. This implies the 
transcription machinery interacts with ERCs much as it does with the chromosome XII 
repeat array. 
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5.2.3 The presence of ERCs had a defined effect on the ageing yeast 
transcriptome 
Having found that ERCs support considerable non-coding non-rRNA transcription, I 
examined transcription from the rest of the genome to determine whether ERCs influence 
coding gene expression as well. Under PCA, samples of different ages and genotypes 
cluster separately (Figure 5.5 A). The rad52Δ aged timepoints are an exception as these 
are present together, unsurprising given rad52Δ cells’ short lifespan means little 
replicative ageing probably occurs between 24 h and 48 h (Park et al. 1999). PC1 (55.5%) 
broadly correlates with sample age and PC2 (11.4%) generally separates samples by 
genotype – PC features and proportions of variance explained are very comparable to the 
Cruz et al. 2018 dataset. My data thus reinforces literature claims that ageing in yeast, at 
least at a transcriptomic level, shows great commonalities between WTs and a range of 
mutants (Cruz et al. 2018; Hendrickson et al. 2018). Furthermore, the PCA results suggest 
high between-replicate similarity without serious outliers to confound analysis. 
My hypothesis was that, if the ERCs have a specific effect on the aged transcriptome, there 
should be overlaps between lists of genes differentially expressed in both mutants when 
compared to WT. I found lists of genes significantly up/downregulated (DESeq2, FDR < 
0.001) at either aged time point for each mutant and filtered out genes differentially 
expressed in the same direction in log phase samples. I refer to genes upregulated in both 
mutants with age as ERC-repressed genes and those downregulated in aged mutants as 
ERC-induced. There was a significant overlap of 62 ERC-repressed genes in both rad52Δ 
(732 total differentially upregulated with age) and spt3Δ (247 total differentially 
Figure 5.4 ERCs are a major source of rDNA-derived Pol II transcripts during ageing 
RNA-seq data prepared as in Figure 5.3. Read depth over the rDNA was quantified in 50 bp 
windows as in Figure 4.7. 
A) There are large increases in Pol II derived transcripts over from the rDNA region in WT 
replicatively ageing yeast. These are especially pronounced in non rRNA-gene regions. 
B) spt3Δ and rad52Δ mutants accumulate very few ERCs during replicative ageing. Both mutants 
show reduced age-related increases in transcripts from non rRNA-gene regions demonstrating 
that much of this transcription originates from ERCs. 
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upregulated with age) (Fisher’s exact test, odds ratio = 3.29, p = 9.7 x 10-13). Similarly, a 
significant overlap of 160 ERC-induced genes was found between rad52Δ (804 total 
differentially downregulated with age) and spt3Δ (489 total differentially downregulated 
with age) (Fisher’s exact test, odds ratio = 4.89, p = 7.2 x 10-44). 
Table 5.3 Selected GO terms enriched among ERC-repressed genes 
GO Term P-value FDR q-value Enrichment 
iron ion homeostasis 6.94E-08 3.65E-04 14.01 
'de novo' protein folding 1.47E-07 3.87E-04 23.12 
cellular response to heat 7.37E-07 6.46E-04 10.41 
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Figure 5.5 ERC-sensitive gene expression is revealed by spt3Δ and rad52Δ mutant RNA-
seq data 
Data were prepared as in Figure 5.3.  
A) Log2 reads counts were calculated over protein coding genes, normalised for total library size, 
and analysed by PCA. Different ages and genotypes separate by PCA, rad52Δ 24 h and 48 h 
cluster together consistent with accelerated senescence phenotype for that mutant. No outliers 
among the data. 
B) Raw read counts were found over protein coding genes. DESeq2 was used to compare age-
matched mutant and WT data to find significantly differentially expressed genes (DESeq2, BH 
corrected FDR < 0.001). Genes differentially upregulated in both mutants in at least one aged 
time point were found. There were 62 such “ERC-repressed” genes. 
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On average, genes differentially expressed in both mutants showed a more extreme 
expression difference in spt3Δ samples at 48 h than 24h (Figure 5.5 B-C). This is consistent 
with there being a greater absolute difference in ERC numbers between spt3Δ and WT 
samples at 48 h, as seen in Figure 5.1. Expression differences between rad52Δ and WT are 
on average slightly less extreme at the 48 h time point (Figure 5.5 B-C). This is harder to 
interpret as rad52Δ cells are short lived and hence it is unclear what physiological state 
these were in by 48 h (Park et al. 1999). It is worth mentioning that the list for ERC-
repressed genes (i.e. those upregulated in both mutants with age) is likely an 
underestimate given that the SAGA complex, of which Spt3 is a key member, is a key 
promoter of transcription genome wide (Huisinga 2005; Baptista et al. 2017). Additionally, 
pathway specific effects of either mutation might obscure genuine ERC-dependent 
candidates. 
5.2.4 ERCs may compromise proteostasis regulation by sequestering 
Hsf1 
Having established the presence of an ERC-dependent transcriptomic signature in my 
aged samples, I used GO term enrichment analysis to highlight functional consequences. 
ERC-induced genes were enriched for those involved in cytoplasmic translation (RP 
genes), amino acid biosynthesis, and ATP synthesis in mitochondria (FDR < 0.05) (Selected 
terms in Table 5.4, full GOrilla output in Appendix Table 8.8). ERC-repressed genes were 
enriched for genes involved in iron / copper ion homeostasis and those with chaperone 
activity (Selected terms in Table 5.3, full GOrilla output in Appendix Table 8.9). 
  
C) Raw read counts were found over protein coding genes. DESeq2 was used to compare 
age-matched mutant and WT data to find significantly differentially expressed genes 
(DESeq2, BH corrected FDR < 0.001). Genes differentially downregulated in both mutants in 
at least one aged time point were found. There were 160 such “ERC-induced” genes. 
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Table 5.4 Selected GO terms enriched among ERC-induced genes 
GO Term P-value FDR q-value Enrichment 
cytoplasmic translation 7.84E-45 2.06E-41 12.6 
translation 6.42E-30 5.63E-27 6.04 
cellular amino acid biosynthetic process 1.17E-27 6.84E-25 10.24 
alpha-amino acid biosynthetic process 3.37E-26 1.48E-23 10.29 
glutamine family amino acid metabolic process 1.82E-09 2.91E-07 8.56 
energy coupled proton transport, down 
electrochemical gradient 4.20E-09 6.49E-07 17.67 
ATP synthesis coupled proton transport 4.20E-09 6.31E-07 17.67 
glutamine family amino acid biosynthetic 
process 1.66E-08 2.37E-06 12.51 
arginine biosynthetic process 6.24E-08 8.41E-06 22.52 
branched-chain amino acid biosynthetic process 1.33E-06 1.67E-04 15.02 
drug metabolic process 2.60E-06 3.11E-04 3.13 
 
It is particularly interesting to see folding chaperones in the ERC-repressed group as they 
have very recently been linked to compromised entry into the cell cycle in replicatively 
aged yeast (Moreno et al. 2019b, a). Availability of multifunctional chaperones is required 
for the nuclear import of Cln3 which, together with the cyclin dependent kinase Cdc28, 
activates expression of the G1/S regulon at the beginning of the cell cycle, termed START. 
Yeast undergo the SEP, a dilation of cell cycle duration, in the final ~5 divisions before 
division arrest (Fehrmann et al. 2013; Morlot et al. 2019). Interestingly, the SEP is preceded 
by rDNA CN increase (and followed by massive rDNA CN amplification), attributed to ERC 
accumulation, and ERC accumulation has been found to cause extended cell cycle times 
(Neurohr et al. 2018; Morlot et al. 2019). Under conditions of proteotoxic stress, 
chaperones localise to protein aggregates to facilitate refolding and clearance of 
damaged proteins (Hsf1 activity in yeast reviewed by Verghese et al. 2012). Extensive 
protein aggregation has been reported in yeast and other organisms during ageing; this 
titrates chaperones, thus reducing the ability to accumulate Cln3 and delaying START 
replicatively aged yeast (López-Otín et al. 2013; Öling et al. 2014; Walther et al. 2015; 
Janssens and Veenhoff 2016; Moreno et al. 2019b, a).  
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I found chaperones to be expressed higher in samples with reduced ERC accumulation; 
therefore I hypothesised that ERC accumulation might adversely affect the cellular 
response to age-related proteotoxic challenge by impairing Hsf1 function. Hsf1 is a 
primary transcriptional activator of folding chaperones and proteostasis maintenance 
factors. Under unstressed conditions Hsf1 is bound and inhibited by Hsp70/Hsp90 family 
chaperones. However, under proteotoxic stress, chaperones localise to aggregates and 
thus Hsf1 can induce target genes, many of which are folding chaperones themselves – 
resulting in a negative feedback regulatory loop (Verghese et al. 2012). Of the ~40 genes 
reported as Hsf1-ChIP targets by Pincus et al. 2018, 11 were in my ERC-repressed gene list 
(HSP82, SIS1, BTN2, HSP104, CUR1, SSA4, HSP42, FES1, RPN4, CPR6, and HSP60). Solís et 
al. 2016 produced a very high-confidence list of 18 Hsf1-target genes by intersecting 
RNA-seq, NET-seq, and ChIP-seq data – plotting the expression of these genes in mutants 
relative to WT revealed a general trend for higher expression when ERCs are less 
Figure 5.6 ERCs may sequester Hsf1 in aged cells 
A) RNA-seq data was prepared as in Figure 5.3. Raw read counts were collected over protein 
coding genes and normalised by DESeq2. 18 high-confidence Hsf1 induced genes (from Solís et 
al. 2016) show generally higher expression with age in mutants with greatly reduced ERC 
accumulation. 
B) S. cerevisiae Hsf1 ChIP-seq data from Pincus et al. 2018 was downloaded and aligned to the 
S. cerevisiae genome. Read depth was quantified genome wide in 50 bp windows and 
normalised by total library size. Counts in windows falling within the rDNA (window start on 
chromosome XII: 451401 – 468901) were normalised to a copy number of 180. There is a ~9-
fold increase in signal over the rDNA at 120 min HS relative to other time points, however there 
is little change in general signal over the genome. 
C) C. elegans ChIP-seq data from Li et al. 2016 was downloaded and aligned to the C. elegans 
genome. Read depth was quantified genome wide in 200 bp windows, normalised by total 
library size, and mean taken between the two biological replicates. Counts in windows falling 
within the rDNA (window start on chromosome I: 15060201 – 15068800) were normalised to a 
copy number of 90. There were no major changes in Hsf-1 association with rDNA under 30 min 
HS at either young adult or L2 larval stages. 
D) RNA-seq data was prepared as in Figure 4.6. Raw read counts were collected over protein 
coding genes and normalised by DESeq2. There were no trends in expression of 18 high-
confidence Hsf1 induced genes (from Solís et al. 2016) with chromosomal rDNA CNV. 
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abundant (Figure 5.6 A). Thus my data are consistent with greater activation of Hsf1 
during ageing when ERCs accumulation is reduced. 
Might ERCs somehow compromise this Hsf1-mediated response to proteotoxicity? Hsf1 
directly stimulates transcription of target genes by binding at a conserved promoter motif; 
I considered that Hsf1 may also bind at rDNA sequences and that age-associated 
accumulation of ERCs might titrate it away from other genomic sites (Verghese et al. 
2012). I downloaded the Hsf1 ChIP-seq data from Pincus et al. 2018 and processed it as 
described in Section 2.5.3. This dataset provided Hsf1 occupancy data for three different 
conditions: a 5, or 120, min heat shock (HS) which strongly induced Hsf1-targets, as well 
as a non-heat shock (NHS) control. In all conditions, baseline signal at the rDNA was much 
higher than the rest of the genome, expected given the 100-200x copy number 
differences even were this simply due to noise, with a maximum in IGS1 – though there 
was no clear Hsf1 binding peak in the rDNA. Rather than using a standard peak calling 
method, I quantified genome wide signal in 50 bp windows, normalised for total library 
size, and separated out bins lying within the rDNA. Average signal (median normalised 
counts adjusted for CN ± IQR) was similar for the non-rDNA genome at under all 
conditions (NHS, 31.0 ± 17; 5 min HS, 24.0 ± 13.7; 120 min HS, 26.1 ± 11.2) (Figure 5.6 B). 
Remarkably however, the median rDNA signal at the 120 min HS time point (120 min HS, 
41.8 ± 20.7) was ~9-fold greater than other conditions (NHS, 4.6 ± 0.9; 5 min HS, 4.9 ± 
1.3). 
I considered two possible biological explanations for this large increase in Hsf1 ChIP signal 
over the rDNA under prolonged HS: massive rDNA amplification under HS conditions 
and/or increased Hsf1 association with rDNA in the same context. rDNA amplification has 
been reported under 30 min heat shock, though it was uncommon and copy number 
increased much less than the 9-fold Hsf1 signal increase (Kwan et al. 2016). ERC 
production is another potential rDNA amplification mechanism however it seems very 
unlikely that cells can accumulate ERCs under HS sufficiently rapidly to account for the 
differences in ChIP signal; ERC production (and the best understood mechanisms of rDNA 
CNV) depend on DNA replication, but 120 min is only enough time for yeast to undergo a 
single division under optimal growth conditions and heat stress slows division (Rowley et 
al. 1993; Ganley et al. 2009). Furthermore, yeast growing under unstressed conditions take 
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around 11 generations to reach steady state ERC levels (Mansisidor et al. 2018). Thus, it 
seems more likely that, under chronic HS, association of Hsf1 with the rDNA increases by 
nearly an order of magnitude (Figure 5.6 B). More generally, this result simply renders 
plausible the idea that age-related ERC accumulation may be able titrate Hsf1 – given that 
Hsf1 does appear capable of associating with rDNA sequences. Consequently, depletion 
of the nuclear pool of Hsf1 by ERCs is a reasonable potential explanation for the 
comparatively higher expression of proteostasis factors and lower expression of RP genes 
in aged samples with a greatly reduced ERC burden. 
Given this possible Hsf1-rDNA / ERC interaction in aged yeast, it is very interesting that a 
cluster of HSPs were among genes showing lower expression in high rDNA CN aged 
worms (Figure 4.1 E). Three significantly differentially expressed genes (hsp-70, F44E5.4, 
F44E5.5 - DESeq2, BH corrected FDR < 0.05), along with several others which behaved 
similarly (hsp-16.1, hsp-16.11, hsp-16.2, hsp-16.41, hsp-16.48 and hsp-16.49), are among 
the genes which show the greatest induction by C. elegans HSF-1 after HS (Brunquell et al. 
2016). I downloaded HSF-1 ChIP-seq data collected from young adult or L2 larval worms 
after 30 min HS, along with NHS control samples, and processed it similarly to the yeast 
Hsf1 ChIP-seq data (see Section 2.5.3) (Li et al. 2016). Here there was no evidence for an 
increased association with rDNA under stress, although the HS was shorter than the 120 
min yeast HS (Figure 5.6 C). Additionally, expression of high-confidence Hsf1 targets did 
not appear to depend on chromosomal rDNA CN in my log phase yeast RNA-seq, 
suggesting that elevated rDNA CN alone is not sufficient to reproduce the possible ERC-
dependent effect in ageing (Figure 5.6 D). 
Overall, the evidence presented is compatible with a model where age-related interaction 
of Hsf1 with rDNA sequences compromises proteostasis (Figure 5.7). There is evidence 
that Hsf1 may associate with rDNA in yeast under chronic stress (Figure 5.6 B). A 
hypothetical mechanism, involving titration of Hsf1 by ERCs under age-related chronic 
stress conditions thereby compromising an Hsf1-mediated transcriptional program, would 
be consistent with the higher expression of Hsf1 targets in my low-ERC mutants (Figure 
5.6 A). There was no obvious effect on Hsf1 target expression of chromosomal rDNA CNV 
in young yeast (Figure 5.6 D) and potential Hsf1 interaction with rDNA was only visible in 
ChIP-seq data under prolonged HS (Figure 5.6 B) (Pincus et al. 2018). Therefore I propose 
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that Hsf1 interaction with ERCs during ageing is not purely driven by the raised rDNA CNV 
but also the prolonged condition of proteostatic stress which may exist in ageing, as 
evidenced by the accumulation of protein aggregates in yeast and other models (López-
Otín et al. 2013; Öling et al. 2014; Walther et al. 2015). A mechanism where expanded 
chromosomal rDNA in worms titrates C. elegans HSF-1 during prolonged stress would also 
fit with the observed differences in chaperone expression in my aged worm RNA-seq 
(Figure 4.1 E). However, I have as yet seen no evidence for dynamic HSF1 and rDNA 
interaction in worms. 
  
Figure 5.7 Proposed mechanism linking ERC accumulation to age-related cell cycle 
pathology in S. cerevisiae 
Suggested mechanism attempting to link findings presented in this work with recently published 
evidence in Neurohr et al. 2018, Morlot et al. 2019, and Moreno et al. 2019. 
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5.2.5 Data are not consistent with ERCs causing age-related global gene 
induction or specific induction at telomeric loci 
The Tyler lab has previously published data suggesting that yeast undergo global gene 
induction during ageing (Hu et al. 2014). Under their model, apparent up- or 
downregulation of specific groups of genes actually results from shifts relative to average 
expression, superimposed upon a background of general activation. The mechanism put 
forward to explain this global transcriptional induction was a genome-wide loss of 
nucleosomes leading to increased chromatin accessibility and loss of silencing. This model 
has been challenged by Hendrickson et al. 2018 who presented ATAC-seq data suggesting 
accessibility is very similar between young and old cells and that the previous apparent 
reduction in nucleosome occupancy may have been artefactual. They did, however, find 
widespread age-related induction of loci which had low expression in young cells. I 
considered the hypothesis that such gene induction might be a consequence of age-
related ERC accumulation. However, this is not compatible with my RNA-seq data – a very 
similar pattern of induction of genes which are expressed at low levels in young 
populations was evident across all three genotypes tested (Figure 5.8 A-C). Hence ERCs 
cannot be a significant causal factor in this widespread age-related gene induction. 
Aside from possible global age-related gene upregulation, subtelomeric loci are 
established as increasing expression relative to the genome average with age (Kim et al. 
1996; Hu et al. 2014; Hendrickson et al. 2018). It has been proposed that this might result 
from redistribution of Sir2, responsible for silencing of some telomeric loci as part of the 
SIR complex with Sir3 and Sir4 (Kennedy et al. 1997; Salvi et al. 2013). Furthermore, it has 
been suggested this redistribution is a function of ERC accumulation sequestering Sir2 in 
the nucleolus. My data offered the opportunity to test this hypothesis – if ERCs were the 
root cause of subtelomeric gene induction one would expect to see generally reduced 
subtelomeric expression with age in both spt3Δ and rad52Δ backgrounds. 
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Figure 5.8 ERCs are not the cause of age-related widespread gene induction 
Data was prepared as for Figure 5.3. Reads counted over protein coding genes. Mean log2 read 
counts per age and genotype were normalised for total library size. All three backgrounds showed 
similar widespread gene induction between log and 48 h time points, demonstrating that ERCs 
cannot be the main cause. Genes labelled as induced were all with log2 expression difference >0 at 
48 h vs. WT in that genetic background. 
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Figure 5.9 Mutant RNA-seq data is not consistent with ERC involvement in age-related 
subtelomeric gene induction 
Data prepared as Figure 5.3. Reads were counted over protein coding genes and normalised with 
DESeq2. Subtelomeric genes defined as in Figure 4.10. 
A) Consistent with previous literature, average expression of subtelomeric genes increased during 
ageing of WT samples. 
B) Average expression of subtelomeric genes was inconsistent between mutants relative to age-
matched WT samples. This is inconsistent with ERCs being the cause for age-related subtelomeric 
gene induction. 
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Consistent with the literature, my WT data show the upregulation of subtelomeric 
transcripts with age, indeed average expression is notably higher at 48 h than even 24 h 
(Figure 5.9 A). As expected, subtelomeric genes were significantly enriched among genes 
significantly upregulated with age (Fisher’s exact test, odds ratio = 1.62, p = 1.05 x 10-5) 
and significantly depleted from those with significant age-related downregulation (Fisher’s 
exact test, odds ratio = 0.34, p = 4.46 x 10-13). However, subtelomeric genes were on 
average expressed lower in the spt3Δ at all time points but conversely expressed higher 
than WT at all time points in the rad52Δ mutants – particularly 24 h (Figure 5.9 B). Note 
that I am cautious about overstating this finding as mutation-specific effects are a 
plausible confounding factor in this observation. rad52Δ display premature loss of 
silencing at the HMR locus and redistribution of Sir3 away from telomeres which may 
provide an ERC-independent mechanism for loss of silencing in that mutant (Park et al. 
1999). 
Nonetheless, my data is not consistent with ERC accumulation being the primary causal 
factor behind either global or subtelomeric gene induction with age. This fits with the 
similar finding, presented in Section 4.2.5 (Figure 4.10), that chromosomal rDNA CNV does 
not affect subtelomeric gene expression in a Sir2-dependent manner, and previous 
literature showing that Sir2 is not broadly distributed over the subtelomeric region (Ellahi 
et al. 2015). 
5.2.6 fob1Δ and sir2Δ mutants do not show ERC related transcriptional 
changes during ageing 
I had found evidence of functionally coherent effects of ERCs on the ageing yeast 
transcriptome by comparison of WT data with two mutants, spt3Δ and rad52Δ where ERC 
accumulation is greatly attenuated (Figure 5.1) (Park et al. 1999; Denoth-Lippuner et al. 
2014). I was interested to compare this dataset with one recently published by the McIsaac 
lab where RNA-seq was performed on ageing fob1Δ and sir2Δ mutant strains 
(Hendrickson et al. 2018). Both genes are main players in the HR-dependent model for 
directed yeast rDNA CNV (Kobayashi et al. 1998; Kobayashi and Ganley 2005; Iida and 
Kobayashi 2019). Deletion of FOB1 stabilises rDNA CN, reduces ERC formation, and 
extends lifespan (Kobayashi et al. 1998; Defossez et al. 1999; Lindstrom et al. 2011). 
176 
 
Conversely, deletion of SIR2 severely destabilises rDNA CN, increases ERC levels in young 
cells, and shortens lifespan (Kaeberlein et al. 1999). I hypothesised that there would be: 
significant overlap between my ERC-induced genes and those differentially 
downregulated in fob1Δ with age; significant overlap between my ERC-repressed genes 
and those differentially upregulated with age in fob1Δ; the opposite trends in sir2Δ. 
I downloaded the RNA-seq data and processed it as for my own samples. My own analysis 
agreed with the published observations (which relied on a different software pipeline) that 
expression differences from WT were considerably greater in the sir2Δ mutant than in 
fob1Δ. 376, 331, and 1206 genes were significantly differentially expressed at log, 20 h, 40 
h between sir2Δ and WT (DESeq2, BH corrected FDR < 0.001). By contrast, the largest 
number of significantly differentially expressed genes between WT and fob1Δ at any time 
point was 9 genes at 40 h (DESeq2, BH corrected FDR < 0.05), even with the less stringent 
FDR < 0.05 criterion. This included FOB1 itself and an adjacent ORF YDR109C whose 
expression was probably affected by marker gene insertion. Remarkably, there was no 
significant overlap between ERC-induced genes and those upregulated with age in sir2Δ 
or between ERC-repressed genes and those downregulated with age in sir2Δ (Fisher’s 
exact test, p > 0.05). I did not test for overlap with fob1Δ differentially expressed genes 
due to the small number of genes changed in that background. 
That there was no consistency between my dataset and one with mutants historically used 
to represent absence or overproduction of ERCs was surprising and potentially challenged 
my conclusion that differentially expressed loci in both spt3Δ and rad52Δ were bona fide 
ERC-sensitive genes. However, there was a large difference between the two experiments 
in that I grew cells under batch conditions in YPD (rich medium containing peptone, 
hydrolysed yeast extract, and 2% glucose) while the McIssac lab grew theirs under 
continuously flowing synthetic YNB media (containing vitamins, trace elements, and salts 
with ammonium sulfate and 2% glucose (+ 2% mannose) as nitrogen and carbon sources). 
Nutrient context, particularly nitrogen source, can have profound effects on metabolic 
gene expression which necessarily affects the cellular environment as a whole, hence it is 
conceivable that this might influence the effects of ERCs on gene expression (Godard et al. 
2007; Alam et al. 2016).  
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Additionally, it is possible that the standard expectations about ERC behaviour in the sir2Δ 
and fob1Δ mutants may have been incorrect. Most literature observations of ERC levels in 
these two backgrounds come from relatively young populations which may not reflect 
accumulation during ageing (Defossez et al. 1999; Kaeberlein et al. 1999; Kobayashi and 
Ganley 2005). Hendrickson et al. 2018 quantified rDNA CN by qPCR and reported a 1.4-
Figure 5.10 Southern blots showing ERC accumulation in fob1Δ, sir2Δ, and rtt109Δ mutants 
Cells grown as Figure 5.1. All wet lab work for this figure performed previously by Jon Houseley. 
A) WT (JH935) or fob1Δ (CJ261) samples and processed as for samples in Figure 5.1.  
B) Quantitation of A, summed ERC intensity normalised by chromosomal rDNA. Despite its role in 
ERC production, fob1Δ mutants accumulate ERCs to within 2-fold of age-matched WT samples. 
C-D) DNA was extracted from log and 48 h aged samples (WT, JH935; fob1Δ, CJ261; rtt109Δ, 
JH1005; sir2Δ, CJ257). 10% log DNA was restriction enzyme digested and run in the right set of 4 
lanes. 90% log DNA was digested with RecBCD exonuclease (which does not cut circular species), 
and run in the middle set of lanes. DNA from 48 h samples was restriction enzyme digested and 
run in the left set of lanes. sir2Δ mutants have greater levels of ERCs in log phase cells however 
accumulation is reduced at aged time points relative to WT. fob1Δ data is relatively consistent with 
A-B. 
178 
 
fold increase in fob1Δ compared with 6-fold in WT, a difference of approximately 4x. By 
contrast, Lindstrom et al. 2011 and unpublished work performed by Jon Houseley (Figure 
5.10 A-B), both using Southern blot assays, show substantial ERC accumulation in ageing 
fob1Δ, closer to a 2x or smaller difference from WT. Interestingly the same work 
performed by Jon suggests that, while sir2Δ possesses considerably more ERCs when 
young, ERC levels are actually lower than WT at 48 h (Figure 5.10 C-D). This contrasts 
directly with the Hendrickson et al. qPCR data for sir2Δ which saw a 10-fold increase in 
rDNA CN between log and 10 h. It is difficult to explain this contradiction, though it is 
worth noting that qPCR would not distinguish between CNV via ERC accumulation or 
chromosomal CNV while Southern blotting does – it is conceivable that ERC integration 
into the genome might explain some of the difference between techniques as this has 
been demonstrated to occur (Ide et al. 2013; Mansisidor et al. 2018).  
Hendrickson et al. 2018 reported that transcripts from rDNA IGS1/2 were among the most 
highly upregulated with age. I also found major increases in read depth over these regions 
in all genotypes with age, but the large difference between WT and mutants showed that 
ERCs were responsible for a large proportion of these transcripts in the WT background 
(Figure 5.4). Given the uncertainty over precise ERC levels in sir2Δ and fob1Δ backgrounds, 
I was interested to examine how levels of these potentially ERC-derived transcripts 
differed across genotypes. I re-quantified read count data from both experiments over 
protein coding genes as well as IGS1 and IGS2. As expected, abundance of transcripts 
from these regions increased profoundly with age in WT (Figure 5.11 A-B). In agreement 
with Hendrickson et al. 2018 and other publications, these were among the most highly 
upregulated and highly significant age-related changes (Pal et al. 2018). Furthermore, 
since read counts were simply summed over the whole IGS1/2 regions, and actual 
transcripts themselves probably do not span the whole regions (see peaks in Figure 5.4), 
abundances shown in Figure 5.11 A-B will be underestimates of the true values for 
individual transcripts. Expression in mutants differed from age-matched controls. As 
reported in Hendrickson et al. 2018, and consistent with other published data, IGS 
expression was markedly elevated in sir2Δ at all time points as would be expected from 
increased ERC levels and compromised IGS silencing normally mediated by Sir2 (Figure 
5.11 D). Expression was elevated in fob1Δ log samples, consistent with its role in targeting 
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Sir2 to IGS, but decreased in aged samples as expected (Figure 5.11 D). As expected, given 
reduced ERC levels, spt3Δ and rad52Δ mutants had much lower IGS expression than WT 
(Figure 5.11 C); indeed, expression in these mutants was lower relative to WT than similarly 
aged fob1Δ – consistent with Southern blot evidence (Figure 5.1, Figure 5.10, Park et al. 
1999, Lindstrom and Gottschling, and Hull et al. 2019) suggesting spt3Δ and rad52Δ 
mutants might have lower ERC abundance than aged fob1Δ – although direct comparison 
is not entirely valid as my oldest samples were taken at 48 h and the McIsaac lab 
harvested cells at 40 h. 
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While I was unable to confirm the ERC-sensitive age-related transcriptional changes, some 
valuable points came out of this analysis. Firstly, evidence from Southern blots strongly 
suggests that deletion of SPT3 and RAD52 results in proportionally greater reduction in 
ERC levels in aged cells than does FOB1 deletion; Figure 5.1, and blots presented in Hull et 
al. 2019 (spt3Δ), Park et al. 1999 (rad52Δ), and Lindstrom and Gottschling 2011 (fob1Δ) 
suggest relative reduction of ERCs with age is ≥10-fold for spt3Δ or rad52Δ but only ~2-
fold in fob1Δ. As such, my RNA-seq provides a much better approximation of an ideal 
ERCs vs. no ERCs comparison during yeast ageing than fob1Δ data, which may explain why 
ERC-sensitive differential expression was detectable in my dataset. Under the assumption 
that aged sir2Δ samples would represent a case where ERCs are overproduced relative to 
WT, I hypothesised that there would be overlap between lists of genes showing age-
related upregulation relative to WT in sir2Δ and ERC-induced genes from my spt3Δ and 
rad52Δ; similarly that there would be overlap between genes downregulated in aged sir2Δ 
and ERC-repressed genes. However, there were no such significant overlaps. This may be 
explained by the Southern blot data suggesting that, contrary to published data for young 
cells, aged sir2Δ may have fewer ERCs than WT (Figure 5.10 C-D) (Kaeberlein et al. 1999). 
Nonetheless, aged sir2Δ cells show greater than WT levels of transcripts originating from 
the rDNA IGS1/2 regions – in this case probably due to major de-repression of Pol II 
transcription at those loci in this genetic background (Kobayashi and Ganley 2005). As 
Figure 5.11 Age-related Pol II transcription from rDNA IGS depends on ERC levels and rDNA 
silencing by Sir2 
RNA-seq reads for WT, spt3Δ, and rad52Δ samples were counted over protein coding genes and 
IGS1/2 regions. IGS1/2 were quantified separately for transcripts originating from the ‘sense’ (-S) 
and ‘antisense’ (-AS) strands. Raw counts were normalised by DESeq2. RNA-seq data from 
Hendrickson et al. 2018 was processed likewise. 
A-B) There were huge increases in IGS transcription during WT ageing in data produced for this 
thesis (A) and that published in Hendrickson et al. 2018 (B). 
C) IGS transcription was considerably reduced in low-ERC mutants. This demonstrates that ERCs 
contribute to the age-related increases in Pol II transcription in WT cells. 
D) IGS expression was closer in fob1Δ to WT than spt3Δ or rad52Δ which may reflect closer levels 
of ERCs to WT as per Figure 5.10. Expression of IGS transcripts was greatly increased in sir2Δ 
consistent with loss of rDNA silencing – however note low ERC levels in aged sir2Δ in Figure 5.10. 
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expected for low-ERC mutants, spt3Δ and rad52Δ cells had reduced levels of these IGS1/2-
derived transcript species. Therefore, I draw the remarkable conclusion that despite the 
huge increase in abundance of these species they do not differentially affect the wider 
transcriptome, and certainly cannot explain differential expression of ERC-sensitive genes, 
as there were no overlaps between genes moving in opposite directions between aged 
sir2Δ and my low-ERC mutants. 
5.2.7 Ageing yeast undergo a switch from productive to unproductive 
pre-rRNA processing 
I was interested to turn to look at the process of ribosome biogenesis in ageing yeast for 
several reasons. Firstly, my RNA-seq data suggested that the age-related accumulation of 
ERCs might influence expression of ribosomal protein genes (Table 5.4, these comprise a 
large fraction of genes annotated to GO term ‘cytoplasmic translation’); the balanced 
production of these with rRNA synthesis is a critical factor which may be compromised in 
aged cells. Secondly, Recent single-cell microfluidics imaging work has identified RNA Pol 
I subunit accumulation in the nucleolus starting from around 5 divisions before cells enter 
the SEP (Morlot et al. 2019). It was further reported that pre-18S rRNA was more abundant 
in the divisions shortly before and after the SEP; both observations hint at changes to 
ribosome biogenesis in old cells. Finally, Jon Houseley had previously collected some pilot 
data which indicated changes in pre-18S rRNA with age in yeast. 
Eukaryotic ribosome biogenesis is extremely complex, involving ~200 protein and RNA 
factors (Klinge and Woolford 2019). The process occurs across three cellular 
compartments (nucleolus, nucleoplasm and cytoplasm) and requires coordination of 
products from RNA polymerases I, II, and III. rRNA synthesis starts with Pol I transcription 
of the 35S rDNA region, with a TSS site at the 5` end of ETS1 and termination site 3` of 
ETS2. The 35S transcript is then processed by exo- and endoribonucleolytic activities, 
some of which occur co-transcriptionally in fast growing cells (Figure 1.3) (Fernández-
Pevida et al. 2015). In rapidly dividing young cells, a cleavage early in the processing 
sequence occurs at site A2 which yields the 20S pre-18S rRNA, further processed to the 
mature 18S for the small ribosome subunit, and the 27S-A2. Conversely, in cells under a 
variety of stressors, an alternative cleavage happens at A3, rather than A2, with the switch 
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known to be under control by TOR and CK2 (Kos-Braun et al. 2017). This altered 
processing pathway produces the 23S pre-18S rRNA and the 27S-A3 species. The 23S is 
not considered a productive intermediate for ribosome biogenesis and is degraded by the 
exosome after polyadenylation by the TRAMP complex (Allmang et al. 2000; LaCava et al. 
2005). The A2 to A3 processing switch is a very early event in the response of ribosome 
synthesis to stress, meaning that the levels of 20S and 23S pre-rRNAs, particularly 20S:23S 
ratio, give a qualitative readout of the extent to which productive ribosome biogenesis is 
disrupted (Kos-Braun et al. 2017). 
I aimed to determine whether ribosome biogenesis might be compromised in ageing 
yeast. I grew three replicates of WT cells to mid-log (OD600 ~0.9), labelled cells with biotin, 
and inoculated YPD ageing cultures, grown in the presence of β-estradiol, at a starting 
density of 1 x 104 cells ml-1 (standard conditions for a MEP ageing culture). Log phase, 24 
h and 48 h samples were fixed in ethanol at harvest. After aged cell purification, RNA was 
extracted from all samples and separated by agarose gel electrophoresis run under 
denaturing conditions. RNA was blotted to a nylon membrane by upward transfer. The 
blot was probed with a 32P-labelled oligo probe (JH1371, Table 2.3) which targets the ITS1 
region allowing visualisation of 35S, 20S, and 23S pre-rRNAs. Probe signal was normalised 
for lane loading by the 18S abundance as determined from an EtBr-stained gel picture 
taken before blotting. 
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Figure 5.12 WT cells switch towards unproductive pre-rRNA processing during replicative 
ageing 
A) Three replicates of WT cells were aged using the MEP protocol as Figure 5.1. Total RNA was 
extracted, glyoxylated, and separated by agarose gel electrophoresis under denaturing conditions. 
Gel was blotted upward transfer and probed with a 32P-labelled oligo probe against IGS (JH1371, 
Table 2.3). The probe allows detection of the 35S, 20S, and 23S pre-rRNA species. 
B) Quantitation of A, blot bands normalised by the per lane 18S intensity from the EtBr image. 
Steady state levels of 35S and the unproductive 23S rise during replicative ageing. This suggests a 
switch from productive 18S synthesis via the 20S towards non-productive processing to the 23S. 
C) Two replicates were grown and processed as A, except: “Shift at 24h” samples had media 
refreshed at 24 h of ageing; “Shift at 45 h” samples had media refreshed at 45 h of ageing; “High 
volume” samples were grown in 4x standard media volume. Aged samples harvested at 48 h except 
“Shift at 45 h” samples which were harvested at 52 h.  
D) Quantitation of C, as B. All aged samples show the same trend of greatly lowered 20S:23S ratio 
demonstrating that the apparently age-related changes are not the result of nutrient depletion or 
media conditioning by yeast. 
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There were notable changes in normalised abundance of all measured RNAs with ageing 
(Figure 5.12 A-B). The switch from productive to unproductive processing is most clearly 
evident in the stark (4 – 8x) decrease in 20S:23S ratio with age (two-sided Student’s t-test, 
48 h vs log, p = 0.0011). Band intensities are a measure of the steady state levels of each 
intermediate, hence one cannot extrapolate to make statements about exactly which 
ribosome biogenesis steps are affected. This is because steady state level changes could, 
without further information, be equally explained by any change in the relative productive 
or degradative fluxes which allowed for such a changed steady state quantity. For 
example, raised 35S might result from increased Pol I transcription, slowed downstream 
processing, or a combination of both effects. As such the Northern blot results can only 
indicate that there are probably profound changes in ribosome biogenesis with age. 
Furthermore, these changes are consistent with an activation of cellular stress responses 
and slowed growth as those lead to a similar drop in 20S : 23S ratio (Kos-Braun et al. 
2017). 
5.2.8 Age-related rRNA-processing changes are not caused by exogenous 
nutrient deficiency in ageing cultures 
I was intrigued by the possibility that ageing influences ribosome biogenesis, but there 
was another plausible hypothesis which could explain the Northern blot result. Nutrient 
depletion was one of the factors found by the Kos lab to induce a switch from A2 pre-
rRNA processing to site A3 (Kos-Braun et al. 2017). Since the MEP inhibits division of new-
born daughters by induction of a β-estradiol-dependent genetic program, population 
growth in my ageing cultures should theoretically be linear rather than exponential. 
Indeed, WT MEP ageing cultures do not typically read OD 1.0 by 48 h. These ODs are well 
within the range where glucose and other macronutrients should not be limiting for 
growth in YPD. Nonetheless it was important to comprehensively rule out the competing 
hypothesis that some form of nutrient depletion, perhaps an enzyme cofactor or other 
trace nutrient, was responsible for compromising ribosome biogenesis.  
I grew ageing cultures in duplicate under standard MEP conditions in YPD as well as under 
three different regimes: YPD with a media replacement with fresh YPD at 24 h and harvest 
at 48 h; YPD with a media replacement at 45 h with fresh YPD and harvest at 52 h; growth 
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in YPD at 4x standard culture volume with the same starting inoculation (2.5 x 103 cells ml-
1 in 500 ml), resulting in 0.25x cell density, and harvest at 48 h. Blotted RNA extracted from 
purified aged cells was probed for ribosome biogenesis intermediates. While biological 
replicates were insufficient for statistical comparisons, there is clearly little-to-no effect of 
growth regime on the 20S:23S ratio (Figure 5.12 C-D). Consequently, I was confident that 
the changes to rRNA intermediate processing seen during ageing were not the result of 
nutrient stress imposed by culture conditions. Furthermore this result renders it similarly 
unlikely that ageing yeast secrete a factor which causes the change to rRNA processing as 
any such factor would have been diluted by the different growth regimes – hence the 
switch is likely due to cell-autonomous processes. 
5.2.9 ERC accumulation is not necessary for age-related rRNA 
processing changes 
My RNA-seq data had highlighted a potential role for ERCs in affecting expression of RP 
genes with age. Furthermore, nucleolar fragmentation was one of the first reported 
phenotypes in aged yeast and very recently excessive rRNA transcription has been 
reported to accompany entry into senescence (Sinclair et al. 1997; Morlot et al. 2019). Both 
phenomena have been attributed to ERC accumulation and are indications of nucleolar 
dysfunction – might ERCs be the cause of changed rRNA processing with age? 
I analysed the triplicate RNA samples used for my WT and spt3Δ RNA-seq (along with 
another replicate grown at the same time) with the same Northern blotting method as 
before. Since RNA was blotted onto two membranes, I further normalised values for each 
band by the mean WT log value for that band from the replicates present on the same 
membrane. Hence band intensities at all ages are expressed as a fold-change relative to 
the WT log value, this allowed simultaneous comparison of all four replicates for both 
genotypes. Unfortunately, the gel and blot qualities were not as high as for other samples, 
partly owing to the reduced concentration of RNA available, and so only 20S, 23S, and 27S 
were clearly visualised. Also 18S abundance was quantified by probing blots with an 18S 
random-primed probe (amplified from S. cerevisiae gDNA with primers 18S F2 / 18S R2, 
Table 2.3) as quality of the EtBr-stained pictures was poor. 
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Figure 5.143 Neither ERC accumulation nor advanced replicative age are entirely necessary 
for potentially age-related rRNA processing changes 
A-B) WT and spt3Δ (JH1069) mutants were grown and processed as Figure 5.13, except 18S 
abundance was measured by a 32P-radiolabelled random primed probe. Data from A and two 
additional biological replicates shown in B. WT and low-ERC spt3Δ mutants showed the same 
age related trend in 20S:23S suggesting changes are not due to ERC accumulation. 
C-D) Short-lived mutants rad52Δ (JH1052) and rtt109Δ (JH1005), grown and processed as Figure 
5.13, which also do not accumulate ERCs, show a similar age-related trend in 20S:23S but do not 
reach the same ratio as WT cells aged for 48 h. Therefore cell senescence does not appear to 
fully explain these changes. 
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The trends WT identified previously (Figure 5.12 A-B) were still evident at age (Figure 
5.143 A-B). On average spt3Δ had lower 20S and higher 23S than WT at all ages while 
showing directionally similar ageing trends in 20S:23S ratio. I found no significant 
interaction between genotype and age on normalised band intensities (ANOVA, p > 0.05). 
As such, this work gave no evidence that ERCs were responsible for age-related rRNA-
processing changes as it seems spt3Δ undergoes the same process with age, possibly just 
with adjusted baseline levels of some species which likely derive from other effects of the 
spt3Δ genotype. 
5.2.10 Age-related rRNA processing changes do not depend solely on 
advanced replicative age or senescence 
Advanced replicative age is associated with senescence in WT yeast, however the two 
phenomena are separable in short lived strains which senesce much earlier (Fehrmann et 
al. 2013; Morlot et al. 2019). My hypothesis was that if putative age-related rRNA 
processing changes were the result of cell senescence they should be visible in aged short 
lived strains as well as ones with WT lifespan. Conversely, if rRNA processing changes were 
a function of cells having divided many times, i.e. deriving from replicative age per se, one 
might not expect to see such changes in short lived strains which only divide a few times. 
rad52Δ strains are short lived, as are strains deleted for RTT109, an H3K56 histone 
acetylase, which would be expected to highlight any effects deriving from early 
senescence (Park et al. 1999; Schneider et al. 2006b; Han et al. 2007; Feser et al. 2010). 
A single replicate each of WT, rad52Δ and rtt109Δ was aged and RNA processed as for 
previous samples. The WT sample demonstrated the expected trends in band intensity 
except for the 35S band at 48 h (Figure 5.14 C-D). 20S:23S is lower at log-phase in the 
mutants but is reduced at both aged time points where it is very similar – consistent with 
little physiological change in that period for cells no longer dividing. Interestingly it 
appears that the 20S:23S ratio is higher at 48 h in the short-lived mutants relative to WT, 
this may indicate that there are contributions to the rRNA processing phenotype from 
both replicative age per se and senescence/SEP. Surprisingly, given the above changes, 
35S band intensity was similar at log and 24 h and higher in rtt109Δ at 48 h. While it is 
impossible to make strong claims about changes to rRNA intermediate processing fluxes 
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from steady state abundance, it seems likely that the two mutants displayed generally 
reduced ribosome synthesis given broadly lower pre-rRNA levels. This would be consistent 
with the profound growth defect seen in both strains during pre-culture which 
complicates interpretation. Both of these mutants show very few ERCs with age however 
that is unlikely to have impacted here as the spt3Δ did not show an effect of ERCs on rRNA-
processing with age. 
This short-lived mutant data, albeit with only a single replicate of each genotype, 
suggested the switch from productive to non-productive pathways might be a product 
both of cell senescence and replicative ageing itself. Specifically the data are not 
consistent with replicative age being the sole cause as both mutants are much younger 
replicatively – owing to earlier arrest of division – than WT while showing similar trends 
and reaching similar levels of some intermediates by 48 h. That said, the growth defects in 
both strains and clear differences in some intermediates at log phase between mutants 
and WT means the data are not as clean and decisive as one would like. 
We determined two more potential ways to test whether rRNA processing changes could 
be differentially attributed to senescence or replicative ageing itself. My hypothesis was 
that, in both cases showing reduced senescence, there would be less tendency to divert 
rRNA into non-productive pathways with age if cell senescence were an important factor 
as implied by the rad52Δ and rtt109Δ experiment. The Houseley lab recently published 
data showing aged cells divide faster, and with reduced cell cycle period variability, when 
grown in galactose media rather than the more standard glucose media (Frenk et al. 
2017). Our current working hypothesis is that cells growing in galactose do not undergo 
the age-related downshift in division rate seen in glucose grown cells, but that they rather 
cease dividing more abruptly when some unknown event occurs (Fehrmann et al. 2013; 
Morlot et al. 2019). The second alternative was to use fob1Δ mutants which, in addition to 
(or perhaps due to) having stabilised rDNA and reduced ERC accumulation, only undergo 
the SEP in about 30% cells (Morlot et al. 2019).  
I grew three replicates of WT cells under either YPD or YPGal. Cells were precultured 
overnight in their respective media to avoid incurring differential growth effects by a 
media switch at the start of ageing. Log and 48 h time points were harvested, samples 
processed as previously. rRNA processing intermediate abundances were 
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indistinguishable between glucose and galactose grown cells with the given number of 
replicates (Figure 5.154 A-B). All samples showed the trends consistent with previous data 
(Figure 5.12 A-B), although one replicate is a bit divergent from the other data points 
which affects the presentation. Nonetheless, the effects of different replicates disappear 
when considering 20S:23S where there was impressively little difference between cells 
grown in different media, especially at the 48 h time point. 
I also compared one replicate each of two different fob1Δ strains and a WT sample, all 
grown in YPD, at log, 24 h, and 48 h (Figure 5.154 C-D). Again, WT trends were like those 
previously observed (Figure 5.12 A-B). fob1Δ strains appeared to accumulate less of the 
unproductive 23S intermediate at aged time points, however surprisingly they also 
showed lower levels of productive intermediates at log and 24 h. Considering the 20S:23S 
ratio showed fob1Δ mutants to behave very similarly to WT. 
Overall, this Northern blot data produced some important findings. They suggest that 
neither ERCs nor the SEP/senescence are necessary to induce shifts towards non-
productive rRNA processing. However, division arrest may be sufficient to partially induce 
the 20S:23S shift, as demonstrated by the short-lived mutant data. As such, further 
investigations should look for potential causes in replicatively aged, but non-senescent, 
cells; this work may need to consider multiple interacting factors with additional analysis 
methods. Interestingly, the finding that fob1Δ cells have changes to rRNA processing - 
especially in log phase cells – confirms the suggestion that Fob1 might be a Pol I 
transcriptional activator made in (Serizawa et al. 2004). Despite the low replicate numbers, 
I am confident this is a real biological effect given it was consistent between two strain 
with FOB1 deleted with different markers by different people. Deletion of FOB1 had 
impressively little effect on the transcriptome at all ages in the Hendrickson et al. 2018 
dataset, certainly the signature of ERC depletion in my spt3Δ and rad52Δ samples is not 
evident; it is therefore interesting to speculate that a different - perhaps lower – initial rate 
of rRNA synthesis contributes to the lifespan extension and/or resistance to SEP in this 
background. Such a finding would represent a significant departure from the hitherto 
universal suggestion that the fob1Δ replicative lifespan phenotype is a direct consequence 
of reduced ERC accumulation and rDNA stabilisation. 
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Figure 5.154 Conditions expected to result in reduced entry in the SEP do not affect age-
related rRNA processing trends 
A-B) WT cells were grown and processed as Figure 5.13 A, however cultures were either grown in 
YPD or YPGal. Different media conditions did not result in a difference in 20S:23S after 48 h 
ageing. 
C-D) WT and fob1Δ (CJ261, CC570) cells were grown and processed as Figure 5.13 A, fob1Δ 
samples show reduced levels of productive intermediates at log phase. However similar trends to 
WT cells are seen during ageing. 
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5.3 Discussion 
5.3.1 The role of ERCs in budding yeast replicative ageing 
A major outcome of my work was to further characterise the role of ERCs in ageing 
budding yeast. For a time ERCs were considered as a possible cause of ageing – they 
accumulate with age in WT cells, are asymmetrically segregated between mother and 
daughter cells, and mutants with increased or decreased formation in young cells showed 
shortened or lengthened replicative lifespans respectively (Sinclair and Guarente 1997; 
Defossez et al. 1999; Kaeberlein et al. 1999). Subsequently the Kobayashi lab advanced a 
view that instability of rDNA itself, of which ERC production might be a symptom, was the 
fundamental ageing factor due to the discovery that induced rDNA instability could 
shorten lifespan even when occurring with reduced ERC production (Ganley et al. 2009; 
Saka et al. 2013; Ganley and Kobayashi 2014). Strong evidence that ERC accumulation 
itself can cause pathology was recently published by the Amon lab which showed heavily 
compromised cell cycle induction in the presence of ERC build up (Neurohr et al. 2018). 
Furthermore, those experiments demonstrated temporary rejuvenation of mother cells, 
and severely shortened lifespan in affected daughters, when a large proportion of ERCs 
segregated into daughters instead. A remarkable single-cell imaging study from the 
Charvin group observed rDNA CN increase, with simultaneous Pol I subunit upregulation 
and 18S pre-rRNA accumulation, in the ~5 divisions of cells preceding the SEP with huge 
increases thereafter (Morlot et al. 2019). The authors advanced a model wherein initial ERC 
excision, potentially a consequence of rDNA instability and occurring stochastically with 
probability modulated by genotype (e.g. fob1Δ or sir2Δ), may be considered the initiating 
event for cell ageing – to some extent synthesising the ERC and rDNA instability 
perspectives. 
However I am not convinced by this proposed model, though the attempt at a 
quantitative formulation is welcome. In my opinion the Charvin lab do not 
comprehensively establish that ERC accumulation precedes changes in rRNA synthesis 
(Morlot et al. 2019). Also, age-related pathology depends on rDNA accumulation (as ERCs) 
under their model; I accept that ERC accumulation may be sufficient for this per Neurohr 
et al. 2018 but not, as the Kobayashi lab has shown, strictly necessary (Ganley et al. 2009; 
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Saka et al. 2013; Neurohr et al. 2018). It seems likely that further single cell approaches will 
be most illuminating, already cell-specific ageing trajectories have been identified in WT 
and other genotypes, which will probably reveal current understanding based on bulk 
observations to be overly simplistic (Li et al. 2017; Crane and Kaeberlein 2018; Neurohr et 
al. 2018; Morlot et al. 2019). Particularly exciting will be to combine imaging approaches 
with single cell -omics techniques, such as single cell RNA-seq, which is now becoming 
possible in yeast (Gasch et al. 2017; Nadal-Ribelles et al. 2019). 
Work published thus far has not examined whether ERC accumulation has consequences 
for the transcriptome. My RNA-seq data suggests that it does, and moreover that certain 
biological functions may be disproportionately affected. A follow-up analysis of published 
Hsf1 ChIP-seq data was consistent possibility that ERC accumulation in the context of 
other age-related stresses might sequester Hsf1 which could potentially explain why my 
ERC-repressed gene set was strongly enriched for Hsf1-induced genes (Figure 5.6 B) (Solís 
et al. 2016; Pincus et al. 2018). If, indeed, Hsf1 activity is titrated by ERCs in aged yeast, 
one would expect that to compromise proteostasis maintenance as Hsf1 targets are 
mostly folding chaperones (Solís et al. 2016; Pincus et al. 2018). This could potentially 
provide the link between several observations in terminally ageing yeast: rDNA CN 
increases precede cell cycle duration increases (Morlot et al. 2019); ERCs compromise 
induction of the G1/S regulon at the START point of the cell cycle (Neurohr et al. 2018); 
import of Cln3, the major de-repressor of early G1/S transcripts, into the nucleus is 
compromised by proteostasis collapse in aged cells (Moreno et al. 2019a) This model was 
summarised in Figure 5.7. 
Two recent publications have revealed a role for Hsf1 in responding to aggregated excess 
ribosomal proteins (Albert et al. 2019a; Tye et al. 2019). In tandem with Hsf1 activation 
and induction of target proteostasis factors, the authors observed specific downregulation 
of RP genes. The proposed mechanism for the RP repression was via incorporation of the 
key RP gene trans-activator Ifh1 into protein aggregates. Interestingly I saw RP genes, but 
not RiBi genes, downregulated relative to aged WT in both low-ERC mutants. However, it 
seems unlikely that the model proposed in Albert et al. 2019 can help explain this. I have 
proposed that, during ageing in the presence of ERCs, Hsf1 is sequestered at rDNA 
sequences and that this might explain the higher expression of many Hsf1 targets in low-
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ERC backgrounds. However, one would then expect aggregate clearance to be impaired in 
the presence of ERCs. Were RP genes aggregating, this might lead to greater 
sequestration of Ifh1 in uncleared aggregates and thus lower RP gene expression in the 
presence of ERCs. The data suggested lower expression of RPs in the low-ERC 
backgrounds and hence it seems unlikely that RP gene aggregates are at play here. As a 
further point, it was extremely interesting that several C. elegans Hsf-1 targets were 
downregulated in aged worms with high rDNA CN (Figure 4.1 E) – this may hint at a more 
general interaction of Hsf1 homologs with rDNA sequences during ageing which will need 
further exploration. 
Other categories of genes were also enriched among those by ERCs beyond those 
involved in the Hsf1-dependent or RP gene sets. Primarily those involved in iron 
homeostasis for ERC-repressed genes, while those annotated to amino acid biogenesis 
and mitochondrial ATP synthesis were ERC-induced. It is not at all clear why these 
functional categories should be affected by ERC accumulation directly, so it seems more 
likely that indirect mechanisms are at work. Genes involved in iron homeostasis are part of 
a well-studied ‘iron regulon’ under transcriptional control by Aft1/2 and post-
transcriptional control by Cth1/2 (reviewed in Outten and Albetel 2013;Martínez-Pastor et 
al. 2017). Interestingly the iron regulon can be repressed by supplementation with amino 
acids via suppression of Gcn2 phosphorylation of eIF2α – the functional logic being that 
several key amino acid biosynthesis enzymes incorporate iron-sulfur complexes 
(Caballero-Molada et al. 2018). However, my reduced-ERC mutants, rad52Δ and spt3Δ, 
showed higher than WT levels of iron homeostasis genes with age but lower levels of 
some amino acid biogenesis genes – not the profile I would expect, assuming 
downregulation of amino acid biogenesis reflects replete amino acid availability. It is 
always possible that a downstream effect of ERC accumulation is disruption of iron or 
amino acid status sensors. These changes will require further investigation before their 
biological importance can be properly understood. 
5.3.2 Yeast adjust their rRNA-processing program during ageing 
Despite the interest in rDNA-related processes during yeast ageing, little attention has 
been paid to rRNA synthesis and processing. I find the general pattern that steady state 
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levels of productive pre-rRNA intermediates decline with age while the unproductive 23S 
pre-18S species becomes much more abundant (Figure 5.12 A-B). While an attractive first 
hypothesis, I found ERC accumulation is not necessary for this change as spt3Δ mutants 
behaved similarly to WT cultures with different baseline levels for some species (Figure 
5.143 A-B). Furthermore, my work with galactose grown cells and fob1Δ mutants suggests 
the switch towards non-productive pathways is separable from cell senescence as well 
(Figure 5.154 A-D). The Koš group saw very similar accumulation of non-productive 
intermediates, with simultaneous depletion of productive ones, as an early consequence 
of various cellular stresses (Kos-Braun et al. 2017). Rapid activation of this response was 
mediated by an S6 kinase (Sch9 in yeast) independent TORC1 signalling pathway which 
seems to be mediated downstream by CK2. Taken at face value, my data imply ageing 
yeast cultures become progressively more stressed with age (although exogenous nutrient 
stress is not responsible (Figure 5.12 C-D). It seems likely that the bulk changes I observed 
are the result of more discrete changes happening at different times in single cells with 
the overall population trending towards greater dysfunction, though my data cannot 
establish that absolutely. 
It is not entirely clear whether this is the same phenomenon seen by the Charvin lab, 
wherein cells approaching or undergoing the SEP show increased FISH signal for a pre-
18S rRNA probe (Morlot et al. 2019). Simply summing the normalised intensities of 35S, 
20S and 23S bands from my WT data (all species which would bind the FISH probe) 
suggests very little change in total ‘FISHable’ material between young and aged cultures. 
While this could be taken to suggest our results differ, it is important to highlight that this 
interpretation critically depends on my normalisation. I was required to assume that 
18S:total RNA ratio did not change between young and aged cells in order to use it for 
loading control normalisation. There are two reasons I strongly suspect this is not the 
case. RNA gels run with young and aged material with equivalent 18S loading show 
obvious age-related brightening of the fast-running broad composite band composed 
primarily of 5S rRNA, 5.8S rRNA and tRNAs (Pal et al. 2018). Also, my aged RNA-seq 
samples showed elevated read depth over the 18S and 25S loci in all genotypes, caveated 
though that is. Together these observations seem to imply 18S rRNA comprises a smaller 
fraction of total aged RNA but that 18S:mRNA ratio increases. As such, it is possible that 
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my normalising by 18S underestimated the absolute abundance changes of pre-rRNA 
intermediates – adjusting upwards estimates of pre-rRNA intermediate levels would lead 
to greater consistency with the Charvin lab’s report (Morlot et al. 2019). Thus it is plausible 
that the age-related shift towards non-productive rRNA processing I have found underlies 
the increase in total pre-18S material before and after the SEP measured by the Charvin 
lab. It is therefore very interesting that I saw similar behaviour, especially regarding 
20S:23S ratio, in WT and low-ERC spt3Δ backgrounds; remarkably, this would imply that 
ERC accumulation is not the cause of RiBi changes associated with the SEP, contrary to the 
model presented in Morlot et al. 2019. 
In summary, the work presented in this chapter revealed that both ERC-dependent and 
ERC-independent processes contribute to the phenotype of replicatively ageing yeast. I 
report novel data demonstrating functionally coherent consequences for ERC 
accumulation during ageing on the mRNA transcriptome. Futhermore, I hypothesised that 
the ERC-dependent effect on expression of proteostasis factors, via possible sequestration 
of Hsf1, might harmonise several recently published findings. This was supported by a re-
analysis of a published Hsf1 ChIP-seq dataset which showed possible association of Hsf1 
with the rDNA under long-term heat shock. Finally, by use of selected mutants and 
carefully controlled growth conditions, I uncovered an ERC-independent process active 
during yeast replicative ageing which induces a switch from productive rRNA processing 
to a largely unproductive mode. 
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6 Summary and Future Work 
6.1 rDNA CN impact both the transcriptome and whole-organism 
phenotypes 
I undertook this project with an overall interest in examining the poorly-understood 
consequences of rDNA CNV, both for whole animal phenotypes and gene expression at 
the organismal and cellular levels. For my initial work in C. elegans I developed and 
optimised a robust technique for assaying both 35S and 5S rDNA CN by PFGE, as well as a 
complementary qPCR-based method. Through the use of these assays I determined that 
there were large CN amplifications, up to 2.5x relative to the standard lab WT strain, in 
several hypomorphic mutants for the worm insulin/insulin-like receptor homolog daf-2. I 
used one of these CN variant strains, along with double fluorescent marker strains which I 
derived, to produce closely related isolates with divergent rDNA CN. Using these reagents 
I determined that rDNA CN is relatively stable at a population level in C. elegans under lab 
growth conditions. CNV in this species appears to be a relatively rare, though detectable 
on the scale of 10-20 generations, and likely biased towards amplifications. There did not 
appear to be detectable drive towards higher CNs over the first few generations of daf-2 
mutations being present in a WT rDNA CN background. This finding, combined with my 
discovery that a commonly used parental worm stock of the daf-2 lines assayed had 
notably raised rDNA CN, suggests that daf-2 mutations were not the major cause of high 
rDNA CN; furthermore rDNA CNV may be widespread among lab strains thought to be 
essentially isogenic. Using my derived CN divergent strains, I conducted several 
phenotypic assays. Unfortunately I was unable to successfully assay the effect of rDNA 
CNV on lifespan due to a pathology common to all of my strains but of undetermined 
cause. Nonetheless, I found evidence for a moderate effect of rDNA CN on worm 
fecundity, nucleolar size, and rRNA synthesis. 
Literature from work in different organisms has consistently found genes differentially 
expressed in the presence of rDNA CNV, although the number of such rDNA CN-sensitive 
genes is somewhat controversial between studies (Paredes et al. 2011; Gibbons et al. 2014; 
Li et al. 2018). I therefore performed RNA-seq on both young adult and aged worm 
samples with divergent rDNA CN. Any differences dependent on CN were swamped by 
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those due to developmental timing among young samples. While this limited the number 
of samples I could use, and hence statistical power, a small number of genes was found to 
be significantly differentially expressed based on CN differences. Conversely, the 
transcriptomes of all aged samples were very similar, however there were again some 
differentially expressed genes between samples of different rDNA CN. Notable among 
these were some targets of Hsf1, these and other such genes showed a trend towards 
lower expression in the high rDNA CN background. There was no major evidence for Pol 
II-dependent expression of non-rRNA regions of the rDNA repeat in C. elegans. These 
results, along with my phenotypic assays, imply that the C. elegans genome is highly 
effective at buffering the effects of rDNA CNV under minimally challenging lab growth 
conditions. Nonetheless, I consider it quite plausible that in more naturalistic contexts, 
involving interaction with other – potentially pathogenic or predatory – organisms and 
variable temperature or nutrient supply, selective advantages of different rDNA CNs might 
become more evident. 
I was interested to compare these findings in nematodes with another model organism, S. 
cerevisiae, where mechanisms of rDNA CNV are comparatively well understood. I analysed 
a previously collected RNA-seq dataset and found significant enrichment among 
differentially expressed genes for several GO categories. This analysis differed from that 
which I had performed in worms as only WT or very low rDNA CN samples were used, 
whereas I had compared WT with high CN worm samples. I therefore generated yeast 
strains with high rDNA CN, and fortuitously one with lower CN, which were isogenic with 
WT CN strains made by a previous PhD student in the Houseley lab. Analysing RNA-seq 
from these samples revealed a few differentially expressed genes shared between the two 
datasets including SIR2, one well studied rDNA-CN sensitive gene in yeast. Furthermore, 
there was a trend towards higher expression of RiBi factors at lower rDNA CNs in both 
datasets, while GO terms related to ribosome synthesis were significantly enriched in the 
WT vs. very low CN comparison. Additionally, I found that expression of Pol II-derived 
transcripts from the rDNA depends greatly on rDNA CN. Indeed, somewhat contrary to a 
leading model of induced rDNA CNV in yeast, low CN strains exhibited lower levels of IGS 
expression while higher CN strains showed more abundant transcripts that WT. Overall 
this data, along with the worm RNA-seq analysis, suggests that under well controlled 
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conditions with relatively uniform genetic background the phenomenon of rDNA CN-
sensitive gene expression is real but probably limited to hundreds of genes at most. 
Production of ERCs during yeast ageing is a different context in which rDNA CN increases 
drastically. Given that chromosomal rDNA CNV affects gene expression, I decided to study 
whether ERC accumulation – implicated as causal in yeast replicative ageing phenotypes – 
might similarly affect the transcriptome in aged yeast. I produced an ageing time course 
of RNA-seq samples from WT and two mutant strains with greatly reduced age-related 
ERC accumulation. Bioinformatics analysis revealed sets of functionally coherent genes 
whose expression was affected by the presence of ERCs. Different levels of Pol II-derived 
rDNA transcripts from IGS regions between WT and low-ERC mutants demonstrates that 
ERCs are transcriptionally active, at least via Pol II. Additionally, I found that ERCs cannot 
explain the widespread induction of gene expression previously reported during yeast 
ageing or more specific induction of subtelomeric loci. I then compared my data with a 
recently published similar transcriptomic dataset where two mutants were assayed which 
have canonically been thought to increase or decrease ERC levels during ageing. 
Interestingly, I did not find the expected overlaps between genes differentially expressed 
in that dataset and my ERC-sensitive gene lists. This, along with published Southern blot 
data or work performed by Jon Houseley, suggests that my data better represents an ERC 
vs. no ERC comparison. Furthermore, comparison of expression of rDNA IGS transcripts 
between mutants suggested that effects on the expression of these is not a primary 
mechanism by which ERCs influence coding gene expression. Finally, I compared several 
different mutants and cell growth conditions to determine that replicatively ageing yeast 
switch from a productive to a largely unproductive mode of ribosome biogenesis; this 
appears to depend on some aspect of replicative ageing per se and was not dependent on 
cell senescence. 
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6.2 An interaction between rDNA and Hsf1 may compromise 
proteostasis in ageing model organisms 
One of the most interesting points I discovered during the latter part of this project was 
that several proteostasis factors, including folding chaperones and a transcriptional 
activator of proteasome genes, were expressed higher during ageing in the low-ERC 
mutants spt3Δ and rad52Δ. Many of these are targets of Hsf1, a conserved transcriptional 
activator which responds to compromised proteostasis (Solís et al. 2016; Pincus et al. 
2018). I considered that the accumulation of ERCs during ageing might titrate Hsf1 
protein, thereby reducing expression of downstream proteostasis factors. However, to my 
knowledge there is no reported association between Hsf1 and rDNA loci. Using the yeast 
Hsf1 ChIP-seq data published in Pincus et al. 2018, I found the signal over rDNA regions 
increased nearly an order of magnitude after prolonged heat shock. This suggests that 
Hsf1 may be able to bind at rDNA repeats and that this binding may be enhanced under 
stresses, potentially particularly chronic ones. I examined the expression of a very high-
confidence set of Hsf1 targets (from Solís et al. 2016) in my young chromosomal rDNA 
CNV datasets, but there was no clear effect of rDNA CN on basal expression. 
Consequently, I hypothesise that potential effects during ageing are due to much greater 
CNV resulting from ERC accumulation, enhancement of Hsf1 affinity for rDNA due age-
related chronic stress, or a combination of both effects. The fact that several C. elegans 
HSF-1 targets showed a trend towards lower expression in aged high rDNA CN worm 
samples, adds further support to the hypothesis that there may be detrimental effects on 
induction of proteostasis regulators during ageing via an Hsf1/rDNA mechanism. 
It is very interesting to consider how a potential sequestration of Hsf1 by rDNA sequences 
may fit with emerging data on yeast age-related functional decline. The Charvin lab have 
found that cells undergoing the SEP, a dramatic increase in cell cycle time for the final few 
divisions of a cell’s lifespan, accumulate rDNA sequences – probably ERCs – for ~5 
divisions prior to cell-cycle disruption (Morlot et al. 2019). ERC accumulation is associated 
with deficiencies in the transcriptional induction of G1/S genes at the START of the cell 
cycle, resulting in prolongation of cell cycle phases – especially G1 (Neurohr et al. 2018). 
Furthermore, mitoses where ERCs are partitioned into daughter cells, rather than 
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asymmetrically retained within mother cells as normal, result in temporary rejuvenation of 
mothers; this manifests as more youthful cell cycle parameters and extended replicative 
lifespan. Under a model of Hsf1 titration by age-related ERC accumulation, one would 
expect lower expression of Hsf1 target proteostasis maintenance factors and thus a more 
disordered proteome – likely manifesting as more and/or larger protein aggregates. 
Folding chaperones localise to misfolded proteins and particularly aggregate structures. 
Therefore this model predicts that availability of free chaperones should become lower as 
ERCs accumulate. Specific chaperones, Ydj1 and Ssa1/2, are required to correctly fold Cln3 
and localise it in the nucleus (Vergés et al. 2007). Cln3 bound to Cdc28 phosphorylates the 
G1/S regulon repressor Whi5 which induces its exclusion from the nucleus at the START 
point (Tyers et al. 1993; de Bruin et al. 2004). Very recently, proteostasis collapse has been 
highlighted as a primary factor in compromising cell cycle induction in yeast after the SEP 
and before death (Moreno et al. 2019a). Therefore I propose titration of Hsf1 by ERCs as a 
mechanism linking ERC accumulation to late-life pathology via compromised proteostasis 
in replicatively aged yeast (Figure 5.7). 
6.3 Testing the potential interaction between Hsf1 and rDNA 
The hypothesis that Hsf1 can interact with rDNA sequences makes some readily testable 
predictions. Firstly, one would expect that chromosomal rDNA CNV would influence 
induction of Hsf1 targets. Therefore I intend to assay the HS response in yeast strains with 
divergent rDNA CNs (RNA-seq data for which is discussed in Section 4.2.3). Samples will 
be collected over a time course of increasingly prolonged heat shock. Transcriptional 
induction of Hsf1 targets can be easily followed by Northern blotting of extracted RNA 
and hybridisation with specific probes. This experiment will also be very informative as to 
whether the speed and/or degree of gene induction would be affected by rDNA CN. 
Furthermore one would expect HS response induction and resistance to depend on ERC 
abundance during ageing. Therefore I will perform a similar HS experiment with aged 
cultures using WT and spt3Δ mutants. The specific prediction would be that age-matched 
spt3Δ mutants would have faster and/or greater induction of Hsf1 targets and potentially 
greater viability after HS. An important control experiment here will be to ensure that 
there is not a difference HS response in log-phase spt3Δ mutants.  
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I will also need to replicate the Hsf1 ChIP-seq data from Pincus et al. 2018. In that data I 
saw increased Hsf1 signal over the rDNA after prolonged HS. It would make sense to first 
directly replicate their experiment, however this should also include a no-antibody sample. 
This would ensure that any possible non-specific differential pull down of rDNA sequences 
would be controlled for. However the main thing I would need to test vis-à-vis ERCs, Hsf1 
and ageing is depletion of Hsf1 from promoters of its normal targets in aged cells in the 
presence of ERCs. The simplest method to do this seems to be again to use the spt3Δ 
mutant. It would also be important to test whether aged spt3Δ mutants have equivalent 
protein levels of Hsf1 by Western blot. 
Assuming the results of these yeast experiments support an interaction of Hsf1 with the 
rDNA, it would be interesting to test whether this is evident in other species as my aged 
worm RNA-seq implies it may be. I would initially plan to use a similar approach in worms 
as that in yeast. Heat shock of young worms with differing rDNA CNs – matched as far as 
possible for developmental staging – followed by testing HS response induction. The 
reagents I have currently would allow testing of high CN vs WT, however there may also 
be some strains within the Million Mutation Project collection which have low rDNA CN 
which I might be able to use (Thompson et al. 2013). By testing the phenotypic recovery 
after heat shock as well I could additionally test whether rDNA CN affects recovery from 
heat stress, which seems plausible given current data. 
6.4 Alternative differential expression analysis models 
During my Viva Voce discussion, it was mentioned that using a more complex model 
design for RNA-seq differential expression testing might offer greater statistical power 
relative to the approaches detailed in Sections 4 and 5. I am very grateful for this 
suggestion as indeed it potentially allows for inclusion of more data when performing 
analyses and avoids many of the filtering and comparison steps detailed above. 
For the yeast dataset which analysed the effect of chromosomal rDNA CN change in log 
phase cultures (see Section 4.2.3) I performed a re-analysis with only samples from the 
Zylstra dataset. I considered including data from the Houseley samples as well, but this 
seemed to overall increase noise and reduce statistical power. A linear model was fit with 
DESeq2 (Love et al. 2014) using data from all single mutant and double mutant sequenced 
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libraries. Gene expression was modelled as the dependent on FOB1 status (fixed categorial 
variable, WT or deleted), MMS22 status (fixed categorical variable, WT or deleted) and 
rDNA CN (continuous variable, estimated from PFGE assay Figure 4.4). At a significance 
level of p < 0.05, there were 12 genes affected by FOB1 status, 2267 genes affected by 
MMS22 status, and 30 genes affected by rDNA CN. This was a smaller set of rDNA 
sensitive genes found relative to the high CN vs. Low CN comparison (62 genes) 
performed previously (Section 4.2.3 and Figure 4.5). I also fitted a similar model where 
rDNA CN was instead coded as a fixed categorial variable with 3 levels (low, WT, high). At 
the same significance level there were a similar number of genes influenced by FOB1 and 
MMS22 status (14 and 2091 respectively) and 58 genes differentially expressed between 
High rDNA CN vs Low rDNA CN. Notably this list included PHO3, which previously found 
to be consistently differentially expressed with rDNA CN in both Zylstra and Houseley 
datasets. However, SIR2 and HMO1 were not called as differentially expressed on the basis 
of rDNA CN in either of these re-analyses. Due to the existing literature around SIR2 
changing expression in an rDNA CN-dependent manner, it represents the best 
approximation to a ground truth available for this analysis. As such, it seems the linear 
modelling approach including single mutant data may not provide additional, or even the 
same, sensitivity. 
I took a similar approach to re-analyse the RNA-seq data from ageing samples which 
examined the effects of ERC accumulation on the yeast transcriptome. Here I included all 
samples from all time points and genotypes and modelled gene expression as dependent 
on: Age, a fixed categorical variable with three levels (log, 24h, and 48h); Genotype, a fixed 
categorical variable with three levels (WT, spt3Δ, rad52Δ); and ERC number, a continuous 
variable estimated from Southern blot data. In this analysis 2020 genes were called as 
significantly differentially expressed dependent on ERC number (BH-corrected FDR < 
0.05). Notably this is considerably more than the 309 genes found after various filtering 
steps in Section 5.2.3, suggesting that the linear model-based approach may be much 
more sensitive. Surprisingly the sets of GO terms enriched among “ERC-induced” genes in 
this latter analysis were rather different to those found previously. Among “ERC-induced” 
genes were many terms related to ribosome biogenesis while translation- and ATP 
synthesis-related terms were absent (Table 8.10). Similarly, terms enriched among “ERC-
203 
 
repressed” genes in this new analysis, including mitochondrial translation and 
carbohydrate metabolism, showed little overlap with those seen in the previous analysis 
(Table 8.11). The terms relating to chaperones and heat shock were absent. It is somewhat 
concerning that the results can differ so severely depending on the analysis pipeline and 
suggests that at least one method badly fails to accurately capture the underlying biology. 
It will be interesting to evaluate the plausibility of these different sets of results in 
validation experiments. 
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8 Appendix 
Table 8.1 Full GOrilla output for GO terms enriched among genes differentially upregulated 
in very low rDNA CN vs. WT rDNA CN 
Description P-value FDR q-value Enrichment 
ribonucleoprotein complex biogenesis 8.99E-15 4.73E-11 6.72 
ribosome biogenesis 4.82E-14 1.27E-10 7.03 
cellular component biogenesis 1.08E-13 1.89E-10 6.05 
rRNA processing 3.89E-12 5.11E-09 5.43 
rRNA metabolic process 1.56E-11 1.64E-08 4.86 
ribonucleoside monophosphate biosynthetic 
process 5.65E-11 4.95E-08 10.04 
nucleoside monophosphate biosynthetic process 9.25E-11 6.95E-08 9.69 
ribonucleoside monophosphate metabolic 
process 3.14E-10 2.06E-07 8.87 
ribonucleotide biosynthetic process 3.63E-10 2.12E-07 8.78 
IMP metabolic process 4.42E-10 2.32E-07 32.43 
ribose phosphate biosynthetic process 8.31E-10 3.97E-07 8.27 
nucleoside monophosphate metabolic process 1.23E-09 5.40E-07 8.03 
ncRNA processing 1.50E-09 6.06E-07 3.93 
ribonucleotide metabolic process 9.12E-09 3.43E-06 6.91 
purine nucleoside monophosphate biosynthetic 
process 1.04E-08 3.65E-06 9.74 
purine ribonucleoside monophosphate 
biosynthetic process 1.04E-08 3.42E-06 9.74 
ncRNA metabolic process 1.24E-08 3.82E-06 3.31 
IMP biosynthetic process 1.53E-08 4.47E-06 30.11 
purine nucleoside monophosphate metabolic 
process 5.28E-08 1.46E-05 8.38 
purine ribonucleoside monophosphate 
metabolic process 5.28E-08 1.39E-05 8.38 
nucleotide metabolic process 6.10E-08 1.53E-05 4.76 
ribose phosphate metabolic process 6.53E-08 1.56E-05 5.94 
purine ribonucleotide biosynthetic process 8.92E-08 2.04E-05 7.98 
nucleoside phosphate metabolic process 9.16E-08 2.01E-05 4.63 
nucleotide biosynthetic process 9.30E-08 1.96E-05 5.77 
nucleoside phosphate biosynthetic process 1.20E-07 2.43E-05 5.66 
ribosomal large subunit biogenesis 1.34E-07 2.61E-05 10.42 
'de novo' IMP biosynthetic process 1.36E-07 2.55E-05 33.45 
purine nucleotide biosynthetic process 2.35E-07 4.25E-05 7.28 
ribonucleoside biosynthetic process 3.24E-07 5.67E-05 14.54 
nucleoside biosynthetic process 4.16E-07 7.06E-05 14.05 
cellular aromatic compound metabolic process 4.17E-07 6.85E-05 1.89 
purine-containing compound biosynthetic 
process 5.05E-07 8.05E-05 6.76 
nucleobase-containing small molecule metabolic 
process 6.83E-07 1.06E-04 4.03 
nucleoside metabolic process 9.42E-07 1.42E-04 10.04 
glycosyl compound biosynthetic process 1.04E-06 1.52E-04 12.4 
maturation of LSU-rRNA 1.11E-06 1.58E-04 9.83 
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heterocycle metabolic process 1.46E-06 2.02E-04 1.84 
purine ribonucleotide metabolic process 1.49E-06 2.01E-04 6.08 
RNA processing 1.58E-06 2.08E-04 2.77 
organic cyclic compound metabolic process 1.59E-06 2.04E-04 1.81 
nucleobase-containing compound metabolic 
process 1.67E-06 2.09E-04 1.87 
ribonucleoside metabolic process 1.91E-06 2.34E-04 11.39 
cellular nitrogen compound metabolic process 2.07E-06 2.47E-04 1.72 
glycosyl compound metabolic process 2.07E-06 2.42E-04 9.09 
maturation of LSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 2.32E-06 2.65E-04 11.09 
purine nucleotide metabolic process 3.28E-06 3.67E-04 5.61 
GMP biosynthetic process 4.75E-06 5.21E-04 30.11 
carbohydrate derivative biosynthetic process 8.18E-06 8.78E-04 4 
GMP metabolic process 8.44E-06 8.88E-04 26.76 
maturation of SSU-rRNA 1.05E-05 1.09E-03 6.3 
maturation of 5.8S rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 1.10E-05 1.11E-03 15.85 
ribonucleoprotein complex export from nucleus 1.18E-05 1.17E-03 8.78 
rRNA-containing ribonucleoprotein complex 
export from nucleus 1.18E-05 1.15E-03 8.78 
ribosomal subunit export from nucleus 1.18E-05 1.13E-03 8.78 
ribosome localization 1.36E-05 1.28E-03 8.6 
guanosine-containing compound biosynthetic 
process 1.39E-05 1.28E-03 24.09 
purine-containing compound metabolic process 1.40E-05 1.27E-03 4.84 
maturation of 5.8S rRNA 1.88E-05 1.67E-03 14.34 
nucleobase metabolic process 2.33E-05 2.05E-03 10.04 
maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 2.39E-05 2.06E-03 6.6 
nucleobase biosynthetic process 2.39E-05 2.03E-03 13.69 
protein export from nucleus 2.62E-05 2.18E-03 7.81 
guanosine-containing compound metabolic 
process 4.55E-05 3.74E-03 18.53 
'de novo' UMP biosynthetic process 8.56E-05 6.93E-03 30.11 
carbohydrate derivative metabolic process 1.04E-04 8.26E-03 3.02 
organophosphate biosynthetic process 1.04E-04 8.19E-03 3.18 
nucleobase-containing small molecule 
biosynthetic process 1.08E-04 8.34E-03 6.29 
nucleocytoplasmic transport 1.21E-04 9.26E-03 3.83 
nuclear transport 1.21E-04 9.13E-03 3.83 
purine nucleoside biosynthetic process 1.44E-04 1.07E-02 14.17 
purine ribonucleoside biosynthetic process 1.44E-04 1.05E-02 14.17 
organophosphate metabolic process 1.71E-04 1.23E-02 2.65 
nucleobase-containing compound transport 1.78E-04 1.27E-02 3.41 
'de novo' pyrimidine nucleobase biosynthetic 
process 2.34E-04 1.64E-02 22.58 
RNA export from nucleus 2.46E-04 1.70E-02 4.23 
RNA metabolic process 2.64E-04 1.81E-02 1.91 
pyrimidine nucleoside transport 2.73E-04 1.84E-02 60.22 
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'de novo' AMP biosynthetic process 2.73E-04 1.82E-02 60.22 
nuclear export 2.77E-04 1.82E-02 4.17 
ribonucleoprotein complex subunit organization 3.18E-04 2.07E-02 3.43 
RNA transport 3.90E-04 2.50E-02 3.63 
establishment of RNA localization 3.90E-04 2.47E-02 3.63 
nucleic acid transport 4.29E-04 2.68E-02 3.58 
organonitrogen compound biosynthetic process 4.70E-04 2.91E-02 1.98 
ribosomal large subunit assembly 4.72E-04 2.89E-02 7.53 
NADH oxidation 4.89E-04 2.96E-02 18.07 
UMP biosynthetic process 4.89E-04 2.93E-02 18.07 
UMP metabolic process 4.89E-04 2.89E-02 18.07 
pyrimidine ribonucleoside monophosphate 
metabolic process 4.89E-04 2.86E-02 18.07 
pyrimidine ribonucleoside monophosphate 
biosynthetic process 4.89E-04 2.83E-02 18.07 
pyrimidine nucleobase biosynthetic process 4.89E-04 2.80E-02 18.07 
purine ribonucleoside metabolic process 4.96E-04 2.81E-02 10.47 
protein-containing complex localization 5.15E-04 2.88E-02 4.9 
glutamine metabolic process 5.88E-04 3.26E-02 10.04 
purine nucleoside metabolic process 5.88E-04 3.22E-02 10.04 
small molecule metabolic process 6.11E-04 3.31E-02 1.99 
amino acid catabolic process via Ehrlich pathway 6.65E-04 3.57E-02 16.42 
amino acid catabolic process to alcohol via 
Ehrlich pathway 6.65E-04 3.53E-02 16.42 
establishment of organelle localization 6.79E-04 3.57E-02 4.68 
ribonucleoprotein complex assembly 7.71E-04 4.02E-02 3.33 
 
Table 8.2 Full GOrilla output for GO terms enriched among genes differentially 
downregulated in very low rDNA CN vs. WT rDNA CN 
GO Term P-value FDR q-value Enrichment 
transposition, RNA-mediated 8.85E-19 4.66E-15 18.19 
transposition 2.56E-18 6.74E-15 17.21 
DNA integration 4.69E-11 8.22E-08 19.33 
RNA-dependent DNA biosynthetic process 1.27E-09 1.67E-06 14.11 
DNA biosynthetic process 4.98E-08 5.24E-05 9.77 
RNA phosphodiester bond hydrolysis,  
endonucleolytic 1.94E-06 1.70E-03 6.64 
cellular response to external stimulus 6.83E-06 5.13E-03 6.61 
cell communication 6.83E-06 4.49E-03 6.61 
cellular response to extracellular stimulus 6.83E-06 3.99E-03 6.61 
response to extracellular stimulus 1.15E-05 6.08E-03 6.2 
response to external stimulus 1.88E-05 9.00E-03 5.84 
DNA recombination 2.13E-05 9.35E-03 4.57 
energy reserve metabolic process 2.86E-05 1.16E-02 13.47 
RNA phosphodiester bond hydrolysis 3.27E-05 1.23E-02 4.83 
response to abiotic stimulus 3.76E-05 1.32E-02 4.76 
regulation of DNA amplification 1.25E-04 4.09E-02 88.92 
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negative regulation of DNA amplification 1.25E-04 3.85E-02 88.92 
proteolysis 2.42E-04 7.07E-02 3.05 
cellular response to nutrient levels 2.47E-04 6.85E-02 5.51 
cellular carbohydrate metabolic process 3.51E-04 9.22E-02 4.5 
glycogen metabolic process 3.65E-04 9.14E-02 11.47 
response to nutrient levels 3.77E-04 9.01E-02 5.14 
response to heat 4.22E-04 9.65E-02 6.06 
nucleic acid phosphodiester bond hydrolysis 4.46E-04 9.77E-02 3.53 
glycogen biosynthetic process 4.52E-04 9.52E-02 19.05 
response to temperature stimulus 5.68E-04 1.15E-01 5.74 
cellular response to starvation 6.08E-04 1.18E-01 7.17 
cellular response to desiccation 7.36E-04 1.38E-01 44.46 
response to desiccation 7.36E-04 1.34E-01 44.46 
response to starvation 7.56E-04 1.33E-01 6.84 
nucleobase-containing compound biosynthetic  
process 7.93E-04 1.35E-01 2.57 
response to stress 9.00E-04 1.48E-01 2.18 
 
Table 8.3 Full GOrilla output for GO terms enriched among genes differentially expressed 
between low rDNA CN vs. WT rDNA CN 
Description P-value FDR q-value Enrichment 
organic acid biosynthetic process 1.51E-11 7.94E-08 10.26 
carboxylic acid biosynthetic process 1.51E-11 3.97E-08 10.26 
small molecule biosynthetic process 8.63E-09 1.51E-05 6.37 
oxoacid metabolic process 8.77E-09 1.15E-05 5.73 
organic acid metabolic process 9.36E-09 9.85E-06 5.71 
carboxylic acid metabolic process 4.72E-08 4.14E-05 5.58 
arginine biosynthetic process 1.56E-07 1.17E-04 71.36 
alpha-amino acid biosynthetic process 6.15E-07 4.04E-04 10.44 
cellular amino acid biosynthetic process 9.97E-07 5.83E-04 9.8 
arginine metabolic process 1.65E-06 8.67E-04 42.81 
gluconeogenesis 2.19E-06 1.05E-03 40.14 
hexose biosynthetic process 2.19E-06 9.59E-04 40.14 
monosaccharide biosynthetic process 2.85E-06 1.15E-03 37.78 
carbohydrate biosynthetic process 7.56E-06 2.84E-03 12.19 
monocarboxylic acid biosynthetic process 1.08E-05 3.79E-03 11.47 
small molecule metabolic process 1.17E-05 3.84E-03 3.31 
alpha-amino acid metabolic process 1.18E-05 3.64E-03 7.06 
ATP generation from ADP 1.72E-05 5.02E-03 24.7 
glycolytic process 1.72E-05 4.76E-03 24.7 
glutamine family amino acid biosynthetic  
process 1.72E-05 4.52E-03 24.7 
pyruvate biosynthetic process 2.01E-05 5.03E-03 23.79 
nucleoside diphosphate phosphorylation 2.70E-05 6.44E-03 22.15 
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nucleotide phosphorylation 3.10E-05 7.08E-03 21.41 
oxaloacetate(2-) transmembrane transport 3.77E-05 8.27E-03 160.56 
oxaloacetate transport 3.77E-05 7.94E-03 160.56 
ADP metabolic process 4.03E-05 8.15E-03 20.07 
ribonucleoside diphosphate metabolic process 4.56E-05 8.89E-03 19.46 
purine ribonucleoside diphosphate metabolic  
process 4.56E-05 8.57E-03 19.46 
purine nucleoside diphosphate metabolic  
process 4.56E-05 8.27E-03 19.46 
nucleotide catabolic process 5.79E-05 1.01E-02 18.35 
nucleoside phosphate catabolic process 7.23E-05 1.23E-02 17.36 
nucleoside diphosphate metabolic process 7.23E-05 1.19E-02 17.36 
glucose metabolic process 8.93E-05 1.42E-02 16.47 
cellular amino acid metabolic process 1.00E-04 1.55E-02 5.24 
ATP biosynthetic process 1.32E-04 1.98E-02 14.94 
pyruvate metabolic process 1.32E-04 1.92E-02 14.94 
nicotinamide nucleotide biosynthetic process 1.32E-04 1.87E-02 14.94 
pyridine nucleotide biosynthetic process 1.44E-04 2.00E-02 14.6 
purine ribonucleoside triphosphate  
biosynthetic process 1.87E-04 2.52E-02 13.66 
purine nucleoside triphosphate biosynthetic  
process 1.87E-04 2.46E-02 13.66 
ribonucleoside triphosphate biosynthetic  
process 2.77E-04 3.56E-02 12.35 
ATP metabolic process 2.99E-04 3.74E-02 12.12 
hexose metabolic process 3.70E-04 4.52E-02 11.47 
pyridine-containing compound biosynthetic  
process 3.70E-04 4.42E-02 11.47 
nucleoside triphosphate biosynthetic process 3.70E-04 4.32E-02 11.47 
glutamine family amino acid metabolic  
process 3.70E-04 4.23E-02 11.47 
organonitrogen compound biosynthetic  
process 3.93E-04 4.39E-02 2.75 
purine ribonucleoside triphosphate metabolic  
process 4.23E-04 4.64E-02 11.07 
monocarboxylic acid metabolic process 4.43E-04 4.75E-02 5.91 
organophosphate catabolic process 4.52E-04 4.76E-02 10.89 
purine nucleoside triphosphate metabolic  
process 4.82E-04 4.97E-02 10.7 
sulfate transmembrane transport 5.57E-04 5.63E-02 53.52 
sulfate transport 5.57E-04 5.53E-02 53.52 
ribonucleoside triphosphate metabolic process 5.81E-04 5.66E-02 10.19 
monosaccharide metabolic process 6.55E-04 6.26E-02 9.88 
nucleobase-containing small molecule  
biosynthetic process 7.35E-04 6.90E-02 9.59 
purine nucleoside monophosphate biosynthetic  
process 7.35E-04 6.78E-02 9.59 
purine ribonucleoside monophosphate  7.35E-04 6.67E-02 9.59 
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biosynthetic process 
drug metabolic process 7.76E-04 6.92E-02 4.46 
C4-dicarboxylate transport 7.77E-04 6.81E-02 45.87 
nucleoside triphosphate metabolic process 9.65E-04 8.32E-02 8.92 
 
Table 8.4 Full GOrilla output for GO terms enriched among genes differentially expressed 
between low rDNA CN vs. high rDNA CN 
GO Term P-value FDR q-value Enrichment 
alpha-amino acid biosynthetic process 8.30E-20 4.36E-16 16.08 
cellular amino acid biosynthetic process 3.05E-19 8.03E-16 15.1 
organic acid biosynthetic process 1.94E-18 3.40E-15 10.42 
carboxylic acid biosynthetic process 1.94E-18 2.55E-15 10.42 
alpha-amino acid metabolic process 2.35E-16 2.47E-13 10.89 
cellular amino acid metabolic process 5.68E-15 4.98E-12 8.51 
small molecule biosynthetic process 6.82E-15 5.13E-12 6.76 
carboxylic acid metabolic process 1.28E-14 8.40E-12 6.17 
oxoacid metabolic process 3.34E-14 1.95E-11 5.92 
organic acid metabolic process 3.73E-14 1.96E-11 5.89 
arginine biosynthetic process 1.59E-10 7.62E-08 59.8 
small molecule metabolic process 1.10E-09 4.82E-07 3.56 
arginine metabolic process 5.80E-09 2.35E-06 37.38 
aspartate family amino acid biosynthetic process 5.27E-08 1.98E-05 14.5 
glutamine family amino acid metabolic process 7.04E-08 2.47E-05 13.99 
organonitrogen compound biosynthetic process 7.77E-08 2.56E-05 3.15 
glutamine family amino acid biosynthetic 
process 1.97E-07 6.09E-05 22.15 
aspartate family amino acid metabolic process 2.28E-07 6.67E-05 12.08 
ornithine metabolic process 1.11E-06 3.07E-04 44.3 
organic substance biosynthetic process 5.59E-06 1.47E-03 2.13 
biosynthetic process 7.15E-06 1.79E-03 2.1 
cellular biosynthetic process 1.03E-05 2.47E-03 2.12 
indole-containing compound biosynthetic 
process 1.88E-05 4.29E-03 49.84 
indolalkylamine biosynthetic process 1.88E-05 4.11E-03 49.84 
tryptophan biosynthetic process 1.88E-05 3.95E-03 49.84 
methionine biosynthetic process 3.32E-05 6.73E-03 13.11 
sulfur amino acid biosynthetic process 4.85E-05 9.45E-03 12.16 
methionine metabolic process 5.46E-05 1.03E-02 11.87 
aromatic amino acid family biosynthetic process 9.86E-05 1.79E-02 15.95 
arginine biosynthetic process via ornithine 9.89E-05 1.73E-02 99.67 
lysine biosynthetic process via diaminopimelate 9.89E-05 1.68E-02 99.67 
diaminopimelate metabolic process 9.89E-05 1.63E-02 99.67 
sulfur amino acid metabolic process 1.05E-04 1.67E-02 10.38 
cellular biogenic amine biosynthetic process 1.09E-04 1.69E-02 29.9 
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amine biosynthetic process 1.09E-04 1.64E-02 29.9 
homoserine metabolic process 2.55E-04 3.73E-02 23 
homoserine biosynthetic process 2.95E-04 4.19E-02 66.45 
lysine biosynthetic process 3.23E-04 4.47E-02 21.36 
sulfur compound metabolic process 3.78E-04 5.09E-02 5.13 
lysine metabolic process 4.00E-04 5.26E-02 19.93 
branched-chain amino acid biosynthetic process 4.00E-04 5.14E-02 19.93 
asparagine biosynthetic process 5.86E-04 7.34E-02 49.84 
ornithine biosynthetic process 5.86E-04 7.17E-02 49.84 
aromatic amino acid family metabolic process 6.37E-04 7.62E-02 9.97 
serine family amino acid metabolic process 7.01E-04 8.19E-02 9.72 
tryptophan metabolic process 7.03E-04 8.04E-02 16.61 
indolalkylamine metabolic process 7.03E-04 7.87E-02 16.61 
indole-containing compound metabolic process 7.03E-04 7.70E-02 16.61 
sulfur compound biosynthetic process 9.71E-04 1.04E-01 6.47 
 
Table 8.5 Full GOrilla output for GO terms enriched among SIR2-induced genes 
GO Term P-value FDR q-value Enrichment 
transposition, RNA-mediated 1.49E-122 7.84E-119 31.28 
transposition 5.57E-118 1.46E-114 29.6 
DNA integration 5.10E-55 8.94E-52 29.17 
RNA-dependent DNA biosynthetic process 1.02E-45 1.35E-42 21.3 
DNA biosynthetic process 2.88E-37 3.03E-34 14.74 
RNA phosphodiester bond hydrolysis, 
endonucleolytic 1.26E-29 1.11E-26 10.01 
DNA recombination 1.87E-25 1.40E-22 6.91 
RNA phosphodiester bond hydrolysis 5.86E-24 3.85E-21 7.29 
nucleic acid phosphodiester bond hydrolysis 1.15E-19 6.75E-17 5.46 
DNA metabolic process 1.62E-16 8.52E-14 3.58 
proteolysis 1.70E-15 8.12E-13 3.9 
nucleobase-containing compound biosynthetic 
process 4.24E-11 1.86E-08 2.98 
aromatic compound biosynthetic process 6.31E-11 2.55E-08 2.79 
heterocycle biosynthetic process 1.39E-10 5.21E-08 2.73 
response to pheromone 9.33E-10 3.27E-07 10.07 
organic cyclic compound biosynthetic process 1.65E-09 5.42E-07 2.53 
positive regulation of conjugation 1.00E-08 3.11E-06 9.46 
positive regulation of conjugation with cellular 
fusion 1.00E-08 2.94E-06 9.46 
positive regulation of multi-organism process 2.32E-08 6.42E-06 8.8 
positive regulation of reproductive process 2.33E-08 6.12E-06 7.79 
pheromone-dependent signal transduction 
involved in conjugation with cellular fusion 1.46E-07 3.65E-05 11.97 
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signal transduction involved in positive 
regulation of conjugation with cellular fusion 1.46E-07 3.49E-05 11.97 
regulation of conjugation with cellular fusion 1.94E-07 4.43E-05 7.28 
regulation of conjugation 1.94E-07 4.25E-05 7.28 
regulation of multi-organism process 6.28E-07 1.32E-04 6.53 
cellular macromolecule biosynthetic process 8.40E-07 1.70E-04 2.09 
macromolecule biosynthetic process 5.99E-06 1.17E-03 1.93 
regulation of reproductive process 1.24E-05 2.33E-03 4.14 
cellular nitrogen compound biosynthetic process 1.64E-04 2.98E-02 1.69 
multi-organism reproductive process 2.13E-04 3.73E-02 8.6 
regulation of transposition, RNA-mediated 7.31E-04 1.24E-01 9.17 
nucleic acid metabolic process 7.67E-04 1.26E-01 1.49 
regulation of transposition 9.53E-04 1.52E-01 8.6 
 
Table 8.6 Full GOrilla output for GO terms enriched among genes upregulated during WT 
yeast ageing 
GO Term P-value FDR q-value Enrichment 
ribonucleoprotein complex biogenesis 2.30E-15 1.21E-11 2.12 
rRNA processing 4.27E-15 1.12E-11 2 
cellular component biogenesis 1.23E-14 2.16E-11 2.02 
ribosome biogenesis 1.76E-13 2.31E-10 2.11 
RNA phosphodiester bond hydrolysis, 
endonucleolytic 2.00E-13 2.11E-10 2.37 
DNA integration 7.43E-13 6.52E-10 3.4 
ncRNA processing 1.00E-12 7.52E-10 1.74 
rRNA metabolic process 1.04E-12 6.86E-10 1.83 
transposition, RNA-mediated 6.02E-12 3.52E-09 2.61 
fungal-type cell wall organization 2.03E-11 1.07E-08 2.03 
cell wall assembly 2.36E-11 1.13E-08 3.13 
cellular component assembly involved in 
morphogenesis 3.27E-11 1.43E-08 2.81 
ascospore wall assembly 3.44E-11 1.39E-08 3.16 
spore wall assembly 3.44E-11 1.29E-08 3.16 
fungal-type cell wall assembly 7.56E-11 2.65E-08 3.09 
transposition 7.75E-11 2.55E-08 2.47 
fungal-type cell wall organization or biogenesis 8.77E-11 2.71E-08 1.95 
cell wall organization 1.17E-10 3.43E-08 1.86 
external encapsulating structure organization 1.17E-10 3.25E-08 1.86 
cell wall organization or biogenesis 1.64E-10 4.32E-08 1.83 
RNA-dependent DNA biosynthetic process 7.60E-10 1.90E-07 2.72 
RNA phosphodiester bond hydrolysis 1.05E-09 2.52E-07 1.94 
anatomical structure formation involved in 
morphogenesis 5.59E-08 1.28E-05 1.87 
ncRNA metabolic process 6.67E-08 1.46E-05 1.47 
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developmental process involved in reproduction 8.20E-08 1.72E-05 1.93 
ribosomal large subunit biogenesis 9.61E-08 1.94E-05 2.63 
ribosomal small subunit biogenesis 1.18E-07 2.30E-05 3.15 
nucleic acid phosphodiester bond hydrolysis 3.39E-07 6.36E-05 1.65 
sporulation resulting in formation of a cellular 
spore 1.07E-06 1.94E-04 1.85 
cell differentiation 1.07E-06 1.88E-04 1.85 
energy coupled proton transport, down 
electrochemical gradient 1.08E-06 1.83E-04 3.74 
ATP synthesis coupled proton transport 1.08E-06 1.78E-04 3.74 
sporulation 1.38E-06 2.20E-04 1.83 
maturation of LSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 2.25E-06 3.49E-04 2.7 
DNA recombination 3.06E-06 4.60E-04 1.64 
meiotic cell cycle process 4.64E-06 6.78E-04 1.58 
rRNA methylation 4.98E-06 7.08E-04 3.84 
maturation of LSU-rRNA 7.22E-06 1.00E-03 2.39 
thiamine metabolic process 1.93E-05 2.61E-03 3.76 
DNA biosynthetic process 2.06E-05 2.71E-03 1.93 
drug metabolic process 2.40E-05 3.08E-03 1.53 
RNA processing 2.80E-05 3.50E-03 1.34 
thiamine-containing compound metabolic 
process 5.53E-05 6.76E-03 3.49 
proton transmembrane transport 7.05E-05 8.42E-03 1.9 
thiamine-containing compound biosynthetic 
process 7.37E-05 8.61E-03 3.67 
thiamine biosynthetic process 7.37E-05 8.42E-03 3.67 
reproductive process 8.70E-05 9.73E-03 1.37 
cleavage involved in rRNA processing 9.17E-05 1.00E-02 1.92 
developmental process 1.05E-04 1.12E-02 1.46 
endonucleolytic cleavage in ITS1 to separate 
SSU-rRNA from 5.8S rRNA and LSU-rRNA from 
tricistronic rRNA transcript (SSU-rRNA, 5.8S 
rRNA, LSU-rRNA) 1.06E-04 1.11E-02 2.27 
transmembrane transport 1.17E-04 1.20E-02 1.35 
cation transmembrane transport 1.28E-04 1.30E-02 1.58 
ion transmembrane transport 1.60E-04 1.59E-02 1.45 
cellular aldehyde metabolic process 1.92E-04 1.87E-02 2.11 
RNA methylation 2.47E-04 2.36E-02 2.21 
respiratory electron transport chain 2.86E-04 2.69E-02 2.37 
ribosomal large subunit export from nucleus 2.89E-04 2.67E-02 2.44 
iron coordination entity transport 2.95E-04 2.68E-02 3.05 
endonucleolytic cleavage involved in rRNA 
processing 3.33E-04 2.97E-02 2.01 
endonucleolytic cleavage of tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 3.33E-04 2.92E-02 2.01 
monovalent inorganic cation transport 3.49E-04 3.01E-02 1.75 
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ornithine metabolic process 3.60E-04 3.05E-02 3.8 
nitrogen utilization 3.60E-04 3.01E-02 3.8 
rRNA base methylation 4.20E-04 3.45E-02 4.19 
rRNA 5'-end processing 4.39E-04 3.55E-02 2.3 
rRNA modification 4.52E-04 3.60E-02 2.54 
purine nucleoside monophosphate metabolic 
process 4.52E-04 3.55E-02 1.82 
purine ribonucleoside monophosphate 
metabolic process 4.52E-04 3.50E-02 1.82 
ncRNA 5'-end processing 5.62E-04 4.28E-02 2.15 
cellular developmental process 5.76E-04 4.33E-02 1.43 
box C/D snoRNA processing 6.74E-04 4.99E-02 3.26 
box C/D snoRNA metabolic process 6.74E-04 4.92E-02 3.26 
endonucleolytic cleavage to generate mature 5'-
end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, 
LSU-rRNA) 6.97E-04 5.02E-02 2.29 
RNA modification 7.45E-04 5.29E-02 1.66 
RNA 5'-end processing 7.98E-04 5.60E-02 2.09 
reproductive process in single-celled organism 9.85E-04 6.81E-02 1.78 
nuclear-transcribed mRNA catabolic process, 
endonucleolytic cleavage-dependent decay 9.88E-04 6.75E-02 3.42 
arginine biosynthetic process 9.88E-04 6.66E-02 3.42 
mitochondrial electron transport, ubiquinol to 
cytochrome c 9.88E-04 6.58E-02 3.42 
 
Table 8.7 Full GOrilla output for GO terms enriched among genes downregulated during WT 
yeast ageing 
Description P-value FDR q-value Enrichment 
peptide metabolic process 1.51E-100 7.94E-97 3.24 
peptide biosynthetic process 8.04E-100 2.12E-96 3.34 
translation 4.03E-99 7.07E-96 3.34 
amide biosynthetic process 1.56E-89 2.06E-86 3.05 
cellular amide metabolic process 1.80E-89 1.89E-86 2.89 
cytoplasmic translation 5.22E-76 4.58E-73 4.12 
organonitrogen compound biosynthetic process 2.37E-68 1.78E-65 2.2 
cellular nitrogen compound biosynthetic process 9.41E-49 6.18E-46 1.89 
organonitrogen compound metabolic process 4.89E-43 2.86E-40 1.5 
cellular biosynthetic process 4.91E-41 2.58E-38 1.62 
organic substance biosynthetic process 4.57E-40 2.19E-37 1.6 
cellular macromolecule biosynthetic process 1.43E-39 6.28E-37 1.92 
macromolecule biosynthetic process 2.70E-39 1.09E-36 1.86 
biosynthetic process 3.23E-39 1.21E-36 1.59 
protein metabolic process 2.62E-37 9.19E-35 1.59 
cellular protein metabolic process 1.15E-32 3.79E-30 1.63 
cellular process 7.34E-21 2.27E-18 1.12 
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nitrogen compound metabolic process 1.33E-18 3.89E-16 1.22 
cellular macromolecule metabolic process 6.00E-18 1.66E-15 1.31 
mitochondrial translation 1.30E-17 3.41E-15 2.75 
cellular nitrogen compound metabolic process 6.29E-17 1.58E-14 1.3 
metabolic process 2.54E-16 6.07E-14 1.17 
cellular metabolic process 3.89E-16 8.91E-14 1.18 
organic substance metabolic process 1.22E-15 2.66E-13 1.18 
primary metabolic process 3.70E-15 7.78E-13 1.18 
establishment of localization in cell 1.16E-12 2.36E-10 1.51 
intracellular protein transport 4.56E-12 8.88E-10 1.66 
intracellular transport 7.76E-12 1.46E-09 1.5 
macromolecule metabolic process 1.82E-11 3.30E-09 1.2 
tRNA aminoacylation for protein translation 4.99E-11 8.75E-09 3.31 
protein-containing complex subunit 
organization 2.59E-10 4.39E-08 1.46 
amino acid activation 2.70E-10 4.45E-08 3.1 
tRNA aminoacylation 2.70E-10 4.31E-08 3.1 
ribosomal small subunit assembly 2.92E-10 4.51E-08 3.66 
protein localization to mitochondrion 4.90E-10 7.36E-08 2.62 
establishment of protein localization to 
mitochondrion 4.90E-10 7.16E-08 2.62 
ribonucleoside diphosphate metabolic process 6.88E-10 9.78E-08 3.3 
purine ribonucleoside diphosphate metabolic 
process 6.88E-10 9.52E-08 3.3 
purine nucleoside diphosphate metabolic 
process 6.88E-10 9.28E-08 3.3 
establishment of protein localization 9.68E-10 1.27E-07 1.45 
protein transport 1.53E-09 1.96E-07 1.45 
ADP metabolic process 2.31E-09 2.89E-07 3.26 
rRNA export from nucleus 2.79E-09 3.41E-07 4.03 
rRNA transport 2.79E-09 3.33E-07 4.03 
establishment of protein localization to 
organelle 2.98E-09 3.49E-07 1.71 
nucleoside diphosphate metabolic process 3.55E-09 4.06E-07 3.07 
ATP generation from ADP 3.73E-09 4.17E-07 3.49 
glycolytic process 3.73E-09 4.09E-07 3.49 
peptide transport 3.78E-09 4.06E-07 1.44 
ncRNA export from nucleus 6.04E-09 6.35E-07 3.16 
amide transport 7.23E-09 7.46E-07 1.42 
nucleoside diphosphate phosphorylation 9.49E-09 9.59E-07 3.29 
cellular protein-containing complex assembly 1.01E-08 1.00E-06 1.47 
pyruvate biosynthetic process 1.14E-08 1.11E-06 3.36 
cellular localization 1.85E-08 1.77E-06 1.33 
nucleotide phosphorylation 2.51E-08 2.36E-06 3.18 
cellular protein complex disassembly 3.42E-08 3.15E-06 2.98 
nitrogen compound transport 4.36E-08 3.95E-06 1.34 
242 
 
protein-containing complex assembly 4.87E-08 4.34E-06 1.44 
nucleic acid transport 9.34E-08 8.19E-06 1.81 
RNA transport 1.34E-07 1.15E-05 1.8 
establishment of RNA localization 1.34E-07 1.14E-05 1.8 
protein folding 1.35E-07 1.12E-05 2 
translational elongation 1.42E-07 1.17E-05 2.98 
protein transmembrane transport 1.56E-07 1.26E-05 2.21 
nucleoside phosphate catabolic process 1.57E-07 1.25E-05 2.82 
nucleotide catabolic process 2.22E-07 1.74E-05 2.85 
oxidoreduction coenzyme metabolic process 2.34E-07 1.81E-05 2.08 
ribonucleoprotein complex subunit organization 3.09E-07 2.35E-05 1.72 
pyridine nucleotide metabolic process 3.58E-07 2.69E-05 2.16 
protein localization 3.63E-07 2.69E-05 1.33 
ribonucleoprotein complex assembly 4.65E-07 3.40E-05 1.73 
regulation of cellular amide metabolic process 4.65E-07 3.35E-05 1.83 
macromolecule localization 5.07E-07 3.60E-05 1.32 
pyridine nucleotide biosynthetic process 5.29E-07 3.71E-05 2.58 
protein import 5.60E-07 3.88E-05 1.89 
nucleobase-containing small molecule metabolic 
process 6.99E-07 4.78E-05 1.6 
nicotinamide nucleotide metabolic process 7.91E-07 5.34E-05 2.12 
vesicle-mediated transport 7.93E-07 5.28E-05 1.45 
proteolysis involved in cellular protein catabolic 
process 8.50E-07 5.59E-05 1.62 
regulation of translation 9.59E-07 6.22E-05 1.81 
organic substance transport 9.67E-07 6.20E-05 1.28 
organic acid metabolic process 1.01E-06 6.38E-05 1.44 
'de novo' protein folding 1.08E-06 6.76E-05 3.09 
posttranscriptional regulation of gene 
expression 1.24E-06 7.68E-05 1.77 
regulation of translational fidelity 1.29E-06 7.86E-05 2.87 
oxoacid metabolic process 1.31E-06 7.93E-05 1.44 
pyruvate metabolic process 1.39E-06 8.33E-05 2.53 
nicotinamide nucleotide biosynthetic process 1.39E-06 8.24E-05 2.53 
regulation of protein complex assembly 1.46E-06 8.52E-05 1.9 
monocarboxylic acid biosynthetic process 1.65E-06 9.56E-05 2.05 
chaperone-mediated protein folding 1.82E-06 1.04E-04 3.24 
nucleocytoplasmic transport 1.82E-06 1.03E-04 1.7 
nuclear transport 1.82E-06 1.02E-04 1.7 
protein refolding 1.84E-06 1.02E-04 2.75 
translational termination 2.92E-06 1.60E-04 3.63 
negative regulation of cellular amide metabolic 
process 3.03E-06 1.64E-04 2.56 
pyridine-containing compound metabolic 
process 3.06E-06 1.64E-04 1.97 
purine ribonucleotide metabolic process 3.07E-06 1.63E-04 1.89 
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nucleotide metabolic process 3.09E-06 1.63E-04 1.61 
cellular component assembly 4.08E-06 2.12E-04 1.3 
nucleoside phosphate metabolic process 4.99E-06 2.58E-04 1.59 
carboxylic acid metabolic process 5.29E-06 2.70E-04 1.42 
protein targeting to ER 5.33E-06 2.70E-04 2.86 
cofactor metabolic process 5.38E-06 2.69E-04 1.54 
purine nucleoside triphosphate metabolic 
process 5.66E-06 2.81E-04 2.19 
protein-containing complex disassembly 5.71E-06 2.81E-04 2.1 
establishment of protein localization to 
membrane 6.20E-06 3.02E-04 1.94 
modification-dependent protein catabolic 
process 6.48E-06 3.13E-04 1.6 
purine ribonucleotide biosynthetic process 7.26E-06 3.47E-04 1.99 
chaperone cofactor-dependent protein refolding 7.63E-06 3.62E-04 3.28 
'de novo' posttranslational protein folding 7.63E-06 3.58E-04 3.28 
small molecule metabolic process 7.85E-06 3.65E-04 1.29 
intracellular protein transmembrane transport 8.12E-06 3.75E-04 2.05 
purine ribonucleoside triphosphate metabolic 
process 8.43E-06 3.86E-04 2.19 
nucleobase-containing small molecule 
biosynthetic process 8.48E-06 3.84E-04 2.1 
regulation of pH 9.66E-06 4.34E-04 2.61 
tRNA aminoacylation for mitochondrial protein 
translation 1.07E-05 4.78E-04 3.56 
establishment of protein localization to 
endoplasmic reticulum 1.08E-05 4.77E-04 2.75 
negative regulation of translation 1.17E-05 5.15E-04 2.52 
protein localization to organelle 1.25E-05 5.43E-04 1.42 
pyridine-containing compound biosynthetic 
process 1.26E-05 5.42E-04 2.19 
protein localization to membrane 1.39E-05 5.95E-04 1.78 
tRNA transport 1.43E-05 6.07E-04 3.02 
purine nucleoside monophosphate metabolic 
process 1.57E-05 6.59E-04 1.98 
purine ribonucleoside monophosphate 
metabolic process 1.57E-05 6.53E-04 1.98 
ribonucleotide metabolic process 1.80E-05 7.45E-04 1.76 
Golgi vesicle transport 2.22E-05 9.12E-04 1.57 
establishment of localization 2.47E-05 1.01E-03 1.19 
trehalose biosynthetic process 2.50E-05 1.01E-03 4.54 
purine-containing compound metabolic process 2.50E-05 1.00E-03 1.7 
regulation of cellular pH 2.58E-05 1.03E-03 2.55 
regulation of intracellular pH 2.58E-05 1.02E-03 2.55 
cellular catabolic process 2.95E-05 1.16E-03 1.27 
pH reduction 3.03E-05 1.18E-03 2.69 
vacuolar acidification 3.03E-05 1.17E-03 2.69 
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intracellular pH reduction 3.03E-05 1.16E-03 2.69 
ribose phosphate metabolic process 3.55E-05 1.35E-03 1.67 
purine nucleotide metabolic process 3.61E-05 1.36E-03 1.74 
cellular protein localization 3.69E-05 1.39E-03 1.35 
purine-containing compound biosynthetic 
process 3.71E-05 1.39E-03 1.82 
ubiquitin-dependent protein catabolic process 3.87E-05 1.43E-03 1.55 
organic substance catabolic process 4.01E-05 1.48E-03 1.28 
purine ribonucleoside triphosphate biosynthetic 
process 4.09E-05 1.50E-03 2.22 
purine nucleoside triphosphate biosynthetic 
process 4.09E-05 1.49E-03 2.22 
organophosphate catabolic process 4.11E-05 1.48E-03 2.08 
transport 4.33E-05 1.55E-03 1.19 
cellular macromolecule localization 4.78E-05 1.70E-03 1.33 
ribonucleotide biosynthetic process 5.33E-05 1.88E-03 1.81 
ribonucleoside triphosphate metabolic process 5.71E-05 2.00E-03 2.02 
nucleobase-containing compound transport 6.20E-05 2.16E-03 1.52 
translational initiation 6.24E-05 2.16E-03 2.17 
catabolic process 6.28E-05 2.16E-03 1.25 
mitochondrial transport 6.31E-05 2.16E-03 1.84 
protein import into mitochondrial matrix 6.40E-05 2.17E-03 2.76 
coenzyme metabolic process 6.42E-05 2.16E-03 1.56 
nuclear export 6.80E-05 2.28E-03 1.68 
protein catabolic process 7.34E-05 2.44E-03 1.54 
intra-Golgi vesicle-mediated transport 7.62E-05 2.52E-03 2.4 
proteasome assembly 7.62E-05 2.51E-03 2.4 
purine nucleoside monophosphate biosynthetic 
process 7.64E-05 2.50E-03 1.96 
purine ribonucleoside monophosphate 
biosynthetic process 7.64E-05 2.48E-03 1.96 
gluconeogenesis 8.25E-05 2.66E-03 3.12 
hexose biosynthetic process 8.25E-05 2.65E-03 3.12 
cellular response to topologically incorrect 
protein 8.25E-05 2.63E-03 3.12 
purine nucleotide biosynthetic process 8.33E-05 2.64E-03 1.81 
RNA export from nucleus 9.46E-05 2.98E-03 1.67 
cellular amino acid metabolic process 1.05E-04 3.28E-03 1.46 
import into nucleus 1.12E-04 3.49E-03 1.95 
proteasomal protein catabolic process 1.13E-04 3.49E-03 1.6 
protein localization to endoplasmic reticulum 1.14E-04 3.51E-03 2.41 
response to heat 1.19E-04 3.65E-03 1.8 
cofactor biosynthetic process 1.26E-04 3.83E-03 1.6 
protein transmembrane import into intracellular 
organelle 1.30E-04 3.92E-03 2.03 
ATP metabolic process 1.34E-04 4.03E-03 2.05 
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nucleoside triphosphate metabolic process 1.35E-04 4.03E-03 1.89 
monovalent inorganic cation homeostasis 1.39E-04 4.14E-03 2.17 
cellular macromolecule catabolic process 1.48E-04 4.37E-03 1.37 
regulation of cellular component biogenesis 1.56E-04 4.59E-03 1.54 
disaccharide biosynthetic process 1.61E-04 4.71E-03 3.97 
oligosaccharide biosynthetic process 1.61E-04 4.69E-03 3.97 
organonitrogen compound catabolic process 1.73E-04 5.01E-03 1.4 
regulation of protein metabolic process 1.77E-04 5.10E-03 1.35 
proteasomal ubiquitin-independent protein 
catabolic process 1.87E-04 5.36E-03 2.94 
monosaccharide biosynthetic process 1.87E-04 5.33E-03 2.94 
regulation of cellular protein metabolic process 1.96E-04 5.55E-03 1.35 
macromolecule catabolic process 2.04E-04 5.73E-03 1.34 
glucose metabolic process 2.06E-04 5.75E-03 2.21 
cellular monovalent inorganic cation 
homeostasis 2.08E-04 5.80E-03 2.16 
proteasome-mediated ubiquitin-dependent 
protein catabolic process 2.34E-04 6.49E-03 1.59 
ribonucleoside monophosphate metabolic 
process 2.35E-04 6.48E-03 1.74 
ribose phosphate biosynthetic process 2.45E-04 6.70E-03 1.71 
response to topologically incorrect protein 2.56E-04 6.99E-03 2.43 
post-Golgi vesicle-mediated transport 2.67E-04 7.24E-03 1.79 
modification-dependent macromolecule 
catabolic process 2.83E-04 7.62E-03 1.45 
ribonucleoside triphosphate biosynthetic 
process 2.83E-04 7.59E-03 2.01 
nucleoside phosphate biosynthetic process 3.06E-04 8.16E-03 1.56 
ATP biosynthetic process 3.10E-04 8.23E-03 2.11 
nucleotide biosynthetic process 3.43E-04 9.06E-03 1.56 
organic acid biosynthetic process 3.44E-04 9.04E-03 1.45 
carboxylic acid biosynthetic process 3.44E-04 9.00E-03 1.45 
nucleoside triphosphate biosynthetic process 3.75E-04 9.76E-03 1.94 
negative regulation of cellular protein metabolic 
process 3.87E-04 1.00E-02 1.67 
negative regulation of protein metabolic process 3.87E-04 9.99E-03 1.67 
mitochondrial membrane organization 4.18E-04 1.07E-02 2 
response to temperature stimulus 4.22E-04 1.08E-02 1.71 
SRP-dependent cotranslational protein targeting 
to membrane 4.72E-04 1.20E-02 3.3 
trehalose metabolic process 4.72E-04 1.19E-02 3.3 
nucleoside monophosphate metabolic process 4.83E-04 1.22E-02 1.66 
RNA import into nucleus 5.17E-04 1.30E-02 4.54 
trehalose metabolism in response to stress 5.17E-04 1.29E-02 4.54 
L-methionine salvage from S-
adenosylmethionine 5.17E-04 1.28E-02 4.54 
removal of superoxide radicals 5.87E-04 1.45E-02 3.53 
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protein localization to nucleus 5.94E-04 1.46E-02 1.84 
nucleobase-containing compound catabolic 
process 6.09E-04 1.49E-02 1.49 
sulfur amino acid metabolic process 6.17E-04 1.50E-02 1.98 
protein import into mitochondrial 
intermembrane space 6.46E-04 1.56E-02 3.89 
cargo loading into vesicle 6.46E-04 1.56E-02 3.89 
methionine metabolic process 6.72E-04 1.61E-02 2.05 
positive regulation of protein complex assembly 7.51E-04 1.80E-02 1.9 
regulation of biological quality 8.15E-04 1.94E-02 1.25 
cellular homeostasis 8.16E-04 1.93E-02 1.43 
nucleoside monophosphate biosynthetic process 9.21E-04 2.17E-02 1.69 
coenzyme biosynthetic process 9.22E-04 2.16E-02 1.56 
protein import into nucleus 9.34E-04 2.18E-02 1.85 
 
Table 8.8 Full GOrilla output for GO terms enriched among ERC-induced genes 
GO Term P-value FDR q-value Enrichment 
organonitrogen compound biosynthetic process 4.92E-58 2.59E-54 5.19 
cytoplasmic translation 7.84E-45 2.06E-41 12.6 
cellular biosynthetic process 5.49E-38 9.63E-35 3.05 
organic substance biosynthetic process 1.05E-36 1.38E-33 2.96 
biosynthetic process 3.32E-36 3.49E-33 2.93 
translation 6.42E-30 5.63E-27 6.04 
peptide biosynthetic process 1.03E-29 7.70E-27 5.98 
peptide metabolic process 8.59E-28 5.65E-25 5.51 
cellular amino acid biosynthetic process 1.17E-27 6.84E-25 10.24 
amide biosynthetic process 1.29E-27 6.77E-25 5.34 
organonitrogen compound metabolic process 1.83E-27 8.76E-25 2.3 
alpha-amino acid biosynthetic process 3.37E-26 1.48E-23 10.29 
cellular amide metabolic process 4.48E-26 1.81E-23 4.77 
cellular nitrogen compound biosynthetic process 1.19E-23 4.45E-21 3.16 
cellular amino acid metabolic process 1.49E-22 5.24E-20 6.26 
alpha-amino acid metabolic process 2.55E-22 8.38E-20 7.38 
organic acid biosynthetic process 1.91E-21 5.92E-19 6.48 
carboxylic acid biosynthetic process 1.91E-21 5.59E-19 6.48 
small molecule biosynthetic process 3.74E-18 1.03E-15 4.56 
carboxylic acid metabolic process 9.66E-17 2.54E-14 4.09 
oxoacid metabolic process 4.66E-16 1.17E-13 3.92 
organic acid metabolic process 5.57E-16 1.33E-13 3.9 
small molecule metabolic process 8.14E-16 1.86E-13 2.99 
cellular macromolecule biosynthetic process 2.82E-15 6.18E-13 2.96 
macromolecule biosynthetic process 3.05E-13 6.41E-11 2.66 
nitrogen compound metabolic process 3.58E-13 7.24E-11 1.58 
organic substance metabolic process 1.85E-12 3.61E-10 1.49 
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cellular metabolic process 1.07E-11 2.00E-09 1.46 
primary metabolic process 1.57E-11 2.85E-09 1.5 
metabolic process 1.51E-10 2.64E-08 1.4 
cellular nitrogen compound metabolic process 2.17E-10 3.68E-08 1.76 
aromatic amino acid family biosynthetic process 3.12E-10 5.13E-08 15.02 
glutamine family amino acid metabolic process 1.82E-09 2.91E-07 8.56 
energy coupled proton transport, down 
electrochemical gradient 4.20E-09 6.49E-07 17.67 
ATP synthesis coupled proton transport 4.20E-09 6.31E-07 17.67 
cellular protein metabolic process 1.41E-08 2.06E-06 2.01 
glutamine family amino acid biosynthetic 
process 1.66E-08 2.37E-06 12.51 
aromatic amino acid family metabolic process 5.73E-08 7.94E-06 9.38 
arginine biosynthetic process 6.24E-08 8.41E-06 22.52 
rRNA export from nucleus 2.07E-07 2.72E-05 14.6 
rRNA transport 2.07E-07 2.65E-05 14.6 
branched-chain amino acid biosynthetic process 1.33E-06 1.67E-04 15.02 
arginine metabolic process 2.08E-06 2.55E-04 14.08 
drug metabolic process 2.60E-06 3.11E-04 3.13 
valine metabolic process 2.85E-06 3.33E-04 18.77 
branched-chain amino acid metabolic process 4.71E-06 5.39E-04 9.73 
isoleucine metabolic process 5.10E-06 5.71E-04 17.06 
ribonucleoside triphosphate metabolic process 5.11E-06 5.59E-04 5.96 
valine biosynthetic process 6.97E-06 7.48E-04 25.03 
ribonucleoside triphosphate biosynthetic 
process 7.39E-06 7.77E-04 6.5 
protein metabolic process 7.69E-06 7.93E-04 1.67 
ATP metabolic process 8.70E-06 8.80E-04 6.37 
nucleoside triphosphate biosynthetic process 1.39E-05 1.38E-03 6.03 
ATP biosynthetic process 1.39E-05 1.35E-03 6.98 
nucleoside triphosphate metabolic process 1.74E-05 1.67E-03 5.21 
purine ribonucleoside triphosphate metabolic 
process 1.86E-05 1.75E-03 5.83 
maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 1.97E-05 1.82E-03 5.14 
ncRNA export from nucleus 1.98E-05 1.80E-03 7.96 
purine nucleoside triphosphate metabolic 
process 2.47E-05 2.21E-03 5.63 
purine ribonucleoside triphosphate biosynthetic 
process 2.75E-05 2.41E-03 6.39 
purine nucleoside triphosphate biosynthetic 
process 2.75E-05 2.37E-03 6.39 
glutamine metabolic process 2.93E-05 2.49E-03 9.38 
ribonucleoside monophosphate metabolic 
process 3.45E-05 2.88E-03 4.39 
serine family amino acid biosynthetic process 4.80E-05 3.95E-03 8.66 
glycine metabolic process 5.50E-05 4.45E-03 16.68 
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ornithine metabolic process 5.50E-05 4.38E-03 16.68 
ribonucleoside monophosphate biosynthetic 
process 6.15E-05 4.83E-03 4.52 
ribosomal large subunit assembly 7.40E-05 5.72E-03 6.57 
proton transmembrane transport 7.56E-05 5.76E-03 4.42 
maturation of SSU-rRNA 8.36E-05 6.28E-03 4.36 
nucleoside monophosphate biosynthetic process 8.36E-05 6.20E-03 4.36 
serine family amino acid metabolic process 8.72E-05 6.37E-03 6.41 
nucleoside monophosphate metabolic process 8.86E-05 6.38E-03 3.97 
histidine metabolic process 8.98E-05 6.38E-03 15.02 
imidazole-containing compound metabolic 
process 8.98E-05 6.30E-03 15.02 
isoleucine biosynthetic process 8.98E-05 6.21E-03 15.02 
histidine biosynthetic process 8.98E-05 6.13E-03 15.02 
organic cyclic compound biosynthetic process 1.17E-04 7.86E-03 1.97 
L-serine metabolic process 1.38E-04 9.20E-03 13.65 
glycine biosynthetic process 1.78E-04 1.17E-02 22.52 
monovalent inorganic cation transport 1.94E-04 1.26E-02 3.95 
ribonucleotide biosynthetic process 1.94E-04 1.25E-02 3.95 
purine nucleoside monophosphate metabolic 
process 2.03E-04 1.28E-02 4.33 
purine ribonucleoside monophosphate 
metabolic process 2.03E-04 1.27E-02 4.33 
ribose phosphate biosynthetic process 3.22E-04 1.99E-02 3.72 
aspartate family amino acid metabolic process 3.27E-04 2.00E-02 4.55 
ribose phosphate metabolic process 3.42E-04 2.07E-02 3.19 
ribonucleotide metabolic process 3.44E-04 2.05E-02 3.41 
indole-containing compound biosynthetic 
process 3.50E-04 2.07E-02 18.77 
indolalkylamine biosynthetic process 3.50E-04 2.04E-02 18.77 
tryptophan biosynthetic process 3.50E-04 2.02E-02 18.77 
purine nucleoside monophosphate biosynthetic 
process 3.63E-04 2.08E-02 4.48 
purine ribonucleoside monophosphate 
biosynthetic process 3.63E-04 2.06E-02 4.48 
pyrimidine nucleobase metabolic process 3.94E-04 2.20E-02 10.73 
lysine biosynthetic process 3.94E-04 2.18E-02 10.73 
lysine metabolic process 5.26E-04 2.88E-02 10.01 
ribosomal small subunit assembly 5.26E-04 2.85E-02 7.22 
ion transmembrane transport 6.50E-04 3.49E-02 2.4 
cation transmembrane transport 6.50E-04 3.46E-02 2.82 
citrulline biosynthetic process 7.05E-04 3.71E-02 37.54 
arginine biosynthetic process via ornithine 7.05E-04 3.67E-02 37.54 
citrulline metabolic process 7.05E-04 3.64E-02 37.54 
neurotransmitter metabolic process 8.79E-04 4.49E-02 8.83 
'de novo' pyrimidine nucleobase biosynthetic 
process 9.41E-04 4.76E-02 14.08 
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neurotransmitter biosynthetic process 9.41E-04 4.71E-02 14.08 
ribonucleoprotein complex assembly 9.95E-04 4.94E-02 2.7 
 
Table 8.9 Full GOrilla output for GO terms enriched among ERC-repressed genes 
GO Terms P-value FDR q-value Enrichment 
iron ion homeostasis 6.94E-08 3.65E-04 14.01 
'de novo' protein folding 1.47E-07 3.87E-04 23.12 
protein folding 1.53E-07 2.68E-04 8.68 
cellular iron ion homeostasis 3.54E-07 4.66E-04 14.66 
response to temperature stimulus 3.68E-07 3.87E-04 9.32 
cellular response to heat 7.37E-07 6.46E-04 10.41 
protein refolding 8.64E-07 6.49E-04 17.52 
iron ion transport 1.82E-06 1.20E-03 22.94 
transition metal ion homeostasis 2.36E-06 1.38E-03 8.96 
response to heat 2.81E-06 1.48E-03 8.76 
response to copper ion 1.05E-05 5.01E-03 57.8 
cellular transition metal ion homeostasis 1.14E-05 4.98E-03 8.87 
inorganic ion homeostasis 1.70E-05 6.90E-03 5.9 
response to abiotic stimulus 1.82E-05 6.85E-03 5.15 
metal ion homeostasis 1.95E-05 6.83E-03 6.76 
cation homeostasis 2.35E-05 7.73E-03 5.67 
chaperone cofactor-dependent protein refolding 2.88E-05 8.91E-03 21.41 
'de novo' posttranslational protein folding 2.88E-05 8.42E-03 21.41 
chemical homeostasis 3.00E-05 8.30E-03 4.87 
ion homeostasis 4.94E-05 1.30E-02 5.16 
chaperone-mediated protein folding 5.50E-05 1.38E-02 18.35 
response to inorganic substance 5.73E-05 1.37E-02 11.75 
cellular metal ion homeostasis 8.27E-05 1.89E-02 6.55 
detoxification of cadmium ion 1.06E-04 2.32E-02 96.33 
detoxification of copper ion 1.06E-04 2.23E-02 96.33 
detoxification of inorganic compound 1.06E-04 2.14E-02 96.33 
transition metal ion transport 1.12E-04 2.18E-02 10.25 
transport 1.44E-04 2.70E-02 1.99 
copper ion import 1.65E-04 3.00E-02 26.27 
iron chelate transport 1.65E-04 2.90E-02 26.27 
siderophore transport 1.65E-04 2.81E-02 26.27 
establishment of localization 2.30E-04 3.79E-02 1.93 
cellular response to organic substance 2.59E-04 4.13E-02 8.6 
homeostatic process 2.77E-04 4.29E-02 3.43 
cellular response to ethanol 3.16E-04 4.75E-02 64.22 
cellular response to alcohol 3.16E-04 4.61E-02 64.22 
oligosaccharide metabolic process 3.86E-04 5.48E-02 11.33 
ion transport 4.18E-04 5.79E-02 3.05 
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iron coordination entity transport 5.41E-04 7.30E-02 18.06 
cellular response to topologically incorrect 
protein 5.41E-04 7.11E-02 18.06 
cellular cation homeostasis 5.81E-04 7.45E-02 4.78 
localization 6.45E-04 8.08E-02 1.78 
cellular ion homeostasis 9.82E-04 1.20E-01 4.38 
 
Table 8.10 Full GOrilla output for GO terms enriched among ERC-induced genes (Linear 
model analysis) 
GO Terms P-value FDR q-value Enrichment 
ribonucleoprotein complex biogenesis 1.49E-96 7.78E-93 4.59 
ribosome biogenesis 2.71E-89 7.07E-86 4.68 
cellular component biogenesis 3.86E-87 6.72E-84 4.2 
ncRNA processing 3.03E-82 3.95E-79 3.39 
ncRNA metabolic process 4.58E-81 4.78E-78 3.05 
rRNA processing 1.02E-75 8.88E-73 3.82 
rRNA metabolic process 4.96E-73 3.70E-70 3.53 
RNA processing 1.53E-48 1.00E-45 2.45 
RNA metabolic process 2.65E-33 1.54E-30 1.85 
cleavage involved in rRNA processing 2.64E-32 1.38E-29 4.45 
organic cyclic compound metabolic process 1.46E-29 6.94E-27 1.53 
heterocycle metabolic process 9.45E-28 4.11E-25 1.52 
cellular aromatic compound metabolic process 1.56E-27 6.25E-25 1.53 
ribosomal large subunit biogenesis 3.30E-26 1.23E-23 4.86 
nucleobase-containing compound metabolic 
process 
7.48E-26 2.60E-23 1.53 
endonucleolytic cleavage involved in rRNA 
processing 
1.33E-25 4.35E-23 4.63 
endonucleolytic cleavage of tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
1.33E-25 4.09E-23 4.63 
rRNA 5'-end processing 2.88E-25 8.36E-23 5.58 
nucleic acid metabolic process 2.30E-24 6.31E-22 1.58 
endonucleolytic cleavage to generate mature 
5'-end of SSU-rRNA from (SSU-rRNA, 5.8S 
rRNA, LSU-rRNA) 
9.45E-24 2.47E-21 5.57 
endonucleolytic cleavage in 5'-ETS of 
tricistronic rRNA transcript (SSU-rRNA, 5.8S 
rRNA, LSU-rRNA) 
5.40E-23 1.34E-20 5.56 
maturation of LSU-rRNA 3.91E-22 9.28E-20 4.59 
endonucleolytic cleavage in ITS1 to separate 
SSU-rRNA from 5.8S rRNA and LSU-rRNA from 
tricistronic rRNA transcript (SSU-rRNA, 5.8S 
rRNA, LSU-rRNA) 
5.20E-22 1.18E-19 4.83 
maturation of LSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
1.19E-20 2.58E-18 4.99 
ncRNA 5'-end processing 1.28E-20 2.67E-18 4.78 
maturation of SSU-rRNA 3.38E-20 6.78E-18 3.54 
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tRNA metabolic process 3.65E-20 7.05E-18 2.57 
RNA 5'-end processing 5.75E-20 1.07E-17 4.67 
maturation of SSU-rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
1.50E-19 2.70E-17 3.75 
RNA modification 2.92E-19 5.08E-17 3.2 
cellular nitrogen compound metabolic process 1.36E-18 2.30E-16 1.37 
tRNA modification 1.75E-15 2.86E-13 3.27 
maturation of 5.8S rRNA 1.78E-15 2.82E-13 5.48 
ribosomal small subunit biogenesis 4.82E-15 7.40E-13 4.78 
cellular amino acid biosynthetic process 1.04E-14 1.54E-12 2.67 
nitrogen compound metabolic process 1.61E-14 2.34E-12 1.22 
alpha-amino acid biosynthetic process 2.46E-14 3.46E-12 2.7 
alpha-amino acid metabolic process 5.65E-14 7.76E-12 2.36 
primary metabolic process 9.23E-14 1.24E-11 1.2 
tRNA processing 1.22E-13 1.59E-11 2.6 
cellular amino acid metabolic process 1.48E-13 1.88E-11 2.12 
maturation of 5.8S rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
3.06E-13 3.80E-11 5.44 
RNA phosphodiester bond hydrolysis 8.93E-13 1.08E-10 2.24 
glutamine family amino acid metabolic process 1.45E-12 1.72E-10 3.44 
RNA phosphodiester bond hydrolysis, 
endonucleolytic 
2.91E-12 3.37E-10 2.45 
tRNA methylation 2.95E-12 3.34E-10 4.78 
RNA methylation 4.22E-12 4.68E-10 3.74 
organic substance metabolic process 8.77E-12 9.53E-10 1.18 
ribonucleoprotein complex export from 
nucleus 
2.10E-10 2.24E-08 3.26 
rRNA-containing ribonucleoprotein complex 
export from nucleus 
2.10E-10 2.20E-08 3.26 
ribosomal subunit export from nucleus 2.10E-10 2.15E-08 3.26 
ribosome localization 3.98E-10 3.99E-08 3.2 
macromolecule methylation 6.44E-10 6.34E-08 2.59 
small molecule biosynthetic process 9.87E-10 9.54E-08 1.73 
protein export from nucleus 1.31E-09 1.24E-07 3.02 
methylation 1.72E-09 1.60E-07 2.38 
cellular metabolic process 1.77E-09 1.62E-07 1.15 
glycosyl compound metabolic process 2.37E-09 2.13E-07 3.09 
glycosyl compound biosynthetic process 2.41E-09 2.13E-07 3.61 
ribosomal large subunit assembly 6.87E-09 5.98E-07 3.28 
ncRNA transcription 1.16E-08 9.90E-07 2.87 
cellular component organization or biogenesis 1.57E-08 1.32E-06 1.22 
polyadenylation-dependent RNA catabolic 
process 
1.69E-08 1.40E-06 4.18 
nucleoside metabolic process 2.40E-08 1.96E-06 3.05 
polyadenylation-dependent ncRNA catabolic 
process 
2.44E-08 1.96E-06 4.31 
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nuclear ncRNA surveillance 2.44E-08 1.93E-06 4.31 
nuclear polyadenylation-dependent ncRNA 
catabolic process 
2.44E-08 1.90E-06 4.31 
ribonucleoside biosynthetic process 2.56E-08 1.96E-06 3.64 
establishment of organelle localization 2.91E-08 2.20E-06 2.38 
glutamine family amino acid biosynthetic 
process 
2.94E-08 2.19E-06 3.9 
nucleic acid phosphodiester bond hydrolysis 3.32E-08 2.44E-06 1.78 
tRNA transcription by RNA polymerase III 3.34E-08 2.42E-06 4.47 
tRNA transcription 3.34E-08 2.39E-06 4.47 
nuclear RNA surveillance 4.29E-08 3.03E-06 3.69 
organic acid biosynthetic process 5.35E-08 3.73E-06 1.84 
carboxylic acid biosynthetic process 5.35E-08 3.68E-06 1.84 
snRNA metabolic process 5.53E-08 3.75E-06 3.52 
nucleoside biosynthetic process 5.53E-08 3.70E-06 3.52 
metabolic process 5.67E-08 3.74E-06 1.13 
snoRNA metabolic process 6.67E-08 4.35E-06 2.87 
nuclear polyadenylation-dependent rRNA 
catabolic process 
1.06E-07 6.86E-06 4.23 
macromolecule metabolic process 1.98E-07 1.26E-05 1.18 
RNA surveillance 1.99E-07 1.25E-05 3.44 
ribonucleoside metabolic process 2.41E-07 1.50E-05 3.19 
rRNA modification 2.72E-07 1.67E-05 3.67 
snoRNA processing 6.93E-07 4.20E-05 2.87 
ribosomal large subunit export from nucleus 7.61E-07 4.56E-05 3.23 
CUT catabolic process 9.30E-07 5.51E-05 4.51 
CUT metabolic process 9.30E-07 5.45E-05 4.51 
glutamine metabolic process 1.02E-06 5.91E-05 3.59 
oxoacid metabolic process 1.17E-06 6.71E-05 1.51 
arginine biosynthetic process 1.21E-06 6.86E-05 5.17 
transcription by RNA polymerase I 1.35E-06 7.58E-05 3.25 
organic acid metabolic process 1.50E-06 8.35E-05 1.51 
ncRNA 3'-end processing 2.04E-06 1.12E-04 2.8 
nucleocytoplasmic transport 2.20E-06 1.19E-04 1.83 
nuclear transport 2.20E-06 1.18E-04 1.83 
carboxylic acid metabolic process 2.35E-06 1.25E-04 1.51 
tRNA wobble uridine modification 2.40E-06 1.26E-04 3.28 
exonucleolytic trimming involved in rRNA 
processing 
2.92E-06 1.53E-04 3.73 
polyadenylation-dependent snoRNA 3'-end 
processing 
2.94E-06 1.52E-04 4.21 
nuclear polyadenylation-dependent mRNA 
catabolic process 
2.94E-06 1.50E-04 4.21 
polyadenylation-dependent mRNA catabolic 
process 
2.94E-06 1.49E-04 4.21 
nucleobase biosynthetic process 3.73E-06 1.87E-04 3.49 
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snoRNA 3'-end processing 4.49E-06 2.23E-04 3.17 
tRNA wobble base modification 4.49E-06 2.21E-04 3.05 
aromatic amino acid family biosynthetic 
process 
7.52E-06 3.67E-04 3.35 
arginine metabolic process 7.92E-06 3.83E-04 3.95 
nuclear polyadenylation-dependent tRNA 
catabolic process 
7.92E-06 3.79E-04 3.95 
RNA export from nucleus 9.24E-06 4.39E-04 1.91 
nucleobase metabolic process 1.18E-05 5.56E-04 2.79 
nuclear export 1.44E-05 6.69E-04 1.88 
ribonucleoprotein complex assembly 1.56E-05 7.19E-04 1.71 
tRNA catabolic process 1.89E-05 8.66E-04 3.72 
nucleolar large rRNA transcription by RNA 
polymerase I 
1.89E-05 8.58E-04 3.72 
nucleoside salvage 1.90E-05 8.55E-04 4.31 
transcription by RNA polymerase III 2.53E-05 1.13E-03 2.97 
ribonucleoprotein complex subunit 
organization 
2.65E-05 1.17E-03 1.67 
assembly of large subunit precursor of 
preribosome 
2.67E-05 1.17E-03 4.59 
nuclear polyadenylation-dependent CUT 
catabolic process 
2.67E-05 1.16E-03 4.59 
snRNA pseudouridine synthesis 2.76E-05 1.19E-03 5.74 
U4 snRNA 3'-end processing 3.17E-05 1.36E-03 3.83 
branched-chain amino acid biosynthetic 
process 
3.17E-05 1.35E-03 3.83 
exonucleolytic trimming to generate mature 3'-
end of 5.8S rRNA from tricistronic rRNA 
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) 
4.10E-05 1.73E-03 3.51 
snRNA processing 4.59E-05 1.92E-03 3.28 
RNA catabolic process 5.15E-05 2.13E-03 1.81 
cellular metabolic compound salvage 6.92E-05 2.84E-03 2.78 
pyrimidine nucleotide biosynthetic process 8.27E-05 3.37E-03 2.99 
pyrimidine nucleotide metabolic process 8.27E-05 3.35E-03 2.99 
nuclear mRNA surveillance 8.51E-05 3.42E-03 3.13 
rRNA transcription 1.09E-04 4.36E-03 2.69 
rRNA methylation 1.24E-04 4.88E-03 3.69 
pyrimidine ribonucleoside biosynthetic process 1.24E-04 4.85E-03 3.69 
pyrimidine nucleoside biosynthetic process 1.24E-04 4.81E-03 3.69 
pyrimidine ribonucleotide biosynthetic process 1.24E-04 4.78E-03 3.69 
pyrimidine ribonucleotide metabolic process 1.24E-04 4.74E-03 3.69 
peptidyl-histidine modification 1.24E-04 4.72E-03 4.47 
ornithine metabolic process 1.24E-04 4.69E-03 4.47 
protein-containing complex localization 1.35E-04 5.08E-03 1.91 
ncRNA catabolic process 1.42E-04 5.31E-03 2.55 
purine nucleoside biosynthetic process 1.47E-04 5.42E-03 3.38 
purine ribonucleoside biosynthetic process 1.47E-04 5.39E-03 3.38 
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rRNA 3'-end processing 1.50E-04 5.47E-03 3 
snRNA 3'-end processing 1.54E-04 5.58E-03 3.16 
mature ribosome assembly 1.59E-04 5.72E-03 5.74 
snRNA modification 1.64E-04 5.88E-03 4.92 
rRNA catabolic process 1.69E-04 5.99E-03 2.61 
nuclear-transcribed mRNA catabolic process 1.96E-04 6.91E-03 1.84 
aromatic amino acid family metabolic process 2.11E-04 7.39E-03 2.48 
branched-chain amino acid metabolic process 2.53E-04 8.79E-03 2.87 
pyrimidine nucleobase metabolic process 2.61E-04 9.03E-03 3.44 
purine ribonucleoside metabolic process 2.72E-04 9.36E-03 3.01 
RNA transport 3.05E-04 1.04E-02 1.63 
establishment of RNA localization 3.05E-04 1.03E-02 1.63 
small molecule metabolic process 3.16E-04 1.06E-02 1.27 
UMP biosynthetic process 3.51E-04 1.17E-02 4.02 
UMP metabolic process 3.51E-04 1.17E-02 4.02 
pyrimidine ribonucleoside monophosphate 
metabolic process 
3.51E-04 1.16E-02 4.02 
pyrimidine ribonucleoside monophosphate 
biosynthetic process 
3.51E-04 1.15E-02 4.02 
isoleucine biosynthetic process 3.51E-04 1.14E-02 4.02 
mRNA catabolic process 3.56E-04 1.15E-02 1.79 
DNA geometric change 3.70E-04 1.19E-02 2 
nucleoside monophosphate metabolic process 4.09E-04 1.31E-02 1.76 
nucleic acid transport 4.13E-04 1.31E-02 1.61 
purine nucleoside metabolic process 4.60E-04 1.45E-02 2.87 
pyrimidine nucleoside monophosphate 
metabolic process 
4.64E-04 1.46E-02 3.53 
pyrimidine nucleoside monophosphate 
biosynthetic process 
4.64E-04 1.45E-02 3.53 
pyrimidine nucleoside metabolic process 5.05E-04 1.57E-02 3.23 
pyrimidine ribonucleoside metabolic process 5.05E-04 1.56E-02 3.23 
organic cyclic compound biosynthetic process 5.53E-04 1.70E-02 1.28 
regulation of cytoplasmic translational 
elongation 
5.60E-04 1.71E-02 4.31 
DNA duplex unwinding 6.04E-04 1.83E-02 2 
DNA conformation change 6.06E-04 1.83E-02 1.79 
anion transmembrane transport 6.60E-04 1.98E-02 1.75 
RNA phosphodiester bond hydrolysis, 
exonucleolytic 
6.62E-04 1.97E-02 2.44 
nucleoside monophosphate biosynthetic 
process 
6.63E-04 1.97E-02 1.83 
valine biosynthetic process 8.16E-04 2.41E-02 4.78 
isoleucine metabolic process 8.20E-04 2.40E-02 3.65 
pyrimidine nucleobase biosynthetic process 8.20E-04 2.39E-02 3.65 
pyrimidine-containing compound biosynthetic 
process 
8.43E-04 2.45E-02 2.24 
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ribonucleoside monophosphate biosynthetic 
process 
8.46E-04 2.44E-02 1.82 
pyrimidine nucleotide salvage 9.16E-04 2.63E-02 5.74 
pyrimidine ribonucleotide salvage 9.16E-04 2.61E-02 5.74 
ornithine biosynthetic process 9.16E-04 2.60E-02 5.74 
nuclear retention of pre-mRNA with aberrant 
3'-ends at the site of transcription 
9.16E-04 2.58E-02 5.74 
pyrimidine nucleoside salvage 9.16E-04 2.57E-02 5.74 
UMP salvage 9.16E-04 2.56E-02 5.74 
nucleotide salvage 9.18E-04 2.55E-02 3.28 
lysine biosynthetic process 9.18E-04 2.54E-02 3.28 
organelle localization 9.39E-04 2.58E-02 1.54 
 
 
Table 8.11 Full GOrilla output for GO terms enriched among ERC-repressed genes (Linear 
model analysis) 
GO Terms P-value FDR q-value Enrichment 
mitochondrial translation 2.34E-12 1.22E-08 2.84 
catabolic process 1.74E-08 4.55E-05 1.44 
vesicle-mediated transport 6.45E-08 1.12E-04 1.63 
trehalose metabolic process 7.73E-08 1.01E-04 5.83 
cellular carbohydrate metabolic process 1.35E-07 1.41E-04 2.08 
energy reserve metabolic process 2.65E-07 2.30E-04 3.63 
glycogen biosynthetic process 2.91E-07 2.17E-04 5.04 
cellular catabolic process 5.05E-07 3.29E-04 1.41 
glycogen metabolic process 5.15E-07 2.99E-04 3.66 
piecemeal microautophagy of the nucleus 6.04E-07 3.15E-04 3.13 
organic substance catabolic process 7.21E-07 3.42E-04 1.43 
oligosaccharide metabolic process 9.83E-07 4.28E-04 3.54 
disaccharide metabolic process 9.99E-07 4.01E-04 3.7 
protein localization to vacuole 2.11E-06 7.86E-04 2.05 
endosomal transport 3.36E-06 1.17E-03 2.16 
modification-dependent protein catabolic 
process 5.82E-06 1.90E-03 1.75 
protein modification by small protein 
conjugation or removal 6.79E-06 2.08E-03 1.8 
mitochondrial respiratory chain complex 
assembly 8.57E-06 2.49E-03 2.73 
autophagy of nucleus 8.57E-06 2.36E-03 2.73 
ubiquitin-dependent protein catabolic process 1.04E-05 2.72E-03 1.74 
protein catabolic process 1.15E-05 2.87E-03 1.76 
lysosomal microautophagy 1.37E-05 3.25E-03 2.59 
proteolysis involved in cellular protein 
catabolic process 1.54E-05 3.49E-03 1.67 
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protein ubiquitination 1.75E-05 3.81E-03 1.98 
carbohydrate metabolic process 2.04E-05 4.26E-03 1.64 
late endosome to vacuole transport 2.05E-05 4.12E-03 2.42 
protein phosphorylation 2.41E-05 4.66E-03 1.79 
vacuolar transport 2.48E-05 4.62E-03 1.88 
proteolysis 2.56E-05 4.61E-03 1.49 
cytosolic transport 2.76E-05 4.80E-03 2.33 
organonitrogen compound catabolic process 3.06E-05 5.14E-03 1.56 
protein localization by the Cvt pathway 4.90E-05 7.99E-03 2.54 
tRNA aminoacylation for mitochondrial 
protein translation 5.01E-05 7.93E-03 4.12 
negative regulation of cellular carbohydrate 
metabolic process 5.53E-05 8.49E-03 3.77 
negative regulation of carbohydrate metabolic 
process 5.53E-05 8.25E-03 3.77 
late nucleophagy 5.53E-05 8.02E-03 3.77 
cytochrome complex assembly 6.08E-05 8.57E-03 2.66 
modification-dependent macromolecule 
catabolic process 6.90E-05 9.48E-03 1.62 
proteasome-mediated ubiquitin-dependent 
protein catabolic process 8.54E-05 1.14E-02 1.79 
trehalose biosynthetic process 8.62E-05 1.12E-02 5.5 
trehalose metabolism in response to stress 9.15E-05 1.16E-02 6.41 
establishment of mitochondrion localization 9.15E-05 1.14E-02 6.41 
protein transport 1.37E-04 1.67E-02 1.34 
autophagosome assembly 1.39E-04 1.65E-02 3.08 
proteasomal protein catabolic process 1.43E-04 1.66E-02 1.74 
peptide transport 1.64E-04 1.86E-02 1.33 
endosome transport via multivesicular body 
sorting pathway 1.74E-04 1.93E-02 2.34 
multivesicular body sorting pathway 1.74E-04 1.89E-02 2.34 
endocytosis 2.17E-04 2.32E-02 1.87 
autophagosome organization 2.22E-04 2.32E-02 2.96 
phosphate-containing compound metabolic 
process 2.41E-04 2.47E-02 1.31 
response to extracellular stimulus 2.66E-04 2.67E-02 1.78 
cellular response to external stimulus 2.90E-04 2.85E-02 1.8 
cell communication 2.90E-04 2.80E-02 1.8 
cellular response to extracellular stimulus 2.90E-04 2.75E-02 1.8 
protein modification by small protein 
conjugation 2.96E-04 2.76E-02 1.71 
disaccharide biosynthetic process 2.99E-04 2.74E-02 4.81 
oligosaccharide biosynthetic process 2.99E-04 2.69E-02 4.81 
amide transport 3.24E-04 2.86E-02 1.31 
late endosome to vacuole transport via 
multivesicular body sorting pathway 3.24E-04 2.82E-02 2.37 
phosphorylation 3.50E-04 3.00E-02 1.49 
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establishment of protein localization 3.72E-04 3.14E-02 1.31 
D-xylose metabolic process 4.78E-04 3.96E-02 5.34 
respiratory chain complex IV assembly 5.18E-04 4.22E-02 2.75 
mitochondrial respiratory chain complex IV 
assembly 5.18E-04 4.16E-02 2.75 
phosphorus metabolic process 5.50E-04 4.35E-02 1.28 
cellular response to desiccation 5.89E-04 4.59E-02 6.41 
response to desiccation 5.89E-04 4.52E-02 6.41 
protein metabolic process 5.97E-04 4.51E-02 1.18 
protein transport to vacuole involved in 
ubiquitin-dependent protein catabolic process 
via the multivesicular body sorting pathway 6.76E-04 5.04E-02 2.82 
import into cell 6.80E-04 5.00E-02 1.7 
cellular response to chemical stimulus 7.77E-04 5.63E-02 1.53 
macromolecule catabolic process 7.99E-04 5.71E-02 1.38 
protein retention in Golgi apparatus 8.45E-04 5.96E-02 3.74 
positive regulation of protein modification by 
small protein conjugation or removal 8.72E-04 6.07E-02 2.91 
response to chemical 9.84E-04 6.76E-02 1.38 
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Figure 8.1 Selected MultiQC plots for the C. elegans RNA-seq dataset 
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Figure 8.2 Selected MultiQC plots for the “Houseley” RNA-seq dataset 
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Figure 8.3 Selected MultiQC plots for the "Zylstra" yeast RNA-seq dataset 
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Figure 8.4 Selected MultiQC plots for yeast ageing RNA-seq data 
265 
 
 
 
